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The aim o f t h is  th e s is  was to  in v e s t ig a te  a lo n g -s ta n d in g  
h y p o th e s is  (S z e n tiv a n y i, 1968) t h a t  th e  u n d e r ly in g  a e t io lo g y  o f 
a to p ic  d iseases ( p a r t ic u la r ly  b ro n c h ia l asthma) may have a 
com ponent r e la t e d  to  b e ta -a d re n o c e p to r  d e fe c ts .  L a te r  
(S z e n tiv a n y i, 1979) t h is  h yp o th e s is  was m o d if ie d  to  in c lu d e  a 
poss ib le  imbalance o f the alpha;beta adrenoceptor r a t i  a
P a tie n ts  w ith  asthma have marked c irc a d ia n  v a r ia t io n  in  
bronchomotor tone, o ften  demonstrated as the C o rn in g  dip** in  FEV^. 
In  terms o f the above inypothesis, th is  oould re s u lt  from changes in  
ad renocep to r k in e t ic s .  E q u a lly , the  **dip** m ig h t be r e la te d  to  
other him o ra l c ircad ian  rhythms.
Owing to  problems in  o b ta in ing  human lung  tissu e  th is  study, in  
acco rd  w ith  many o th e rs , used human lym phocytes as the ta rg e t  
t is s u e  f o r  a d re n o c e p to r  in v e s t ig a t io n s .  B e tag -ad r enoce p to r 
k in e t ic s  were studied using rad io ligand  b ind ing  techniques in  both 
no rm a ls  and a s th m a tic  p a t ie n ts  ( e x t r in s ic )  a t  0800 h and 1600 h. 
In  a d d it io n ,  the e f fe c ts  o f o r a l ly  a d m in is te re d  sa lb u ta m o l w ere  
fo llo w e d  a t  s im i la r  tim es . Any d is p a r i t y  in  th e  ad renocep to r 
k in e t i c s  o f  the  c o n t r o l / a s t h m a t ic  g ro u p s  w o u ld  s u p p o r t  
S ze n tiv  any i*s  hypothesis,
A s ig n if ic a n t c ircad ian  v a r ia t io n  in  beta2 -adrenooeptor number 
was observed in  both groups. The expected dow n-regu la tion o f the 
receptors occurred in  both groups on a dn in i  s t r a t i  on o f sa l butamol, 
bu t the c irc a d ia n  rhythm  p e rs is te d  a lth o u g h  i t s  m agn itude  was 
reduced. Both groups appeared to  compensate the dow n-regu la tion  by
XII
in c re a s in g  re c e p to r  a f f i n i t y .  A t no p o in t  in  the study were the  
re s u lts  fo r  the two groups s ta t is t ic a l ly  s ig n if ic a n t ly  d if fe re n t .
In  a second study, both b e t ^ -  and alpha2 -a  drenoce p to r k in e t ic s  
w ere s tu d ie d  under s im i la r  c o n d it io n s  to  th e  f i r s t  s tudy. In  
a d d itio n , the r a t io  o f alpha2 :beta2  adrenoceptors was fo llo w e d  to  
see i f  any s h i f t s  o ccu rred , p a r t ic u la r ly  in  th e  a s th m a tic  group. 
The be ta 2  r e s u l t s  were s t a t i s t i c a l l y  s im i la r  to  the  f i r s t  s tudy. 
The k in e t ic s  o f  th e  a lp h a 2 -a d re n o c e p to rs  rem ained co n s ta n t 
throughout the study, i.e, they d id  not shew a c ircad ia n  v a r ia t io n  
and were not a ffe c te d  by sal butamol adn in i  s t r a t i  on. A lth o u ^  there  
was a s ig n i f ic a n t  d if fe re n c e  in  the a lph a 2 :b e ta 2  r a t io  a t  0800 h 
and 1800 h, th is  re la te d  so le ly  to  the c ircad ian  v a r ia t io n  and/or 
down-reguLation o f the be t ^ - a  drenoce p to r s.
In  co n c lu s io n , t h is  study produces no evidence to  su p p o rt 
S ze n tiva n y i*s  h yp o th es is . R eceptor fu n c t io n  in  the a s th m a tic  
groups was rem arkab ly  s im i la r  to  th a t  o f  the  c o n tro l group. 
N e ith e r  was the re  any evidence f o r  a beta to  a lpha s h i f t  in  
asthm atic pa tien ts .
XIII
DUBODUcnm
1. DEFINITION OF ADRENQCEPTQBS
The autonom ie nervous system is  th e  p a r t  o f the  nervous system 
concerned w ith  the re g u la t io n  o f  v is c e ra l a c t i v i t i e s  and i s  
com prised o f  the nerve c e l ls  and f ib r e s  th a t  a re  d is t r ib u te d  to  
smooth muscle, card iac muscle, and glands. The e ffe re n t autonomic 
nervous system is  d iv id e d , on th e  b a s is  o f  the anatomy o f the 
o u tf lo w  o f nerves from  the c e n tra l nervous system, in t o  two 
po rtions  designated sym pathetic and parasympathetic (F ig  1).
The term " sympathetic ”  i s  an anatom ical term re fe r r in g  to  the 
neural pathways th a t o r ig in a te  from neurons w ith  th e ir  c e ll  bodies 
i n  th e  th o ra c o lu m b a r  segm en ts  o f  th e  s p in a l  c o rd . The 
p a ra sym p a th e tic  pathways o r ig in a te  from  neurons t h a t  have t h e i r  
c e ll  bodies in  the m idbrain, the medulla, cr the sacral p o rtion  o f 
the sp ina l cord.
The sympathetic pathways consis t o f th ree major components -  
p re g a n g lio n ic  neurons, p o s tg a n g lio n ic  neurons and re sp o n s ive  
tissues. The preganglion ic neurons, which o r ig in a te  in  the sp ina l 
cord, synapse w ith  the p o s tg a n g lio n ic  neurons in  the s ym p a th e tic  
t r u n k  g a n g l ia  o r i n  s p e c ia l is e d  c o l l a t e r a l  g a n g l ia .  The 
p o s tg a n g lio n ic  neurons then te rm in a te  a t  nerve end ings on the  
responsive organs (F ig  2).
Most, but n o t a l l ,  p o s tg a n g lio n ic  sym pathetic f ib re s  release 
catecholamines from th e ir  endings on the responsive organs and are 
designated as adrenergic neurons.
Thus, the term A d re ne rg ic " re fe rs  to  the neurons th a t  re lease 
a p a r t ic u la r  type o f t r a n s m it te r .  The end organ re c e p to rs  fo r  
adrenergic tra n s m itte rs  have been termed Adrenoceptors", and the 
responses e l ic i te d  by s tim u la tio n  o f adrenerg ic nerves are termed 
"a d re n e rg ic  responses".
FIG. 1
C la s s i f ic a t io n  o f au tonom ic responses. The d iv is io n  between 
p a ra s y m p a th e t ic  and s y m p a th e t ic  responses i s  based on th e  
a n a to m ica l lo c a t io n  o f the nerve c e l l  bod ies. A d re n e rg ic  and 
c h o lin e rg ic  responses are d is tin g u ish e d  by the chemical nature o f 
the neu ro t ra n s m it te r  re le a s e d  a t  the end organ. Beta and a lpha  
responses are d is tingu ished  by the pharmacological s p e c if ic i ty  o f 
the responses (W illiam s and L e fkcw itz , 1978a).
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FIG. 2
Autonom ic nervous system. Pre, p re g a n g lio n ic  neuron; P os t,
postgang lion ic  neuron (Ganong, 1981).
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In  vivOf these responses can be e l ic i te d  by:
(a) C atecho lam ine  t r a n s m i t t e r s  ( e s p e c ia l ly  n o ra d re n a l in e )
released a t  the nerve ending as a re s u lt  o f adrenergic nerve 
s tim u la tio n .
(b) C atecho lam ines, e s p e c ia lly  a d re n a lin e , re le a se d  in t o  th e
c irc u la t io n  from the adrenal medulla,
(c )  P a r e n te r a l ly  a d m in is te re d  c a te c h o la m in e s  o r r e la te d
adrenergic agents.
I n  v i t r o , a d re n e rg ic  responses can be e l i c i t e d  by exogenous 
catecholamines in  denervated or in  innervated preparations, thereby 
in d ic a t in g  th a t  the nerve ending per se i s  n o t re q u ire d  fo r  the  
response. The spec ia lised  p a rt o f the e ffe c to r  c e l l  through which 
a d re n e rg ic  compounds a c t to  evoke a c h a r a c te r is t ic  response i s  
defined as the adrenoceptor,
2. PHABMAmi/r.Tr.Af. a ^ m c k T T C M  ng AnRomrPProws
The b io lo g ic a l e ffe c ts  o f catecholamines are among the most d iverse  
and im p o r ta n t o f  any known c la s s  o f  chem ica l agents. Thus i t  i s  
no t s u rp r is in g  th a t  over the past se ve ra l decades much resea rch  
has been d ire c ted  towards the goal o f a b e tte r m der standing o f  the 
pbys io log ica l and biochemical basis fo r  th e ir  ac tions.
An im p o r ta n t concept th a t  has he lped  d ir e c t  a g re a t dea l o f  
th is  e f fo r t  was f i r s t  pu t fo rw ard by A h lqu is t (1948) who proposed, 
on the basis o f a se ries  o f  ph ys io log ica l experiments, th a t the re  
were two d is t in c t  types o f receptors  fo r  catecholamines. He ca lle d  
these alpha- and beta-adrenoceptors. These recep to rs  were defined 
in  terms o f the re la t iv e  potency se ries  fo r  several catecholamines 
and re la te d  drugs fo r  s t im u la t in g  a v a r ie ty  o f  p h y s io lo g ic a l 
responses.
Alpha-adrenoceptor s, such as those th a t mediate smooth muscle 
c o n tra c t io n  and p la t e le t  a g g re g a tio n , were c h a ra c te r is e d  by the 
potency s e r ie s  a d re n a lin e  > n o ra d re n a lin e  > is o p re n a lin e . In  
con tras t fo r  the be ta-a drenoce p to r responses, which inc lude  smooth 
muscle re la xa tio n , the p o s it iv e  in o tro p ic  and chrono trop ic  card iac 
responses, and m e ta b o lic  responses such as l ip o ly s is ,  an a lm ost 
o p p o s ite  r e la t iv e  potency s e r ie s  was found w ith  is o p re n a l ine  > 
adrenaline > noradrenaline (F ig . 3).
A lth o u ^  very few adrenergic antagon ists were a v a ila b le  a t the 
tim e  th a t  A h lq u is t d id  h is  o r ig in a l  s tu d ie s , he d id  f in d  th a t  the  
n a tu ra l ly  o c c u rr in g  e rg o t a lk a lo id s  were capable o f b lock ing  the 
a lpha-adrenergic responses whereas the be ta - a d re n e rg ic  responses 
w e re  u n a f f e c t e d .  S i m i l a r l y ,  h a lo a lk y  lam  in e s  su ch  as 
phenoxybenzamine cou ld  b lo c k  a lp h a - but no t b e ta -a d re n e rg ic  
responses. Th is c la s s if ic a t io n  scheme was not w e ll accepted u n t i l  
some years la te r  when s p e c if ic  beta-adrenerg ic antagonists, such as 
proprano lo l, were developed
As more was learned about the adrenoceptors from p h ys io log ica l 
stud ies, i t  became c lear th a t although the o r ig in a l c la s s if ic a t io n  
rem ained u s e fu l,  i t  re q u ire d  fu r th e r  re fin e m e n t. In  p a r t ic u la r ,  
th e re  a ppea red  to  be s u b ty p e s  o f  b o th  a lp h a -  and b e ta -  
ad renocep to rs , Two m a jo r subtypes o f  each o f the  ad re n o ce p to rs  
have been described so fa r ,
2.1. BEIÜr-ADBEMQCEPTP& SUBUPEg
In  1967, Lands and c o -w o rke rs  id e n t i f ie d  tw o  subtypes o f  b e ta - 
ad ren o ce p to rs  w h ich  were des igna ted  "beta^** and "b e ta 2 *** These 
subtypes were defined by comparing the  potency o f adrenaline and 
noradrenaline a t  various beta-adrenoceptors. In  the f i r s t  subtype.
FIG. 3
A d re n e rg ic  responses o f a smooth muscle c e l l .  A lpha - and b e ta - 
adrenoceptors are ind icated by the indenta tion  on the ou ter su rface  
o f Uje c e ll. Adr= adrenal ine; NAdr=nor adrenal ine; Xso= isoprena l ine 



















b e ta^, the  ca techo lam ines  a d re n a lin e  and n o ra d re n a lin e  a re  
approxim ately equipotent in  e l i c i t i n g  a response, whereas in  the 
second subtype, beta2 , adrenaline is  considerably more potent than 
noradrenaline. Thus, the potency se ries  fo r  beta^-adrenoceptors i s  
isoprena l ine > adrenaline = noradrenaline; whereas fo r  the beta2 -  
a drenoce p tor s i t  i s  iso p re n a l! ne > adrenaline > noradrenaline. The 
group o f beta^ responses inc ludes the p o s it iv e  in o tro p ic  e f fe c t  on 
the  h e a r t , the  l i p o l y t i c  response o f ad ipose  t is s u e  and the 
in h ib it io n  o f in te s t in a l m o t i l i ty .  Typ ica l beta2  responses inc lude 
broncho d ila t io n , glycoge n o lys is  in  s k e le ta l muscle, and re la x a tio n  
o f  the  u te ru s . A lthough  se ve ra l b e ta -a d r enoce p to r b lock ing  drugs 
(e .g ., p ro p ra n o lo l,  p ra c to lo l and d ih y d ro a lp re n o lo l)  have been 
developed over the years which may have s l ig h t ly  g rea ter a f f in i t y  
f o r  one or the o th e r subtype, such as p ra c to lo l  th a t  have a 
somewhat greater a f f in i t y  fo r be ta  ^ -adrenoceptors than fo r  beta2 -  
a drenoce p to r s, h igh ly  s e le c tiv e  b e ta -a d re n e rg ic  a n ta g o n is ts  have 
no t y e t  been developed (F ig , 4 ).
2,2, ALPHA^ADRENOCEPTDR SUBTYPES
More re ce n tly , subtypes o f alpha-adrenoceptors have been described 
as w e ll.  The i n i t i a l  development o f th is  concept occurred in  the 
e a r ly  1970*s (Langer, 1974) and was based on th e  o b s e rv a tio n  th a t  
n o ra d re n a lin e  and o th e r ca te ch o la m ine  a g o n is ts  were capable  o f 
m e d ia tin g  fe e d  back in h ib i t io n  o f  n o ra d re n a lin e  re le a s e  from  
^ m p a th e tic  nerve te rm ina ls ; This feed back mechanism appeared to  
be an a lp h a -a d re n o ce p to r -  m edia ted p rocess and was b locked  by 
ty p ic a l a lpha-adrenergic antagonists. However, as a d d it io n a l work 
was done, i t  became c le a r  th a t  the  d e ta ile d  p h a rm a co lo g ica l 
p ro p e rtie s  o f these so-ca lled  "pre synaptic" alpha-a drenoce p to r s was
FIG. 4



























somewhat d if fe re n t from th a t o f the ty p ic a l "postçynaptic”  a lpha- 
a d re n o ce p to rs  m e d ia tin g  the usual p h y s io lo g ic a l  e f f e c t s  o f  
catecholamines (Langer, 1974, 1976; Borowski 1977; Starke,
1977; W e s tfa ll,  1977).
A w ide  v a r ie ty  o f drugs have been found to  have s e le c t iv e ly  
g re a te r potency a t  e ith e r  p re s y n a p tic  or p o s ts y n a p tlc  a lp h a - 
adrenoceptors, in  much the same way th a t some be ta -ad rene rg ica lly  
a c t iv e  compounds have s e le c t iv e ly  g re a te r  potency a t  e i th e r  
be ta^- or beta2 -adrenoceptora
A fu r th e r  evo lu tion  o f th is  scheme has occurred in  the  past few 
years as i t  has become inc reas ing ly  c lea r th a t alpha-adrenoceptors 
possessing  many o f the  c h a ra c te r is t ic s  o f  the  "p re s y n a p t ic ” 
re c e p to rs  can a lso  be found  in  "p o s ts y n a p tic "  lo c a t io n s .  Thus, 
ty p ic a l  "p re s y n a p t ic "  re c e p to rs  have been dem onstra ted  on human 
p la te le ts  (H offm an 1979), in  se ve ra l c u ltu re d  c e l l  l in e s
(Sabol and N ire n b e rg , 1979), and in  f r o g  s k in  (P e tt in g e r ,  1977). 
Thus, the term inology o f "postsynaptlc  and presynaptic" should be 
re p la c e d  by the  d e s ig n a tio n s  *h lpha^"- and % lpha2 "-adrenooeptors, 
re sp e c tive ly  (Berth e l sen and P e ttinge r, 1977).
A lp ha ^ -ad re n o ce p to rs  in c lu d e  ty p ic a l  p o s ts y n a p tlc  a lp h a - 
a d ren o ce p to rs  m e d ia tin g  sraooth-m uscle c o n tra c t io n . A lpha2 -  
adrenoceptors inc lude not only a l l  known presynaptic au to regu la to r y 
a lp h a -a d re n o ce p to rs  bu t a lso  some le s s  ty p ic a l  p o s ts y n a p tlc  
receptors e x is t in g  on, fo r  example, himan p la te le ts  (Hoffman a i ,  
1979; Wood ^  1979). Thus fa r ,  no s u c c in c t d e f in i t io n  o f
a lpha^- and alpha2 «adrenoceptors analogous to  th a t used in  d e fin in g  
beta-|- and beta2 -adrenocep to r subtypes has emerged.
Many drugs have appeared to  be p u ta t iv e ly  alpha^ or a lpha 2  
s e le c t iv e  in  a number o f is o la te d  t is s u e s  from  v a r io u s  a n im a ls .
However, in  many cases g e n e ra lit ie s  about the s e le c t iv ity  o f a drug 
are not possible because o f the great v a r ia b i l i t y  o f responses to  
i t  from  one t is s u e  to  ano the r. For a g o n is ts  i t  has been suggested 
th a t  methoxamine and p hen y le ph rin e  a re  alpha-; s e le c t iv e ,  th a t 
c lo n id in e  i s  a lp h a 2  s e le c t iv e ,  and t h a t  a d re n a l in e  and 
noradrenaline, having approx im ate ly  equal potency a t  a lpha -;- and 
a l pha2 -a d r  enoce p to r s, a re  non s e le c tiv e  (Berth e l sen and P e ttinge r, 
1977), Among alpha-adrenergic antagonists, prazosin (Cambridge 
j i ,  1977; C avero  ^  j i ,  1977; Doxey a 1 , 1977) and
phenoxybenzamine (Doxey ^  j l I i  1977) are co ns id e re d  alpha-; 
se le c tive , yohimbine (a p lan t a lk a lo id )  alpha2  s e le c tiv e  (Doxey ^  
J l I i  1977), and phento la ra ine  n o n s e le c tiv e  (Cavero ^  i l l ,  1977), 
(F i&  5). These designations o f  alpha^ and alphd2  s e le c t iv ity  have 
g e n e ra lly  been de te rm ined  in  e xp e rim e n ts  in  w h ich  e f fe c ts  on 
alpha-;-adrenoceptors were determined in  term s o f  smooth -  muscle 
co n tra c tion  and e ffe c ts  on alpha2 -a  dr enoce p tors determined through 
assessment o f noradrenaline release from nerve te rm ina ls .
At present, one o f the most usefu l and w ide ly  app lied  c r i t e r ia  
fo r  d is t in g u is h in g  p h a rm a co lo g ica lly  between a lpha^- and alpha2 -  
a dreno ce p to r s is  the re la t iv e  p o te n c ie s  o f the  a lpha a n ta g o n is ts  
p ra z o s in  and yoh im b ine . P razos in  i s  much more p o te n t than 
yohimbine a t  alpha-;-adrenoceptors, whereas yohimbine is  genera lly  
somewhat more potent a t  alpha2 -adrenoceptors (Hoffman ^  1979).
HISTORICAL PERSPECTIVE OF RADIOLIGAND BINDING STUDIES
The f i r s t  receptors stud ied by rad io ligand  b ind ing  techniques were 
the polypeptide hormone and n ic o t in ic  c h o lin e rg ic  receptors. P rio r 
to  the  use o f r a d io a c t iv e  lig a n d s , the  approach to  th e  study o f 
hormone and neuro transm itte r receptors  was to  in fe r  c h a ra c te r is t ic s
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o f the receptors from an examination o f the phys io log ica l response 
to  the a c t iv e  agents. The s p e c i f ic i t y  o f the  hormone -  re c e p to r  
in te ra c t io n  was de lineated by measuring the b io lo g ic a l response to  
s t r u c tu r a l  ana logs o f the  hormone. A l te r a t io n s  o f the b io lo g ic a l  
responses to  hormones induced by pa tho log ica l or phannaoological 
m a n ip u la t io n s  w ere o fte n  a t t r ib u te d  to  changes in  the number o r 
fu n c tio n  o f receptors, but these changes could never be documented. 
Hence the in te r p r e ta t io n  o f  many e a r ly  p h y s io lo g ic a l s tu d ie s  o f  
horm one re c e p to r s  was l im i t e d  by th e  n e c e s s ity  o f  m a k in g  
observations o f the b io lo g ic a l response, a response th a t i s  several 
s teps  d is t a l  to  the  a c tu a l in te r a c t io n  o f  hormone w ith  re c e p to r. 
I t  was no t u n t i l  1969 th a t  the in te r a c t io n  o f a hormone w ith  i t s  
re c e p to r  was s tu d ie d  d ir e c t ly .  In  t h a t  ye a r two groups, u s in g  
[1 25 i]ac ire noco rtico troph ic  hormone (ACTH) and [ ^ ^ ^ I ]a n g io te n s in ,  
r e s p e c t iv e ly ,  dem onstra ted  th a t  r a d io a c t iv d y  la b e lle d  hormones 
cou ld  be used to  study d ir e c t ly  the  in te r a c t io n  o f hormones w ith  
s p e c i f ic  membrane b in d in g  s i te s  (L e fk o w itz  ^  j d t  1970; L in  and 
Goodfriend, 1970). In  the next few years the approach was extended 
to  th e  study o f  a v a r ie ty  o f p e p tid e  hormone and n ic o t in ic  
c h o lin e rg ic  receptors as reviewed elsewhere (Kehn, 1975; Le fkow itz  
jgJ tjJ»  1976a; K a r l in ,  1974).
.^1. BETA-ADREMOCEPTQRS
A lthough  e x te n s iv e  pha rm aco log ica l s tud ies o f  adrenoceptors had 
been perfo rm ed fo r  th ree  decades, d ir e c t  b in d in g  s tu d ie s  o f 
a d re n o ce p to rs  lagged  behind those o f polypeptide and c h o lin e rg ic  
r e c e p to r s .  D u r in g  th e  1950*s and 1960*s, a w e a lth  o f  
p h a rm a co lo g ica l data on a d re n e rg ic  responses appeared. S tu d ie s  
such as those o f Ariens (1967) docunented in  d e ta il the s tru c tu re  -
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a c t i v i t y  r e la t io n s h ip s  re s p o n s ib le  fo r  e l i c i t i n g  a d re n e rg ic  
responses^ The apparently com petitive  nature o f the antagonism o f 
b e t a - a d r e n e r g i c  r e s p o n s e s  by a n t a g o n is t s  su ch  as 
d ich lo riso p re n a lin e  and propranolo l was also demonstrated.
The stud ies o f A h lqu is t (1948) had demonstrated the  existence 
o f a t  le a s t  two d is t in c t  types o f ad renocep to rs . D e sp ite  these 
advances in  th e  unde rs tand ing  o f  ad renerg ic  pharmacology, by the 
la te  1960*5 the l im ita t io n s  o f c la ss ic  pharmacological methods were 
becoming apparent, as was the fa c t th a t fu r th e r  in fo rm a tio n  about 
the  re c e p to rs  cou ld  on ly  be o b ta in e d  by new te ch n iq u e s , such as 
r a d io l i^ n d  b ind ing studies.
One o f the e a r lie s t  a ttem pts a t  using a ra d io a c tive  oompomd to  
study be ta - ad renocep to rs  was th a t  o f  P o tte r  (1967). I t  was found  
th a t the ra d io a c tiv e  antagonist [^H ]proprano lo l bound to  pieces o f 
a t r ia l  muscle J d v i t r o  and to  subce lluLar fragments derived from 
such tis s u e . However, under the c o n d it io n s  u t i l i z e d ,  the  b in d in g  
appeared to  be n o nsa tu rab le  and d id  n o t have the c h a r a c te r is t ic s  
one would expect o f b ind ing  to  beta-adrenoceptors (see section  6), 
S u b s e q u e n tly  a num ber o f  i n v e s t ig a t o r s  a t te m p te d  to  use 
[^H ]p roprano lo l and [^^C ]proprano lo l to  perform b ind ing  s tud ies  on 
f r a c t io n s  d e rive d  from  b ra in  (De R o b e rt is  and F is z e r de P lazas, 
1969), h e a rt (V a tne r and L e fk o w itz ,  1974), b ro n c h ia l t is s u e  
(Furchgott 1973), and other tissues (Huunan-Seppala, 1972).
In  none o f these s tu d ie s  w ere s i te s  la b e l le d  th a t  had th e  
appropria te  c h a ra c te r is tic s  o f beta-adreroceptors (see section 6). 
W ith h inds igh t, i t  i s  now c le a r th a t the s p e c if ic  ra d io a c t iv ity  o f 
[ p ro p ra n o lo l was much to o  low  to  have p e rm itte d  a c c u ra te  
id e n t i f ic a t io n  o f the sm all number o f be ta - adrenoceptors present in  
most tissues.
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D uring  th e  same p e rio d  (196? -  1974) s e v e ra l groups began to  
e x p lo re  the p o s s ib i l i t y  o f us ing  ra d io la b e lle d  b e ta - a d re n e rg ic  
a g o n is ts  such as t r i t i a t e d  is o p r e n a l in e ,  a d r e n a l in e ,  and 
n o ra d re n a lin e  to  id e n t i f y  the  re c e p to rs . The b in d in g  o f these 
ra d io a c t iv e ly  la b e lle d  ca techo lam ines  was s tu d ie d  in  membrane 
fra c tio n s  derived from  l iv e r  (Tomasi ^  1970; M a r in e tt i ^
1969), heart (Le fkow itz and Haber, 1971), adipose tissue  (J a re tt  e t
1974), e ry th ro c y te s  ( B i le z ik ia n  and Aurbach, 1973) and o th e r  
tissues  (F iszer de Plazas and De R obertis, 1972).
The b in d in g  s i te s  la b e l le d  in  these s tu d ie s  a ls o  f a i le d  to  
d e m o n s tra te  th e  b in d in g  c h a r a c t e r is t i c s  expected  o f  b e ta - 
a dreno ce p to r s. The b ind ing d id  not demonstrate s te re o s p e c if ic ity ,  
and th e  c o m p e t i t iv e  b e ta -a d re n e rg ic  a n ta g o n is t p ro p ra n o lo l 
i n h ib i t e d  b in d in g  o n ly  a t  v e ry  h ig h ,  n o n - p h y s io lo g ic a l  
concentrations. In  a d d itio n , compomds such as catechol, which are 
devo id  o f b e ta -a d re n e rg ic  b io lo g ic a l a c t i v i t y ,  s ig n i f i c a n t ly  
in h ib ite d  the b in d in g  Thus i t  became inc reas ing ly  apparent th a t 
in  these s tu d ie s  the s i te s  la b e l le d  by ca te ch o la m ine s  were n o t 
be ta - adrenoceptor s.
I t  was proposed th a t  t h is  ca techo lam ine  b in d in g  was to  th e  
catechol -  0 -  methyl transferase system (Cuatrecasas ^  1974)
o r to  a catecholamine o x id iz in g  system. However, the exact nature 
o f these "n o n re ce p to r"  b in d in g  s i te s  rem ains mknown. Some 
e v id e n c e  e x is t s  f o r  th e  c o v a le n t  b in d in g  o f  th e  la b e l le d  
ca te ch o la m ine s  to  the  re c e p to r  s i te s  as a r e s u l t  o f an o x id a t iv e  
process ( M a g u i r e ^  j d ,  1974; W o lfe  ^  1974). Such b in d in g
cannot be used to  characterise  beta-adrenooeptors. Thus by 1974, 
th e re  had been no re p o r ts  o f  su cce ss fu l id e n t i f i c a t io n  o f  b e ta - 
a dreno ce p to r s u s ing  ra d io a c t iv e  lig a n d s . In  th a t  ye a r, th re e
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groups independently developed methods th a t appeared to  pe rm it the 
d ire c t study o f be ta-a drenoce p tor s. In  each case the rad io lig a n d  
used was a potent beta-adrenergic antagonist. L e v itz k i ^  ^  ( 1974) 
used [ ^H ] p r o p r a n o lo l ,  L e fk o w itz  ^  ^  (1 9 7 4 ) used ( - )  
[ ^ H ]d ih y d ro a lp re n o lo l ([^H ]DHA), and Aurbach ^  (1974) used
[ T ^^ ljlyd ro xyb e n zy lp ln d o lo l (^^^IJH Y P ), (F ig . 6). L a t te r ly  o th e r 
groups have worked w ith  be ta -a d r  enoce p to r  a g o n is ts  and fo r  
convenience, the d if fe r in g  approaches w i l l  be discussed separately.
3.1.1. Radioligand studies using beta-adrenoceptnr
During the fo llo w in g  two years the te chn ique  us in g  r a d io a c t iv e ly  
la b e l le d  b e ta -a d re n e rg ic  a n ta g o n is ts  was app lied  to  a v a r ie ty  o f 
catechol ami ne-se n s itive  ^ste rns (W illia m s  1976a,b; Muldierjee
1975a; A lexander j i l ,  1975a,b; Za tz  ^  j i l ,  1976; M agu ire  
^  j i l ,  1976a; B y lund and Snyder, 1976) and a lso  proved u s e fu l in  
s tu d y in g  s o lu b i l iz a t io n  o f  the  re c e p to r  (Caron and L e fk o w itz ,
1976), s i t e  -  s i t e  in te r a c t io n s  among re c e p to rs  (L im b ird  and 
L e fk o w itz , 1976), a l te r a t io n s  o f  re c e p to r number caused by a 
v a r ie ty  o f p hys io log ica l m a n ip u la tio n s  (M ukherjee  ^  j l I ,  1975b; 
M ickey, al, 1975; M ukherjee, ^  al, 1976; M ukherjee  and 
L e fk o w itz ,  1976a; Kebablan ^  al, 1975; Harden al, 1976; 
W il l ia m s  al 1977a; Shear al, 1976), a l t e r a t io n  o f  the 
recep to r a f f in i t y  caused by nucleo tides (L e fko w itz  at al, 1976b), 
the id e n t i f ic a t io n  o f ectop ic beta-adrenooeptors (W illia m s  at al, 
1977b), and the g e n e tic  re g u la t io n  o f re c e p to rs  in  v a r io u s  c e l l  
c lo n e s  (M agu ire  at al, 1976a). The success o f  s tu d ie s  us in g  
ra d io a c tiv e ly  la b e lle d  antagon ists to  id e n t i f y  be ta -a  dreno cep to rs  
can be a t t r i b u t e d  to  a v a r ie t y  o f  f a c t o r s ,  in c lu d in g  th e  
a v a i la b i l i t y  o f h ig h -a f f in i ty  an tagon ists la b e lle d  to  h igh s p e c if ic
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FIG. 6
S truc tu res  o f radioactive:!}' .labelled b e ta -a d re n e rg ic  a n ta g o n is ts . 
S ite s  o f  s p e c if ic  ra d io a c t iv e  la b e l l in g  a re  in d ic a te d  by an 
a s te r is k .
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r a d io a c t iv i t y  and an inc re a se d  awareness o f  the  a p p ro p r ia te  
techn ica l cond itions  fo r  de tection  o f be ta-a dreno ce p to r s.
From 1974 to  1976 the  te c h n ic a l aspects o f  m easuring b in d in g  
were improved to  such an ex ten t th a t the assays could be ro u tin e ly  
pe rfo rm ed  u s in g  a w ide  v a r ie ty  o f t is s u e s . Hence by 1976 the  use 
o f ra d io a c tiv e ly  la b e lle d  antagonists had become w e ll es tab lished  
as a va luab le  to o l fo r the d ire c t study o f beta-adrenoceptors;
Two a n ta g o n is t l ig a n d s  have been w id e ly  used, nam ely, ( - )  
[^H]DHA and (± ) [ ^^^I]HYP. Both lig a n d s  have been v a lid a te d  in  
d i f f e r e n t  t is s u e s  and appear to  g iv e  f a i r l y  com parable r e s u lt s  
(In s e l and S too l man, 1978). (-)[^H]DHA has the advantages o f  being 
a pure ( - )  isomer compound, having a very long  physica l h a l f - l i f e  
(12 y e a rs )  and i s  n o t r e a d i ly  s u s c e p t ib le  to  r a d io a c t i v e  
decomposition. I t s  b ind ing has a high s p e c if ic ity  which leads to  a 
low n o n -sp e c ific  b in d in g  I t s  s p e c if ic  ra d io a c t iv ity  however i s  not 
ve ry  h ig h  (90 -  120 C i/m m ol) and i t  i s  necessary to  use la rg e  
amomts o f membrane p ro te ins  bearing the beta-adrenoceptors to  get 
measurable re s u lts .
In  c o n tra s t,  [^^^ I]H Y P  has th e  advantage o f h ig h e r s p e c if ic  
ra d io a c t iv ity  o f about 2200 Ci/mmol and h igher a f f in i t y  fo r  be ta -  
adr enoce p to rs  than i t s  [^H] co w te rp a rts . These p rope rtie s  a llow  
the use o f  much s m a lle r  amounts o f p ro te in  in  b in d in g  s tu d ie s . 
However, as a consequence o f the phene thy 1 an i  ne side chain (Fig,
6), [1^^I]HYP binds to  alpha-a dreno oe p tors (Aggerbeck 1979)
and 5-HT (5 -hy droxy t r y  p tam ine) re c e p to rs  (D ickinson .a l, 1981). 
Furthermore, depending on the rea c tion  cond itions, the io d in a t io n  
p rocedure  fo r  hydroxy benz y Ip in d o lo l  lea ds  to  th e  fo rm a t io n  o f  2 
d i f f e r e n t  io d i  n a tio n  p roducts  (B e a re r .a t .a l,  1980), m oreover 
[**^5x ] hyp i s  a racemic oompomd.
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N e ith e r compound d is c r im in a te s  between the beta-j- and beta2 -  
a dreno ce p to rs ;  i.e ,, in  a membrane or c e l l  suspension c o n ta in in g  
both be ta -|- and beta2 -a d re n o ce p to r s i te s  these lig a n d s  w ou ld  be 
expected  to  la b e l bo th  w ith  equal a f f i n i t y  (Hancock .a t i d ,  1979; 
Minneman a i  .a l, 1979).
Recently, an a lte rn a t iv e  lig a n d  [ ‘^ ^^ ijcyanop indo lo l (['*25 i ] cyp) 
has been used to  study be ta-a dreno ce ptors (Engel, 1980; Davies and 
L e fk o w i tz ,  1 983 ). [1 2 5 i]c Y P  has th e  advan tag e  o f  h ig h e r
s p e c i f ic i t y  fo r  be ta -a  dreno ce p to rs  due to  a la c k  o f a f f i n i t y  f o r  
alpha-adrenoceptors and 5-HT receptors as compared w ith  [125%]HYP 
(E n g e l,  1980). U n fo r tu n a te ly  [^ ^ ^ I ]C Y P  was u n a v a i la b le  
com m ercia lly a t the commencement o f th is  study.
3.1.2. BadioligaiKLstudies using beta-adrenoceptor agonista
A t th e  same tim e , two b e ta -a d re n e rg ic  a g o n is ts  have been used as 
ra d io lig a n d s , i.e .  [^ H ]h y d ro x y b e n z y lis o p re n a lin e  (L e fk o w itz  and 
W illia m s , 1977) and [^H ]adrenaline (U*Prichard .a l, 1978), (F ig,
7). (± )[^H ] hyd roxyb enzy lisop rena line has a h ig h e r a f f i n i t y  f o r  
beta2 -  than b e ta ^ -a d re n o ce p to rs  (L e fk o w itz  and W il l ia m s , 1977; 
W L ilia n s  and L e fko w itz , 1977c). I t  i s  approxim ately equipotent w ith  
is o p re n a lin e  a t  b e ta ^ -a d re n o ce p to rs  and genera lly about 10 tim es 
more potent than isop rena line  a t be ta2 -a  drenoce ptors.
In te rp re ta tio n  o f agonist b ind ing to  adrenoceptors, however, is  
much more complicated than in te r p r e ta t io n  o f a n ta g o n is t b in d in g . 
S evera l p o in ts  need to  be developed in  o rde r to  p ro v id e  a c le a r  
p ic tu re  o f the s ig n if ic a n c e  o f a g o n is t b in d in g . I t  now appears 
th a t  a findam ental property o f agonists a c tin g  a t  adenylate cyclase 
-  coupled beta-a dreno ce p to rs  i s  the a b i l i t y  to  induce cr s ta b il is e  
a h ig h  a f f i n i t y  form o f the  be ta -ad re n o cep to r (Kent .a t j i ,  1980).
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FIG. 7
S tru c tu re s  o f ra d io a c t iv e ly  la b e lle d  b e ta -a d re n e rg ic  a g o n is ts .  
S ite s  o f  s p e c if ic  ra d io a c t iv e  la b e l l in g  a re  in d ic a te d  by an 
a s te r is k .
. 9 "  H / - ^
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T h is  fo rm  o f the  re c e p to r does no t d is p la y  p r e fe r e n t ia l  a f f i n i t y  
fo r  an ta g on is tic  drugs. Thus, in  the presence o f a beta-adrenerg ic 
agon is t, the beta-adrenooeptors w i l l  e x is t  in  two a f f in i t y  sta tes, 
one o f h ig h e r and one o f lo w e r a f f i n i t y .  I t  has been shown th a t  
the a b i l i t y  to  fonn the h i ^  a f f in i t y  s ta te  is  d ire c t ly  co rre la te d  
w ith  tiie  in t r in s ic  a c t iv i t y  cr e ffica cy  o f the beta-adrenerg ic drug 
(K en t ^  j l I ,  I 9 8 O). Guanine n u c le o tid e s  such as guano s i ne 
triphospha te  (GTP) w liich are v i r tu a l ly  required fo r  catecholamine 
s tim u la tio n  of adenylate cyclase (W ill ia m s  and L e fk o w itz ,  1977c) 
appear to  m ed ia te  a t r a n s i t io n  o f  the  h ig h  a f f i n i t y  s ta te  o f  the  
receptor to  i t s  lew a f f in i t y  sta te  (Kent .f it .a i, 1980; L e fko w itz  .gt 
a l ,  1976b; M aguire  .f it  j 1 ,  1976b; Mai bon f i t  a l ,  1978). Thus, in  
the presence o f guanine nucleotides, a l l  o f the beta-adrenooeptors 
in  the presence o f agonist w i l l  be in  the low er o f the two a f f in i t y  
forms. This can be demonstrated experim enta lly  as a nuc leo tide  -  
prom oted r ig h tw a rd  s h i f t  in  an a g o n is t d isp lacem e n t cu rve  o f a 
ra d io lig a n d  such as [^H]EHA (Fig. 8) or [^ ^ I]H Y P . In  a d d it io n  to  
s h i f t i n g  to  the  r ig h t ,  the  c o m p e tit io n  cu rve  steepens s in ce  now, 
ra th e r than two a f f in i t y  sta tes o f the receptor, in  the presence o f  
n u c le o tid e  th e re  i s  o n ly  the  one o f lo w e r a f f i n i t y .  A n ta g o n is t 
displacement curves are not sh ifte d  by nuc leo tides since they la b e l 
only a s in g le  a f f in i t y  s ta te  o f homogeneous a f f in i t y  (Kent f i t  f i l ,  
1 9 8 0 ) in  the presence o r absence o f n u c le o tid e s . In  g e n e ra l, f o r  
f u l l  a g o n is ts  th e  a f f i n i t y  o f the  h ig h e r a f f i n i t y  s ta te  i s  50 to  
100 tim es higher than th a t o f the low er a f f in i t y  s ta te  (Kent f i t  f i l ,  
1 9 8 0 ) .  T h u s , w hen  an  a g o n i s t  l i g a n d  s u c h  as  
[3H ]lyd roxybenzylisoprena line  is  used, there i s  p re fe re n t ia l,  i f  
n o t e x c lu s iv e , la b e l l in g  o f  on ly th e  h ig h  a f f i n i t y  s ta te  o f  the  
receptor. The low a f f in i t y  sta te , in  general, cannot be d ire c t ly
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FIG. 8
C üinputer-rnode lled co m p e tit io n  curve f o r  in h ib i t io n  o f  [^H]DHA 
b ind ing  by ( - ) isoprenaline in  the presence and absence o f guanosine 
triphosphate (GTP). Frog erythrocyte membranes were incubated w ith  
2 .1 r i iio l/ l  [%]DHA in  compétition w ith  increasing concen tra tions o f  
the b e ta -a d re n e rg ic  a g o n is t ( - ) is o p re n a lin e , in  both the absence 
and presence o f 0.1 mmol/1 GTP. and denote the  d is s o c ia t io n  
co n s ta n ts  fo r  b in d in g  o f the drug to  the h ig h - a f f in i t y  and lo w -  
a f f i n i t y  fo rm s o f  the re ce p to r, re s p e c t iv e ly , and Rp| and R^ th e  
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determined w ith  a lig a n d  such as [^H]hydroxybenzylisoprenaline* 
I t  should be stressed tha t since only the high a f f in i t y  fonn o f the 
recep to rs  can be d ire c t ly  la b e lle d  w ith  low concentra tions o f  an 
agon is t such as [ ^  H] ty  droxy be n z y li soprenal i  ne, the to ta l number 
o f  b in d in g  s i t e s  o b s e rv e d  w i t h  an a g o n is t  su ch  as 
droxybenzylisoprenaline may be fewer than th a t observed w ith  
an an tagon ist lig a n d  such as [3h]DHA. Moreover, the re la t io n s h ip  o f  
these two values w i l l  depend c r i t i c a l l y  on va ria b le s  such as, f o r  
example, the c o n c e n tra tio n  o f endogenous guanine n u c le o tid e s  
contam inating a membrane preparation. Thus, the greater the amount 
o f  n u c le o tid e s  p resen t, the g re a te r the  e x te n t to  w h ich  h ig h  
a f f i n i t y  s ta te  re c e p to rs  w i l l  be converted  to  low  a f f i n i t y  
receptors, and the greater the discrepancy w i l l  become between the 
n u m b e r o f  be t a - a d r  e no ce p t o r  s l a b e l l e d  w i t h  C ^H ] 
hydroxybenzylisoprenaline as opposed to  an an tagon ist lig a n d  (Kent 
1980), Thus, w ith  b e ta -a d re n e rg ic  a g o n is t l ig a n d s  such as 
[^H ] hydroxy benzyl isoprena line cr [3h] adrenaline, i t  must be borne 
in  m ind th a t  on ly  a f r a c t io n  o f the t o t a l  be ta -a  drenoce p to r  pool 
may be la b e l le d .  T h e o re t ic a l ly ,  the  lo w e r a f f i n i t y  s ta te  o f  the  
be ta-a dreno ce p to rs could be la b e lle d  w ith  high concentra tions o f 
[^H ] hydroxy benzy l is o p re n a lin e , but i n  p ra c t ic e  t h i s  i s  n o t
possib le  to  carry out experim enta lly  because o f problems w ith  non­
s p e c i f i c  b in d in g  a t  v e ry  h ig h  c o n c e n t ra t io n s  o f  [3 h ]  
by droxy be n z y li soprenaline.
In  p u r if ie d  plasma membranes from fro g  e ry th rocy tes , in  which 
endogenous guanine n u c le o tid e  c o n ta m in a tio n  i s  p resum ably q u i te  
lo w , up to  90 to  95% o f  the  beta2 ~ ad renocep to rs  t h a t  can be 
l a b e l l e d  w i t h  (3 h ]D H A  a r e  a ls o  l a b e l l e d  w i t h  
[3H ]hy droxy be n z y lis o p re n a lin e  (Kent 1980). However, in
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le s s  p u r if ie d  preparations only 60 to  65% o f the s ite s  are la b e lle d  
w ith  the agonist (Kent ^  j l ,  1980).
^.2. ALPHA-ADRENOCEPTORS
P r io r  to  1976 th e re  had been no re p o r ts  o f  the  su cce ss fu l 
id e n t i f i c a t io n  o f a lp ha -a d re nocep to rs  by ra d io lig a n d  b in d in g  
stud ies, A number o f early studies had demonstrated the  b ind ing  o f 
a lp h a -a d re n e rg ic  ra d io lig a n d s  to  h ig h  -  c a p a c ity  lo w  -  a f f i n i t y  
s i te s  th a t  d id  n o t have the  s p e c i f ic i t y  o f alpha- adrenoceptors 
(Moran 1967; Yong and N icke rso n , 1973; T e r n e r ^ j i l ,  1971;
F is z e r  de P lazas and De R o b e rtis , 1972). In  re tro s p e c t ,  these 
s tud ies  were probably unsuccessful fo r  several reasons:
1, In  general, these attem pts used ra d io a c tiv e ly  la b e lle d  ligands
o f re la t iv e ly  low s p e c if ic  ra d io a c t iv ity  (25 to  50 mCi/mmol) 
i n  c o m p a ris o n  w i t h  those  c u r r e n t ly  a v a ila b le  (30 -  90 
Ci/mmol). Thus in  order to  id e n t ify  the very sm all nunber o f  
tru e  receptors, high concentrations o f  lig a n d  were required. 
A t these high concentrations, non-spec ific  b ind ing  o f  lig a n ds  
to  h ig h -c a p a c ity  lo w - a f f in i t y  nonrecep to r s ite s  presumably 
obscured b ind ing to  the sm all nunber o f phys io log ica l h igh  -  
a f f i n i t y  recep to rs
2 . In  e a r ly  a t te m p ts  to  i d e n t i f y  a lp h a -a d re n o c e p to rs  by
ra d io lig a n d  b in d in g , in t a c t  s t r ip s  o f t is s u e  were used as a 
source o f re c e p to rs  (Moran 1967; Yong and N ic k e r son,
1973). The use o f  membrane p re p a ra tio n s  p robab ly  a llo w s  the  
atta inm ent o f higher receptor s i te  concentrations and may also 
e lim ina te  some o f the drug and hormone uptake processes th a t 
occur in  in ta c t tissue .
The f i r s t  r e p r te d  successful id e n t if ic a t io n  o f alpha-adrenoceptors
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by ra d io lig a n d  b in d in g  tech n iqu es  was in  1976 (W il l ia m s  and 
L e fk o w itz ,  1 976; W i l l i a m s £ i ^ ,  1976c; W il l ia m s  and L e fk o w itz ,  
1977a,b). In  these s tu d ie s , [^ H jd ih y d ro e rg o c ry p tin e , a t r i t i a t e d  
a lpha-adrenergic antagonist w ith  a high s p e c if ic  ra d io a c t iv ity  (23 
Ci/mmol), was used to  la b e l b ind ing s ite s  in  membrane preparations 
from  r a b b it  u te ru s , a t is s u e  th a t  c o n tra c ts  on a lp h a -a d re n e rg ic  
s tim u la tio n . This lig and  was subsequently used to  id e n t i fy  a lpha- 
adrenoceptors in  the r a t  p a ro tid  gland (S tr it t ra a tte r  iSLt 1977) 
and in  human p la te le ts  (Newman ^  j i ,  1978). By c o n tra s t ,  
[^H ld ihydroergocryp tine  -  b ind ing  to  r a t  b ra in  preparations d id  no t 
have the s p e c if ic i ty  c h a ra c te r is tic s  expected o f b ind ing  to  alpha- 
adrenoceptors (S tr it tm a t te r  ^  1977). Other ligands have been
u s e fu l in  s tu d y in g  a lp h a - a d reno cep to rs  in  the c e n tra l nervous 
system , U *P richard  and Snyder (1977) have re p o rte d  th e  use o f an 
a lpha-adrenergic an tagon is t, [^H]WB4101, and the a lp h a -a d re n e rg ic  
a g o n is ts  [^ H ]c lo n id in e , [ ^ h] a d re n a lin e , and [% ]noradrenaline to  
d ire c t ly  id e n t ify  alpha-adrenoceptors in  b ra in  membranes. Another 
lig a n d , [^H ld ihydrcezapetine, was a lso  used in  an attem pt to  la b e l 
a lp h a -a d re n e rg ic  b in d in g  s i te s ,  a lthough  the s i te s  th a t  w ere 
la b e l le d  d id  n o t appear to  have an a f f i n i t y  fo r  a lp h a -a d re n e rg ic  
agon ists (R u ffo lo  ^  ü l ,  1976).
In  analogy w ith  the beta-adrenoceptors discussed above^ some o f 
the a lp h a -a d re n o ce p to rs  a re  a lso  capable o f  e x is t in g  in  h igh  and 
low  a f f i n i t y  s ta te s  (Hoffman juL, 1980a). The h ig h  a f f i n i t y  
s ta te  i s  u n iq u e ly  promoted by a g o n is ts  and is  c o n v e r t ib le  to  the  
low er a f f in i t y  s ta te  by guanine nucleotides (Hoffman j i ,  1980a; 
Tsai and L e fko w itz , 1979). However, only the alpha^-a drenoce p to rs  
and n o t the  a lp h a ^-a d re n o ce p to rs  d is p la y  such h e te ro g e n e ity  o f 
b ind ing  modulated by guanine nucleotides (Hofftaan je t JBli 1980a).
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A lp h a -a d re n o ce p to rs  can now be d ir e c t ly  id e n t i f ie d  u s in g  
an tagon is t rad io ligands, such as [^H ld ihydroergocryp tine  ([3h]CHE) 
which la b e ls  both alpha^- and alpha2 -adrenoceptors (W illia m s  and 
L e fk o w itz ,  1976), [^ H lp ra z o s in  w hich  s e le c t iv e ly  la b e ls  alpha<j- 
ad ren o ce p to rs  (Barnes sX  1979), and [^H ]yo h im b in e  w hich  
s e le c t iv e ly  la b e ls  a l pha2-a  dreno ce p to rs  (M o tu lsky  ^  jSd, 1980; 
Hoffm an 1981; D a i g u j i ^ ^ ,  1981), (F ig . 9 ).
4. ADRENOCEPTOR FUNCTION
The b ind ing  o f hormcfies, catecholamines or drugs to  adrenoceptors 
b rings about a v a r ie ty  o f b io lo g ic a l responses such as a change in  
th e  r a te  or s tre n g th  o f c a rd ia c  b e a tin g  o r change in  th e  tone o f 
vascular smooth muscle.
In  case o f be ta-adrenoce ptors, the hormone-receptor in te ra c t io n  
r e s u lt s  in  a c t iv a t io n  o f the membrane -  bound enzyme a d e n y la te  
cyc la se . I t  i s  suggested th a t  b in d in g  o f  hormonal a g o n is ts  to  
adrenoceptors changes the f lu id i t y  o f the c e ll  membrane so th a t the 
hormone -  re c e p to r complex d if fu s e s  la te r a l ly  along the  membrane 
su rfa ce  u n t i l  i t  coup les w ith  and thereby a c t iv a te s  a d e n y la te  
cyc lase  (H ira ta  ^  1979). A second p ro te in  appears to  be
invo lve d  in  the a c tiv a tio n  o f adenylate cyclase th a t re s u lts  from 
the hormone -  receptor in te ra c tio n . Th is p ro te ir^  which has been 
ca lle d  guanine nuc leo tide  regu la to ry  p ro te in  (N) (Ross ^  j i ,  1978; 
R o d b e ll, 1980; L im b ird , 1981; S p ieg e l and Downs, 1981) in te r a c ts  
w ith  both the recep to r and the cyclase. In te ra c tio n  o f the hormone 
w ith  the receptor a ffe c ts  N in  such a way th a t i t  binds GTP, the N- 
GTP then a p p a re n tly  a c t iv a te s  the cyc lase  (P fe u f fe r ,  1977). 
Adenylate cyclase, a fte r  i t s  a c tiv a tio n  by the hcrmone -  receptor 
complex, s tim u la tes  conversion o f adenosine triphosphate (ATP) to
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FIG. 9
S truc tu res  o f ra d io a c tive ly  la b e lle d  a lpha-adrenergic an tagon is ts . 
S ite s  o f  s p e c if ic  ra d io a c t iv e  la b e l l in g  a re  in d ic a te d  by an 
a s te r is k .












adenosine 3 * -5 * -monophosphate ( c y c l ic  AMP), w h ich  se rves as th e  
"second messenger" fo r  the hormone (Sutherland and R a il, I960) and 
a c t iv a te s  in t r a c e l lu la r  p ro te in  k inases  (Niramo and Cohen, 1977; 
Greengard, 1978). These in  t i r n  cause phosphorylation o f enzymes 
th a t  le a d  to  the  c h a r a c te r is t ic  c e l lu la r  response, such as 
re la x a tio n  o f smooth muscle c e lls .
In  case o f alpha-adrenoceptors, one popular hypothesis i s  th a t 
the hormone -  recep to r in te ra c t io n  a c tiv a te s  the membrane -  bound 
enzyme g u a n y la te  cyc lase  and p o s s ib ly  thereby increases c e l lu la r  
le v e ls  o f guano s i ne 3 *-5'-monophosphate (c y c lic  GMP) by converting  
guano s i  ne tr ip h o s p h a te  (OTP) to  c y c l ic  GMP (G oldberg  and Haddox,
1977), w h ich  serves as the "second messenger" f o r  th e  hormone 
(Lees, 1981). The c y c l ic  GMP genera ted  by the  cyc lase  i s  then  
th o u g h t to  a c t iv a te  the c y c l ic  GMP -  dependent p ro te in  k inases  
(Le fkow itz , 1976; Baxter and Funder, 1979) and u lt im a te ly  produce 
the observed b io lo g ic a l  e f fe c t  o f the  hormone. However, i t  was 
observed th a t alpha2 -adrenoceptors (Tsai and Le fko w itz , 1979; Sabol 
and N ire n b e rg , 1979) but n o t a lp h a ^-a d re n o ce p to rs  are coupled to  
adenylate cyclase, and i t  appear th a t alphag-adrenooeptors in h ib i t  
adenylate cyclase a c t iv i t y  and the re fo re  reduce c y c lic  AMP le v e ls  
(Hoffman and Le fkow itz , 1980b). Alpha^-adrenoceptors do no t a ffe c t  
the adenylate cyclase system and probably have a d ire c t  e f fe c t  on 
calcium  ion  f lu x  across the c e ll  membrane (Butcher, 1978).
R. REGULATION OF ADRENOCEPTORS
Measurements o f  both re c e p to r number and a f f i n i t y  by d ir e c t  
rad io liga nd  b ind ing  methods have g re a tly  advanced the m derstand ing 
o f various fa c to rs  th a t  regu la te  adrenoceptor a  I t  i s  now apparent 
th a t  a w id e  v a r ie ty  o f hormones, d rugs and p h y s io lo g ic a l and
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p a th o lo g ic a l c o n d it io n s  may change adrenocepto r number and 
th e re fo re  s e n s i t iv i t y  o f t is s u e s  to  ca techo lam ines  (L e fk o w itz , 
1 979 ). Many o f  these  f in d in g s  have  im p o r ta n t  c l i n i c a l  
im p lic a tio n s .
Regulation o f adrenoceptors has been c la s s if ie d  as homologous" 
and "heterologous". Homologous re g u la tio n  i s  the re g u la tio n  o f the 
a d re n o ce p to rs  by the hormones o r agon ists th a t  norm ally in te ra c t 
w ith  those ad renocep to rs . By c o n tra s t,  h e te ro lo g o u s  re g u la t io n  
r e fe r s  to  a l l  o th e r in f lu e n c e s  th a t  re g u la te  th e  ad renocep to rs , 
such as o th e r types o f hormones or drugs th a t do n o t n o rm a lly  
in te ra c t d ire c t ly  w ith  the adrenoceptor (Le fkow itz , 1979).
TWo a d d itio n a l terms are commonly used to  describe adrenoceptor 
re g u la tio n . The terms «down re g u la tio n " and "up re g u la tio n "  re fe r  
to  d ir e c t io n a l  changes in  the number o f a d reno ce p to rs  under a 
p a r t i c u l a r  s e t  o f  p h y s io lo g ic a l  o r p a th o p h y s io lo g ic a l  
circumstances. Thus an in te rv e n tio n  th a t leads to  a reduc tion  in  
th e  number o f ad renocep to rs  on c e l ls  w ou ld  be s a id  to  "down 
re g u la te " the adrenoceptors, whereas an increase in  adrenoceptors 
would be re fe rre d  to  as "Up re g u la tio n " (Le fkow itz , 1979).
R.1. HOMOLOGOUS REGULATION
Homologous re g u la tio n  i s  re g u la tio n  o f the recep to rs  by hormones or 
drugs th a t normally in te ra c t w ith  those receptors.
I t  became apparent th a t  a w ide  v a r ie ty  o f hormones and drugs 
have the a b i l i t y  to  re g u la te  the c o n c e n tra t io n  o f  th e i r  own 
re c e p to rs  in  t is s u e s . In  g ene ra l, the  p a tte rn  t h a t  has been 
o b s e rv e d  i s  o f  an in v e r s e  r e la t io n  be tw een  th e  a m b ie n t 
concentra tion  o f the b io lo g ic a lly  a c tive  molecule and the number o f 
i t s  re c e p to rs  ( T e l l  a l ,  1978). Thus, h ig h  c o n c e n tra t io n s  o f
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hormone or drug seem to  "down re g u la te "  t h e i r  co rre sp o n d in g  
re c e p to r  number. In  c o n tra s t,  when hormone c o n c e n tra t io n s  are 
lowered, th e ir  corresponding receptor concentrations may increase 
("up re g u la t io n " ) .
With adrenoceptors, these hormone- and drug- re la te d  changes in  
adrenoceptor concentra tion appear to  mediate re a l changes in  tissue  
s e n s it iv ity  or responsiveness to  catecholanines (Le fkow itz , 1979).
5.1.1. J)oMn..rgftuIatiPD
C ontinued exposure to  in c re a se d  c o n c e n tra tio n s  o f  ca techo lam ine  
hormones or agon ists o ften  reduces adrenoceptor numbers, le a d in g  to  
a f a l l  in  tissue  responsiveness to  th a t agon ist (Wood, 1980). Such 
d im in ished responsiveness occurring  as a re s u lt  o f chron ic exposure 
to  a h ig h  le v e l  o f  th e  a g o n is t  i s  o f te n  r e f e r r e d  to  as 
ta c h y p h y la x is , de s e n s it is a t io n ,  r e f r a c to r in e s s  or to le ra n c e  
(Le fkow itz , 1980; M o tu ls l^  and In s e l, 1982a).
S eve ra l d i f f e r e n t  c e l lu la r  mechanisms a re  In v o lv e d  in  these 
processes. A ll  have in  common th a t they are promoted by agonists 
but no t antagon ists and u lt im a te ly  lead  to  the tra n s lo ca tio n  o f the 
su rfa c e  re c e p to rs  to  an in t r a c e l lu la r  lo c a t io n  (L e fk o w itz  and 
M ic h e l, 1983). In  some cases the  in t r a c e l lu la r  t ra n s p o r t  i s  
accomplished by specia l endocytotic ve s ic le s  th a t  a rise  a t  the c e ll  
s u rfa c e  (G o ld s te in  ^  j l ,  1979). Once w i t h in  the c e l l  th e  
recep to rs  may be degraded, processed, or recycled  back to  the c e ll 
surface. Agonist -  promoted in te rn a lis a t io n  o f recep to rs  may serve 
a number o f  very d is t in c t  fu n c t io n s . In  some cases i t  se rves to  
a tte n u a te  c e l lu la r  s e n s i t iv i t y  to  fu r th e r  hormonal o r a g o n is t 
s tim u la tio n . This may be accomplished by reduction  o f the number 
o f  f u n c t io n a l  r e c e p to r s  a t  the  c e l l  s u r fa c e  and by t h e i r
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s e q u e s tra tio n  w i t h in  th e  c e l l  in  compartments p h ys ica lly  removed 
from  the normal e f fe c to r  u n its . T h is  i s  one o f a number o f 
mechanisms responsib le  fo r  tachyphylaxis or de s e n s it is a tio n  to  drug 
and hormone actions. A lte rn a tiv e ly , in te rn a lis a t io n  o f the hormone 
-  re c e p to r complex may serve  as an e s s e n t ia l pathway in  th e  
a c t iv a t io n  o f the b io lo g ic a l response (Le fkow itz  and M ichel, 1983).
5.1.2. J)j3L régulation
By con tras t experimental ^m p a th e tic  denervation (e ith e r  s u rg ic a lly  
or p h a rm a c o lo g ic a lly  w ith  g u a n e th id in e  o r 6 - hydroxy dopamine) 
removes th e  to n ic  re le a se  o f n e u ro tra n s m itte r  n o ra d re n a lin e , 
le a v in g  adrenoceptors unoccupied. This re s u lts  in  an increase in  
adrenoceptor number lead ing  to  increased adrenerg ic responsiveness 
or d e n e rv a tio n  h y p e rs e n s i t iv it y  ( S p o r n ^ a l ,  1976; G la u b ig e r ^  
a l ,  1978). S im i la r ly ,  c h ro n ic  b lockade o f a d renocep to rs  by 
s p e c if ic  antagonists causes an increase in  receptor number. In  an 
anim al model, chronic treatm ent w ith  the adrenoceptor antagonist 
p ro p ra n o lo l le a d s  to  an in c re a s e  in  b e ta -a d re n o ce p to r number 
(G la u b ig e r  and L e fk o w i tz ,  1 977). In  h e a lth y  v o lu n te e r s ,  
a d m in is t r a t io n  o f  160 mg o f p ro p ra n o lo l d a ily  f o r  seven days 
increased lymphocyte beta-adrenoceptor number hy 30 to  50% (Aarons 
1980). A fte r  w ithdraw al o f propxrandol, the number o f beta- 
a d re n o c e p to r  s d e c re a se d  to  n o rm a l o ve r f o u r  days , b u t no 
p ro p ra n c ld  was detectab le  in  the plasma a fte r  the f i r s t  day; thus, 
f o r  se ve ra l days these s u b je c ts  had an in c re a se d  number o f 
recep to rs  in  the absence o f the beta-a(k*enooeptor b lock ing  <**ug, 
People w ith  hy per te n s io n  o fte n  have abnormal s y m p a th e tic -  
nervous-system responses, which resemble a hyperadrenergic s ta te , 
y e t  i s  a s s o c ia te d  w ith  on ly s l ig h t l y  increased concentra tions o f
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plasma catecholamines (Golcistein, 1981); in v e s tig a to rs  have looked 
f o r  p o s s ib le  changes in  ad renocep to rs . S tu d ie s  in  a n im a ls  us in g  
ra d io lig a n d  b in d in g  te chn iques  have supported  the n o tio n  th a t 
adrenoceptors are a lte red  in  experim ental hypertension (Woodcock e t  
1978; Woodcock and Johnston , 1980; Y a m a d a ^ ^ ,  1980; L im as 
and Limas, 1978,1979; P e ttinge r ^  j l ,  1982). In  hunans, Kafka 
^  (1979) found no d iffe re nce  in  [8h]DHA b ind ing to  lymphocytes o f  
h y p e rte n s iv e  s u b je c ts , and re p o rte d  th a t  the  number o f a lp h a - 
ad renocep to rs  (u s in g  the ra d io lig a n d  [3h]DHE) on the p la t e le t  
membranes o f  men (bu t no t women) w ith  h y p e rte n s io n  was norm al. 
M o tu lsky  ^  Jd  (1983), us ing  the a lpha2 - s e le c t iv e  ra d io lig a n d  
[^H]yohimbine, perfcrmed a study on normal and hypertensive men and 
found no d iffe rence  between h yp e rten s ive  s u b je c ts  and no rm a ls  in  
the  number o f a lpha 2 -a d re n o ce p to rs  on in t a c t  p la te le ts  o r i n  th e  
a f f in i t y  (d isso c ia tio n  constant) o f these s i te s  f o r  (^H lyo h im b in e  
or adrenaline. Furthermore^ an ti-hy  per tens ive  trea tm ent w ith  the 
alpha2 -a g o n is t guana be nz or the beta-antagonist p ropranolo l d id  not 
change the number or a f f in i t y  o f p la te le t  alpha2 > adrenoceptor s.
5.2. HETERQLQGWS REGULATION
Not only do the catecholamines themselves regu la te  th ie ir  rece j^o rs , 
b u t v a r io u s  hormones and o th e r in f lu e n c e s  a lso  c o n tro l re c e p to r  
numbers and p ro p e r t ie s . One o f the  more in te r e s t in g  exam ples i s  
th y ro id  hormones. C lin ic ia n s  have th ough t th a t  many o f  the 
symptoms o f c l in ic a l  hyperthyroidism  are s im ila r  to  what would be 
expected fo r  a "hyper-be ta -ad renerg ic" s ta te . These in c lu d e  such 
m an ifes ta tion s  as tachycardia, hyperdynamic c irc u la t io n , increased 
pulse pressure, hyperh idrosis, anxie ty and tremor. This impression 
has been s tren g th ene d  by the f in d in g  t h a t  p ro p ra n o lo l,  a b e ta -
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a d ren o ce p to r a n ta g o n is t, p ro v id e s  r e l i e f  in  many p a t ie n ts  w ith  
symptomatic hyperthyro id ism  (Le fkow itz , 1979). Nonetheless, c le a r- 
c u t evidence o f inc re a se d  s e n s i t i v i t y  to  b e ta -a d re n o c e p to r  
catecholamines in  pa tien ts  w ith  hyperthyro id ism  has been d i f f i c u l t  
to  document (Levey, 1971). I t  seems c le a r  th a t  t is s u e  and serum 
le v e ls  o f  ca techo lam ines  a re  n o t e le va te d  i n  p a t ie n ts  w ith  
hyperthyro id ism  (Christensen, 1972). The p o s s ib il i ty  th a t t ly r o id  
hormones m ig h t a l t e r  the  c o n c e n tra t io n  o f  b e ta -a d re n o ce p to rs  in  
t is s u e s  has been e xp lo re d  in  r a ts  rendered hyper th y ro id  by 
in je c t io n  o f  th y ro x in e  or t r i io d o th y ro n in e .  T h e re w a sa  h ig h ly  
s t a t i s t i c a l l y  s ig n i f i c a n t  in c re a s e  in  the  num ber o f  b e ta -  
adrenooeptors in  the hearts o f these hyper th y ro id  an im als w ith o u t 
ary change in  the a f f in i t y  o f b inding o f the an tagon ist C^HJEHA to  
these receptors  (W illia m s  1977a). Conversely, Banerjee and
Kung (1977) have shown th a t  the number o f  be ta - a d ren o ce p to rs  i s  
decreased in  the hearts o f hypothyroid ra ts .
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6. MIHODOLOGICAL APPROACH TD RADIOLIGAND
BiimiHG snm iEs ne adbehoceptors
6.1. GENERAL COMSTnFRATTnilS
The goal o f ra d io lig a n d  b in d in g  e xp e rim e n ts  i s  to  study the  
physicochemical in te ra c tio n  between ra d io a c tive ly  la b e lle d  lig a n d s  
and a d re n o c e p to rs . The b a s ic  te c h n ic a l  re q u ire m e n ts  f o r  
a d renocep to r s tu d ie s  are  a ra d io a c t iv e ly  la b e l le d ,  b io lo g ic a l ly  
a c t iv e  a d re n e rg ic  l ig a n d  (a g o n is t or a n ta g o n is t) ,  a t is s u e  
p re p a ra tio n  c o n ta in in g  ad renocep to rs , and a v a l id  method fo r  
separation o f bound and fre e  lig a n d  However, merely dem onstrating 
the presence o f bound l ig a n d  i s  no t s u f f i c ie n t  to  prove th a t  the 
observed b in d in g  i s  in  fa c t  to  a re c e p to r s i te .  In  o rd e r to  
e s ta b lis h  th a t the b in d in g  m easurem en ts  t r u l y  r e f l e c t  th e  
in te r a c t io n  o f l ig a n d  w ith  p h y s io lo g ic a lly  re le v a n t re c e p to rs , 
several c r i t e r ia  must be s a tis f ie d :
1. The ra d io lig a n d  must be p h ys io lo g ica lly  a c tive  and chem ica lly
pure. The presence o f even a sm a ll p e rce n t o f  r a d io a c t iv e  
im p u rity  might com plicate the in te rp re ta t io n  o f b ind ing  data.
2. S ince  there  should  on ly  be a f i n i t e  number o f re c e p to r  s i te s ,
the  b in d in g  o f  ra d io lig a n d  to  re c e p to r p re p a ra tio n s  must 
demonstrate s a tu ra b il ity  a t  the receptors.
3. The c o n c e n tra tio n  range over w hich  the  l ig a n d  o ccu p ies  th e
receptors should be comparable to  the concentra tion ran go over 
which i t  e l i c i t s  a b io lo g ica l response.
4. The b ind ing s ite s  la b e lle d  by the rad io lig and  must e x h ib it  the
s p e c if ic i ty  and s te re o s p e c if ic ity  o f the adrenergic response. 
The order o f potency o f agon ists in  e l ic i t in g  the b io lo g ic a l
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response should be r e f le c te d  in  t h e i r  o rder o f potency in  
competing fo r  the b inding s ites . The b io lo g ic a lly  a c tive  ( - )  
stereoisom ers o f adrenergic agonists should be more potent in  
com peting  fo r  the b in d in g  s ite s  than the le s s  a c t iv e  (+) 
s te re o is o m e rs .  S p e c if ic  a n ta g o n is ts  th a t  i n h i b i t  the  
b io lo g ic a l  a d re n e rg ic  response should b lo ck  the b in d in g  o f 
ra d io lig a n d .
5. The k in e t ic s  o f  b in d in g  should r e f le c t  th e  k in e t ic s  o f  the  
a d re n e rg ic  lig a n d  in  e l i c i t i n g  or a n ta g o n is in g  a b io lo g ic a l  
response.
In  general, i f  these c r i te r ia  are s a tis fie d , i t  i s  l ik e ly  th a t the 
m easured b in d in g  o f r a d io l ig a n d  re p re s e n ts  b in d in g  to  
adrenoceptors in  the tissue preparations under in ve s tig a tio n .
D u rin g  th e  la s t  tw o  decades hundreds o f  compounds have been 
synthesised th a t in te ra c t as e ith e r  a g o n is ts  or a n ta g o n is ts  w ith  
adrenoceptors (Table 1). The la rge  number o f these compounds and 
the w ea lth  o f pharmacological data on th e ir  ac tions  have provided a 
v i r t u a l l y  l im i t l e s s  source o f lig a n d s  th a t  can p o te n t ia l ly  be 
ra d io a c t iv e ly  la b e lle d .  For s p e c if ic  s tu d ie s  the cho ice  o f 
ra d io lig a n d  depends on several considerations, in c lu d in g  whether an 
a g o n is t o r a n ta g o n is t i s  d e s ira b le  and w he the r a t r i t i a t e d  or 
iod in a te d  lig a n d  is  most s u ita b la  However, there  are a number o f 
c h a r a c te r is t ic s  th a t  any c u r re n t ly  a v a ila b le  or new a d re n e rg ic  
ra d io lig a n d  should hava
1. The ra d io lig a n d  shou ld  have demonstrable b io lo g ic a l a c t iv ity
as an agon is t or antagonist.





























































tissues is  small, the rad io ligand  should have a h i ^  s p e c if ic  
ra d io a c t iv ity .  In  most cases i t  i s  very d i f f i c u l t  to  work w ith  
rad io ligands having a s p e c if ic  ra d io a c t iv ity  o f le s s  than 5 or 
10 C i/mmol.
3. The ra d io lig a n d  should  have a h igh  a f f i n i t y  fo r  the  re c e p to r
s ite s ,  thus p e rm it t in g  the use o f the  ra d io lig a n d  a t  low  
concentrations and reducing the l ik e lih o o d  o f b ind ing  to  non­
s p e c if ic  s ite s . In  add ition , the ra te  o f d isso c ia tio n  o f the 
ra d io l ig a n d  from  the re c e p to r s i te s  should be s u f f ic ie n t ly  
slow to  a llow  separation o f bound and fre e  rad io lig a n d  using 
cu rre n tly  a va ila b le  techniques.
4. The ra d io lig a n d  should  be c h e m ica lly  s ta b le  under th e  assay
con d it io n s  employed.
5. Id e a lly  the ra d io ligan d  should s p e c if ic a lly  in te ra c t w ith  only
one type o f re c e p to r s i te  under the assay c o n d it io n s  used. 
Thus the use o f ligands (e.& [^Hjphenoxybenzamine) w ith  the 
p o te n t ia l  to  b ind  to  seve ra l re c e p to r types w ould g iv e  a 
complex b ind ing  pa tte rn  th a t would be d i f f i c u l t  to  in te rp re t. 
Both t r i t i a t e d  and io d in a te d  lig a n d s  have been used f o r  b in d in g  
s tud ies o f adrenoceptors. Each type o f iso to p ic  la b e l l in g  has i t s  
advantages. T r i t ia t e d  lig a n d s  o f fe r  the advantages o f a lo n g  
ra d io a c tiv e  h a l f - l i f e  and no s ig n if ic a n t a lte ra t io n  o f the chemical 
s t ru c tu re  o f the  lig a n d  because o f the presence o f the  is o to p e . 
The p r in c ip le  advantage o f iod inated ligands i s  the high s p e c if ic  
ra d io a c t iv ity ,  fo r  example, the inco rpo ra tion  o f one atom per 
m olecule o f lig and  would give > 2000 C i/mmol. The disadvantages o f 
us in g  io d in a te d  lig a n d s  fo r  b in d in g  s tu d ie s  are  the  r e la t iv e ly  
sh o rt h a l f - l i f e  (60 days fo r  and the p o te n tia l a lte ra t io n  o f
b io lo g ic a l a c t iv i t y  caused by iod in a tio rv  However, fo r  s tud ies  o f
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systems in  which the amount o f b io lo g ica l m a te ria l is  very lim ite d , 
the  use o f  h ig h  s p e c i f ic  a c t i v i t y  io d in a te d  l ig a n d s  may 
s ig n if ic a n t ly  enhance th e ir  fe a s ib i l i t y .
C urren tly  ava ilab le  ra d io lig a n d s  have been used p r im a r i ly  in  
th ree  types o f experiments: k in e t ic  stud ies, sa tu ra tion  assays and 
com petitive  b ind ing experiments.
K in e tic  experiments determine how ra p id ly  a rad io ligand  binds 
to  a recep to r and d issocia tes from i t ;  these stud ies y ie ld  the ra te  
co n s ta n ts  c h a ra c te r is in g  th e  ra d io lig a n d - re c e p to r  in te r a c t io n .  
K in e tic  experiments also give p ra c tica l in fo rm a tio n : how long  i t  
ta k e s  fo r  the b in d in g  re a c t io n  to  reach e q u il ib r iu m  and how much 
ra d io lig a n d  d issocia tes from the receptors during the tim e requ ired  
to  separate bound from unbound rad io ligand.
S a tu ra tion  assays q u a n tita te  the concentration o f receptors and 
the a f f in i t y  o f these receptors fo r  the rad io ligan d  and have been 
the p r in c ip a l type o f experiment to  study adrenoceptors in  human 
tis s u e s . These assays a re  perform ed by in c u b a tin g  a co n s ta n t 
concen tra tion  o f tissue adrenoceptors w ith  various concentra tions 
o f  the rad io ligand . Radioligands ty p ic a lly  bind to  adrenoceptors 
in  a sa tu rab le  manner. The s p e c if ic  b inding approaches a maximum 
(B^ax^ th a t  represents the to ta l q uan tity  o f adrenoceptors present. 
The concentra tion  o f rad io ligand  tha t binds to  h a lf  th is  number o f  
adrenoceptors i s  the d issoc ia tion  constant (K^) and i s  a measure of 
the a f f in i t y  o f the adrenoceptors fo r  the rad io ligand, A sim ple 
rearrangement o f the s p e c if ic  b inding data in to  a Scatchard (1949) 
p lo t  (B /F  vs. B, where B and F re fe r  to  the amounts o f bound and 
f r e e  l ig a n d  re s p e c t iv e ly ) ,  a tra n s fo rm a tio n  th a t  u s u a lly  y ie ld s  
s t r a ig h t  l in e s  f o r  ra d io lig a n d  b in d in g  to  a d ren ocep to rs  and is  
commonly used to  d isplay and analyse the re su lts .
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C o m p e titive  b in d in g  experim ents de te rm ine  the a b i l i t y  o f  
v a r io u s  compounds to  compete w ith  the ra d io lig a n d  in  b in d in g  to  
a d ren o ce p to rs . These are c a r r ie d  ou t by in c u b a tin g  a co n s ta n t 
concentra tion  o f tissue adrenoceptors and rad io lig a n d  w ith  various 
concentra tions o f the competing com poind. As the concentra tion  o f 
th e  c o m p e tito r  inc rea se s , more adrenoceptors are occupied by i t ,  
and fe w e r are occupied by the ra d io lig a n d . The a f f i n i t y  o f the  
a d ren o ce p to rs  fo r  the  co m p e tito r (expressed as th e  d is s o c ia t io n  
constant K^) is  determined from the com petitive b ind ing curves
6.3. TIS9VL PREPARATIONS
Since many organs a re  respons ive  to  a lp h a - or b e ta - a d re n e rg ic  
s t im u la t io n ,  or both, the re  a re  many p o te n t ia l sources o f t is s u e  
fo r  adrenerg ic b ind ing studies. In  the ide a l s itu a tio n , the tissu e  
stud ied would consis t o f a sing le  c e ll type, since in te rp re ta t io n  
o f  b ind ing  data i s  complicated i f  the c e ll  type responsib le  fo r  the 
observed b ind ing is  unknown. In  a d d itio n  i t  would be advantageous 
to  use a t is s u e  th a t  i s  h ig h ly  en riched  in  ad reno ce p to rs , by 
analogy w ith  the e lec trop lax  (e le c t r ic  organ o f the e le c t r ic  eel) 
tissue  th a t has been extremely useful fo r the study o f c h o lin e rg ic  
receptors. U nfortunate ly to  date no human tissue  have been found 
th a t  i s  p a r t ic u la r ly  en riched  w ith  a lpha- or beta-adrenoceptors. 
T issues can be processed in  a v a r ie ty  o f  ways in  p re p a ra tio n  f o r  
b ind ing  stud ies. B inding o f adrenergic ligands has been measured 
in  is o la te d  in t a c t  c e l ls  (Brown .SLt .âl> 1976; M ukherjee and 
L e fk o w itz ,  1976b; In s e l ^  .a i, 1977), in  p a r t ic u la te  membrane 
fra c tio n s  (L e v itz k i .at .a l, 1974; Le fkow itz  ^  j i ,  1974; Aurbach ^  
j l I ,  1974; A lexander ^ . a l ,  1975a,b; W i l l i a m s £ i ^ ,  1976a,b; Za tz  
.a l, 1976; Maguire 1976a; Bylund and Sryder, 1976), and in
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so lub le  preparations (Caron and Le fkow itz, 1976). The measurement 
o f s p e c if ic  b in d in g  in  in t a c t  m ic ro sco p ic  p ieces  o f t is s u e  i s  
d i f f i c u l t  because of the lew density o f adrenoceptors and the  high 
n o n -s p e c if ic  r e te n t io n  o f  lig a n d  in  the t is s u e . P e rfo rm in g  
b in d in g  s tu d ie s  us ing  is o la te d  in ta c t  c e l ls ,  in  c o n tra s t w ith  
s tud ies  on membrane preparations or so lu b ilis e d  tissue , o ffe rs  the 
obvious advantage of m a in ta in ing  a s tru c tu ra l and m etabo lic  s ta te  
c lo s e r  to  th a t p resen t j j 3 ^ Iv o . However, the p re p a ra tio n  o f 
membrane f r a c t io n s  o f te n  a llo w s  a p a r t ia l  p u r i f ic a t io n  and 
concentra tion  of the s p e c if ic  type o f membrane m a te r ia l  (u s u a lly  
plasma membrane) con ta in ing  the greatest density o f receptors.
In  general, receptor b inding s ite s  are somewhat la b i le  as can 
be observed by the p a r t ia l  lo s s  o f  b in d in g  a c t i v i t y  when th e  
prepara tions are stored (unfrozen) fo r  several hours. However, the 
l a b i l i t y  o f the b ind ing s ite s  i s  in  most cases not nearly as g rea t 
as th a t  o f the adeny la te  cyc lase  c a ta ly t ic  a c t i v i t y .  In  genera l 
q u ic k  f  re e z in g  o f  membrane p re p a ra tio n s  p e rm its  p re s e rv a tio n  o f 
bo th  b in d in g  and adeny la te  cyclase  a c t i v i t ie s .  However in  some 
systems fre e z in g  and subsequent thawing o f tissue cause a s l ig h t  
increase in  the le v e l o f non-specific  b ind ing o f radioliggind.
6.4. ME-mODS OF ASSAYING SPECIFIC RADIOLIGAND BINDING
A v a r ie t y  o f  m ethods have been used to  q u a n t i f y  s p e c i f i c  
ra d io l ig a n d  b in d in g . In  genera l these methods re q u ire  a t o ta l  or 
p a r t ia l physical separation o f bound and fre e  ligand. They inc lude  
f i l t r a t i o n  and ce n trifu ga tio n .
FiltraUop
The most ra p id  and w ide ly used technique fo r  separating bound and 
f re e  l ig a n d  has been f i l t r a t i o n .  In  t h is  method a membrane
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prepara tion  i s  incubated w ith  rad io ligand  fo r  an appropria te  leng th  
o f tim e . Then th is  in c u b a tio n  s o lu t io n  or a p o r t io n  o f  i t  i s  
ra p id ly  f i l te r e d  under suction th ro u ^  a h o rizo n ta l 2.4 cm f i l t e r  
composed o f paper or o th e r a p p ro p r ia te  m a tr ix ,  and the  amount o f 
p a r t ic u la te  bound ra d io a c t iv ity  re ta ined on the f i l t e r  i s  measured. 
I f  a sm all volume is  used fo r  the incubation, i t  i s  advantageous to  
ra p id ly  d i lu t e  the  in c u b a tio n  in  b u ffe r  to  a volum e th a t  can 
homogeneously cover the f i l t o ^  to  m inim ize sample lo s s  on tra n s fe r 
o f the tube con ten ts . A fte r  f i l t r a t i o n ,  the  f i l t e r s  a re  washed 
ra p id ly  w ith  b u ffe r (5 to  30 ml) to  remove n o n -s p e c ific a lly  trapped 
l ig a n d . The optimum volume o f w ashing shou ld  be th e  amount th a t  
g ive s  the  maxim al re d u c t io n  in  n o n -s p e c if ic  b in d in g  w ith o u t  
re d u c in g  th e  le v e l  o f s p e c if ic  b in d in g . The most im p o r ta n t 
p r in c ip le  in v o lv e d  in  t h is  assay procedure i s  th a t  the  amount o f 
measured b in d in g  shou ld  r e f le c t  th e  amount o f  b in d in g  in  th e  
in c u b a t io n  ju s t  p r io r  to  se p a ra tio n  o f bound and f r e e  l ig a n d . 
Hence th e  se p a ra tio n  method must be s u f f i c ie n t ly  ra p id  th a t  an 
appreciab le  amount o f a sso c ia tio n  or d is s o c ia t io n  o f  l ig a n d  does 
not occur during the assay procedure 
CentrifuRatiQD
In  the c e n tr ifu g a tio n  method, a membrane preparation i s  incubated 
w ith  ra d io lig a n d  f o r  an a p p ro p r ia te  le n g th  o f tim e . A f te r  
c e n t r i fu g a t io n ,  the amount o f  p a r t ic u la te  bound ra d io a c t iv ity  is  
de te rm ined  by s im p ly  m easuring the r a d io a c t iv i t y  in  the p e l le t .  
The speed in  th e  c e n tr i fu g a t io n  method i s  ach ieved  by the  use o f 
" ta b le  to p "  c e n tr ifu g e s , w h ich  a llo w  ra p id  p e l le t in g  o f sm a ll 
a l iq u o ts  (100 to  200 ^ 1 ) .
The main disadvantage in  the c e n tr ifu g a tio n  technique, is  th a t 
the background le v e l o f nor>-specific b inding (possib ly because o f
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the  tra p p in g  o f  f re e  l ig a n d  in  the  p e l le t )  i s  h ig h e r than w ith  
o the r methods.
6 .5 . INCUBATION CQNDITTQMS
The incuba tion  o f rad io ligand  and receptor p reparation  should be a t 
a phys io log ica l pH, temperature, and io n ic  composition. W ith in  the 
broad co n s tra in ts  o f these conditions, there are very few absolute 
re q u ire m e n ts  th a t  must be met in  the in c u b a tio n  c o n d it io n s . 
S evera l types o f b u ffe r  systems, in c lu d in g  Hepes, phosphate and 
Tris-HCL, have been used in  adrenergic rad io ligand  b ind ing stud ies, 
which are usually ca rrie d  out a t  pH 7.4 -  7.6. The concentra tion  
o f ra d io lig a n d  in  the incubation  m ixtu re  i s  obviously an im portan t 
v a r ia b le ,  s ince  the  f r a c t io n  o f to ta l  b in d in g  o f  l ig a n d  t h a t  i s  
n o n -s p e c if ic  and n o n -s a tu ra b le  i s  h ig h e s t a t  h ig h  ra d io l ig a n d  
c o n c e n tra t io n s , i t  i s  a te c h n ic a l advantage i f  assays can be 
performed a t  re la t iv e ly  lew concentrations o f ra d id ig a n d .
6.6. NQMr.§PECIFl(I.BINDlMC
R a d io a c t iv e ly  la b e lle d  l ig a n d s , l ik e  many o th e r compounds, non- 
s p e c if i c a lly  adsorb to  glass, paper, c e llu la r  membranes, and o the r 
substances. Thus when measuring the amount o f ra d io a c t iv ity  bound 
to  a receptor preparation, i t  i s  im portan t to  su b tra c t the amount 
o f r a d io a c t iv e  "background" th a t  represents non receptor b in d in g  
In  p ra c t ic e ,  " n o n -s p e c if ic "  b in d in g  i s  d e fin e d  as the  amount o f  
measured r a d io a c t iv i t y  no t d isp la ce d  by a d re n e rg ic  a g o n is ts  and 
a n ta g o n is ts . The le v e ls  o f n o n -s p e c if ic  b in d in g  depend on a 
v a r ie ty  o f fa c to rs  in c lu d in g  th e  t is s u e  p re p a ra tio n , the  assay 
method, and the ra d io lig a n d  used. The na tu re  o f n o n -s p e c if ic  
b in d in g  i s  unknown. I t  i s  u s u a lly  n o n -s a tu ra b le  and g e n e ra lly
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occu rs  in s ta n ta n e o u s ly , A p o r t io n  o f n o n -s p e c if ic  b in d in g  may 
represent physical trapp ing  o f rad io ligand.
6.7. VALIDITY OF TN VTTRO ESTIMATIONS o f ADEIjYlJtTE CYCLASE COUPLED 
BETA-ADREMOCF.PTOBS
S u th e rla n d  and h is  co lleagues  developed th e  now w id e ly  accepted 
theo ry  th a t the  l i n k  between re c e p to r occupancy and b io lo g ic a l  
response is  o ften  in  the form o f so -ca lled  "second messengers" such 
as c y c lic  3% 5*- adenosine monophosphate (cAMP) and o th e r c y c l ic  
n u c le o tid e s  (S u th e rla n d  and R a il,  I9 6 0 ). They were th e  f i r s t  to  
demonstrate  tha t s tim u la tio n  o f m yocard ia l and h e p a tic  a d e n y la te  
cyclase by catechol anines in  broken c e ll preparations was mediated 
by a b e ta -a d re n o ce p to r. The order o f potency o f a g o n is ts  f o r  
enzyme s tim u la tio n  was isoprena line  > adrenaline > noradrenaline; 
and s tim u la tio n  was antagonised by the beta-adrenergic an tagon is t 
d ich lo riso p re n a lin e  (Murad jg i 1962).
Subsequently, a number o f in v e s tig a to rs  have studied, in  some 
d e ta i l ,  the  pharm aco log ica l c h a ra c te r is t ic s  o f  the  a d e n y la te  
c y c la s e  co u p le d  b e ta -a d re n o c e p to r  s. . I n  a l l  r e s p e c ts  th e  
s p e c if ic i ty  o f the receptor/cyclase complex determined in  v i t r o  is  
id e n t ic a l  to  the s p e c i f ic i t y  o f the complex as de te rm ined  by 
ph a rm a co lo g ica l techn iques on in ta c t  t is s u e s  ( R o s e n 1970;  
Mayer, 1972; G runf e ld  ^ 1974;  Kaumann and B irnbaum er, 1974; 
L e fkow itz , 1975; Mukherjee ^  j&l, 1975a).
A number of c h a ra c te r is tic s  o f adenylate qydase s tim u la tio n  by 
ca techo lam ine s  p rov id e  evidence th a t  the  b e ta -a d re n o ce p to r i s  
m e d ia tin g  these e f fe c ts .  When s tu d ie d  J j3 vitro, ca te ch o la m ine  
s t im u la t io n  o f the re c e p to r /c y c la s e  complex i s  c o m p e t it iv e ly  
antagonised by beta-adrenergic an tagonists; e ffe c ts  o f agon is ts  and
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a n t a g o n is t s  on th e  c o m p le x  d is p la y  th e  same m a rk e d  
s te re o s p e c if ic ity  th a t i s  apparent fo r  th e ir  ph ys io log ica l ac tions  
on in t a c t  t is s u e s , i.e . ( - )  isom ers a re  co n s id e ra b ly  more p o te n t 
than (+) isoraers (M ukherjee 1975a; T e l l  and C uatrecasas,
1974); th e  a b i l i t y  o f be ta - a d ren e rg ic  agents to  s t im u la te  or 
c o m p e t it iv e ly  an tagon ise  s t im u la t io n  o f the a d en y la te  c y c la se  
enzyme d ir e c t ly  p a r a l le ls  t h e i r  e f f ic a c y  a t  p h y s io lo g ic a l b e ta - 
adrenoceptor s, Moreover, the d iffe rences among beta-adrenoceptors 
in  in t a c t  t is s u e s  (e.g. be ta^, beta2 ) a re  c lo s e ly  m ir ro re d  by the  
s p e c if ic i ty  o f the adenylate cyclase -  coupled b e ta -a d re n o ce p to rs  
(L e fk o w itz ,  1975). S tud ies  o f  adeny la te  cyc lase  a c t iv a t io n  in  
broken c e l l  p re p a ra tio n s  have d e m o n s tra te d  t h a t  the  b e ta -  
adrenoceptors o f heart and adipose tissue  are beta^ (Mayer, 1972; 
Kaumann and B irnbaum er, 1974; L e fk o w itz , 1975), whereas those o f 
l iv e r ,  s ke le ta l muscle and l in g  are beta2 (Mayer, 1972; L e fkow itz , 
1975; Burges and B la ckbu rn , 1972). These f in d in g s  s u p p o rt the  
c o n te n t io n  th a t  both beta<j and beta2 ad renocep to rs  coup led  to  
a d e n y la te  c y c la s e  a re  the  p h y s io lo g ic a l ly  r e le v a n t  b e ta -  
a d re n o ce p to rs ; a g o n is t occupancy o f these re c e p to rs  s t im u la te s  
adenylate cyclase thereby increasing  c e llu la r  le v e ls  o f adenosine 
3 ', 5 ' monophosphate (c y c lic  AMP).
R ecently  i t  has been observed th a t alpha2-adrenoceptors (Tsai 
and L e fk o w itz ,  1979; Sabol and N ire n b e rg , 1979), but n o t a lpha^ 
receptors  are coupled to  adenylate cyclase, they in h ib i t  adenylate 
cyclase a c t iv i t y  and in  tu rn  decrease c e llu la r  q y c lic  AMP le v e ls .
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7. ADRENOCEPTORS IN DISEASE
7.1. GENERAL CONSTnF.RATTQH.^
There i s  a g row ing  awareness o f the need to  study d isease 
mechanisms a t  a c e l lu la r  le v e l .  Work w ith  is o la te d  organs or 
t is s u e  s l ic e s  re p re se n t moves in  th a t  d ir e c t io n ,  though many 
a r t i f a c ts  are in tie re n t in  th e ir  preparation, and th e ir  a p p lic a tio n  
to  man i s  very lim ite d . C e llu la r elements o f periphera l blood have 
th e re fo re  a g re a t h e u r is t ic  appeal s ince  they possess re c e p to rs  
s p e c i f ic  to  a number o f endogenous compounds, and they can be 
is o la te d  repeatedly and w ith  re la t iv e  ease, even during periods o f 
severe i l ln e s s . They the re fo re  provide a useful to o l fo r studying 
a number o f c e l lu la r  mechanisms. F o llo w in g  the d isco ve ry  o f 
a d e n y la te  cyc lase  in  so n ica te d  le u c o c y te s  (S c o tt, 1970) and th e  
presence o f b e ta -ad re n o cep to rs  in  p e r ip h e ra l b lood  le u c o c y te s  
(S m ith  and P arke r, 1970), i t  has been found th a t  these c e l ls  
possess h istam ine receptors (Bourne ^  1971) and prostag landin
re c e p to rs  (Bourne and Mel mon, 1971). In s u l in  (G avin ^  j i ,  
1 972; G avin  ^  jg l,  1974) and grow th  hormone re c e p to rs  (A rch e r ^  
a l , 1973) have also been described.
Since the section on reg u la tio n  o f adrenoceptors (see section  
5) has d e sc rib e d  v a r io u s  adrenocepto r d is o rd e rs  in  d iseases, the 
present d iscussion w i l l  concentrate on adrenoceptor dysfunction  in  
b ro n d iia l asthma, which i s  the sub ject o f th is  thesis.
7 .2 . SZENTIVANYI HYPOTHESIS
S ^entivany i (1968) postu la ted th a t the a top ic  s ta te  and bronch ia l 
h y p e r - r e a c t i v i t y  in  asthm a r e s u l t s  fro m  a re d u ce d  b e ta -  
adrenoceptor fu n c tio n  and a re la t iv e  increase in  a lpha- adrenergic 
a c t i v i t y .  Th is  c o n te n tio n  was based on o b s e rv a tio n s  o f reduced
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beta2 m e ta b o lic  responses such as hyperg lycaem ia  and p e r ip h e ra l 
v a s o d ila t io n  in  a s th n a tic  pa tien ts  fo llo w in g  a d m in is tra tio n  o f beta 
a g o n is ts  as compared to  these responses in  n o n -a to p ic  norm al 
sub jects  (Cookson and Reed, 1963; M iddleton and Finke, 1968).
O ther w o rke rs  showed th a t  beta a d re n e rg ic  blockade enhances 
b ro n c h ia l r e a c t iv i t y  to  in h a le d  a lle rg e n s  (O u e lle t te  and Reed, 
1967) o r to  m e thacho line  (McGeady ^  1968) in  p a t ie n ts  w ith
seasonal a lle rg ic  r h in i t i s  w ith o u t a previous h is to ry  o f b ronch ia l 
asthma. By progressively increasing doses o f the beta b locker, an 
acute airway o b s truc tion  could be produced which seemed to  reach an 
in t e n s i t y  th a t  may be found in  p a t ie n ts  w ith  b ro n c h ia l asthma 
(McGeady ^ 1968) .  A d m in is tra t io n  o f beta b lo c k e rs  has a ls o  
been re p o rte d  (M c N e ill,  1964) to  aggrava te  a lread y  e x is te n t  
asthm atic  cond itions and to cause p rec ip itou s  and prolonged f a l l s  
in  Forced E xp ira to ry  Volume in  1 second (FEV-j). Blockade o f beta- 
a d renocep to r s was found to  inc re ase  s ig n i f ic a n t ly  the b ro n c h ia l 
s e n s it iv i ty  o f asthm atic subjects to  methacholine, whereas no such 
e f f e c t  was d e te c ta b le  in  normal human s u b je c ts  as judged by the  
change in  FEV^  (Zaid and B e a ll, 1966).
This hypothesis has there fore  a ttra c te d  considerable a tte n t io n  
and provoked a g reat deal o f research. Several groups (Logsdon
1972; Parker and Smith, 1973; A lston ^  1974) have stud ied
a s th m a tic  p a t ie n ts  us ing  leucocyte  beta-adrenoceptors. They have 
reported  depressed beta-adrenoceptor func tio n , a t  le a s t during the 
a c t iv e  phases o f  the disease and have in te rp re te d  these data as 
supporting  Szentivary i*s hypothesis. However, o ther workers (Grieco 
1968; Z a i d £ l ^ ,  1968; G i l le s p ie  j a t 1974) were unab le  
to  f in d  a s ig n if ic a n t d iffe rence  between normal sub jects  and most 
a s th m a t ic  p a t ie n t s .  C o n o lly  (1 9 8 0 ), re je c te d  S ze n tiva n y i» s
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Inypo tiies is  be lie v in g  th a t the depressed beta-adrenoceptor a c t iv i t y  
found in  such pa tien ts  can be tte r be explained as a consequence o f 
prolonged exposure to  h igh le v e ls  of exogenous or endogenous beta- 
adrenerg ic agonists (Greenacre and Conolly, 1978).
7.1. ALPHA-ADRENOCEPTORS TN A5^TH /^l
In c re a se d  a lp h a -a d re n e rg ic  responsiveness has been d e sc rib e d  in  
a s th n a tic  pa tien ts  (Henderson ^  1979) although l i t t l e  is  known
about th e  r o le  o f a lpha -ad reno cep to rs  in  human asthma, a lpha  
re c e p to r  a n ta g o n is ts  have been shown to  m od ify  e x e rc is e  and 
a lle rg e n - in d u c e d  asthma (P a te l and K err, 1975; P a te l ^ J i l , 1 9 7 6 ) .  
In  an animal model o f chronic asthma a small decrease in  pulmonary 
beta-adrenoceptor numbers accompanied ty a pronounced increase in  
a l pha-ad renocep to r numbers has been shown (Barnes 1980a).
In  human lu n g  th e re  i s  some evidence fo r  in c re a se d  a l pha- 
a d ren o ce p to r s in  lu n g s  from  p a tie n ts  w ith  a irw a ys  o b s tru c t io n  
(Barnes ^  j l ,  1980b). Previous stud ies using [^H]DHE were ab le to  
id e n t i f y  a lp h a -a d re n o cep to rs  in  human lym phocytes (Sano jg i ja l,  
1981a,b), but th e  subtype was no t d e fine d , and th e  p re lim in a ry  
evidence has ind ica ted  th a t the lymphocytes o f p a tien ts  w ith  asthma 
have e levated numbers o f [3 h]DHE-b ind ing  s ite s , which are presumed 
to  in d ic a te  increased numbers o f a l pha-adrenoceptor s.
7 .4 . BRONCHIAL ASTHMA
B ro n c h ia l asthma i s  a c o n d it io n  c h a ra c te r is e d  by e p is o d ic  and 
va ria b le  breathlessness. This breathlessness re s u lts  from  w ide -  
spread narrow ing o f in t r  a pulmonary airways and va rie s  in  seve rity  
over short periods o f time, e ith e r spontaneously or w ith  treatm ent. 
V a ria b le  narrow ing o f the periphera l airwsys i s  ciie to  one or a l l
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of the fo llc w in g :
1. Contraction o f bronchial smooth muscle (b ronchoconstric tion )
2. Oedema of the mucous membrane
3. Mucus w ith in  the lumen
B ro n c h o c o n s tr ic t io n  may be re la te d  to  exposure to  e n v iro n m e n ta l 
fa c t ix s ,  e spec ia lly  inha led  substances in  c o n c e n tra t io n s  th a t do 
not a f fe c t  the m a jo rity  o f persons, or may occur w itho u t apparent 
e x te rn a l cause. D e te c ta b le  fa c to rs  in c lu d e  s p e c if ic  a n t ig e n -  
a n tib o d y  (Ig E ) re a c tio n s , u s u a lly  to  in h a le d  a n tig e n s , hyper­
r e a c t iv i t y  o f the a irw a ys  to  p h ys ica l and chem ica l s t im u l i ,  and 
exercise.
R e s tin g  b ro n c h ia l * tone' can be dem onstra ted in  b ro n c h ia l 
musculature by a decrease in  airway res is tance a fte r  a d m in is tra tio n  
o f b ronchod ila to r drugs.
In  th e  la s t  f i f t e e n  yea rs  i t  has been recogn ized  th a t  the  
airways in  normal sub jects are under the con tro l o f the autonomic 
nervous system and c o n s tr ic t re f le x ly  fo llo w in g  many chemical and 
m echan ica l s t im u l i ,  a lthough  th is  n a rro w in g  u s u a lly  does n o t 
produce symptoms or signs. The dominant symptom in  bronch ia l asthma 
is  b re a th le ssn e ss  -  an unp leasan t awareness o f d i f f i c u l t y  in  
b re a th in g  w h ich  may be sensed n o t on ly  in  e x p ira t io n  but a ls o  in  
in s p i r a t io n  e s p e c ia lly  when th e re  i s  marked h y p e r - in f la t io n .  
T ig h tn e ss  in  th e  chest i s  then a lso  a component o f  the  dyspnoea. 
Wheezing usually  accompanies both in s p ira t io n  and e x p ira tio n  unless 
the  asthma i s  so severe th a t  the reduced a i r  f lo w  is  unab le  to  
c re a te  the sound. The p a t te r n  o f  wheezy b re a th in g  v a r ie s  
considerably, i t  may be ep isod ic in  which the episodes are sho rt or 
long  or i t  may p e rs is t fo r  very long periods.
There i s  now a w ide choice o f te s ts  fo r  assess ing  a irw a y
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fu n c t io n .  Tests based on the fo rc e d  e x p ira to ry  manoeuvre a re  
re p e a ta b le  and fo r  many purposes measurement o f  peak e x p ira to ry  
f lo w  (PEF) or fo rc e d  e x p ira to ry  volume in  one second (FEV-|) i s  
adequate. Pulmonary function  te s ts  in  asthma have th ree  main uses; 
f i r s t ,  to  make the diagnosis; second, to  a s s is t in  the assessment 
o f the s e v e r ity  o f an a s th m a tic  a t ta c k ; t h i r d ,  to  m o n ito r the  
course and i t s  m od ifica tio n  by treatment.
Some re g a rd  t h is  b ro n ch ia l h y p e r - re a c t iv ity  as th e  c e n tra l 
a b n o rm a lity  in  the a s th m a tic  s u b je c ts . The p re c ise  causes a re  
u n c e rta in . The amount o f  muscle in  th e  b ro nch i o f a s th m a tic  
s u b je c ts  i s  inc reased , bu t i t  has no t been shown to  be more 
r e a c t iv e  in  v i t r o . Both nervous and hum oral fa c to rs  have been 
postu la ted  in  the pathogenesis o f bronchial r e a c t iv ity .  There i s  
d ispute  as to  whether a stim ulus causes an abnormal acute response 
( in c re a s e d  re le a se  o f humoral m e d ia to rs  o r abnorm al f i r i n g  o f a 
nervous r e f le x )  o r w hether the enhanced r e a c t iv i t y  i s  due to  a 
normal acute response superimposed on increased re s tin g  bronchia l 
tone. Abnormal release o f mediators has not been demonstrated but 
temporary h y p e r-re a c tiv ity  develops in  normal sub jects  w ith  v i r a l  
in fe c t io n s ,  p o s s ib ly  due to  abnormal s t im u la t io n  o f i r r i t a n t  
recep to rs  in  the bronchial mucosa. There is  no doubt tha t c l in ic a l  
and fu n c t io n a l evidence o f h y p e r - re a c t iv ity  is  g re a t ly  enhanced 
when th e re  i s  p re -e x is t in g  a irw ay na rrow ing . There a re  a t  le a s t  
th ree  reasons fo r  th is  e ffe c t o f airway narrow in& F ir s t ,  a given 
absolute change in  airway d iane te r w i l l  produce a la rg e r  increase 
in  a i r f lo w  re s is ta n c e  i f  i n i t i a l  d iam e te r i s  reduced; second, 
in c re a s e s  in  b ro n c h ia l tone may p o te n t ia te  the s t im u la t io n  o f  
i r r i t a n t  r e c e p t o r s  a n d  t h e  i n i t i a t i o n  o f  r e f l e x  
b ro n c h o c o n s tr ic t io n ; th i r d ,  in c re a se s  in  tone p o te n t ia te  the
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e ffe c ts  o f b ronchoœ nstric tor drugs.
Asthma i s  b road ly  d iv is ib le  in to  two groups: e x t r in s ic  and 
in t r in s ic .
Extrinsic or atopic asthnrg
T h is  r e fe r s  to  the la rg e  group in  whom asthma i s  due to  Ig E - 
mediated h y p e rs e n s itiv ity  reac tions  to  in h a le d  a n tig e n s  commonly 
p re sen t i n  th e  a ir .  Many o f them a lso have seasonal or p e re n n ia l 
a l le rg ic  r h in i t is .  Most of them s ta r t  having wheezy breathlessness 
e a r ly  in  l i f e ,  in  some a f te r  i n f a n t i l e  eczema. In  some th e  e a r ly  
ep isodes are pro longed, and masquerade i n i t i a l l y  as a t ta c k s  o f  
b r o n c h i t is  and bouts o f  coughing. The s p e c ia l l i a b i l i t y  which 
these p a tie n ts  show to develop IgE an tibod ies as a re s u lt  o f minor 
exposure to  common env ironm en ta l a n tigens  has been e s tim a te d  to  
a f fe c t  about 10% o f people and is  presumably genetic. I t  has been 
c a l le d  a to p y . In  th e  name used f o r  t h i s  s o r t  o f  asthm a, 
‘ e x t r in s ic ’ im p lie s  th a t asthma i s  p re c ip ita te d  by c o n ta c t w ith  
e n v iro n m e n ta l a n t ig e n s  and ’ a to p ic *  r e fe r s  to  th e  s o r t  o f  
h y p e rs e n s it iv ity  re a c tion  th a t is  concerned.
Intrinsic asttm
W ith  i n t r i n s i c  asthma on th e  o th e r hand wheezy b re a th le ssn e ss  
a lth ou g h  e p is o d ic  a t  f i r s t  tends to  be much more p e rs is te n t .  The 
i l ln e s s  usually  s ta r ts  la te r  in  l i fe ^  o ften  in  the la te  20s or 30s, 
but no age is  exempt. A fra n k  a lle rg ic  background is  not found but 
p e re n n ia l r h i n i t i s  i s  no t uncommon. A s p ir in  s e n s i t iv i t y  is  
som etim es a fe a tu re  and nasal po lyps n o t an in f re q u e n t f in d in g .  
The onset o f  i n t r in s ic  asthma i s  o f te n  re la te d  to  an acu te  
re s p ir a to r y  in fe c t io n  and p e rs is te n ce  o f in f e c t io n  i s  a s e r io u s  
ill a t te r .
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B ro n cho d ila to rs
B ro n c h o d i la to r  drugs are  d e fin e d  as drugs w h ich  re la x  b ro n c h ia l 
1 .iu s c le  and decrease b ro n c iiia l tone. In  anim als, the e f fe c t  
uiay be d e i.io n s tra te d  on is o la te d  b ro n c h ia l smooth m uscle and in  
in t a c t  a n im a l p re p a ra tio n s , by in h ib i t in g  b ro n c h o c o n s tr ic t io n  
induced  by h is ta m in e  and a c e ty lc h o lin e  a dm in is tra tion . In  man, 
the  el f e e t  may be dem onstrated by the r e l i e f  o f  'spontaneous* 
bronchospasm or th a t induced by exercise or other challenge.
At present, bronchodila tor drugs, as defined above, are e ith e r  
a n t i-c h d in e rg ic s ,  adrenergics or xanthine d e riva tives . In  a d d itio n  
to  re la x in g  the smooth muscle o f the bronchus, they have o th e r 
a c t io n s  w h ic h  may be o f im p o rta n c e  in  r e l i e v in g  a irw a y s  
o b s tru c t io n .  They are known to  in f lu e n c e  sm a ll b lood  vesse l 
fu n c t io n  and so may reduce oedema and in  a d d it io n  can e x e r t  a 
p ro p h y la c tic  e ffe c t by in h ib i t in g  m ed ia to r re le a s e  from  the  lu n g  
mast c e lls . They can be used fo r  the r e l ie f  o f the acute a tta ck  or 
they may be taken continuously, where they e xe rt a 'p rophy lac tic * 
e ffe c t. Presumably, th e ir  e ffectiveness when given ch ro n ica lly  is  
p a r tly  due to  in h ib it io n  o f mediator release but may also be due to  
suppressing the bronchoconstrictor e ffe c t o f the re leased m ediators 
on the bronchia l smooth muscle.
A d re n e rg ic  drugs a re  extrem e ly  u s e fu l in  th e  management o f  
asthma, whereas a n t ic h o l in e rg ic s  have a l im i t e d  ro le .  I t  may be 
th a t  d e s p ite  the poor in n e rv a t io n  th e re  are  numerous b e ta - 
a d ren o ce p to rs  w h ich  can respond to  c i r c u la t in g  a d re n a lin e  or to  
a d re n e rg ic  drugs used in  the rapy. S t im u la t io n  o f  ad renocep to rs  
produces broncho d i la ta t io n  in  a n im a ls  and a decrease in  a irw a ys  
re s is ta n c e  in  man. R ecently , evidence has accum ula ted to  suggest 
th a t there are alpha-adrenoceptors in  the bronchi and these could.
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w hen s t im u la t e d  u n d e r c e r t a in  c irc u m s ta n c e s , p roduce  
b ronchoconstric tion . N o rm a lly , however, the b e ta -a d re n o ce p to rs  
(b ronch ia l re laxant) are the predominant adrenoceptors in  a irw ays 
smooth m us c l e. A d rene rg ic  b ro n c h o d ila to r  drugs m ust th e re fo re  
s tim u la te  beta-adrenoceptors.
C la s s i f i c a t io n  o f b ro n c h o d ila to r  drugs i s  based on th e  
a u to n o m ic  p h a rm a c o lo g y  o f  b r o n c h ia l  s m o o th  m u s c le .  
B ronchod ila ta tion  is  produced by beta-adrenoceptor s tim u la tio n  and 
b ronchoconstric tion , by s tim u la t io n  o f c h o lin e rg ic  re c e p to rs  and 
p o s s ib ly  too, a l ph a -adrenocep tor s. The a v a ila b le  drugs can be 
c la s s if ie d  as:
1. A n tic h o lin e rg ic  drugs, e,g, atropine
2. Sympathomimetic (adrenergic) drugs
a) w ith  alpha and beta e ffe c ts , e,g, adrenaline, ephedrine
b) w ith  beta^ and beta2 e f fe c ts  but no a lpha e f fe c ts ,  e,g.
isoprena line
c) w ith  se le c tive  be 1^2 e ffec ts , e,& salbutarndl, te rb u ta lin e
3. O the rs , m e thy l xan th ines , e,g, a m in o p h y llin e  and c h o lin e
U ieophy llina te .
Gluoocorticoidg
These should be reserved fo r  more severe or p ro tracted  asthma th a t 
does no t respond to  the proper use o f bronchodila tors. T he ir mode 
o f  a c t io n  in  th e  r e l i e f  o f the a irw ay o b s tru c t io n  i s  unknown. 
However, the e ffe c ts  are not immediate^ and as much as 6 hours may 
be needed before any b e ne fit can be demonstrated Consequently, in  
acu te  s i tu a t io n s ,  v igo rous  b ro n c h o d ila to r  therapy should  be 
co n tin u e d  w h i le  s te ro id s  a re  be ing a d m in is te re d  In  a d d it io n ,  
th e re  i s  some suggestion  th a t g lu c o c o r t ic o id s  can re s to re  b e ta - 
a d re n e rg ic  responsiveness in  both normal and a s th m a tic  s u b je c ts
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(E l lu l-H i c a lle f  and Fenech, 1975; Hclgate ^  1977; S henfie ld  ^
1 975).
Ô. .CIRCADIAN RHYTHM (DIURNAL VARIATION)
8 .1 . GENERAL CONSIDERATIONS
A ltnough  research  in  th e  f i e ld  o f  human 24 -  hour rhy thm s has a 
h is to r y  o f about 150 years, i t  i s  on ly d u rin g  the  l a s t  15 ye a rs  
th a t re a l progress has been made towards a b e tte r understanding o f 
the mechanisms involved, A few genera lisa tions can new be made 
(Aschoff and VJever, 1976):
1. N early  a l l  s tru c tu re s  and fu n c t io n s  seem to  undergo re g u la r
changes from  day to  n ig h t. These d iv e rs e  rhythm s keep 
d is t in c t  phase re la t io n s h ip s  to  each o th e r under normal 
cond itions, representing temporal order w ith in  the organism,
2. In  s u b je c ts  kept in  is o la t io n  and d e p rive d  o f  p e r io d ic  (24-
hour) in p u ts  from the environment, the rhythms continue w ith  
periods s l i ^ t l y  d if fe re n t from 24 hours. Le; the rhythms are 
"free -runn ing ", l ik e  autonomous s e lf -s u s ta in e d  o s c i l la t io n s ,  
and hence belong to  the class o f c ircad ian  rhythms,
3. The human c irc a d ia n  system c o n s is ts  o f a m u l t i p l i c i t y  o f
o s c i l la t o r s  th a t  a re  u s u a lly  coupled to  each o th e r but may 
change th e ir  phase re la tio n s h ip  depending on cond itions, and 
may even become desynchronized, free -runn ing  w ith  d if fe re n t  
frequencies.
8.2. DIURNAL VARIATION IN ASTHMA
I t  i s  w e l l  known th a t  c e r ta in  fe a tu re s  o f  asthma show a marked 
d iu rn a l v a r ia t io n . Large d iu rn a l sw ings in  peak e x p ira to ry  flo w  
ra te  (PEFR) and early  morning wheezing are commonly seen in  asthma
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p a t ie n ts  and may be re la ted  to  the high incidence o f sudden asthma 
deaths in  h o s p ita l in  the early rncrning (Cochrane and C lark, 1975) 
as some have been known to  have marked d iu rn a l sw ings in  peak 
e x p ir a to r y  f lo w  be fo re  th e i r  death. Also p a t ie n ts  w ith  a irw a ys  
o b s tru c tio n  commonly complain tha t th e ir  wheeze v a rie s  in  seve rity  
fro m  t im e  to  t im e , o fte n  c o n s is te n t ly  a t c e r ta in  tim e s  o f  the  24 
hours. Th is  was f i r s t  documented in  I960 (Lewinschn ^  I960),
but l i t t l e  i s  known of the prevalence and nature o f such v a r ia t io n  
in  a s th m a t ic s  and in  o the r p a t ie n ts  w ith  a irw a ys  o b s tru c t io n  
(T u rne r-Warwick, 1977).
C o r t ic o s te ro id  drugs do n o t reduce d iu rn a l v a r ia t io n  in  PEFR 
(S o u ta r ^  1975), a lthough they may w e l l  produce b e t te r
subsequent c o n tro l o f the a tta c k . The best p h a rm aco log ica l 
s o lu t io n  to  the problem appears to  be to  ensure th a t  adequate 
th e ra p e u t ic  le v e ls  o f  sym pathom im etic drugs a re  m a in ta in e d  
th ro u ^ o u t the n igh t, although they reduce d iu rn a l v a r ia t io n  but do 
not abo lish  them,
8 .3 . CIRCADIAN RHYTHM OF ALPHA- AND BETA-ADRENQCEPTQBS
R e ce n tly , i t  was shown th a t th e re  i s  a d iu rn a l v a r ia t io n  in  the 
number o f s p e c if ic  b e ta -a d re n e rg ic  b in d in g  s i t e s  in  r a t  p in e a l 
g land ( R o m e r o ^ ^ ,  1975), w ith  the  h ig h e s t number a t  1800 h and 
th e  lo w e s t a t  0600 h. A lso c irc a d ia n  rhy thm s in  th e  numbers o f  
alpha- and b e ta -ad re nocep to rs  e x is t  in  the r a t  fo re b ra in  and 
hypothalanus (Kafka ^  1981). I t  has also been reported  th a t
in  a s th m a tic  s u b je c ts , plasma c y c l ic  AMP showed a s ig n i f i c a n t  
c ircad ia n  v a r ia t io n  w ith  peak values a t  1600 h and t r o u ^  values a t  
0400 h (Barnes ^  3 l t  1982). In  norm als, plasma c y c l ic  AMP 
c o n c e n tra t io n s  a lso  dem onstrated a c irc a d ia n  v a r ia t io n  w ith  the
53
inaxirnurj concentration a t  1400 h and the minimun a t  0200 h (M ikuni 
1978).
9. UMPHQCnES as a tool for receptor stddies in asthmatics
Hiere are d i f f i c u l t ie s  th a t hinder d ire c t in v e s tig a tio n  o f c e l lu la r  
mechanisms in  human lun&  A simple so lu tio n  to  th is  problem, f i r s t  
suggested by Sm ith and Parker (1970), has been to  use p e r ip h e ra l 
b lood le u c o c y te s , which them se lves  possess b e ta -a d re n o ce p to rs . 
This approach presupposes a pharm aco log ica l id e n t i t y  between the  
lu n g  and le u c o c y te  re c e p to rs . There has been c o n s id e ra b le  
enthusiasm fo r  the use o f leucocytes, e ith e r as a mixed popula tion 
o f c e lls  or as p u r if ie d  lymphocytes.
S evera l s tu d ie s  ( L o g s d o n 1972;  P arker and S m ith , 1973; 
A ls to n  ^  _al, 1974; G i l le s p ie  1974) have been re p o rte d .
These a u th o rs  have a l l  assumed th a t  the  b e ta -ad re n o cep to r o f the  
le u c o c y te  i s  id e n t ic a l  w ith  th a t in  the  lun g . C ono lly  and 
Greenacre (1977)» showed th a t the lymphocyte beta-adrenoceptor is  
r e a d i ly  b locked by (± ) p ro p ra n o lo l, b u t appears to  be f a r  le s s  
s e n s it iv e  to  the  e f fe c t  o f  p ra c to lo l.  The same p a tte rn  o f 
s u s c e p t ib i l i t y  to  the d i f f e r e n t  b e ta -b lo c k e rs  i s  seen in  lu n g  
t is s u e . Both p ro p ra n o lo l and p ra c to lo l  have been shown in  o th e r 
tissues to  e xe rt only a simple com petitive  antagonism, and stud ies 
w ith  another beta b locking drug, a lp re no lo l, in  human lymphocytes 
(W illia m s  .â l, 1976b) in d ic a te  tha t beta blockade i s  a re v e rs ib le  
co m p e tit ive  antagonism in  th is  c e ll  model. Salbutamol s tim u la ted  
the lymphocyte beta-adrenoceptor, being about one ten th  as a c tiv e
as isop ren a lin e .
On the basis o f these studies the lymphocyte adrenoceptor may 
a c c o rd in g  to  La nd 's  c l a s s i f i c a t i o n  (L a nd s  j u l » 1967) be
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c a te g o ris e d  as be ta  2 and in  t h is  re sp e c t i s  v a l id  as a model fo r  
studying beta-adrenoceptor fu n c tio n  in  asthma.
In  summary, the fc l lc w in g  workers have used lymphocytes in  the 
search fo r  adrenoceptor d isorders in  asthma; Conolly and Greenacre, 
1976; Kariman and Le fkow itz , 1977; Greenacre _al, 1978; Brooks ^  
1979; S z e n t i v a n y i ^ ^ ,  1979; S a n o ^ ^ ,  1981b; M e u r s ^ ^ ,  
1 982; T a s h k i n ^ ^ ,  1982; Van den B e r g ^  j l ,  1982,
10. 1H£ THESIS
S zentivany i ' s  (1968) h yp o th es is  th a t  an in h e re n t d e fe c t o f b e ta - 
adrenoceptors might underlie  a range o f a to p ic  diseases, in c lu d in g  
bronch ia l asthma has s tim u la ted  a g reat deal o f research. Several 
re p o rts  (Haddock ^  jg l, 1975; Kariman and Le fkow itz , 1977; Brooks 
^  3 l f  1 979) appeared to  suppo rt t h is  idea , however, o th e rs  (Z a id  
e t  1968; G i l le s p ie  ^  j l ,  1974) f a i le d  to  c o n firm  these 
f in d in g s .  I t  has a lso  been suggested by o th e rs  (C o n o lly  and 
Greenacre, 1976; Galant ^  1980) th a t the receptor abnorm ality
is  drug induced.
P a tien ts  w ith  asthma have marked v a r ia t io n s  in  b reath ing over 
24 h w h id i is  not seen in  nor>-asthmatic subjects. This v a r ia t io n  
is  thought to  be due to  changes in  con tro l o f the bronch ia l muscle 
tone and mediated v ia  the receptors in  the bronchia l smooth muscle, 
fo r  the Qfmpathetic nervous system.
T h is  c irc a d ia n  v a r ia t io n  in  th e  bronchom otor tone, o fte n  
demonstrated as the morning d ip  in  FEV  ^ could be due to  changes in  
the  numbers and/or the s e n s it iv ity  o f beta-adrenoceptors or re la te d  
to  humoral c ircad ian  rhythms.
B lood  lym phocytes have s im ila r  beta-adrenoceptors (beta2) and 
t h is  study uses these lym phocyte  re c e p to rs  as a model o f events
55
ta k ing  place in  the bronchia l smooth muscle over a 24 h period.
The l im i ta t io n  of previous work were:
1. No in d ic a tio n  o f sample time,
2. No a tte m p t to  in v e s t ig a te  re c e p to r number and re c e p to r
s e n s it iv i ty  a t d if fe re n t times of the day.
These c r i te r ia  are im portant because in  asthm atic p a tie n ts  lung
fu n c t io n  i s  on ly im p a ire d  a t  a c e r ta in  tim e  d u rin g  the day, and
obviously the tim e fo r  c o lle c tin g  blood sample i s  very im portant,
11. AIMS OF THIS THESIS
1, V a lid a tio n  o f previous beta-adrenoceptor methodology in  human 
lymphocytes,
2, To in v e s t ig a te  be ta -ad re nocep to r fu n c t io n  in  norm a ls  and 
a s tlm a tic  p a tien ts  a t d if fe re n t tim es o f the day and n igh t. 
Many a s th m a tic  p a t ie n ts  have n o c tu rn a l asthma around m id ­
n ig h t and a morning d ip  in  FEV^. These changes in  v e n t i la t io n  
may be a consequence o f a d iu r re l rhythm in  the number and/or 
the s e n s it iv ity  o f the beta-adrenoceptors,
3, To assess th e  e f fe c t  o f  o r a l ly  a d m in is te re d  b e ta -a g o n is t
(s a lb u ta m o l)  on b e ta -ad re n o cep to r fu n c t io n  and to  see 
w hether, in  accordance w ith  the h y p o th e s is  o f  S z e n tiv a n y i 
th e re  was some appa ren t re c e p to r d y s fu n c tio n  in  e x t r in s ic  
a s th m a tic s  and i f  exposure to  a beta2-a g o n is t  induced  
tac ty  phylaxi s,
4, To e s ta b lis h  an assay fo r  e s t im a tin g  lym phocyte  a lpha2-  
adrenoceptors,
5 , To com pare th e  a lp h a ib e ta  a d re n o c e p to r  r a t i o ,  A lp h a -
a d ren o ce p to rs  have re c e n t ly  been i d e n t i f i e d  i n  human 
lym phocy tes  and p re lim in a ry  evidence in d ic a te  in c re a se d
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number o f a lpha-adrenoceptors  in  lym phocytes o f a s th m a tic  
p a tie n ts . Therefore comparing the alphaibeta receptor r a t io  




L is t in g  o f  a l l  reagents and consumables used in  th is  th e s is  can be
found in  Appendix A.
HETHODS
1. M T  LUNG STUDIES
1.1. preparation of RAT-LUNH
H ale  Sprague-Dawley ra ts  (200-250 g) were k i l l e d  by c e rv ic a l 
d is lo ca tio n . Lungs were homogenised using an u L tra -tu rra x  (6 x 10 
sec) in  20 voluiies o f 025 mol/1 sucrose conta in ing  50 mmol/1 T ris , 
1 mmol/1 ligC l2 pH 7.4, fo llow ed by 10 strokes using a motor d riven  
te f lo n -p e s t le ; the homogenate was f i l t e r e d  th ro u ^  three la y e rs  o f 
gauze. A fte r ce n tr ifu g a tio n  (lOOOg, 10 min, 4C) the crude nuclear 
p e lle t  was discarded. The supernatant was cen trifuged  (lOOOOg, 20 
m in, 4 0  and the crude m ito c h o n d r ia l p e l le t  d isca rded . The 
su p e rn a ta n t was re c e n tr ifu g e d  (70000g, 60 min, 4C) to  o b ta in  th e  
microsomal p e lle t  which was resuspended in  assay b u ffe r (50 mmol/1 
I r i s ,  5 mmol/1 MgCl2 pH 7 .8 ). The m icrosom al p e l le t  (s to re d  on 
ice ) was used in  a l l  experiments,
1 .? . SATURATTOH SUJDIES WITH f3H1DHA
In  the sa tu ra tion  assay, membrane suspension (0.3-0.35 mg p ro te in ) 
was incubated a t  30C w ith  [3h]DHA (1-12 nm ol/1), and n o n -sp e c ific  
b ind ing was determined in  the presence o f 10 ;m o l / l  ( - )  p ropranolo l 
in  a f i n a l  volume o f 250 )j1. A f te r  20 rain, 2.5 ml ic e -c o ld  assay 
b u ffe r  was added to  each tube and f i l t e r e d  under reduced pressure 
through Whatman GPC glass m ic ro fib re  f i l t e r s  (p re-w etted  in  assay 
b u f fe r ) ,  then the f i l t e r s  were washed tw ic e  w ith  8 ml ic e - c o ld
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assay b u ffe r  ( f i l t e r i n g  and w ash ing to o k  le s s  than  15 sec). The 
f i l t e r s  were d r ie d  a t  room tem pera tu re , then shake^ w ith  10 ml 
to lu e n e  ; T r i to n  X-100 (2 : 1) s c i n t i l l a t o r  and th e  r a d io a c t iv i t y  
determined (e ff ic ie n c y  50%). The to ta l b ind ing a t each p o in t was 
determined by measuring the ra d io a c t iv ity  obtained when incubations 
were perfo rm ed in  the absence o f the a n ta g o n is t ( - )  p ro p ra n o lo l.  
The s p e c if ic  b in d in g  a t  each [XJint was d e fin e d  as th e  d if fe re n c e  
between to ta l  and n o n -s p e c if ic  b in d in g . S a tu ra t io n  assays were 
c a r r ie d  o u t in  p o ly s ty re n e  tu b e s  (12 x 75 mm). P r o te in  
concentra tion  was estim ated using the commercially a va ila b le  B io - 
Rad k i t  based on dye-binding assay (Coomassie B r i l l i a n t  Blue G-250) 
as described by Bradford (1976).
1 .3 . EQUILIBRIUM BINDING TIME
Tubes w ith  lung membrane suspension (0.3-0.35 mg p ro te in ) in  assay 
b u f fe r  were set up on ic e . A t d i f f e r e n t  t im e  in te r v a ls  s ta r t in g  
from  ze ro  tim e , [ ^H]DHA (4 nm ol/1) was added to  th e  tubes. Non­
s p e c if ic  b in d in g  was de te rm ined  in  the presence o f  10 pm ol/l  ( - )  
p roprano lo l fo r each tim e; the f in a l  volume was 250 pi. The tubes 
were incubated a t  30C fo r  various in te rv a ls  (15 sec, 30 sec, 1 min,
2 min, 4 min, ............ 60 m in). Then 2.5 ml o f ic e -c o ld  assay
b u f fe r  was added to  each tube , f i l t e r i n g  and d ry in g  as b e fo re . 
T o ta l and n o n -s p e c if ic  b in d in g  were de te rm ined  i n  p a r a l le l  
dup lica te  saaples and a t each tim e in te rv a l.  Assays were c a rr ie d  
out in  polystyrene tubes (12 x 75 mm).
1 . 4 .  DISSOCIATION O FJB hidha FM H  LUNG H M M J ffiS
D isso c ia tio n  o f s p e c if ic a lly  bound [3h]DHA from  receptor s ite s  was 
evaluated by incuba ting  membrane suspension (0.3**(5*35 mg p ro te in )
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a t 30c w ith  [^HJDHA (4 nmol/1) to  e q u ilib riu m . Then 10 >jmdL/l ( - )  
p ro p ra n o lo l was added, and s p e c if ic  b in d in g  was e s tim a te d  a t 
v a ry in g  t im e  in te r v a ls  (10 sec, 20 sec, 30 sec, 45 sec, 1 min, 2 
m in, ........... 10 m in).
1 .5 . .CQMPmTIVE BINDING STUDTRS
Membrane suspension (0.3-0.35 mg p ro te in )  in  assay b u f fe r  was 
in cuba ted  a t  30C w ith  [3h]DHA (4 nmol/1) and vary ing  concentra tions 
o f (+) o r ( - )  p ro p ra n o lo l in  a f i n a l  volume o f 250 p i .  A f te r  20 
min the samples were f i l t e r e d  and d ried  as before. To ta l b ind ing 
was de te rm ined  by measuring th e  amount o f  [3h]DHA bound when 
in c u b a t io n s  w ere  p e rfo rm e d  in  the  absence o f  (+ ) o r  ( - )  
p ro p ra n o lo l.  Other drug d isp lacem en t curves w ere  o b ta in e d  
s im ila r ly  by s u b s titu t in g  the appropriate drug fo r  proprano lo l.
2. LYMPHOCTTE SIVDIES
2.1. LYMPHOCYTE ISOLATION
Lymphocytes were prepared from heparin !sed blood by a m o d if ic a tio n  
o f the techn ique  o f  H a r r is  and U k a e jio fo  (1970), w h ich  produced a 
c e ll  population o f approximately 90-96% lymphocytes, the remainder 
o f the c e lls  were monocytes, and recoveries o f  90-94%.
Blood (50 ml) was co llec ted  in to  Evans h e p a rin !sed b o ttle s , 8 
m l/b o t t le ,  g e n tly  mixed to  d is t r ib u te  h e p a rin  and c e n tr ifu g e d  
(250g, 20 min, 15C). The p la t e le t - r ic h  plasma was a s p ira te d  and 
d isca rded . The p e l le t  was d ilu te d  1 : 3 (V /V) w ith  b u f fe r  A. 
B u ffe r A was prepared by adding 0.1% c a l f  serum and 20 mmol/1 Hepes 
to  E a r le 's  Balanced S a lt  S o lu t io n  (w ith o u t  sodium b ic a rb o n a te ) 
a d ju s te d  to  pH 7 .6 . 8 ml p o r t io n s  o f  t h i s  s u s p e n s io n  o f
e ry tliro cy tes and leucocytes were c a re fu lly  Icyered  onto 12 ml o f
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ly n if iio c y te  separa tion  medium, density 1,077 ±  0.001 g ml“ 1, in  30 
ml un iversa l containers and centrifuged (250g, 25 min, 15C). The 
m ilk y  la y e r o f lymphocytes was harvested from the in te rfa c e  using a 
pasteur p ip e tte , washed by d ilu t in g  1:3 w ith  b u ffe r A, cen trifu ge d  
(250g, 15 rnin, 150  and the supernatant discarded. The p e lle t  was 
res us pen dec in  20 nil of bu ffe r A and gently disaggregated.
The a d d i t io n  o f 0.1% c a l f  serum to  th e  medium red uce d  
ly m p h o c y te  a g g re g a tio n  and ensured an adequate y ie ld  (90-94%) o f 
c e l ls .  C e l ls we r e counted in  a C ou lte r C e ll C ounter; f i n a l  c e l l  
c o n c e n t ra t io n s  w ere u s u a lly  in  th e  range o f  2 .5 -3 .0  x 10^ 
l y  niphocy te s /m l.  C e ll v i a b i l i t y  was assessed by t r y  pan blue 
e x c lu s io n  and was found to  be g re a te r than 95% d u r in g  a l l  the 
procedures described above,
2 .2 . LÏMPHQCÏTE (X)UNTIMG AND VIABILITY
2 2 .1 . V ia b le  c e ll count
The use o f tryp a n  blue s ta in  i s  based on th e  a b i l i t y  o f  v ia b le  
c e lls  to  exclude the dye (Merchant ^  jd ,  I960).
0.1 ml o f 0.4% tryp a n  blue (0.4 g try p a n  blue in  BSS) were 
added to  0.5 ml o f lymphocyte suspension in  a polystyrene tube (12 
X 75 mm). The co n te n ts  were m ixed and a llo w e d  to  stand fo r  5 min. 
C e lls  were counted using an "improved Neubauer" counting chamber a t  
a m a g n if ic a t io n  o f 40 to  g iv e  the to ta l  lym phocyte  count and 
percentage o f unstained lymphocytes; unstained c e lls  are assumed to  
be v iab le ; Results are expressed as % v ia b le  lym phocytes
222. Coulter counter settings for white blood cell counting
The instrum ent was set up w ith  a 100 p i  o r if ic e ,  0.5 ml manometer
volume and the a ttenua tion  sw itch  (which sets the s e n s it iv i ty  o f
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the  C o u lte r Counter a m p li f ie r )  to  p o s it io n  0,707. The a p e rtu re  
c u r re n t s w itc h  (w hich  c o n tro ls  the amount o f c u r re n t f lo w in g  
between the two e lectrodes) was set to  p o s itio n  16. The th resho ld  
co n tro l (which determines the s ize  le v e l above which the Model ZF 
counts; the instrum ent w i l l  count a l l  o f the pulse t ip s  which reach 
or exceed the g iven th re s h o ld  va lue , but none below) was s e t to  
p o s it io n  10. These were standard se ttin g s  cu rren tly  in  use in  the 
Haematology Dept, fo r  lymphocyte counting,
2 2 .3 . W h ite  blood c e ll counting
40 p i o f lyrnpliocyte suspension were d ilu te d  w ith  20 ml ISOTON IL  
To o b ta in  w h ite  blood c e ll counts the use o f a s trom ato lys ing  agent 
was necessary. 6 drops o f  ZAPONIN (a fa s t  a c t in g  l y t i c  agent fo r  
the com p le te  l y s is  o f red c e lls )  was added and a f te r  m ix in g  by 
in v e rs io n  th e  red  c e l ls  ly s e d  im m e d ia te ly  as co n firm e d  by 
m icroscopy. The C ou lte r Counter was set up as describe d  (2 .2 .2 .) 
and th e  c e l ls  counted as fo l lo w s :  th e  v ia l  c o n ta in in g  th e  w h ite  
c e ll  d i lu t io n  was placed on the beaker p la tfo rm , making sure th a t 
the o r i f ic e  wafer and externa l electrode were f u l ly  immersed. The 
co n tro l tap was opened to  zero the counter mechanism, and a c tiv a te  
the two e lectrodes. The con tro l tap was then closed and the  w h ite  
c e l l  count read d ir e c t ly  from  the d is p la y  as c e l l  count per 
m ic r o l i t r e  o f s o lu t io n . The number o f w h ite  b lood  c e l ls  i n  th e  
b lood  and in  the sample were e s tim a te d  each tim e , and the  
percentage o f lymphocytes was estim ated by preparing a blood f i lm  
sta ined w ith  Romancwsky sta ins. These s ta in s  vary in  com plexity 
but depend fo r  t h e i r  e f fe c ts  on th e  in te r a c t io n  o f  a b a s ic  dye 
(methylene blue) and an a c id ic  dys (eosin).
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2.3. LYMPHOCYTE BETiUAnRFMnrFpT^fi^
2.3.1. -S a tu ra tion  analysis
The l ig a n d  L ^ ^ ^ I]h y d ro x y b e n z y lp in d o lc l (L^^^I]H Y P ), w hich has a 
h igh  a f I i  n i ty  fo r  be ta -ad renocep to rs  (Aurbach 1974) was
used.
The sa tu ra tion  assays were done in  polypropylene tubes (12 x 75 
mm) in  a f i n a l  volume o f  500 p i  co m p ris ing  fo r  the to ta l  b in d in g , 
lymphocyte suspension (250-350 pg p ro te in ) and [125 i ] hyp in  a range 
o f c o n c e n tra tio n s  (50-800 pm ol/1) in  b u ffe r  A. Tubes used to  
de te rm in e  n o n -s p e c if ic  b in d in g  con ta in e d  ( - )  p ro p ra n o lo l (0.3 
p m o l/1 ). T o ta ls  and n o n -s p e c if ic  b in d in g  were e s tim a te d  in  
d u p lica te  a t each [T^^1]HYP concentration. The tubes were se t up 
on ic e  and [^^^ I]H Y P  added to  s ta r t  the re a c t io n  fo llo w e d  by 
in c u b a tio n  a t  30C in  th e  dark ( to  m in im ise  p h o to ly s is  o f  the  
[^^^I]HYP) fo r  45 min. The re ac tion  was stopped by the a d d itio n  o f 
2.5 ml b u f fe r  B (50 mmol/1 T r is  (pH 7 .6 ), 0.9% sodium c h lo r id e  and 
0,1 mmol/1 (±) propranolol a t 370). The samples were then allowed 
to  stand fo r  45 sec b e fo re  f i l t e r i n g  th rough  Whatman GFC g la s s  
m ic ro fib re  f i l t e r s  (presoaked fo r  60 min in  b u ffe r B) by app ly ing  a 
vacuum o f 3-4 psi, and the f i l t e r s  were rinsed  w ith  3 x 10 ml o f 50 
mmol/1 T r is  (pH 7.6) and 0.9% sodium c h lo r id e  a t  370. F i l t e r in g  
and r in s in g  w ere com plete w ith in  12 sec. The f i l t e r s  w ere  a i r  
d r ie d , shaken w ith  10 ml o f e m u ls if ie r  s c i n t i l l a t o r  299 and the  
ra d io a c t iv ity  was determined (30% e ffic ie n c y ).
Pj»Qggij-] c o n c e n tra t io n  was e s tim a te d  us ing  the c o m m e rc ia lly  
a v a ila b le  Bio-Rad k it .
2.3.2. Ifinptlc analysis of fl^ TIHTP binding
Tubes w ith  lymphocyte suspension (250-350 >Jg p ro te in ) in  b u ffe r A
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were set up on ice. A t d if fe re n t tim e in te rv a ls  s ta r t in g  from zero 
tim e, [^^^I]HYP a t  appropriate concentration (0,4 nm ol/1) was added 
to  the  tub e s ; and n o n -s p e c if ic  b in d in g  was de te rm ined  in  th e  
presence o f 0.3 prnol/l ( - )  propranolol in  a f in a l  volume o f 500 p L  
The tubes w ere incuba ted  a t  30C fo r  v a rio u s  in te r v a ls  (1 min, 2
m in, 4 m in, o min, .............  60 m in), then 2.5 ml o f b u f fe r  B was
added to  each tube, f i l t e r in g  and drying as before. Tota l and non­
s p e c if ic  b in d in g  were e s tim a te d  in  p a r a l le l  d u p lic a te s  a t  each 
tim e  in te rv a l.
D isso c ia tion  o f s p e c if ic a lly  bound [ ‘•25i]hyp was evaluated by 
in cuba ting  lymphocyte suspension (250-350 pg p ro te in ) in  b u ffe r A 
a t 30C w ith  [ 1]HYP (0.4 nmol/1) fo r 45 min to  a llow  e q u ilib r iu m , 
then 0.3 jjnol/1 ( - )  p rop randc l was added, and s p e c if ic  b ind ing was 
e s tim a te d  a t  v a ry in g  t im e  in te r v a ls  (1 min, 2 min, 4 min, 10 min,
20 m in, ...............  60 m in), as above. Assays were perfo rm ed in
polypropylene tubes (12 x 75mm).
2.3.3. C om petitive b ind ing  s tu d ie s
To dem onstra te  s te re o s p e c if i c i  ty o f the b e ta -a d re n o ce p to rs , 
lym phocyte  suspension (250-350 pg p ro te in )  in  b u f fe r  A was 
in cu b a te d  a t  30C w ith  a f ix e d  c o n c e n tra tio n  o f [^^^ I]H Y P  (0.4 
nm ol/1) in  the presence o f varying concentrations o f the (+) or ( - )  
s te re o is o m e rs  o f  p ro p ra n o lo l (10 pmol/1  to  1 m m ol/1) in  a f i n a l  
volum e o f  500 p i .  A f te r  45 min, the samples w ere f i l t e r e d  and 
d r ie d  as be fo re . T o ta l b in d in g  was de term ined by m easuring th e  
amount o f  [125i]hyP bound when incubations were performed in  the 
absence o f (+) or ( - )  propranolo l. The s te re o sp e c ific  assays were 
pe rfo rm ed  in  d u p lic a te  in  po lyp ropy lene  tubes. O ther drug 
d isp la ce m e n t curves were ob ta ined  s im i la r ly  by s u b s t i tu t in g  th e
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appropriate dr'ug for propranolol,
2 .4 . H ljPHQCYTE ALPHAo-ADRENOCEPTDRS
2 .4 .1 . S atu ra tion  ana1v< i^
The l ig a n d  [ -^H ]yohim bine, a po ten t and se le c tiv e  pharmacological 
an tagon is t w itn  nigh a f f in i t y  fo r  alpha2-adrenoceptors (Motulsky 
Âlf 1980; D a i g u j i ^ ^ ,  1981) was used.
The s a tu ra t io n  assays were done in  po lyp ro p y le n e  tubes (12 x 
75mm) in  a f in a l  volume of 500 p i comprising fo r  the to ta l binding, 
lymphocyte suspension (250-350 pg p ro te in ) and [^H lyohim bine in  a 
range o f c o n c e n tra tio n s  (1-20 nm ol/1) in  b u ffe r  A. In  tubes used 
to  de te rm ine  n o n -s p e c if ic  b in d ing , phento lam ine (10 p m o l/1 ) was 
a ls o  added. T o ta l and n o n -s p e c if ic  b in d in g  w ere e s tim a te d  in  
dup lica te  a t each [^HJyohimbine concentration.
The assay m ixtures were prepared on ice  and then incubated fo r  
25 min a t  25C, The reac tion  was stopped by the a d d itio n  o f 2,5 ml 
o f b u f fe r  C (50 mmol/1 T r is  and 0.9% sodium c h lo r id e , pH 7.6) a t  
25C, The samples were then f i l t e r e d  th rough  Whatman GFC g la s s  
m ic ro fib re  f i l t e r s  (pre-wetted in  bu ffe r C) by applying a vacuum o f 
3-4 p s i,  and the f i l t e r s  were r in se d  w ith  2 x 10 ml o f  b u f f  er C a t  
25C, F i l t e r in g  and r in s in g  were com plete w i t h in  12 sec. The 
f i l t e r s  w e re  a i r  d r ie d ,  shaken w i t h  10 ml o f  e m u ls i f i e r  
s c i n t i l l a t o r  299 and th e  r a d io a c t iv i t y  was de te rm ined  (50% 
e f f ic ie n c y ) .  P ro te in  c o n c e n tra tio n  was e s tim a te d  u s in g  the  
com m ercially a va ilab le  Bio-Rad k i t .
2.4.2. KinPt.ic Misivs ts  o f  r^Hlvohlmbine binding
Tubes w ith  lymphocyte suspension (250-350 pg p ro te in ) in  b u ffe r A 
were set up on ice. At d if fe re n t tim e in te rv a ls  s ta r t in g  from  zero
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tim e , [ -^H] y o h im b ine (5 n m o l/1) was added to  the  tube s ; and non­
s p e c if ic  b in d in g  was de term ined in  the presence o f  10 pm ol/1  
phentol amine in  a f in a l  volume o f 500 p i.  The tubes were incubated
a t  25C f o r  v a r io u s  in te r v a ls  (0 .25, 0 .5 , 1.0 , 2 .0 , 4 .0, .........
3O.O m in ), then 2.5 ml o f b u ffe r  C was added to  each tube, 
f i l t e r i n g  and d ry in g  as be fo re . T o ta l and n o n -s p e c if ic  b in d in g  
were estim ated in  dup lica te  a t each tim e in te rv a l.
D issoc ia tion  of s p e c if ic a lly  bound [3 H]yohimbine was evaluated 
by incuba ting  lymphocyte suspension (250-350 pg p ro te in ) in  b u ffe r 
A a t  25c w ith  [^H ]yoh im b ine  (5 nm ol/1) f o r  25 min to  a llo w  
e q u ilib r iu m , then 10 pmol/1  phentol amine was added, and s p e c if ic  
b in d in g  was e s tim a te d  a t  v a ry in g  tim e  in te r v a ls  ( 0 .5 , 1.0 , 2 .0 ,
4.0, 10.0, ............ 60.0 min) same as above. Assays w ere done in
polypropylene tubes (12 x 75mm).
2.4.3. Coffpgtitive bindinR studigg
To demonstrate s te re o s p e c ific ity  o f the alpha2-adrenooeptor s ite s , 
lym ph o cy te  suspension (250-350 pg p ro te in )  in  b u f fe r  A was 
incubated a t  25C w ith  [^H]yohimbine (5 nmol/1) in  the presence o f 
v a ry in g  c o n c e n tra t io n s  o f  (+) or ( - )  s te re o iso m e rs  o f  a d re n a lin e  
(10 pmol/1  to  1 m m ol/1) w ith  the a d d it io n  o f  0.8 mmol/1  a s c o rb ic  
ac id  (to  in h ib i t  ox ida tion  o f the catecholamine), in  a f in a l  volume 
o f  500 p i .  A f te r  25 min, the samples were f i l t e r e d  and d r ie d  as 
before; Tota l b inding was determined by measuring the  amount o f 
[3H]yohimbine bound when incubations were performed in  the absence 
o f  (+) o r ( - )  a d ren a lin e . T o ta l and n o n -s p e c if ic  b in d in g  w ere 
e s tim a te d  in  d u p lic a te  using po lyp ropy lene  tubes. O ther drug 
d isp la cem e n t curves were performed s im ila r ly  ty  s u b s titu t in g  the 





F ive p a tie n ts  w ith  e x tr in s ic  asthma and f iv e  normal v o lm te e rs  were 
s tu d ie d . The a s th m a tic  p a t ie n ts  were in  re m is s io n  and w ere a l l  
known to  have re v e rs ib le  a ir f lo w  obstruction. A ll sympathomimetic 
drugs in d u c in g  salbutamol and theop l:y lline  com pounds were stopped 
and the p a tie n ts  maintained on ip ra trop ium  bromide as necessary fo r 
seven days be fo re  commencing the study, so th a t  the b e ta - 
a d re n o ce p to rs  w i l l  have recovered from  any be ta -a g o n i s t induced  
de s e n s it is a t io n .  None o f the p a t ie n ts  was on in h a le d  or o ra l 
s te ro id  therapy. The pa tien ts  gave informed consent and the study 
was approved by the Medical E thics Committee o f the h o sp ita L
PrQtQQgl
Studies were performed in  the re sp ira to ry  u n it  and the asthm atic 
p a t ie n ts  were a d m itte d  a t  le a s t  2 days be fo re  the study was 
commenced so as to  become accustomed to  th e  su rround ings . Both 
groups were fa m i l ia r  w ith  having blood samples taken.
The fo llo w in g  sequence o f te s ts  was performed on each p a tie n t 
or vo lun tee r. On day 1, 50 ml o f blood was w ithdrawn a t  1800 h fo r  
e s t im a t io n  o f plasma c o r t is o l  and is o la t io n  o f  lym phocy tes  fo r  
b e ta -a d re n o ce p to r e s tim a tio n . On day 2 , 50 ml o f b lood  was 
w ith d ra w n  as above a t 0800 h and then 4 mg o f  sa lb u ta m o l was 
a d ii i in i s te re d  o r a l ly  a t  4 h in te r v a ls .  A t 1800 h, a fu r th e r  b lood  
sample was taken and the dosage o f salbutamol continued. On day 3 
(0800 h ), 50 ml o f b lood was w ithd ra w n  as above, the sa lb u ta m o l 
stopped and previous therapy resumed. FEV^  and FVC were determined
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a fte r  ta tdng each blood sample,
3 .2 . STUDY I I
Subjects
Four p a tie n ts  w ith  e x tr in s ic  asthma and f iv e  normal vo lun teers were 
s tu d ie d , ihe a s th m a tic  p a t ie n ts  were in  re m is s io n  and w ere a l l  
known to  have re v e rs ib le  a ir f lo w  obstruction. They were taken o f f  
a l l  in h a le d  and o ra l sym pathom im etic drugs and m a in ta in e d  on 
in h a le d  ip ra tro p iu m  bromide as re q u ire d  fo r  seven days b e fo re  
commencing the study. None o f the pa tien ts  was on inha led or o ra l 
s te ro id  therapy. The p a tien ts  gave informed consent and the study 
was approved by the h o sp ita l Medical E th ica l Committee,
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Studies were performed in  the resp ira to ry  u n it  and the asthm atic 
p a t ie n ts  were a d m itte d  a t  le a s t  2 days b e fo re  the study was 
commenced. Both groups were f a m i l ia r  w ith  ha v ing  b lood  sam ples 
taken. The s u b je c ts  were tre a te d  a cco rd in g  to  the p ro to c o l 
d e s c r ib e d  above w ith  th e  a d d i t io n  o f  a lp h a 2 -a d re n o c e p to r  
es tim a tion .
In  both studies, plasma c o r t is o l was estim ated using C o rt is o l 
Radioimmunoassay k i t  in  the MRC-Blood Pressure U n it, Western 
In firm a ry .
3.3. DETERMINATION OF FEV  ^ AMD FVC
Forced E x p ira to ry  Volume in  one second (FEV^) and Forced V i t a l  
C ap a c ity  (FVC) w ere measured us ing  a V ita lo g ra p h  dry wedge 
sp irom eter (Cotes, 1975). The best o f three attem pts was used fo r  
a n a ly s is  and volume co rre c te d  to  body tem pera tu re  and p re ssu re
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s a tu ra te d  (BTPS),
4 . TECHNIQUES OF RECEPTOR AMAl.YSTS
4.1. TOEQBÏ-.OF. LIGAND -  RECEPTOR TMTRRAnTTnHS
A lthough  the exact phys icochem ica l na tu re  o f the  in te r a c t io n  o f 
a d re n e rg ic  agen ts w ith  re c e p to r s i te s  is  unknown, the use o f 
tliennodynaiijic p r in c ip le s  a llow s the d e riva tio n  o f sim ple equations 
t i ia t  appear to describe the behaviour of adrenergic drug -  receptor 
system s. These c a lc u la t io n s  can be a p p lie d  to  the  a n a ly s is  o f  
b in d in g  da ta  from  s tu d ie s  us ing  ra d io a c t iv e  a d re n e rg ic  lig a n d s . 
Host o f  the concepts p resented  here  are  d e rive d  from  the  mass 
a c t io n  la w  ( H i l l ,  1909), from  the p harm aco log ica l theory o f  A.J. 
C lark (1933), and from the c lass ic  Michael is  -  Menton a n a lys is  o f 
enzyme substra te  k in e tic s . The ana lys is  presented here depends on 
a number o f s ta te d  assum ptions, and o u t l in e s  th e  s p e c i f ic  
experim enta l cond itions requ ired  i f  the ana lys is  i s  to  be app lied  
to  ra d io lig a n d  b ind ing studies,
4.1.1. Law o f mass ac tio n
The s im p le s t m e c h a n is tic  assum ption th a t  can be made about th e  
in te ra c t io n  of a rad io a c tive  ligand, L, w ith  a receptor, R, i s  th a t 
a s in g le  m o le cu le  o f L re a c ts  rev er s ib ly  w ith  a s in g le  re c e p to r  
molecule, R, to  form a complex RL, as shown in  Eq. (1 );
K.
L + R < — FL . . . . ( 1 )
K_1
Each m olecu lar in te ra c t io n  i s  assuned to  be independent o f other 
in te ra c tio n s . Then a t e qu ilib rium , a d ire c t consequence o f the law
of mass a c tio n  is
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[R] [L]
[RL] . . . . ( 2 )
where [R ] ,  [ L ] , and [RL] re p re se n t the  c o n c e n tra tio n s  o f  f re e  
re c e p to r  s i te s ,  unbound l ig a n d , and l ig a n d - re  ce p to r  complex 
r e s p e c t iv e ly .  K-j and a re  th e  k i n e t i c  c o n s ta n ts  f o r  
assoc ia tion  and d isso c ia tion  (ra te  constants) and and Kq are the 
e q u ilib r iu m  d isso c ia tio n  and associa tion  constants. The e q u ilib r iu m  
and k in e t ic  constants are re la ted , such th a t:
^d “
Then the to ta l concentration o f receptor s ite s  [R^] i s  equal to  [R] 
+ [RL] and
[ ( R t ) - ( R L ) ] [ L ]
  = . . . . ( 3 )
[RL]
which can be rearranged to
[RL] [L ]
. . . . ( 4 )
[R t] K j + [L ]
The r a t i o  [R L ] / [R ^ ]  re p re s e n ts  th e  f r a c t io n  o f  t o ta l  re c e p to rs  
occup ied  by lig a n d . A t h a l f  maximal occupancy o f the  re c e p to r , 
[R L ] / [R ^ ]  = 1 /2  and = [ L ] .  Hence th e  c o n c e n tra t io n  o f  L 
requ ired  fo r  h a l f  -  maximal occupancy o f the recep to r i s  equal to  
K^. An a d d itio n a l rearrangement o f Eq. (4) g ives:
[R f] [L ]
[RL] -  — #. «.(  5)
K j + [L ]
Equation (5) is  the fa m il ia r  hyperbo lic fu n c tio n  in  which [RL] = 0 
when [L ]  = 0, and [RL] approaches [R ^] when [L ]  i s  ve ry  la rg e .  
The d e r iv a tio n  o f th is  equation i s  completely analogous to  th a t fo r  
the c la s s ic  M ic h a e lis  — Menton equa tion  and i s  m a th e m a tic a lly  
s im i la r  to  the  d e r iv a t io n  o f the a d s o rp tio n  iso th e rm  o r ig in a l ly  
d e rive d  by Langm uir fo r  the a d s o rp tio n  o f gases to  a su rfa c e .
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Equation (5) is  p a r t ic u la r ly  useful in  b ind ing s tud ies in  d e riv in g  
the Kç^  and the number o f b in d in g  s i te s  R^, E x p e r im e n ta lly  the 
ra d io l ig a n d  i s  added over a range o f c o n c e n tra t io n s  to  a f ix e d  
c o n c e n tra t io n  o f re ce p to rs . The le v e l o f b in d in g  approached 
a s y m p to t ic a l ly  a t  h igh  lig a n d  c o n c e n tra tio n s  i s  R^, and th e  
concen tra tion  o f fre e  ligand  th a t e l ic i t s  a le v e l o f b ind ing  equal 
to  [R ^ ]/2  represents the (Fig. 10).
Tne assumptions th a t have been made fo r  th is  an a lys is  are th a t 
the re a c tio n  is  a simple b im olecular reaction  Eq. (1) and th a t the 
measurements o f b in d in g  a re  made a t  e q u il ib r iu m . I t  should be 
emphasised th a t  in  Eq. (5) and in  F ig . (10) th e  c o n c e n tra t io n s  o f  
l ig a n d  [L ]  r e fe r  to  the c o n c e n tra tio n s  o f " f r e e "  L. I f  on ly  a 
small f ra c t io n  o f L is  bound, then the concentration o f to ta l L can 
be used to  approximate the concentration o f fre e  U This co n d itio n  
i s  u s u a lly  met when th e  to ta l  b in d in g  s i t e  c o n c e n tra t io n  i s  
considerably low er than the o f L fo r  the s p e c if ic  s ite s ,
4 .1 2 . Scatchard ana lys is
A usefu l rearrangement o f Eq. (3) is
[RL] ,
Z  [(R ^) -  (RL)] K j - l  ....(6 )
[L ]
w hich  i s  th e  form  o f the equa tion  d e rive d  by S catchard  (1949). 
Thus a p lo t  o f the ra t io  o f bound to  fre e  lig a n d , [R L ]/[L ],  versus 
the  c o n c e n tra t io n  o f bound l ig a n d , [R L ], g ive s  a s t r a ig h t  l in e  
w ith  a s lope  o f and an in te r c e p t  w ith  the a bsc issa  o f  [R^3
(Fig. 11). The main advantage o f Scatchard a n a lys is  (Fig, 11) over 
the a n a ly s is  u s ing  Eq, (5) (F ig . 10) i s  th a t the  S ca tcha rd  p lo t  
l in e a r is e s  th e  data, som ething p a r t ic u la r ly  v a lu a b le  in  b in d in g  
systems th a t have a h igh le v e l o f non-spec ific  binding. In  these
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FIG. 10
P lo t o f the r e la t io n s h ip  o f  (RL)/(R^) to (L ), (RL), c o n c e n tra t io n  
o f ligand-recep to r complex; (R^), concentration o f to ta l receptor 
s i te s ;  (L ), c o n ce n tra tio n  o f fre e  lig a n d ; K j, the e q u i l ib r iu m  
d isso c ia tio n  constant.





S ca tchard  p lo t .  (R^-) re fe rs  to  the co n c e n tra tio n  o f the  t o t a l  
nun.her o f b in d in g  s i te s ;  (RL), co n cen tra tio n  o f l ig a n d - re c e p to r  
complex; (L), concentration of free  lig a n d  The slope o f the l in e  
i s  the negative rec ip roca l o f the equ ilib rium  d isso c ia tio n  constant
(R L ) / ( L )
(RL)
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sy s te m s , m easurem en ts  o f  b in d in g  a re  d i f f i c u l t  a t  h ig h  
concentra tions o f rad io ligand because the re la t iv e  c o n tr ib u tio n  o f 
nonsaturable, non -spec ific  •’background" b ind ing i s  h ip e s t  a t  high 
lig a n d  concentrations, thus making the es tim a tion  o f (and hence 
I<d) d i f f i c u l t  u s in g  Eq, (5) and F ig ,(1 0 ), By c o n tra s t, u s in g  
S ca tcha rd  a n a ly s is  data can be c o lle c te d  a t  low  o r in te rm e d ia te  
c o n c e n tra t io n s  o f  L and th e  l in e a r  p lo t  can be e x tra p o la te d  to  
estim ate  and K^.
A r t i fa c tu a l in te rp re ta tio n  (W illia m s and Le fkow itz , 1978a) o f 
Scatchard p lo ts  w i l l  occur when:
1. The va lu e s  used fo r  [RL] and [L ] a re  no t tru e  measures f o r
s p e c if ic a lly  bound and fre e  hormone, respec tive ly .
2. The measurements a re  made when th e  system i s  n o t a t  a tru e
s ta te  of e q u ilib riu m  fo r  a l l  concentrations o f lig a n d  tested. 
In  order to  demonstrate th a t a ^stem  is  a t  true e q u ilib r iu m , 
i t  i s  necessary to show th a t the f in a l  concentrations o f R, L,
and RL in  the eq u ilib riu m  R + L ^ -----— FL can be reached from
e ith e r  d ir e c t io n ,  i,e , by s ta r t in g  e ith e r  from  excess RL o r 
from excess R + U I t  should be noted th a t a ^s tem  a t steady 
s ta te  le v e l  o f b in d in g  (h e . the amount o f b in d in g  does n o t 
change w ith  tim e) is  not necessarily a t equ ilib rium .
3. The re c e p to r - c o n ta in in g  p re p a ra t io n  i s  c o n ta m in a te d  by
enzymes th a t in a c tiv a te  the ligand.
4. ihe separation o f bound and fre e  hormone is  not can p ie  te.
5. B in d in g  to  l o w - a f f i n i t y  s i t e s  d is s o c ia te s  d u r in g  th e
separation o f bound and fre e  hormones.
6. There i s  a d iffe rence  in  a f f in i t y  or k in e t ic  constants between
n a tive  lig a n d  and i t s  la b e lle d  analog.
I f  the above methodological com plications can be avoided, the shape
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o f the  S c a tc h a rd  p lo t  can p rov ide  u se fu l in fo rm a t io n  abou t 
receptor -  l ig a n d  in te ra c t io n .  For example a curved Scatchard p lo t , 
can be in d ic a t iv e  o f co-operative in te ra c tio n s  among receptors and
can be a lso  ob ta ined  i f  the ligand  is  b inding to  two or more s ite s
w ith  d i f f e r e n t  a lT in i t ie s ,
4.1 .3 . l:D m D etitive  b ind ing stud ies
In  in v e s t ig a t io n s  of the s p e c if ic ity  o f receptor b ind ing s ite s , the 
a b i l i t y  o f an m la b e lle d  adrenergic agent, I ,  to  compete w ith  the 
ra d io lig a n d , L, f o r  the b in d in g  s i t e  i s  o fte n  measured. I f  the  
competing agent, 1, is  assumed to  be a com petitive  in h ib ito r  o f the 




From these e q u il ib r ia ,  two simultaneous equations o f the form o f 
Eq. ( 2) can be w r i t t e n  and so lved f o r  RL to  g iv e ;
[L ][R t ]
[RL] z , I——  I .. ..(7 )
K j  (1 + I / K j )  + [L ]
where [ 1 ] i s  the concentration o f free  unlabelled competing lig a n d ,
and Kj i s  the e q u ilib r iu m  d isso c ia tion  constant fo r  the in te ra c t io n
o f 1 w ith  the receptor:
[R ] [ I ]
Kt = '
^ [R I]
when there  i s  no com peting lig a n d  p resen t [ ( I )  = 0]» then the 
amount of binding [RL]q which is  th e  c o n c e n tra tio n  o f  the  d ru g - 
receptor canpLex ju s t  p r io r  to d ilu t io n  or a d d itio n  o f a competing
lig a n d  i s  given by:
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rmi  [ " [ K t ]LRL]q = ---------- —-  . . . . ( 8 )
K j  + [L ]
v;h ich i s  as expected from  Eq, (5 ). When th e  com peting l ig a n d  i s  
added a t  a c o n c e n tra tio n  [ l ^ g ]  a t  w hich the va lue  o f b in d in g  
[RL]^0 is  reauced to  50/» o f the binding in  the absence o f competing 
ligand , then Eq. (7) can be w r it te n  as
[ L ] [ R . ]
[R U 50 = ---------------------- ---------------  . . . . ( 9 )
K j (1 + ) + [ L]
S ince  when I  = I^ q , LRLJ^q = [RL]q/2, Eqs. ( 8) and (9 ) g ive
2 [L ][R ^ ] [L ][R t-]
Kj (1 + I^Q/K^) + [ L ]  K j  + [L ]
which s im p lif ie s  to
. . . . ( 10)
^50
Ki  =     . . . . ( 1 1 )
1 + [ L ] / K j
Thus u s in g  Eq. (11) th e  e q u il ib r iu m  d is s o c ia t io n  co n s tan t o f  an 
un labe lled  competing ligand, I ,  can be determined by measuring the 
concen tra tion  o f I  which ha lf-m axim a lly  in h ib its  the b ind ing
o f the  ra d io lig a n d  p re s e n t a t  the  c o n c e n t ra t io n  [ L ] ,  The 
d e r iv a t io n  o f t h is  equa tio n  i s  a f te r  th a t  o f Cheng and P ru s o ff  
(1973) fo r  com petitive  in h ib ito rs  o f enzymes. Again, i t  should be 
em phasised th a t  the co n ce n tra tio n s  o f I  and L in  these e q u a tio n s  
r e fe r  to  the c o n c e n tra tio n s  o f fre e  I  and L a t  e q u il ib r iu m . 
E x p e r im e n ta lly  the  c o n c e n tra tio n  o f f re e  I  may be d i f f i c u l t  to  
a s c e r ta in  and can be a p p ro x im a te d  by th e  v a lu e  f o r  th e  
concen tra tion  o f to ta l 1 i f  the amount o f I  bound i s  low compared 
to  Kj. Th is  c o n d it io n  is  u s u a lly  s a t is f ie d  i f  R^ «  Kj .  I f  Rt > 
K j, the  va lu e  o f K j from  Eq. (11) w i l l  be an o v e re s tim a te  o f the
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t r u e  va lu e  o f Kj.
.CompgtitlYS bindinK studies with multiple binding sites
U n t i l  re c e n t ly ,  i t  has been b e lie ved  th a t  in d iv id u a l t is s u e s  
c o n ta in  on ly  one o f the be ta -ad renocep to r subtypes. However, 
p h a rm a co lo g ica l s tu d ie s  by C a r ls s o n ^ _ a l,  ( 1972) dem onstra ted  a 
m ix tu re  o f beta^ and beta2 adrenoceptors in  k i t t e n ,  but n o t r a t  
heart. S im ila r  phys io log ica l techniques have ind ica te d  th a t fro g  
myocardium m ight conuain a small beta^ component in  a d d itio n  to  a 
p redom inan t p o p u la tio n  o f beta2 adrenocepto rs (S tene -La rsen  and 
H elle , 1978). Using ra d ia la b e lle d  lig a n d  techniques, Barnett ^  a l , 
( I 9 7 8 ) d e m o n s tra te d  a m ix tu re  o f  25% beta<j and 7 5 % b e ta 2 
adrenoceptors in  r a t  lung, but r a t  heart stud ies demonstrated only 
one c la s s  o f s ite s  (be ta -|). N a h o r s k i ^ ^ ,  (1979) found  in  r a t  
sp leen  membranes, the co -e x is ten ce  o f both b e ta ^ - and be ta2-  
a d ren o ce p to r s i te s  (30-35% beta^; 65-70% b e ta2). Minneman ^  ^  
( 1979b) exam ined r a t  h e a rt, lung  and f i v e  re g io n s  o f  b ra in , and 
found  th a t  each o f these tis s u e s  co n ta in  both be ta -j- and b e ta ^ -  
adrenoceptors in  d if fe r in g  ra tio s ,
H iere are two basic approaches th a t have been developed using 
the b ind ing  assays to  q u a n tita te  receptor subtypes.
The f i r s t  approach uses a rad io ligand  th a t i s  se le c tiv e  fo r  one 
receptor subtype. I f  one has a rad io ligand  th a t i s  100% se le c tive  
( i ,e .  i t  b inds to  on ly  one subtype) then i t  i s  o n ly  necessary to  
cha rac te rise  the binding of the ligan d  to  th is  receptor to  define 
th e  p ro p e r t ie s  o f  the re ce p to r subtype. However, t y p ic a l ly  
ra d io lig a n d s  w i l l  bind to  more than one subtype. Therefore, i t  i s  
iTgcessary to  use a ma*e invo lved mathematical ana lys is  to  
d e te rm in e  the p ro p e r t ie s  and d e n s it ie s  o f the  re c e p to r sub types
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p re se n t in  ^ tis s u e . For a p a r t ia l l y  s e le c t iv e  ra d io l ig a n d  a 
s a tu ra t io n  curve  is  de term ined and the da ta  i s  then u s u a lly  
transform ed by the method o f Scatchard (1949). Scatchard a n a lys is  
o f the b in d in g  o f a p a r t ia l l y  s e le c t iv e  ra d io lig a n d  w i l l  y ie ld  a 
c u rv il in e a r  p lo t in  the presence of receptor subtypes,
A second approach to  s tu d y ing  re ce p to r subtypes in v o lv e s  the  
use o f a s e le c t iv e  com peting lig a n d . A d isp lacem en t cu rve  fo r  a 
se le c tive  competing drug is  generated and the data analysed by the 
method o f  Eadie (1952) and H ofstee  (1952), aga in  g e n e ra tin g  
cL .rv ilin e a r p lo ts  in  hie presence of receptor subtypes.
Early work by Barnett ^  (1978) had used a manual graph ica l
method derived fra n  the c la ss ica l Scatchard (Scatchard, 1949) data 
a n a ly s is  (pseudo-S catchard) to  assess the re la t iv e  p roportions o f 
re c e p to r  subtypes. Hancock ^  ^  (1979) have shown th a t  t h is  
method p ro v id e s  le s s  accu ra te  p re d ic t io n s  than  a n o n - l in e a r  
computer model, and have given an analys is o f the e rro rs  invo lved,
4 .1 .5 . Computer m odelling
For the com petitive  reac tion  between the fre e  concentrations o f  a 
re c e p to r  R, the ra d io la b e lle d  lig a n d  L and a b e ta -a d re n o ce p to r 
b lock ing  agent B, the fo llo w in g  equations are v a lid  as described by 
Wenke (1971) fo r  a com petitive  reac tion  scheme:





and %  represent the  d isso c ia tion  constants o f  L and B.




Rt = R + RB + FL 
hie concentra tion  of bound rad io ligand  is
RL = 1 j J  ...,(12)
l i  two types o f be ta -ad renocep to rs  are p resen t in  the membrane 
f r a c t io n  and each component obeys th e  s im p le  mass a c t io n  law  
w it lio u t any in te rfe rence , then equation (12) can be generalised to
R ji
RL     . . . . ( 1 3 )
i=1 1 +------ (1 + --------- )
L '  Ko. /% i
w here i  = 1, 2 o r 3 c lasses  o f b in d in g  s ite s .
In  e q u a tio n  (13) i t  i s  fu r th e r  assumed th a t  the  ra d io l ig a n d  L 
b in d s  w ith  equal a f f i n i t y  to  be tay- and be ta2-a d re n o ce p to rs , 
whereas B possesses a d if fe re n t a f f in i t y  to  each receptor subclass.
E x is t in g  packages SCAT F IT (Rodbard, 1973), SAAM 26 (E ngel, 
1980) and LIGAND (Munson and Rodbard, 1980) provide the necessary 
a lg o ritlim s  fo r  the le a s t squares ana lys is  o f receptor subtypes. In  
a d d it io n  C la rk  developed a n o n - lin e a r  re g re s s io n  based cu rve  
f i t t i n g  package (RECFIT), (C la rk  ^  _al, 1984) f o r  q u a n t i t a t iv e  
a n a ly s is  o f  be ta -ad reno cep to r subtypes w h ich  has th e  a d d it io n a l 
fe a tu re  o f simultaneous estim ation  o f non-spec ific  binding,
5 .  STATISTICAL METOQDS
S t a t is t i c a l  a n a ly s is  was done w ith  p a ire d  S tu d e n t's  t —te s ts  
(com parisons on the  same su b je c t group) and tw o -sam p le  t - t e s t s  
(comparison between p a tie n t and vo lunteer ^oups) as appropria te  on 
an ICL-2976 computer using the package MINITAB ( R y a n ^ i^ ,  1976).
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Computer a s s is te d  a n a ly s is  o f a lpha- and b e ta -a d re n o ce p to r 
s a tu ra t io n  assays was c a r r ie d  out by Scatchard a n a ly s is  (see 
s e c tio n  4 .1 .2 ., C l a r k ^ ^ ,  1983).
A n a ly s is  o f  be ta -ad renocep to r sub -popu la tions  was performed 
using a le a s t squares c u rv o - f it t in g  package (RECFIT), ( d a rk  
1984). Because o f the c u rre n t l im i t a t io n s  o f  RECFIT when u s in g  
s e le c tiv e  rad io ligands, alpha2~adrenoceptor s u b -p o p u la tio n s  were 
a n a lysed  by the  method o f Cheng and P ru s o ff ( 1973), see s e c tio n  
(4 .1 .3 . ) .
A l l  data shown a re  the mean ±  standard  d e v ia t io n  w here 
in d ica te d .
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DEVELOPPENT OF METHODS
1* INITIAL RECEPTOR FAMTI.TARISATIQN STtlDTRS
The i n i t i a l  aim o f the p ro je c t was to  become f a m i l i a r  w ith  the 
te ch n iq u e s  f o r  is o la t in g  and c h a ra c te r is in g  b e ta -a d re n o ce p to rs , 
p r io r  to  commencing a study o f the changes in  beta-adrenoceptors in  
asthma, where the ta rg e t tissue  fa *  study would be the lymphocyte. 
The i n i t i a l  fa m ilia r is a t io n  stud ies were performed on the r a t  
lu n g , w ith  the advantage th a t no t on ly has the r a t  lu n g  b e ta - 
ad renocep to r been c h a ra c te r is e d  by o the r w o rke rs  (B a rn e tt e t  a l,  
1 977» 1978; M in n e m a n ^ ^ ,  1 979a»b) bu t the t is s u e  was e a s ily  
obtained and re la t iv e ly  inexpensive,
1.1. RATkLUNG CELL MEMBRANE RECEPTORS
R at-lung c e l l  membranes were prepared as described (M a te ria ls  and 
M e th o ds , 1 .1 .) . The f i r s t  p a r t  o f  th e  w o rk  showed th a t  
approxim ately 95% o f c e ll  receptors in  the crude homogenate were 
re c o v e re d  i n  th e  v a r io u s  f r a c t io n s  ( i . e .  n u c le a r :5 - 1 0%, 
m itochond ria l : 18-20% and microsomal ;67-70%) and the maximum y ie ld  
was in  the  m icrosom al f r a c t io n  w ith  a 9 ± 2  f o ld  p u r i f ic a t io n  o f 
tlie  beta-adrenoceptors in d ic a tin g  th a t the receptors were membrane 
bound. Therefore the microsomal fra c t io n  was ro u tin e ly  used in  the 
work. TVie receptors were not so lub le since none could be detected 
in  the 70000g supernatant,
Whatman GFC g la s s  m ic r o f ib r e  f i l t e r s  gave the  h ig h e s t 
recoveries (95%) o f beta-adrenoceptors based on a comparison w ith  
es tim a tin g  beta-adrenoceptors in  the crude homogenate, Whatman GFB 
g lass m ic ro fib re  f i l t e r s  were in fe r io r  in  th is  respect, g iv in g  only 
86% re co ve ry , and g re a te r s c a tte r  in  th e  e xp e rim e n ta l re s u lts ,  
p o s s ib ly  the much lo w e r ra te  o f f i l t r a t i o n  a llo w e d  the b in d in g  
e q u i l ib r iu m  to  be d is tu rb e d . 0.45 ^m M i l l ip o r e  f i l t e r s  as
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ro u tin e ly  used f o r  Radioimmunoassay and com petitive  p ro te in  b ind ing  
assays w ere no t s u ita b le ;  they c lo g  to o  e a s ily ,  w ith  an adverse 
e f fe c t  on t iie  re s u lts  s im ila r  to  the GFB f i l t e r s .
Freezing  both the crude homogenate and microsomal fra c t io n  a t  
-20C f o r  24 h re s u lte d  in  a decrease of approxim ate ly 50% in  beta- 
a d r e n o c e p t o r  number. Because o f t h i s  a d ve rse  e f f e c t  a l l  
p re p a ra tio n s  were assayed immediately,
1.2. KINETIC ANALYSIS OF r3HlDHA BINDING
The next stage was to  c h a ra c te r is e  the lu n g  b e ta -a d re n o ce p to r. 
When ch a rac te ris ing  receptors i t  i s  essen tia l to  demonstrate th a t 
the b in d in g  o f the chosen r a d io a c t iv e  l ig a n d  i s  s p e c i f i c ,  
saturable, s te reose le c tive  and re v e rs ib le
K in e tic  analyses were performed and repeated tw ice  as described 
(M a te r ia ls  and Methods, 1.3. and 1.4.). B in d in g  o f  [^H]DHA to  r a t  
lu n g  membranes a t  30C was a ra p id  process, w ith  h a lf-m a x im a l 
s p e c i f i c  b in d in g  ( t« | / 2 ) o f  0 .4 -0 .5  m in  (F ig .  1 2 ), re a c h in g  
e q u ilib r iu m  w ith in  18-20 min. B inding remained s tab le  f o r  60 min 
a t  30C. An in c u b a tio n  t im e  o f 20 min was chosen to  re p re s e n t 
e q u il ib r iu i i  b ind ing in  subsequent experiments.
The i n i t i a l  ra te  cons tan t (K^^) fo r  the  a s s o c ia tio n  re a c t io n  
o b ta in e d  from  the slope (F ig . 12, in s e t)  was 0.748 m in“ ** f o r  4 
nmol/1 [^HJDHA. D issoc ia tion  o f bound [3h]DHA a t 30C was determined 
by incuba ting  r a t  lung membranes to  e q u ilib r iu m , and then adding 10 
jum o l/1  ( - )  p ro p ra n o lo l ( f i n a l  c o n c e n tra t io n )  a t  t im e  z e ro  and 
measuring res idua l s p e c if ic  b in d in g  a t subsequent t im e  in te r v a ls  
(F ig . 13), D is s o c ia t io n  was ra p id  w ith  a t ^ /2  5-6  m in, and th e




Time course o f [^H]DHA b ind ing  to  ra t- lu n g  membranes. R a t- lu n g  
niQiibranes in  assay bu ffe r were incubated w ith  [^HlDHA (4 nm o l/l) in  
the absence and presence o f lOjuimol/l ( - )  p ro p ra n o lo l. A t the 
in d ic a te d  tim e s , the samples were d ilu te d  w ith  ic e - c o ld  assay 
b u ffe r and f i l te re d .  Specific  binding was determined in  d u p lic a te  
a t  each tim e  in te r v a l ,  ( In s e t)  the  reg re ss io n  l in e  ( r  = 0,99) was 
determined by the p lo t o f In  [Bgq/(Bgq -  B^)] vs. time, where B^q = 
b ind ing a t  equ ilib rium  and B^ = binding a t time t. i s  equal to  
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FIG. 13
Time course fo r  d is s o c ia tio n  o f  [^H]DHA b in d in g  to  r a t - lu n g  
membranes, Rat>-lung manbranes in  assay bu ffe r were incubated w ith  
[3 h]DHA (4nm oi/l) fo r  20 min to  allow equ ilib rium . A t zero tim e, 
1 0 jjm o l/ l ( - )  p ro p ra n o lo l ( f in a l  co n ce n tra tio n ) was added to  th e  
samples and s p e c if ic  b ind ing  was determ ined a t  v a r io u s  t im e  
in te rv a ls . 100% binding re fe rs  to  the sp e c ific  b ind ing ju s t  p r io r  
to  the a d d it io n  o f  ( - )  p ro p ra n o lo l. B. F irs b -o rd e r  ra te  p lo t  o f 
d is s o c ia t io n  o f [3 h]DHA b ind ing . Kg is  equal to  the  s lope  o f  the  

















The a s æ c ia t io n  ra te  constant (K < j)  o f [3h]DHA b ind ing  was then 
c a l c u l a t e d  fro m  th e  e q u a tio n  (B e n n e t t ,  1 9 7 8 ); K-; = (Kgb -  
K2)/[DHA], where [DBA] i s  equal to  the concentration o f [^HJDHA in  
the assay (4 nm o l/1 ), was 1.555 x 10^ ± 0.027 x 10^ m in” **.
The e q u ilib r iu m  d isso c ia tion  constant (K^), determined from the 
r a t io  K^/K^, was 0.71 ±0 .1  nm ol/1.
1 .3 . SAIV m iL m  OF f3mPHA BINDING
The stud ies  were ca rried  out as described (M a te ria ls  and Methods,
1 .2 .) .  The b in d in g  c h a r a c t e r is t i c s  o f  [3h]DHA to  r a t - lu n g  
membranes is  shown in  Fig. (14). S p e c ific  b ind ing o f [^HIDHA (the 
b ind ing  th a t  could be displaced by 10 ^m o l/1  ( - )  p roprano lo l) was 
c le a r ly  s a tu ra b le  and o f h igh  a f f i n i t y .  Apparent s a tu ra t io n  o f 
b in d in g  s i t e s  seemed to  occur a t  [^H]DHA c o n c e n tra t io n s  o f  4-6 
nmol/1, w ith  h a lf  maximal b inding occurlng a t  about 0.4-0.5 nmol/1.
S ca tcha rd  a n a ly s is  (F ig . 15) o f  the s a tu ra t io n  data y ie ld e d  a 
s tra ig h t l in e ,  in d ic a tin g  tha t [^H]DHA bound to  a s ing le  c lass o f 
h ig ji a f f in i t y  receptors. The to ta l number o f b ind ing  s ite s  (B^^^) 
was 120 ±  19 ftnol/rng p ro te in , and the d isso c ia tion  constant (K^) o f  
the b ind ing  was 0.53 ±  0.07 n m d / l  (10 experiments).
1Ü, OF KINETIC STUDIES
These re s u lts  demonstrated th a t the b ind ing o f [3 h]DHA was ra p id  
and re v e rs ib le  a t  300. The s p e c if ic  b ind ing o f [3 h]EHA represented 
80-85% o f  the  to ta l  b in d in g  and was c le a r ly  s a tu ra b le  w ith  a 
d isso c ia tio n  constant (K j) o f  0.53 ±  0.07 nmol/1. This i s  s im ila r  
to  th a t  observed by o the r w o rke rs  (B a rn e tt 1977)* T h is  K j
(0.53 ±  0.07 nmol/1), which was estab lished from e q u i l ib r ia  data 
was a ls o  s im i la r  to  the K j o f 0.71 ±  0.1 nm o l/1  de te rm ine d  by
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FIG. 14
S pe c ific  binding o f [3 h]EHA to  r a t t l in g  membranes as a fu n c tio n  o f  
concentration o f [3 h]DHA. Rat-lung membranes in  assay b u ffe r were 
incubated w ith  various concentra tions o f  [^H]DHA in  the p resence 
and absence o f 10^m ol/1  ( - )  p ro p ra n o lo l. S p e c if ic  b in d in g  was 
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FIG. 15
S catchard  a n a ly s is  o f the b ind ing  data (F ig . 14) y ie ld in g  a o f
0.49 nm o l/l and the to ta l number of binding s ite s  was 117 ftnol/mg 
p ro te in .
600-1
500-








50 75 100 12525
DHA Bound (fmol/mg protein)
87
id. ne t i c  methods ( i,e . ra t io  o f a s s o c ia tio n  and d is s o c ia t io n  ra te  
co n s ta n ts ).
1.5. W H E ETITION FOB r % D H A  BIMDTHr. .STTES BY ADREMEBGIC COMPOUNDS
Com petition stud ies were performed and repeated tw ice  as described 
(M a te r ia ls  and Methods, I .5 . ) .  B e ta -ad ren ocep to rs  t y p ic a l l y  
e x h ib i t  s te r e o s e le c t iv i ty  in  the exp ress io n  o f p h a rm a co lo g ica l 
a c t iv it y .  As Fig, (16) shows, ( - )  propranolo l is  approxim ately 100 
tim e s  more p o te n t in  in h ib i t in g  b in d in g  o f  [3h]DHA than (+) 
p ro p ra n o lo l (T a b le  2 ), Moreover, the  r e la t iv e  p o te n c ie s  o f  a 
number o f drugs (Table 2) suggests th a t the be ta-a dreno ce p to r s in  
r a t - lu n g  a re  p redom inan tly  o f the be ta  2 subtype. For example, 
H35/25 (1 -(  ^ m e th y l phenyl)- 2 - is o  p ropy l ami n o -p ro p ra n o lo l) ,  a non­
s p e c i f ic  b e ta -a n ta g o n is t and sa lb u ta m o l, a r e la t iv e ly  s p e c if ic  
be ta2 a g o n is t, more p o te n tly  in h ib ite d  [^H]DHA b in d in g  than (± ) 
p r a c to lo l ,  beta^ a n ta g o n is t, w ith  va lu e s  o f  0 .38, 1.10 and 12.6 
jjmol/1 f o r  H35/25, salbutamol and p ra c to lo l re sp e c tive ly  (F ig . 17). 
T a b le  2 sum m arises th e  r e s u lts  w hich  are in  accord  w ith  those o f 
B a rn e t t  ^  (1977).
The p re lim in a ry  work has shown th a t  the  r e s u lt s  f o r  the  lu n g  
beta-adrenoceptor s a tis fy  the requirements la id  down fo r  v e r ify in g  
th e  e x is te n c e  o f a re ce p to r and in d ic a te  th a t  the  m a jo r i ty  o f 
receptors detected were be ta2-a  dreno ce ptor s,
9  nFVFTnPMFNT OF LYMPHOCYTE ISQLAHQM
2.1. AIMS
Since i t  was in te nd e d  to  perform  m u lt ip le  lym phocyte  re c e p to r  
s tud ies  on pa tien ts  and volunteers, the aims o f th is  work were to  
deve lop  a techn ique  w hich g ive s  a h ig h  y ie ld  and p u r i t y  o f
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FIG. 16
S te re o s e le c tiv ity  ol [^HJCHA binding s ite s  in  ra t> li« g  membranes. 
V a rio u s  co n c e n tra tio n s  o f ( - )  p ro p ra n o lo l W  and (+) p ro p ra n o lo l 
(A) were incu b a te d  w ith  ra t- lu n g  membranes and (4 n m o l/ l)
fo r  20 min. The samples were then d ilu ted  and f i l te r e d .  S p e c if ic  
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TABLE 2
Tl:ie d isso c ia tio n  constants (K j) o f drugs determined by com petition
far [^H]DHA binding
D issocia tion  Constant (K j)
( - ) P ropranolol 4.07 ± 1 .0 9  x 10“ **°
(+ )Propranolol 3.98 ± 0 .9 6  x 10"^
H 35/25 3.82 ± 0 .3 3  x 10"'^
Salbutamol 1.10 ± 0 .1 5  x 10“ ^
P ra c to lo l 1.26 ±  0.23 x 10“ ^
The d isso c ia tio n  constant (Kj) was ca lcu la ted  using a le a s t squares 
c u r v e - f i t t i n g  package (RECFIT), ( C la r k ^ _ a l ,  1984). R esu lts  a re  
expressed as the Mean ±  SD (3 experiments).
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FIG. 17
Competition fo r  [^H]aiA binding s ites  by adrenergic drugs in  r a t -  
lung  manbranes. Various concentrations o f H 35/25 (O), salbutamol 
(A) and p r a c to lo l (#) were incubated w ith  ra t- lu n g  membranes and 
[^H]DHA (4 n m o l/ l)  fo r  20 min. The samples were then d i lu te d  and 
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lymphocytes as w e ll as a c e ll  v ia b i l i t y  w h ile  using the le a s t  
poss ib le  blood volume»
2.2. EXISTING METHODS
I n i t i a l l y  us in g  the  recommended methods (C on o lly  and G reenacre, 
1976; W illia m s  ^  _al, 1976b) problems were encountered w ith  poor 
re c o v e r ie s  (30-40%) o f  lym phocytes and a g g re g a tio n  o f c e l ls  was 
fre q u en tly  observed.
By a process o f  e lim in a t io n  i t  t ra n s p ire d  th a t  the  type o f 
b u ffe r, the presence of sodium bicarbonate (NaHCOg), the presence 
o f  added p r o te in ,  th e  d i l u t i o n  o f  c e l l s  p r io r  to  d e n s ity  
c e n tr ifu g a tio n , the g ra v ita t io n a l fo rce  (g) used to  ha rves t washed 
c e l ls ,  and th e  b u ffe r  pH were a l l  c r i t i c a l  fa c to rs .  D e ta ils  o f  
these s tud ies  are set out below,
2.3. DEVELOPMENT OF THE PRESENT METHOD
E a r le 's  B a la n c e d  S a l t  S o lu t io n  ( w i t h o u t  NaHCOg) w i t h  th e  
supplem ents o u t l in e d  in  T ab le  3 gave best r e s u lts ,  p a r t ic u la r ly  
when the recommended phosphate buffered sa line  (PBS) was replaced 
by E a r le 's  medium (w ith o u t NaHCOg), The presence o f NaHCOg in  th e  
b u ffe rs ,  gassed w ith  95% a i r  and 5% CO2 re s u lte d  in  u n s ta b le  pH 
va lu e s  (pH 7 .2 -7 ,8 ) in  th e  open te s t  tubes le a d in g  to  a f a l l  in  
v ia b i l i t y .  Hepes b u ffe r a t pH JJS was op tim al fo r  good v ia b i l i t y .  
HaHCOg i t s e l f  seemed to  have a d e le te r io u s  e f f e c t ;  w ith  0.22% 
WaHCOo (recommended concentration) in  the presence o f  Hepes a t pH
7 .6 , r e c o v e r ies f e l l  to  30% (T ab le  3 ).
I n i t i a l  s tu d ie s  were p e rfo rm e d  u s in g  a 10% c a l f  serum  
supplem ent as w id e ly  re p o rte d  in  th e  l i t e r a t u r e  (H a r r is  and 
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markedly in f  e r i cr to those l is te d  above^ w ith  recoveries as low as 
30-40% accompanied by marked aggregation of the lymphocytes. 0.1% 
c a l f  serun added to  the mediun was optim al in  reducing lymphocyte 
a g g re g a tio n  and e s s e n t ia l to  ensure an adequate y ie ld  o f c e l ls .  
Aggregation during is o la t io n  o f lymphocytes was fu r th e r  reduced by 
ranoving  the p la te le t- r ic h  plasma from the i n i t i a l  c e n tr ifu g a tio n  
o f whole blood and rep lac ing  i t  w ith  Earle 's medium, sim ultaneously 
d ilu t in g  the packed c e lls  to  three times the o r ig in a l blood volume. 
The r a t i o  o f d i lu te d  b lood (suspension o f e ry th ro c y te s  and 
leucocytes) to  the lymphocyte separation medium was also c r i t i c a l ,  
8 111 d ilu te d  blood to  12 ml separation medium in  a 30 ml conta iner 
gave m in im a l c lum p ing ; in c re a s in g  the blood:mediurn r a t io  le d  to  
in c re a s e d  a g g re g a tio n . A f te r  h a rv e s tin g  th e  lym ph ocy te s  i t  was 
necessary to  wash than free  o f the viscous separation medium. Use 
o f  p h o sp h a te  b u f fe r e d  s a l in e  or T r is  b u f fe r  gave r i s e  to  
aggregation and Hepes b u ffe r was chosen in  preference. I t  was also 
n e c e s s a ry  to  h a rv e s t  th e  c e l l s  a t  250g and n o t  lOOOg as 
recommended, to  fu r th e r  reduce aggregation.
Since beta-adrenoceptor estim ations were to  be performed a t  30C 
in  the presence of various drugs, the e ffe c ts  o f extended exposure 
to  (+) o r ( - )  p ro p ra n o lo l on lym phocyte  v i a b i l i t y  were a lso  
in v e s tig a te d  fo r  each of the c u ltu re  media d e ta ile d  in  Table 3. In  
summary, Earle 's medium (w ithou t NaHCDg) which gave best y ie ld  and 
v i a b i l i t y  d u rin g  lym phocyte  is o la t io n ,  a lso  gave the  h ig h e s t 
v ia b i l i t y  during a 60 min incubation a t  30C. The presence o f (+) 
o r ( —) p ro p ra n o lo l had no d e le te r io u s  e f fe c ts  on lym phocyte  
v i a b i l i t y  (Table 3).
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3. jÆVELOPMENT OF LTGAWn RTNDIMG TR3 MTDUKS
3.1. r3m  DHA BINDTWn ASSAY
[•^ri]DHA has been used as a ra d io lig a n d  fo r  be t a - adrenocepto r 
b in d in g  s tu d ie s  i n  lym phocytes and po lym orphonuclear c e l ls  
(W 'i l l ia m s  iL t 1976b; Karim an and Le fkow itz , 1977; Brooks ^  3 I ,  
1979; B isn op ric  1980; Galant 198O). However, in  th is
study s a tu ra t io n  a n a ly s is  i n  human lymphocytes using [^H]DHA was 
ve ry  d i f f i c u l t  to  perform  because very low  s p e c i f ic a l ly  bound 
counts were achieved and marked sca tte r was observed on Scatchard 
a n a ly s is . Of more concern i s  the f a c t  th a t some o f the above 
w o rk e rs  (Brooks 1979; G alant 1980) were u s in g  ve ry
h igh  concentra tions o f  [3h]EHA (30 nmol/1, 48 nmol/1 o r 60 nmol/1) 
in  t h e i r  assays but d u r in g  th e  course o f t h is  s tudy , i t  has been 
found  w ith  t is s u e s  from  r a t  lu n g  i s  th a t  a t  c o n c e n tra t io n s  o f 
[ 2h]DHA above 20 nm ol/1, th is  liga nd  appears e ith e r  to  s o lu b ilis e  
i n  the c e ll  membrane or to  p a r t i t io n  in to  membrane m ice lles  ( Le, 
cannot be d is p la c e d  by the degree o f w ash ing used h e re ). T h is  
mechanism appears to  be blocked by the propranolo l used in  the non­
s p e c if ic  b ind ing tubes and so the trapped lig a n d  does not appear as 
n o n -sp e c ific  b inding (C lark ^  Jd, 1985).
The m a jo r d isadvantage o f us ing  [% DHA invo lves  s e n s it iv i ty .  
The s p e c i f ic  a c t i v i t y  o f p re p a ra tio n s  i s  u s u a lly  in  the  range o f  
30-70  C i/mmol, the re fo re  in  ty p ic a l membrane fra c t io n s  th a t  con ta in  
re c e p to r  b in d in g  a c t i v i t y  a t  100 fm o l/m g  p ro te in ,  1 mg p ro te in  
w ou ld  be re q u ire d  to  o b ta in  2,500 cpm bound when th e  l ig a n d  i s  
present a t  a concentration equal to  i t s  (d is so c ia tio n  constant).
Maguire ^  (1977) using [125i]hyP have shown th a t  two orders 
o f  m agnitude  le s s  p ro te in  a re  re q u ire d  to  o b ta in  the same 
s p e c i f ic a l ly  bound counts as compared w i t h  [^HlDHA. I t  has a ls o
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been c o n iirn ie d  th a t using in  b in d in g  s tu d ie s  fo r  both
t^ranulocytes and mononuclear c e lls  o ffe r  the advantage o f re q u ir in g  
fewer c e lls  and there fore  sm a lle r q u a n tit ie s  o f blood (Hotulsky and 
In se l, 1982a). Therefore fo r  the studies in  th is  thes is , [ 
o f fe r  a p o s it iv e  advantage when repeated es tim a tions  are to be made 
on a given subject.
3.2 . r 125IIHYP BINDING ASSAY CONDITIONS
3.2.1. Assay tubes
The l ig a n d  [^^^ I]H Y P  adsorbs to  both g la ss  and p o ly s ty re n e  tubes 
and v a r ia b i l i t y  o f b ind ing from tube to  tube was p a r t ic u la r ly  h igh 
w ith  the la t t e r  type. In  add ition , polystyrene i s  so lub le  in  e th y l 
aceta te , the so lven t in  which [ ^^^I]HYP is  stored (Maguire e t a l, 
1 977). P o lyp ropy lene  tubes seem to  be the  best a l t e r n a t iv e  as 
these r e ta in  the lo w e s t counts o f a l l  tubes te s te d  (g la s s , 
poly sty rene and polypropylene).
3.2.2. M in im is ing  non-specific , b ind ing
One o f  th e  p ro b le m s  o f  u s in g  [*^^^I]H YP  was th e  la c k  o f  
re p ro d u c ib il ity  and poor c o e ffic ie n ts  o f v a r ia t io n  on quad rup lica te  
samples (T ab le  4, o p tio n  1). T h is  was tra c e d  to  a d s o rp tio n  o f 
[125 i ] hyp to  the f i l t e r s  and to  v a r ia b i l i t y  in  the amount o f non- 
s p e c if ic a l ly  bound [^^^IjHYP lo s t  on f i l t e r in g ,
To overcome th is  the fo llo w in g  approach was used. The a d d itio n  
o f  0.1 mmol/1 (±) p ro p ra n o lo l to  b u ffe r  B encourages th e  non- 
s p e c i f ic a l ly  bound to  le a ve  the  membrane w h ile  n o t
s ig n i f i c a n t ly  a f fe c t in g  s p e c if ic a l ly  bound lig a n d  ( M a g u i r e -âJL> 
1976a) and a lso  to  e lim in a te  n o n -s p e c if ic  r e te n t io n  o f counts on 
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alone o r ra d io lig a n d  p lus c o m p e tito rs  o f b in d in g  ( In s e l and 
S tool man, 1978).
Since [^^^I]HYP also binds to  the f i l t e r s ,  these are pre-soaked 
f o r  60 m in in  b u f fe r  B; the (±) p ro p ra n o lo l b lo cks  n o n -s p e c if ic  
b ind ing  o f ra d io a c tiv ity  to  the f i l t e r s  (Galant and A llre d , 1981). 
A lso  le a v in g  the samples to  stand f o r  45 sec b e fo re  f i l t e r i n g  
a llo w e d  n o n -s p e c if i c a l l y  bound or occluded 1 igand to  d is s o c ia te  
(Sporn and M o lin o ff, 1976).
The re s u lts  in  Table 4 were obtained by s e ttin g  up [^^^IJHYP 
b in d in g  assay s in  q u a d ru p lic a te  to  re p re se n t " t o t a l " b in d in g  and 
"n o n -sp e c ific "  b ind ing  (NSB) w ith  0.3 ;jm dL /l ( - )  p roprano lo l. The 
c o n c e n tra t io n  o f  [125%]HYP was (0.4 nm o l/1 ). The assays w ere  
te rm ina ted  under permutations o f the fo llo w in g :
1. Pre-soaked f i l t e r s ,
2. B u ffe r B contains propranolo l.
3. F i l t e r  p a pe rs  w e t te d  j u s t  b e fo re  f i l t e r i n g  to  see i f
a c c id e n ta l ly  w e t t in g  th e  f i l t e r s  in t e r f e r e d  w i t h  th e  
re p ro d u c ib il ity  of the assays.
The questions to  be answered were:
1. Is  pre-soaking f i l t e r  papers w ith  propranolo l b e n e fic ia l.
2. Is  p roprano lo l in  b u ffe r B b e n fic ia l.
3. Is  a combination be tte r.
4. Does w e ttin g  the pre-soaked f i l t e r  papers w ith  r in s in g  b u ffe r
(which does not contain propranolo l) have an adverse e ffe c t,
5. Is  f i l t e r in g  a t  3-4 psi b e tte r than 20 psi.
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The c r i ueris used fo r  t i i is  c ru c ia l experiment were:
1, A lo w  c o e f f i c i e n t  o f  v a r ia t io n  f o r  th e  q u a d r u p l ic a te
observations.
2. Ihe low est non-spec ific  binding (NSB),
O p tio n  4 in  Table 4, (Y, Y, N), was chosen as s a t is fy in g  the above 
c r i t e r ia ,  g iv in g  optimum r e p ro d u c ib i l i t y  coupled w ith  a good
Total:I'1SB d if fe re n c e .
O ther w o rke rs  perform ed t h e i r  assays in  th e  presence o f 
phentolamine (Pochet ^  1979; Tolmeh and Cryer, 1980; Aarons ^
1 980) o r in  th e  presence o f ca techo l and phen to lam ine  (G a lan t 
-Si 1978a; G a la n t and A llre d ,  1981) to  reduce n o n -s p e c if ic  
b in d in g  w ith o u t  a f fe c t in g  s p e c if ic  b in d ing . But a t  le a s t  i n  one 
case, r a t  hypothalam us membranes, phen to lam ine  was found  to  
d is p la c e  [^^^ I]H Y P  from  be t a - adrenoceptors  (Sporn and M o lin o f f ,  
1976). I t  was also noted tha t phentolamine, a t  the concentra tion  
range o f 10 p m o l/1  to  0.1 mmol/1, can b lo ck  th e  is o p re n a lin e -  
dependent aden y la te  cyc lase  a c t iv a t io n  in  neu rob las tom a-g lyom a  
hybrids (A tla s  1979).
The use o f phento lam ine or ca techo l and phen to lam ine  in  th e  
p re s e n t assay system had no s ig n i f ic a n t  e f fe c t  on the r e s u lts .  
T h is  i s  in  agreement w ith  Pochet ^  (1979), who a lso found th a t
the a d d it io n  o f phentolamine to  In ta c t  lym phocyte b in d in g  assays 
was n o t c r u c ia l ,  as d id  A t la s  ^  j i  (1979) who found  th a t  the  
e f fe c t  o f phen to lam ine  i s  m a rg ina l and so phen to lam ine  can be 
om itted  from the assay,
3 . 2 . 3 .  T n t - a n h  p . e i i s  V S  c f t U  B M b f a n e a
Some in v e s t ig a to r s  (W ill ia m s  .â li 1976 tj Brooks 1979î
Aarons 1980; G a la n t i d ,  1980; Tohmeh and C rye r, 1980)
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s tu d ie d  b e ta -a d re n o c e p to r s in  lym p h o cy te  fragpients (membranes), 
w h ile  o th e rs  (C o n o l ly  and Greenacre, 1976; In s e l and S too lm an, 
1978; P om et ^  _al, 1979; Galant and A llre d , I 98I ;  Hui ^  1981)
used in ta c t  lymphocytes.
A com parison o f in ta c t  c e l ls  w ith  c e l l  membranes was made, A 
p re p a ra tio n  of lym phocytes was ha lved and c e l l  membranes were 
p repared  u s in g  a m in i-bom b c e l l  d is ru p t io n  chamber, 15 ml o f 
i n t a c t  lym phocyte  suspension were p laced in s id e  the d is ru p t io n  
chamber (w liic h  was precoo led  by im m ersion in  an ic e  ba th) and 
exposed to  500 psi n itrogen fo r  45 min. During th is  tim e n itrogen 
i s  taken in to  in d iv id u a l ce lls . The pressure was slow ly released 
and as the p re ssu rise d  suspension was exposed to  a tm o sp h e ric  
p re ssu re  the  gas expands and ru p tu re s  th e  c e l ls .  T h is  a d ia b a t ic  
e x p a n s io n  was s u f f i c i e n t  to  ly s e  g re a te r  th a n  90% o f  the  
lymphocytes. The suspension was centrifuged (400g, 10 min, 4C) to  
remove in t a c t  c e l ls  and n u c le i,  and then the c e l l  membranes were 
h a rve s te d  from  the superna tan t (78000g, 30 min, 4 0  and and 
K j estim ated  as described (M a te ria ls  and Methods, 2.3,1,) fo r  both 
the membranes and the o r ig in a l in ta c t lymphocytes. The re s u lts  are 
sum m arised in  Table 5. These r e s u lts  show no s ig n i f i c a n t  
d if fe re n c e  between the  number ( 8^ 2%) and a f f i n i t y  (K^) o f  b e ta - 
a d ren o ce p to r s f o r  in t a c t  and d is ru p te d  ly m p h o c y te s  (p > 0 ,1 ) . 
However, Inse l and Stoolman (1978) found th a t the d is ru p tio n  o f S49 
lymphoma c e l ls  decreases the response o f aden y la te  cyc la se  to  
is o p re n a lin e  and o th e r hormones, a lso  the  c o u p lin g  between 
recep to rs  and cyclase appears to be a lte red . Another disadvantage, 
i s  th a t ions and nucleotides (e.g, GTP) are im portan t mocUlators o f 
r e c e p to r  f u n c t io n ,  b u t they a re  la r g e ly  w ashed away when 
"membranes" are prepared (Motulsky and In s e l, 1982a).
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TABLE 5
^max values fo r  binding o f to  in ta c t  and d isrupted
lymphocytes
^max Kd
(fm ol/IO ^ lymphocytes) (rm o l/1 )
In ta c t  lymphocytes 6.25 ± 0.53 0.36 ±  0.05
D isrupted lymphocytes 6.03 ±  0.64 0.29 ±  0.06
max = to ta l nimber o f b inding s ite s .
K j = d isso c ia tio n  constant.
Data represent Mean ±  SD (5 experiments).
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F in a lly , the in ta c t c e ll model may perm it a b e tte r app rec ia tion  
o f the mechanism ol a lte red  beta-adrenoceptor fu n c tio n  in  several 
c l in i c a l  e n t i t ie s  in  man than has been p o s s ib le  w ith  plasma 
membrane p re p a ra tio n s , which la c k  a com parable p h y s io lo g ic a l 
component (Galant and A llre d , 1981). Therefore in ta c t  lymphocytes 
were chosen fo r  subsequent studies,
4. CHABACTEBISATIQN OF THE LYMPHOCYTE BETA-ADRENOCEPTOR PROPERTIES
Lym phocytes w ere prepared as described  (M a te r ia ls  and Methods,
2 .1 .) u s in g  E a r le 's  B a la n ce d  S a l t  S o lu t io n  ( w i t h o u t  sod ium  
b icarbonate) supplemented w ith  0,1% c a lf  serun and 20 mmol/1 Hepes 
a t pH 7.6 which gave best y ie ld .
F in a l  c e l l  c o n c e n t ra t io n s  w e re  u s u a l ly  2 .5 -3 .0  x 10^ 
lym p h o cy te s /m l w ith  c e l l  p o p u la tio n s  o f a p p ro x im a te ly  90-95% 
lym phocytes , the rem ainder be ing  monocytes. C e ll v i a b i l i t y  
rem ained g re a te r than 95% d u rin g  a l l  the d e scrib ed  procedures as 
determ ined by trypan blue exclusion.
4.1. KTWCTTC ANALYSIS OF BIHDIMg
The in te ra c t io n  o f beta-adrenergic agents w ith  beta-adrenoceptors 
i s  a r e la t iv e ly  ra p id  and re v e rs ib le  process. A c c o rd in g ly , a 
rea sonab le  e x p e c ta tio n  i s  th a t  the b in d in g  in te r a c t io n  o f  a 
ra d id  a b e lled  adrenerg ic  l ig a n d  w ith  beta—adrenocep to r s w i l l  be
s im ila r ly  rap id  and re v e rs ib le
K in e tic s  o f b ind ing were performed as described (M a te ria ls  and 
M e th o d s , 2 .3 .2 .) .  S p e c i f ic  b in d in g  o f  [1 2 5 i]h y p  to  human 
lym p h o cy te s  a t  30C achieved e q u il ib r iu m  w it h in  30-40 min, w ith  
ha lf-m ax im a l s p e c if ic  binding ( t ^ / 2) o f 3-4 min (F ig . 18). B ind ing  
rem ained s ta b le  fo r  60 min a t  30C. A 45 min in c u b a tio n  t im e  was
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FIG. 18
Time course o f  [ 1^^I]HYP b in d ing  to  in t a c t  human lym phocytes . 
Lympliocytes in  bu ffe r A were incubated w ith  [*^^^I]HYP (0 .4nm ol/l) 
i n  the absence and presence o f 0 .3 /jm o l/ l ( - )  p ro p ra n o lo l. A t the 
in d ic a te d  tim e s , the samples were d ilu te d  w ith  b u f fe r  B and 
f i l t e r e d .  S p e c if ic  b in d ing  was determ ined in  d u p lic a te  a t  each 
tim e  in te r v a l .  ( In s e t)  the re g ress io n  l in e  ( r  = 0.98) was 
determined by the p lo t o f In  [Bg^/(Bgq -  B^)] vs. time, where B^^ z 
b ind ing a t  e q u ilib r iu n  and B^ = binding a t  time t. i s  equal to  














r o u t in e ly  used to  re p re s e n t e q u il ib r iu m  in  subsequent b in d in g  
experiments.
The i n i t i a l  ra te  co n s ta n t (K^^) fo r  the a s s o c ia t io n  re a c t io n  
o b ta in e d  from  the slope (F ig . 18, in s e t)  was 0.14 m in"^ f o r  0.4 
nm o l/1  [^^^IJH YP. D is s o c ia t io n  o f bound [*^^^I]HYP a t  30C was 
determined by incuba ting  lymphocyte suspension to  e q u ilib r iu m , then 
add ing  0.3 ju m o l/ l ( - )  p ro p ra n o lo l ( f i n a l  c o n c e n tra t io n )  a t  t im e  
ze ro  and m easuring re s id u a l s p e c if ic  b in d in g  a t subsequent tim e  
in te rv a ls  (Fig. 19). D issoc ia tion  was ra p id  w ith  a (t<|/2^ o f 8-10 
min, and the d is s o c ia t io n  ra te  co n s ta n t (K2) was 0.077 ±  0.0085 
m in” ** (F ig . 19, in s e t ) .
The a s s o c ia t io n  ra te  co n s ta n t (K^) o f  [**25l]HYP b in d in g  was 
then ca lcu la ted  from the equation: K-j = (K^^ -  K2)/CIHYP], where
[IHYP] i s  equal to  the concentra tion  o f [^^^I]HYP in  the assay (0 .4  
n m o l / l ) ,  K, was 1.566 x 10^  ±  0 . 2 1  x 10® M"'' m in " ' '.  The 
e q u ilib r iu m  d is s o c ia tio n  constant (K j) , determined from the r a t io  
K2/K 1, was 0.47 ±  0.11 n m o l/l (2 experiments).
4.2. SATURABILITY OF
S a tu ra t io n  s tu d ie s  were c a r r ie d  o u t as d e sc rib e d  (M a te r ia ls  and 
Methods, 2 .3 .1.) .  W ith  in c re a s in g  c o n c e n tra t io n s  o f  [^^^ I]H Y P , 
s p e c if ic  b inding (the b ind ing  tha t could be displaced by 0.3 /m o l/1  
( - )  p ro p ra n o lo l)  reached s a tu ra t io n  a t  500-600 pm o l/1  (F ig . 20 ), 
w ith  h a lf  maximal b ind ing  occurlng a t  about 150-250 pmol/1.
S catchard  a n a ly s is  (F ig . 21) o f  the  s a tu ra t io n  data y ie ld e d  a 
s tra ig h t l in e ,  in d ic a t in g  th a t [1^^I]HYP boind to  a s ing le  c lass o f 
h i ^  a f f in i t y  receptors in  in ta c t lymphocytes. The to ta l nunber o f 
b ind ing s ite s  (B^ax) was 6.42 ±  0.88 flno l/IO ^ lymphocytes, and the 
d is s o c ia tio n  constant (K^) o f the b ind ing  was 0.33 ±  0.07 n m o l/l (8
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FIG. 19
Time course fo r  d isso c ia tio n  o f  b ind ing to  in ta c t  human
lymphocytes. Lymphocytes in  bu ffe r A were incubated w ith  [**^^I]HYP 
(0 .4 n m o l/ l)  f o r  45 min to  a llo w  e q u il ib r iu m . A t z e ro  tim e , 
0 .3 )Jm o l/l ( - )  p ro p ra n o lo l ( f i n a l  c o n c e n tra tio n ) was added to  th e  
samples and s p e c if ic  b in d in g  was de te rm ined  a t  v a r io u s  t im e  
in te rv a ls , 100% b ind ing  re fe rs  to  the s p e c if ic  b ind ing  ju s t  p r io r  
to  the a d d itio n  o f  ( - )  p roprano lo l. (Inse t) f i r s t - o r d e r  ra te  p lo t  
o f d isso c ia tio n  o f [^^^I]HYP b in d in g  Kg is  equal to  the slope o f 

















S p e c if ic  b in d in g  o f  [125 l]H Y P  to  in t a c t  human lym phocytes as a 
fu n c t io n  o f c o n c e n tra t io n  o f [^^^ I]H Y P . Lymphocytes in  b u ffe r  A 
w ere in cu b a te d  w ith  v a r io u s  c o n c e n tra tio n s  o f  [^ ^^ I]H Y P  in  the 
presence and absence o f 0 .3 p m o l/ l ( - )  p ro p ra n o lo l.  S p e c if ic  
b ind ing was deterrrlned a t each concentra tion  o f  [^^^I]HYP,
0 2  0 3 0-4 0 5  0 6 0 70 01
C'25jQ hyp  (nmol/0
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FIG. 21
S ca tcha rd  a n a ly s is  o f the b in d in g  data (F ig . 20) y ie ld in g  a K j^ o f  
0 .2 7 n m o l/l and the  to ta l  number o f be t a - ad renocep to rs  was 7.3 
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experiments).
4.3 . -DISCUSSION OF KINETIC gniDTES
ÏVie re s u lts  in d ica te d  th a t the s p e c if ic  b ind ing  o f [ ^^^I]HYP, which 
re p re s e n te d  70-75% o f the  t o t a l  b in d in g ,  to  i n t a c t  human 
lym phocy tes  was c o n s is ta n t w ith  the  c r i t e r ia  expected o f  l ig a n d  
in te ra c t io n  a t  a beta-adrenoceptor. [ ^^^I]HYP b ind ing  was rap id , 
re v e rs ib le  and sa tu rab le  w ith  a K^, estim ated from e q u ilib r iu n , o f 
0.33 ±  0.07 nm o l/l which was compatible w ith  those o f o ther w orkers 
(P a ie tta  ^  1982) using [**^^X]HYP as b ind ing lig a n d  and a lso  in
agreement w ith  tiie o f 0.47 ±  0.11 nm o l/l ca lcu la ted  from k in e t ic  
data.
4 .4 .COMPETITION FOR [ ^^ 11  HYP BINDING SITES BY ADRENERGIC
imEQum
C o m p e titio n  o f b e ta -a d re n e rg ic  compounds w ith  [^^^ I]H Y P  w ere  
pe rfo rm ed  and repea ted  th re e  tim e s  as describe d  (M a te r ia ls  and 
Methods, 2 .3 .3 .). These s tu d ie s  in d ic a te d  both s te re o s e le c tiv ity  
(F ig . 22), where the ( - )  isom er o f p ro p ra n o lo l was two o rd e rs  o f  
magnitude more potent in  in h ib it in g  [^^^I]HYP b ind ing  than the (+)
iso m e r, and a rank o rder o f c o m p e tito rs  ty p ic a l  o f  b e ta g -
adrenoceptors, Beta2 s p e c if ic ity  was shewn by rank order potency
o f [*^25i]hyp in h ib it io n  by salbutamol, a re la t iv e ly  s p e c if ic  beta2-  
a d re n e rg ic  a g o n is t, w hich was about 2 5 - fo ld  more p o te n t than  
p r a c to lo l ,  a b e ta ^ -a d re n e rg ic  a n ta g o n is t (F ig . 22, Tab le  6). The 
d is s o c ia tio n  constants (K^) fo r the in h ib it io n  o f [**^5i]hyp b ind ing  
fo r  the various competing drugs were ca lcu la ted  using a non -linea r 
le a s t  squares curve  f i t t i n g  package (RECFIT, C la rk£ _ t.â 2 , 1984). 
The r e s u lt s  in d ic a te d  on ly  a one s i t e  f i t  ( i .e ,  b e ta 2), Tor b o th
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FIG. 22
C o m p e titio n  fo r  [**^^I]HYP b in d in g  s ite s  by a d re n e rg ic  d rugs in  
i n t a c t  human ly m p h o c y te s . V a r io u s  c o n c e n t ra t io n s  o f  ( - )  
p ro p ra n o lo l # ,  ( +) p ro p ra n o lo l (^), sa lb u tam o l (■) and p r a c to lo l  
(O) were incubated w iü i lymphocytes and [**^^I]HYP (0.4nm o l/l) fo r 
45 min. The samples were then d i lu te d  and f i l t e r e d .  S p e c if ic  















The d is s o c ia tio n  constants (K^) o f drugs determined by com petition
fo r  [*^^^I]HYP b ind ing
Drug D issoc ia tion  Constant (K^)
( - ) Propranolol 5.45 ± 1 .6 6  x 10“ ^^
(+ )Propranolol 6.68 ±  1.84 x 10"^
Salbutamol 5,68 ±  1.69 x 10” ^
P ra c to lo l 1.42 ±  0.22 x 10“ ^
The d isso c ia tio n  constant (K j) was ca lcu la ted  using a le a s t squares 
c u r v e - f i t t i n g  package (RECFIT), ( C la r k ^ _ a i ,  1984). R esu lts  a re  
expressed as the Mean ±  SD (4 experiments).
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sa lb u ta m o l and p ra c to lo l ,  w ith  no d e te c ta b le  c o n ta m in a tio n  from  
b e ta i-a d re n o c e p to rs . The d e r iv a t io n  o f th is  c o n f irm a t io n  i s  
exp la ined elsewhere (C lark ^  _al, 1984).
5XHARACTERISATTQM OF THE LYMPHOCYTE 
ALPHA-ADRENQCEPTOR PROPERTIES
R a d io lig a n d s  have been s u c c e s s fu l ly  used to  la b e l  a lp h a -  
adrenoceptors in  d if fe re n t tissues  (W illia m s and Le fko w itz , 1978b; 
B e g in -H e ic k  _al, 1 9 7 9 ; H oick _al, 1 979; T sa i and L e fk o w itz , 
1979; Carman-Krzan, 1980). In  the la s t  few years i t  become c le a r 
th a t there are two subtypes of alpha-adrenoceptors, termed alpha^ 
and alpha2 receptors (Berth e l sen and P e ttin g e r,1 977).
Using rad io ligand  b ind ing techniques, two d if fe re n t  approaches 
have been ap p lied  to  characterise the presence o f alpha^ and alpha2 
re c e p to rs . The f i r s t  in v o lv e s  the use o f a n o n -s e le c t iv e  
ra d io lig a n d  such as [^H jd ihydroergocryptine ([^H]DHE) to  la b e l the 
e n t ire  alpha receptor population, then d is tin g u is h in g  between the 
a lpha  re c e p to r subtypes by c o n s tru c tin g  com petition  curves using 
an tagon is t can pounds which have se le c tive ly  greater potency fo r  one 
or the other alpha subtype (Miach ja t j d i  1978; Hoffman ^  1979;
Hoffman and L e fko w itz , 1980a; Hoffman ^  1980a,b).
The second, the  more u s e fu l and w id e ly  a p p lie d  c r i t e r io n  fo r  
d is t in g u is h in g  between alpha re c e p to r subtypes, is  by u s in g  
ra d io lig a n d s  w h ich  them selves s e le c tiv e ly  labe l e ith e r alpha^ or 
alphag receptors (Barnes 1979; Green grass and Bremner, 1979;
K a r l in e r  ^  1979; D a ig u ji  ^  j j . ,  1981; M otu l sky and In s e l,
1982b; Hoffm an ^  1981 ; Tharp 1981; M ukherjee , 1981;
M otu l sky ^  1980; E n g f e l d t ^ ^ ,  1983). [^H ] p ra z o s in  i s
s e le c tiv e  fo r  alpha<j receptors whereas [^H lyohim bine i s  se le c tive
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to r  alpha2 receptors. Because no other worker have characterised  
s i 1^1 So- a dr e no ce p to r  s on human lymphocytes, the  fo l lo w in g  methods 
were developed,
5 .1 . KINETIC ANALYSIS OF f 3»]YOHIMBINE BINDING
K in e t ic s  o f  b in d in g  were perform ed as described  (M a te r ia ls  and 
M ethods, 2 ,4 .2 ,) .  B in d in g  o f  [ ^H] yohimbine to  hunan lymphocytes 
a t  25c was rap id , w ith  ha lf-m axim al s p e c if ic  b inding ( t ^ / 2) o f  1.5-
2.0 rain (Fig, 23), reaching e q u ilib r iu m  w ith in  16-20 m ia 
B ind ing  remained stab le  fo r  30 min a t  25C. An incuba tion  tim e
of 25 min was chosen to  represent e q u ilib r iu m  b ind ing  in  subsequent 
experiments. The i n i t i a l  ra te  constant (I^g) fo r  the a sso c ia tio n  
re a c t io n  o b ta in e d  from  the slope (F ig . 23» in s e t)  was 0.32 min“  ^
f o r  5 nmol/1 [^H]yohimbine; D issoc ia tion  o f bound [^H lyohim bine
a t 2 5 c was determined by incubating lymphocytes to  e q u il ib r iu n  and 
tfien adding 10 jumol/1 phentolam ine ( f i n a l  c o n c e n tra t io n )  a t  t im e  
ze ro  and m easuring  re s id u a l s p e c if ic  b in d in g  a t  subsequent t im e  
in t e r v a ls  (F ig . 24), D is s o c ia t io n  was ra p id  w ith  a t ^ /2  5 .0 -
6.0 min (Fig. 24) and the d isso c ia tio n  ra te  constant (K2) was 0.127 
± 0 ,0 1 6  min"** (F ig . 24, in s e t ) .
Ihe associa tion  ra te  constant (K^) was then ca lcu la ted  from the 
e q u a tio n : = (K^^ -  K2) / [y o h im b in e ] ,  where [y o h im b in e ] i s
equal to  the  c o n c e n tra t io n  o f [ ^H ]yoh im bine  in  th e  assay (5  
n m o l/1 ), was 0.386 x 10^ ±  0.027 x 10® M"** min"**. The
e q u ilib r iu m  d isso c ia tio n  constant (K j), determined from the r a t io  
o f K2/K 1, was 3.49 ±  0.39 nmol/1 (3 experiments).
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FIG. 23
Time course of [ % yohimbine binding to  in ta c t hunan lymphocytes. 
Lymphocytes in  bu ffe r A were incubated w ith  [5 H]yohimbine (5 n m o l/l)  
in  th e  absence and presence o f lO jjm ol/1  phento l amine. A t th e  
in d ic a te d  tim es, the samples were d ilu te d  w ith  b u f fe r  C and 
f i l t e r e d .  S p e c if ic  b ind ing  was determ ined in  d u p lic a te  a t  each 
t im e  in t e r v a l .  ( In s e t )  the re g re s s io n  l in e  ( r  = 0 .9 9 ) w as 
determined by the p lo t o f In  [Bgq/(Boq -  Bg)] vs, time, where = 
b inding a t e q u ilib r iu n  and B^ = binding a t  time t, Kq^ i s  equal to  







Time course fo r  d is s o c ia t io n  o f  yohim bine b in d in g  to  in t a c t  
human lym phocytes . Lymphocytes in  b u ffe r  A were in cu b a te d  w i t h  
[3 H]yohimbine (5nm o l/l) fo r  25 min to  allow equ ilib rium . A t zero 
tirne^ 10pm ol/1 phentolanine ( f in a l concentration) was added to  the 
samples and s p e c if ic  b in d in g  was determ ined a t  v a r io u s  tim e  
in te rv a ls . 100% b ind ing  re fe rs  to  the sp e c if ic  b inding ju s t  p r io r  
to  the a d d itio n  o f phentol ami ne. (Inse t) f ir s t - o rd e r  ra te  p lo t o f 
d is so c ia tio n  o f [ ^H]yohimbine b in d in g  K2 is  equal to  the slope o f 

































5 .2 . gAPIRABIL IT Ï  OF r3mY0HIMBTNF. RTWnTMr.
S a tu ra t io n  s tu a ie s  were c a r r ie d  o u t as described  (M a te r ia ls  and 
Methods, 2.4.1,), Tine b ind ing c h a ra c te r is tic s  o f [^H]yohimbine tos
in ta c t  hunan lymphocytes is  shown in  Fig. 25. S p e c ific  b ind ing  o f 
[ ^ H ]y o h im b ine (th e  b in d in g  th a t  cou ld  be d is p la c e d  by 10 jjm o l/1  
phentol ami ne) was c le a rly  saturable and o f h ig li a f f in i t y .
Apparent s a tu ra t io n  o f b in d in g  s i te s  seemed to  occur a t  
[^H Jyoh im b ine  c o n c e n tra tio n  o f  14-16 nm o l/1 , w ith  h a lf-m a x im a l 
b in d in g  o c c u r in g  a t  about 2-3 nm ol/1 . Scat chard a n a ly s is  (F ig .
25, in s e t )  o f the s a tu ra t io n  da ta  y ie ld e d  a s t r a ig h t  l in e ,  
in d ic a tin g  th a t [^H]yohimbine botnd to  a s ing le  c lass o f receptors. 
Hie d isso c ia tio n  constant (K j) o f b ind ing was 3.7 ±  0.86 nmol/1 (8 
e xp e rim e n ts ) and th e  t o ta l  number o f b in d in g  s i  te s  w as 19.9 ±  5.3 
fm o l/io '^  lymphocytes.
5 .3 . .DISCUSSIQÜ-QF KlfiEHC STWIES
The re s u lts  ind ica te d  th a t the s p e c if ic  b ind ing  o f  [^H]yohimbine, 
w h ich  re p re se n te d  70-80% o f the t o ta l  b in d in g , was ra p id , 
r e v e r s ib le  and s a tu ra b le .  The d is s o c ia t io n  c o n s ta n t  o f  
[^H lyohim bine (3.7 ± 0.86 nmol/1) es tab lished  a t  e q u ilib r iu m  was in  
agreement w ith  the o f 3.49 ±  0.39 nmol/1 determined from k in e t ic  
data ( i .e .  r a t io  o f a s s o c ia t io n  and d is s o c ia t io n  ra te  c o n s ta n ts ). 
S im i la r  d is s o c ia t io n  co n s ta n ts  have been observed fo r  human 
p la te le ts  (Motulsky ^  1980) and fo r  hunan ad ipocyte  membranes
(Tharp ^  1 981 ).
S.U.COMPKTITION FOR [BmITOHIMBHIE BINDING SITES BY ADRENERGIC 
COMPOUNDS
Com pétition stud ies o f adrenergic compouids w ith  [3H]yohimbine were
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FIG. 25
S p e c ific  b ind ing o f  [^H]yohimbine to  in ta c t  human lymphocytes as a 
fu n c tio n  o f concentra tion  o f [ ^H]yohimbine. Lymphocytes in  b u ffe r 
A were incubated w ith  various concentrations o f [^H]yohimbine in  
the  presence and absence o f IO ^m o l/1  phento l amine. S p e c if ic  
b in d in g  was de te rm ined  a t each c o n c e n tra tio n  o f  [^H ]yo h im b ine . 
( In s e t)  Scatchard  a n a ly s is  o f  the  b in d in g  data y ie ld in g  a o f  
4 .2 4 n m o l/l and the t o ta l  number o f re c e p to rs  was 24.8 fmol/10*^ 
lymphocytes.
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p e rfo rm e d  and re p e a te d  th re e  t im e s  as d e s c r ib e d  ( M a te r ia ls  and 
M ethods, 2 .4 ,3 .).
B in d in g  o f  [ ^H ]yoh im bine was s te re o s p e c if ic a lly  in h ib ite d  by 
a d re n a lin e  (Tab le  7 ); the ( - )  isom er was more p o te n t than the (+) 
s te re o iso m e r. A d rene rg ic  a g o n is ts  competed fo r  [ y o h i mb i ne 
b ind ing s ite s  w ith  a potency order o f c lon id ine  > ( - )  adrena line  > 
( - )  n o ra d re n a lin e  > (+) a d re n a lin e  »  ( - )  is o p re n a lin e , w ith  
v a lu e s  o f  0 .28 , 1.50, 6.74 and 16,00 jumol/1 f o r  c lo n id in e ,  ( - )  
adrenaline, ( - )  noradrenaline and (+) adrenaline re sp e c tive ly  (F ig, 
26 and Tab le  7). The b e ta -a d re n e rg ic  a g o n is t, ( - )  is o p re n a lin e , 
was a very  weak in h ib i t o r  o f yoh im b i ne b in d in g  (K^ = 126.00 
jum ol/1 , F ig . 26 and Table 7).
The a lp h a -a d re n e rg ic  a n ta g o n is ts  phentol am ine, yohimbine and 
prazosin  competed f o r  [^H]yohimbine b ind ing s ite s  w ith  a potency 
o rd e r of yohim bine > phento l am ine > prazosin (Fig, 27 and Table 7). 
Yohimbine, an alpiia2-ad renerg ic  antagonist competed fo r  the b ind ing  
s i t e s  w ith  a o f  0,01 jjm o l/1 , Phento l am in e , a n o n -s e le c t iv e  
a lp h a -a d re n e rg ic  a n ta g o n is t competed w ith  a K j o f  0.03 p n o l/1 .  
Prazosin, a s p e c if ic  alpha^-adrenerg ic antagonist, competed w ith  a 
K j o f  2,00 pmol/ l .
The d is s o c ia t io n  co n s ta n ts  (K^) fo r  the  in te r a c t io n  o f these 
various com peting unlabe lled  adrenergic agents w ith  [^H jyohim bine 
b in d in g  s i t e s  w ere  c a lc u la te d  from  the c o n c e n tra t io n  o f  these 
a g e n ts  r e q u ire d  to  i n h i b i t  50% o f the s p e c if ic  [^H ] yo h im b i ne 
b in d in g  based on th e  eq ua tion  o f Cheng and P ru s o ff  ( 1973), ta k in g  
in to  account the concentration o f the ligan d  [^H] yohimbi ne in  the 
assay and th e  d is s o c ia t io n  co n s ta n t o f  [^H ] y o h im b i ne d e te rm in ed  
frcxn b in d in g  experim ents. Moreover, the d is s o c ia t io n  co n s ta n ts  
fo r  these ad renerg ic  compounds (Table 7) were in  accord w ith  data
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TABLE 7
The d isso c ia tio n  constants (K^) o f drugs determined by com petition
fo r  [ yotûinbi ne bi ndi ng
Drug D issoc ia tion  Constant (K^, /m o l/ l )
C lon id ine 0.28 ±  0.027
(-)A d re n a lin e  1.51 ± 0 .1 5
(+ )Adrenal ine 16.20 ±  1.3
( - )  Noradrenal ine  6.74 ±  0.65
( - )  I  soprenaline 126.00 ±  12.0
Yohimbine 0.01 ±  0.0011
Phentol amine 0.03 ±  0.0028
Prazosin 2.10 ±  0.2
The d is s o c ia t io n  con s tan t ( K w a s  c a lc u la te d  a c c o rd in g  to  th e  
equation o f Cheng and P ruso ff (1973). Results are expressed as the 
Mean ±  SD (4 experiments).
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FIG. 26
Competition fo r  [ 3 H] yohimbi ne binding s ites by adrenergic agon is ts  
in  in ta c t human lymphocytes. Various concentrations o f c lo n id in e  
(^), ( - )  a d re n a lin e  (O), ( - )  noradrenaline (Û) and ( - )  is o p re n a lin e  
(#) were incubated w ith  lymphocytes and [^H]yohimbine (5nm o l/l) fo r  
25 min. The samples were then d ilu te d  and f i l t e r e d .  S p e c if ic  
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FIG. 27
C o m p e t it io n  f o r  [ ^H] y o h im b i ne b in d in g  s i te s  by a d re n e rg ic  
an tagon ists in  in ta c t  human lymphocytes. Various concentrations o f 
yoh im b ine  (^ ) , phen to l amine (O) and p razos in  (#) were in cu b a te d  
w ith  lym phocytes and [ 3 H] yoh im b i ne (5 n m o l/l)  f o r  25 min. The 
samples w ere then d i lu te d  and f i l t e r e d .  S p e c if ic  b in d in g  was 
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reported by Motulsky ^  ^  (1980) fo r  hunan p la te le ts .
Therefore these observations in d ic a te  the presence o f p u ta tive  
alphao-adreiioceptors on hunan lymphocytes.
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RESULTS OF THE aiNXCIL STUDIES
STUDY I
Beta-adrenoœ ptor nimber
Both normal and asthm atic groups not on salbutamol showed a marked 
c irc a d ia n  v a r ia t io n  in  the number o f be ta2-a d re n o cep to rs
found  on lym phocytes  (p<0,05, Tab le  8) w ith  the b ig e s t number o f 
receptors  a t 1800 h. This c ircad ian  v a r ia t io n  i s  not abolished on 
exposure to  sa l butam o l. R e p re se n ta tive  s a tu ra t io n  cu rves fo r  a 
norm al s u b je c t and an a s th m a tic  p a t ie n t ,  both on sa l butam o l,  a re  
shown in  Figs 28 and 29 w ith  the corresponding Scatchard analyses 
in  F igs  30 and 31.
In  both groups, the number o f receptors a t0 8 0 0  h on sa l butam o l 
i s  s ig n i f i c a n t ly  le s s  than found  when sa l bu tarn o l was no t be ing  
taken  (p<0.05) show ing th a t  “down re g u la t io n ” o f  the  re c e p to rs  i s  
induced by sal butam o l. This "down re g u la tio n ” i s  not observed fo r  
the 1800 h samples.
For com parable reg im ens ( i,e ,  o f f  or on s a l butam o l / t im e  
co m b in a tio n s ), no s ig n i f ic a n t  d if fe re n c e  in  re c e p to r  number was 
observed between asthm atic p a tie n ts  and normals,
Beta2-adrenoceptor nunber (B^^g^) has been expressed in  terms o f  
fm o l/1 0 ^  lym phocytes in s te a d  o f  f  mol/m g p ro te in , where although 
th e re  was a c o r re la t io n  ( c o r r  = -35.9%, p<0.05, F ig . 32) between 
the  amount o f  p ro te in  in  lym phocytes  compared w ith  lym phocy te  
numbers in  pooled da ta  from  a l l  o b s e rv a tio n s , th e re  was a la rg e  
degree o f s c a tte r  w h ich  i s  n o t a cce p ta b le  when e v a lu a t in g  
in d iv id u a l re s u lts . This emphasises the importance o f expressing 
r e s u lt s  in  te rm s  o f  c e l l  numbers ra th e r  than c e l l  p ro te in  as i s  
o ften  done.
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TABLE 8
Mean va lu e s  (±  SD) o f b e ta -a d re n o cep to r number in  f i v e




( f b o l / 10  ^ lymphocytes)
C ontro l (5) 1800 9.02 ± 2.21
*
Not on sa lbutanol 0800 5.40 ± 1.16
On s a l butam o l 1800 7.18 ± 2.01
**
0800 2.01 ± 1.74
AsUm atic (5) 1800 6.86 ±  2.72
**
Not on sal butanol 0800 3.40 ± 1.50
On sal butam ol 1800 5.12 ± 1.48
**
0800 1.28 ± 0.41
* p<0.05
**  p<0.01
In  a d d it io n ,  the com parison o f c o n tro ls  w ith  a s th m a tic  p a t ie n ts  
w ith  and w ith o u t  o ra l sa l butam o l d id  n o t re v e a l any s ig n i f i c a n t  
d iffe re n ce .
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FIG. 28
[125 i]hyp  binding to  in ta c t lymphocytes of a contro l su b je c t w h ile  
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FIG. 29
[ ^^^I]HYP b in d in g  to  in ta c t  lym phocytes o f an a s th m a tic  p a t ie n t  
w h ile  on the sa l butam ol regimen a t 1800 h (day 2 ,# ) and 0800 h 








Scatchard ana lys is  o f the sa tu ra tion  data from Fig. 28: 1800 h (day 
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FIG. 31
Scatchard a na lys is  o f the sa tu ra tion  data from Fig. 29: I 8OO h (day 
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FIG. 32
P lo t o f lymphocyte p ro te in  vs. lymphocyte nimber.
300-1
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Beta-adrenoceptor a f f in i t y  (K^)
In  no rm a ls , th e re  was no s ig n i f ic a n t  d if fe re n c e  in  th e  re c e p to r  
a f f i n i t y  (K j)  between 1800 h and 0800 h w h ile  o f f  s a lb u ta m o l, b u t 
on s a lb u ta m o l a c i r c a d ia n  v a r ia t io n  a p pe a re d  w it ih  th e  
s ig n i f i c a n t ly  lo w e r  (p<0.05, F ig . 30) ( i.e . the  re c e p to r  i s  more 
s e n s it iv e )  a t  0800 h. Receptor a f f i n i t y  a t  1800 h was n o t 
s ig n if ic a n t ly  a ffected  by the a d m in is tra tio n  o f salbutamoL
In  asthm atic  pa tien ts , a c ircad ian  v a r ia t io n  in  was present 
both  o f f  and on sa lb u ta m o l (p<0.05). The a d m in is t r a t io n  o f 
salbutam ol n e ithe r s ig n if ic a n t ly  a lte re d  receptor a f f in i t y  a t 0800h 
nor a t  1800 h nor abolishes the e x is t in g  c ircad ia n  v a r ia t io n ,
VJith the exception o f es tim a tion  a t  0800 h o f f  salbutam ol, 
w here the f o r  a s th m a tic  p a t ie n ts  was s ig n i f i c a n t ly  lo w e r  
(p<0.01. Tab le  9) than  norm als, the  K^'s o f  both groups a t  
comparable tim es were not s ig n if ic a n t ly  d if fe re n t ,
FEV^/FVC r a t io
In  th e  norm al group no c irc a d ia n  v a r ia t io n  in  FEV^/FVC r a t i o  was 
o b s e rv e d , (T a b le  10) e i t h e r  o f f  o r on s a lb u ta m o l th e ra p y . 
A s th m a tic  p a t ie n ts  n o t re c e iv in g  sa lb u ta m o l showed th e  expected 
c irca d ia n  v a r ia t io n  in  FEV^/FVC ra t io ,  g iv in g  r is e  to  the 'tao rn ing - 
d ip "  i n  FEV^/FVC r a t io  (p<0.05) w hich was a b o lis h e d  on g iv in g
sal bu tarn d  th era py.
For comparable regimens, there  was no s ig n if ic a n t  d iffe re n ce  in  
FEV<j/FVC r a t io s  between the two groups e xce p t a t  0800 h o f f  
sa lb u ta m o l when th e  FEV^/FVC r a t i o  fo r  a s th m a tic  p a t ie n ts  was 
s ig n if ic a n t ly  low er than the normals (p^O.001), th is  corresponding 
to  the % crn in g -d ip " in  the asthm atic pa tien ts .
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TABLE 9
Mean v a lu e s  (± SD) o f be ta - ad renocep to r a f f i n i t y  (K^) in  f i v e




(n rn o l/ l)
C ontro l (5)





0.35 ±  0.11
On salbutamol 1800 0.46 ±  0.14
*
0800 0.21 ±  0.19
Asthmatic (5) 1800 0.31 ±  0.04
* *
Mot on sal butanol 0800 0.14 ±  0.06
On salbutamol 1800 0.42 ±  0.15
*
0800 0.23 ±  0.11
* p<0.05
**  p<0.01
n. s . , not s ig n if ic a n t
The comparison o f co n tro ls  w ith  asthm atic p a tie n ts  w ith  and w ith o u t 
ora l sal butanol d id  not reveal any s ig n if ic a n t d iffe re nce  except a t 
0800 h o f f  salbutamol.
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TABLE 10
Mean v a lu e s  (±  SD) o f FEV-|/FVC (%) in  f iv e  c o n tro l and f i v e








83.2 ±  7 .2
n. s.
82.9 ±  7.9
On salbutamol 1800 86.2 ±  6.8
n. s.
0800 83.9 ± 5 .8
Asthmatic (5) 1800 69.8 ±  14.1
*
Not on salbutamol 0800 51.9 ±  10.3
On salbutamol 1800 71.8 ±  14.4
n. s.
0800 67.5 ±  19.4
* p<0.05
n. s , , not s ig n if ic a n t
The comparison o f co n tro ls  w ith  asthm atic p a tie n ts  w ith  and w ith o u t 
o ra l salbutamol d id not reveal any s ig n if ic a n t d iffe re nce  except a t 
0800 h o f f  salbutamol.
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Plasma c o r t is o l concentra tions
Plasma c o r t is o l  c o n c e n tra t io n s  showed th e  expected c irc a d ia n  
v a r ia t io n  in  both normals and asthm atic pa tien ts  (p<0X)5i Table 11) 
o f f  and on sa lb u ta m o l. A d m in is tra t io n  o f sa lb u ta m o l d id  n o t 
s ig n i f i c a n t ly  a f fe c t  plasma c o r t is o l  c o n c e n tra t io n s  in  e ith e r  
group.
For comparable regimens there  was no s ig n if ic a n t d iffe re nce  in  
plasma c o r t is o l concen tra tions  between the normal and a s th m a tic  
groups.
STOPY 11
A lp h ^a d re n o ce p to r number (B^% )
No c ircad ian  v a r ia t io n  in  alpha2-adrenoceptor number was observed 
in  e ith e r  norm als o r a s th m a tic  p a t ie n ts  w he the r o f f  or on 
salbutamol therapy (Table 12). A dm in is tra tio n  o f salbutamol d id  
no t s ig n i f i c a n t ly  a f fe c t  the number o f a lpha2-a d re n o c e p to rs  in  
e i t h e r  groups
For com parable reg im ens ( i .e .  o f f  or on s a lb u ta m o l/ t im e  
co m b in a tio n s ) th e re  was no s ig n i f ic a n t  d if fe re n c e  in  a lpha2-  
adrenoceptor number between normals and asthm atic  p a tien ts ,
Alpha^-adrenoceptor a f f in i t y  (K^)
In  both normals and asthm atic  p a tien ts , there  was no s ig n if ic a n t 
d iffe re n ce  in  the alpha2-adrenoceptor a f f in i t y  between 18(X) h and 
0800 h w h i le  o f f  or on s a lb u ta m o l (T a b le  1 3 ) , and a g a in  
a d m in is tra tio n  o f salbutamol d id  not s ig n if ic a n t ly  a lte r  receptor 
a f f in i t y  a t e ith e r times.
For comparable regimens, no s ig n if ic a n t d iffe re n ce  was observed 
in  a lphag -ad reno cep to r  a f f i n i t y  between no rm a ls  and a s th m a tic
132
TABLE 11
Mean values (± SD) o f c o r t is o l concentrations in  f iv e  controL and
f iv e  asthmatic sub jects
Time
(h)
C o rtiso l
(jug/d l)




8.3 ±  1.7
*
15.1 ±  3.3
On salbutamol 1800 9.8 ±  3.3
*
0800 18.1 ±  2 .7
Asthmatic (5) 1800 11.8 ±  5.7
* *
Not on salbutamol 0800 21.0 ±  8.2
On salbutamol 1800 9.4 ±  5.9
*
0800 22.1 ±  9 .0
* p<0.05
p<0.01
The comparison o f co n tro ls  w ith  asthm atic p a tie n ts  w ith  and w ith o u t 
o ra l salbutamol d id  not reveal any s ig n if ic a n t d iffe rence .
S im ila r ly  salbutamol d id  not have any s ig n if ic a n t e ffe c t on plasma 
c o r t is o l concentrations a t  the respective  times.
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TABLE 12
!-îean values (±  SD) o f a l pha2 -a  dreno ce p to r number in  f i v e




( 111o l / 10  ^ ly  rnph ocy te s )




20.91 ±  0.91
n. s.
20.26 ±  4.22
On salbutamol 1800 22.30 ±  3.33
n. s.
0800 22.25 ±  1.56
Asthmatic (4) 1800 21.73 ±  1.83
n. s.
Not on salbutamol 0800 21.70 ± 4 .0 7
On salbutamol 1800 22.61 ±  2.33
n. s.
0800 20.15 ±  2.84
n. s .,  not s ig n if ic a n t
The comparison o f co n tro ls  w ith  asthm atic p a tie n ts  w ith  and w ith o u t 
o ra l sa lbu tand  d id  not reveal any s ig n if ic a n t d iffe re n ce .
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TABLE 13
Mean va lues  (±  SD) o f a l pha2 -a  dreno ce p to r  a f f i n i t y  (K^) in  f i v e









4.23 ±  0.47
n. s.
3.97 ±  0.77
On salbutamol 1800 4.21 ±  0.58
n. s.
0800 4.42 ±  1.02
Asthmatic (4) 1800 4.32 ±  0.32
n. s.
Not on salbutamol 0800 4.38 ±  0.10
On salbutamol 1800 4.29 ±  0.41
n. s.
0800 4.23 ±  1.07
n. s ., not s ig n if ic a n t
The comparison o f co n tro ls  w ith  asthm atic p a tie n ts  w ith  and w ith o u t 
o ra l salbutsraol d id  not reveal any s ig n if ic a n t d iffe re n ce .
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p a ti ents.
Beta-adrenoceptor nunber ( B ^ )
Both normal and a s th m a tic  groups showed a s ig n i f ic a n t  c ir c a d ia n  
v a r ia t io n  in  the number o f be 182- a dr e no ce p to r  s w ith  the
b ig e s t number o f re c e p to rs  a t  1800 h (p< 0 .05 , Tab le  14) w hich was 
not abolished on treatm ent w ith  salbutamol. On salbutam ol, "dcwn- 
regu l a tio n " o f be ta - adrenoceptor number occurred in  both groups in  
the  0800 h samples (p<0,05) and no evidence f o r  ” d o w n -re g u la tio n ” 
was found in  the 1800 h samples.
No s ig n i f ic a n t  d if fe re n c e  in  b e ta -a d re n o ce p to r number was 
observed e ith e r a t  OBOOh or I800h between the normal and asthm atic  
groups whether o f f  or on salbutamol,
Beta-adrenoceptor a f f in i t y  (K^)
No s ig n i f ic a n t  d if fe re n c e  in  th e  re c e p to r  a f f i n i t y  (K^j) was 
observed between 1800 h and O8OO h in  normal s u b je c ts  w h ile  o f f  
salbutamol, but on salbutamol a c ircad ia n  v a r ia t io n  appeared in  
w i t h  lo w e r  va lu e s  a t  O8OO h (p<0.05). A s th m a tic  p a t ie n ts  had a 
c ircad ia n  v a r ia t io n  in  both o f f  and on sa lbu tam d (p<0J)5), w ith  
the  lo w e r a t  O8OO h.
For com parable reg im ens, no s ig n i f ic a n t  d if fe re n c e  in  th e  
re c e p to r  a f f i n i t y  between normal and a s th m a tic  s u b je c ts  was 
observed except a t  0800 h o f f  salbutamol (p<0,05, Table 15).
Alphc^ ; beU^ recep to r r a t io
Both normal and asthm atic groups showed a s ig n if ic a n t d iffe re n ce  in  
the  a lpha 2 : be ta2 r a t io  between I 8OO h and O8OO h o f f  and on 
salbutamol w ith  the r a t io  s ig n if ic a n t ly  h l^ e r  a t  0800 h (p<0,05,
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TABLE 14
Mean va lues  (±  SD) o f b e ta -a d re n o ce p to r number (B ^g^) in  f i v e




( fm o l/10  ^ lymphocy te s )
C ontro l (5) 1800 8.87 ±  1.45
*
Not on sal butanol 0800 5.41 ± 0.83
On salbutamol 1800 7.31 ±  1.76
**
0800 2.79 ±  0.85
Asthmatic (4) 1800 6.94 ±  1.82
*
Not on salbutamol 0800 3.91 ±  1.06
On salbutamol 1800 5.11 ±  1.71
*
0800 1.93 ±  0.21
* p<0.05
p<0.01
The comparison o f co n tro ls  w ith  asthm atic p a tie n ts  w ith  and w itho u t 
o ra l salbutsmoL d id  not reveal any s ig n if ic a n t d iffe re n ce .
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TABLE 15
Mean va lues  (± SD) o f b e ta -a d re n o ce p to r a f f i n i t y  (K j)  in  f i v e









0.50 ±  0.12
n. s.
0.40 ±  0.12
On salbutamol 1800 0.39 ±  0.08
*
0800 0.22 ±  0.08
AsUimatic (4) 1800 0.33 ±  0.07
*
Not on sal butanol 0800 0.16 ±  0.04
On salbutam d 1800 0.41 ±  0.06
*
0800 0.24 ±  0.07
*  p<0.05
n .s . , not s ig n if ic a n t
The comparison o f co n tro ls  w ith  asthm atic p a tie n ts  w ith  and w itho u t 
ora l salbutamol d id  not reveal any s ig n if ic a n t d iffe re nce  except a t 
0800 h o f f  salbutamol.
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Table 16). In  normals and asthm atic pa tien ts , the a d m in is tra tio n  
o f sa lb u ta m o l s ig n i f ic a n t ly  inc rea se d  th e  r a t i o  in  th e  0800 h 
samples (p<OJ35), w h ile  no s ig n if ic a n t d iffe re n ce  was observed in  
the r a t io  fo r  the 1800 h samples.
For comparable regimens, there  was no s ig n if ic a n t d iffe re n ce  in  
the alpha2 : beta^ ra t io  between the normal and asthm atic groups,
FEV^/FVC r a t io
A s th m a tic  p a t ie n ts  n o t re c e iv in g  sa lb u ta m o l showed th e  expected 
c irca d ia n  v a r ia t io n  in  FEV^/FVC ra t io ,  g iv in g  r is e  to  the % orn ing  
d ip ” (p<0.05, Table 17). This was abolished on g iv in g  salbutamol 
therapy. In  normal sub jects, no c ircad ia n  v a r ia t io n  in  FEV-j/FVC 
r a t io  was observed e ith e r  o f f  or on salbutamol.
There was no s ig n i f ic a n t  d if fe re n c e  between the  two groups 
except a t  0800 h o f f  sa lbu tam o l when th e  FEV^/FVC r a t i o  fo r  
a s th m a tic  p a t ie n ts  was s ig n i f i c a n t ly  lo w e r than the no rm a ls
(p<0,002).
Flaana oortisol concentrations
Plasma c o r t is o l  c o n c e n tra t io n s  showed th e  expected c irc a d ia n  
v a r ia t io n  in  both norm als and a s th m a tic  p a t ie n ts  (p<0,05, Table 
18), o f f  and on s a lb u ta m o l; th e  c o n c e n tra t io n s  in  n e ith e r  group 
were s ig n if ic a n t ly  a ffected  by the a d m in is tra tio n  o f sal butanol.
No s ig n if ic a n t d iffe rence  in  plasma c o r t is o l concentra tions was 
observed between the normal and asthm atic groups.
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TABLE 16
-lean va lues  (± SD) o f a lpha 2 :b e ta 2  a d renocep to r r a t i o  i n  f i v e
con tro l and fou r asthm atic sub jects
Time
(h)
Alpha2 :beta2 ra t io
C ontrol (5)
Not on sal butanol
1800
0800
2.4 ±  0.35
*
3.7 ±  0.48
On salbutamol 1800 3.2 ±  1.12
«
0800 8.7 ± 3.65
Asthmatic (4) 1800 3.0 ±  0.73
*
Not on sa lb u ta n d 0800 5.3 ±  1.50
On salbutamol 1800 5.1 ±  1.84
0800 10.6 ±  0.71
* p<0.05 
i:'* p<0.01
The comparison o f co n tro ls  w ith  asthm atic p a tie n ts  w ith  and w ith o u t 
ora l sal butanol d id  not reveal any s ig n if ic a n t d iffe re n ce .
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TABLE 17
'lean va lues  (±  SD) o f FEV-|/FVC { % )  in  f i v e  c o n tro l and fo u r




C ontro l (5)
Not on sal butanol
1800
0800
83.9 ±  6 .9
n. s.
82.3 ±  3.8
On salbutamol 1800 85.6 ±  4.1
n. s.
0800 84.5 ± 2 .2
Asthmatic (4) 1800 73.2 ±  8.3
*
Not on salbutamol 0800 56.0 ± 6 .0
On salbutamol 1800 78.7 ±  4.9
n. s.
0800 79.7 ±  5.5
* p<0.05
r u s . , not s ig n if ic a n t
The comparison o f co n tro ls  w ith  asthm atic p a tie n ts  w ith  and w ith o u t 
ora l salbutamol d id  not reveal any s ig n if ic a n t d iffe re nce  except a t 
0800 h o f f  salbutamol.
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TABLE 18
Mean values (± SD) o f c o r t is o l concentrations in  f iv e  con tro l and
fo u r asthmatic sub jects
Time
(h)
Cor t is o l  
(p g /d l)
C ontro l (5)
Not on sal butanol
1800
0800
8.5 ±  2.08
**
16.0 ± 0.81
On salbutamol 1800 9.2 ±  2.21
*
0800 17.7 ±  3.68
Astlim atic (4) 1800 7.0 ±  1.41
*
Not on sal butanol 0800 19.0 ±  6.37
On sal'out am ol 1800 9.7 ±  3.20
*
0800 22.2 ±  8.50
* p<0.05
p<0.01
Tne oom pari son o f co n tro ls  w ith  asthm atic p a tie n ts  w ith  and w itho u t 
o ra l sa lbu tand  d id  not reveal arv s ig n if ic a n t d iffe re n ce .
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DISCUSSION
The aim o f the studies described in  th is  the s is  was to  in v e s tig a te  
i f  there i s  an inherent defect in  beta-adrenoceptors th a t m i ^ t  be 
invo lved  in  the development o f bronchia l asthma. The ta rg e t tissue  
o f choice fo r  studying these adrenoceptors i s  the lung, but the re  
are  obv ious  c o n s tra in ts  th a t  h in d e r the  in v e s t ig a t io n  o f  b e ta - 
ad renocep to r s in  human lu n g , p a r t ic u la r ly  the  d i f f i c u l t y  o f 
o b ta in in g  is o la te d  healthy l in g  tissues  i f  repeated stud ies  w ith in  
an in d iv id u a l subject or p a tie n t are re q u ire d  For these reasons, 
a lte rn a tiv e  tissues have been examined by several authors (Parker 
and S m ith , 1973; C ono lly  and G reenacre, 1976, 1977; Karim an and 
L e fk o w itz ,  1977; G reenacre ^  js l ,  1978; B rooks ^  j d ,  1979; 
S zentivany i  A l ,  1 979; Sano ^  1979; Meurs ^  j i ,  1982;
Tashkin  1982; Van den Berg ^ j a l ,  1982) and in  p a r t ic u la r
the periphera l blood lymphocytes, as a re a d ily  accessib le  source o f 
beta-adrenoceptors, has received specia l a tte n tio n . Before such a 
model could be accepted, i t  was necessary to  compare and con tras t 
as e x te n s iv e ly  as p o s s ib le  th e  ly m p h o c y te  and lu n g  b e ta -  
adrenoceptor s.
E a r l ie r  s tu d ie s  on human lym phocy tes  (Conolly and Greenacre^
1977) showed th a t  the  lym phocyte  b e ta -a d re n o ce p to r was r e a d i ly  
b locke d  by p ro p ra n o lo l (n o n -s e le c t iv e )  b u t appear to  be f a r  le s s  
s e n s it iv e  to  the e f fe c t  o f p r a c to lo l  (beta^ s e le c t iv e ) ;  the same 
pa tte rn  o f s u s c e p t ib i li ty  to  the d if fe re n t  be ta -b lockers was seen 
in  lu n g  tis s u e . A lso  the pA2 v a lu e s  f o r  both  p ro p ra n o lo l and 
p ra c to lo l as derived by Conolly and Greenacre (1977) corresponded 
c lo s e ly  to  those o b ta in e d  by o th e r  w o rke rs  (Hedges and T u rn e r, 
1971; B a r r e t t 1973)  and conform  to  th e  p a tte rn  which w ould  
be p re d ic te d  f o r  a t is s u e  p o s s e s s in g  a be ta 2-a  d reno  ce p to r .  
Moreover, sa lbutam d s tim u la ted  the lymphocyte beta-adrenoceptor.
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being about one tenth as active as isoprenaline and these findings 
corresponded closely to those of CiiLlum (1969) who reported a
10:1 potency ratio between isoprenaline and salbutamd on guinea- 
pig tracheal chain. Therefore, on the basis of those findings 
Conolly and Greenacre (1 9 7 7 ) stated that the lymphocyte 
adrenoceptor may be categorised as beta2 supporting the validity of 
using lymphocytes as a model to study beta-adrenoceptor fmction in 
bronchial asthma.
Recently, Davis ^  (1980) have compared the cyclic AMP 
response to different beta-agonists and antagonists in lymphocytes 
and in human lung parenchyma with the results of some beta-agonists 
that cause 50% inhibition (relaxation) in human bronchial musde, 
They concluded that the beta-adrenoceptors of the lymphocyte, 
bronchial smooth musde and lung parenclyma have bet^ selectivity 
althou^ they differ somewhat quantitatively from each other.
Another potential obstade to the use of lymphocytes has been 
the presence of subpopulations of lymphocytes (B and T cells), as 
differences in adrenoceptor number or cydic AMP responsiveness of 
lymphocytes from patients with specific diseases might be 
attributable to differences in the relative numbers of B and T 
lymphocytes. Therefore Bishopric ^  (1980) carried out a study 
to compare B and T cells obtained from the same population of 
peripheral dood lymphocytes for direct beta-adrenoceptor binding 
characteristics as well as their biological response to beta- 
adrenoceptor agonists. They found that the number of beta- 
a dreno ce ptor s of B cells did not differ significantly from the 
number found in T cells. Similarly, there was no significant 
difference in their dissociation constants. In addition, assays 
performed on mixed unseparated lymphocytes revealed no significant
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d if fe re n c e s  in  number o r a f f i n i t y  from  the p u r i f ie d  B and T 
p o p u la tio n s . A lso they found th a t  B and T lym pho cy tes  had 
comparable s tim u la tio n  o f c y c lic  AMP accumulation by isop rena line . 
B is h o p r ic  ^  (1980) suggest t h a t  v a r ia t io n s  in  ad renocep to r
c o n te n t found  among w ho le  lym phocyte  p o p u la tio n s  in  d i f f e r e n t  
d isease s ta te s  cou ld  n o t be a t t r ib u ta b le  to  v a r ia t io n s  in  th e  
p ro p o r t io n  o f  B and T s u b p o p u la tio n s  and w ou ld  th e re fo re  r e f l e c t  
changes in t r in s ic  to  the disease sta te.
Consequently, a long  w ith  many o th e r w o rke rs , the use o f  
lym phocyte  be ta -ad re n o ce p to r as a model fo r  the  lu n g  b e ta - 
adrenoceptor seems ju s t i f ie d .
O ther p o te n t ia l  p rob lem s w ith  lym phocytes m igh t conceivably 
a r is e  from the use o f c a lf  serum in  the is o la t io n  o f lymphocytes. 
The presence o f th ym ic  fa c to r s  in  th e  c a l f  serum may w e ll a f fe c t  
the  r e s u l t s  o f the assays, s in ce  these th ym ic  fa c to r s  may induce  
the  convers ion  o f " n u l l ”  c e l l s  to  T - ly  mphocy te s  (By rom ^  a l ,
1978). However th is  assay used c a l f  serum a t  a c o n c e n tra t io n  o f  
on ly  0.1%, in  c o n tra s t to  th e  c o n c e n tra t io n  o f  10$ used by o th e r 
workers (H a rris  and U k a ^ io fo , 1970; Conolly and Greenacre, 1977). 
Furthermore, the c a lf  serum a l l  came from the same batch so i t  was 
reasonable to  assume tha t, were ary thym ic fa c to rs  in te ra c t in g  w ith  
the receptors, these should be constant in  th e i r  e ffe c ts . Work by 
Thomson ^  (1978) and S a ra c la r  ^  ^  (1977) has shown th a t
fo e ta l c a l f  serum has no apparent e f fe c t  on B- and T - lymphocyte 
c e ll  counts in  asthm atic p a tie n ts  or on th e ir  response to  doses o f 
concanaval in  A or p h y to h a e m a g g lu tin in . T h e re fo re , to  im pro ve  
lym phocyte  re c o v e r ie s , the use o f c a l f  serum seems j u s t i f i e d  
p a r t ic u la r ly  since i t s  concentra tion  i s  so low and the  volume o f 
blood samples a va ila b le  was lim ite d .
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5 I U D Y . I
T h is  study was undertaken to  in v e s t ig a te  th e  number and
s e n s it iv i ty  (K^) o f the lymphocyte be t ^ - a  dreno ce p to r w ith  a view 
to  e xp la in in g  the 'morning dip^ observed in  p a tie n ts  w ith  e x tr in s ic  
asthma. Each p a tie n t or vo lun teer sample was characterised  using 
7-9 concentrations o f the ra d id ig a n d  so th a t the B^g^ and the 
cou ld  be d e te rm ined  from  Scat chard a n a ly s is  (S ca t cha rd , 1949), 
ra th e r than from ju s t  1 or 2 concentra tions (Kariman and Le fkow itz , 
1977; Van den Berg ^  jlI ,  1982). C h a ra c te r is a t io n  o f c e l l  
a d renocep to rs  a t  on ly  one or two l ig a n d  c o n c e n tra t io n s  p ro v id e s  
l i t t l e  in fo rm a tio n  about the s ta tus  o f the adrenoceptors and does 
not detect a change in  adrenoceptor a f f in i t y  fo r  b ind ing  ligands. 
A lso  th e re  i s  no re a l assurance th a t  an a c c u ra te  B^^g^ i s  be ing  
o b ta in e d . I t  i s  in te r e s t in g  to  no te  th a t  L e fk o w itz  has re c e n t ly  
re ve rse d  h is  o p in io n s  on the use o f a s in g le  s tandard  (L e fk o w itz  
and M ic h e l, 1983) and changed to  u s in g  f u l l  c h a ra c te r is a t io n  in  
agreement w ith  the fin d in g s  o f th is  thes is .
The asthm atic p a tie n ts  were in  rem ission  and were a l l  known to  
have re v e rs ib le  a ir f lo w  o b s tru c t io n .  A l l  sym pathom im etic  d rugs 
in c lu d in g  theo phy llin e  oom pounds were stopped fo r  a t  le a s t 7 days 
b e fo re  com m encing th e  s tu d y  to  a llo w  re c o v e ry  o f  any 
de s e n s it is a tio n  which may have occurred, I t  should be re a lise d , o f 
course, th a t  asthma i s  a v a r ia b le  d isease and some p a t ie n ts  do 
re q u ire  b ro n c h o d ila to r  therapy fo r  r e l i e f  o f acu te  symptoms. 
P a tien ts  were allowed to  use the a n tic h o lin e rg ic  agent ip ra tro p iu m  
brom ide g iven  as an a e ro so l (80 mgm) as re q u ire d . I t  i s  g e n e ra lly  
accepted by c l in ic ia n s  (Dr P a te l, pe rsona l com m un ica tion ) th a t  
ip ra trop ium  bromide, un like  ^m pathom im etic agents has no d ire c t
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e f fe c t  on the a lpha - or b e ta -a d re n o ce p to rs , a lthough  no re a l 
documentary evidence to  th is  e f fe c t oould be fom d.
T h is  i s  the  f i r s t  tim e  th a t such an e x te n s iv e  study o f the  
e f fe c ts  o f  c irc a d ia n  v a r ia t io n  on adrenoceptor k in e t ic s  has been 
undertaken in  the human lyraphooyte. Since the lymphocyte is  used 
by mary workers as a model fo r  the lung  beta2~adrenoceptor (Brooks 
1979; Karim an, 1980; S a n o ^ j l ,  1981b; Meurs ^  1982)
t h is  study is  o f  p a r t ic u la r  va lu e , as many w o rke rs  n e g le c t to  
mention the time o f sampling. One l im i ta t io n  o f th is  present work 
is  the fa c t  th a t samples were only determined a t  0800 h and 1800 h. 
Sampling tim es were a ffec ted  by several ex te rna l co n s tra in ts  such 
as the need fo r  sequentia l s tud ies which re s tr ic te d  the  amount o f 
b lood  w h ich  cou ld  be w ith d ra w n  from  each s u b je c t and the tim e  
requ ired  to  analyse the samples to  avoid undue delay in  processing 
the blood samples. The chosen tim es were the most p ra c tic a l,
A s ig n i f ic a n t  c irc a d ia n  v a r ia t io n  was dem onstra ted  in  th e  
number o f be ta2-a  dreno ce p to r s (B^g^) in  both normals and asthm atic  
p a t ie n ts ,  w ith  the le s s e r  number o f ad reno ce p to rs  in  th e  e a r ly  
(0800 h) sample. T h is  v a r ia t io n  p e rs is te d  when bo th  groups w ere  
g ive n  sa lbu tam o l though * down-regulation* o f adrenoceptor numbers 
o ccu rre d  in  both groups in  the  0800 h sample. T h is  acco rds  w ith  
th e  f in d in g s  o f  o th e rs  (G a la n t^ j i l ,  1978b; T a s h k i n ^ ^ ,  1982), 
assuming th a t th e ir  samples were taken in  the m orn ing No evidence 
fo r  'down-regulation* was found in  the  la te  (1800 h) sample and as 
ye t no exp lanation  fo r  th is  can be o ffe red . This oould be fu r th e r  
inve s tig a ted .
No s ig n if ic a n t d iffe rence  in  adrenoceptor numbers was observed 
e ith e r  a t  0800 h or 1800 h between the normal and asthm atic groups 
whether o f f  or on salbutamol and th is  con tras ts  w ith  other reported
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r e s u lts  (Karim an and L e fk o w itz ,  1 977; B rooks ^ 1 979; Sano ^
1979) th a t asthm atic  p a tie n ts  genera lly  have s ig n if ic a n t ly  less  
beta-adrenoceptcrs than normals. However, m ost o f these  w o rke rs  
e ith e r  do not mention the tim e o f sampling or else only used one or 
two concentrations of rad io ligan d  to  ob ta in  the B ^g^  I t  may w e ll 
be th a t  the  r e s u lts  in  t h i s  th e s is  d i f f e r  because th e  B^g^ data 
reported  here were derived from f u l l  sa tu ra tio n  a n a lys is  and no t a 
s in g le  estim ation . I t  would be expected th a t the form er would g ive  
the more re lia b le  resu lts^
W ith regard to  the observed c ircad ian  v a r ia t io n s , i t  has a lso 
been found  th a t plasma cAMP c o n c e n tra t io n s  in  no rm a ls  show a 
c irca d ia n  v a r ia t io n  w ith  the maximum concen tra tion  a t  1400 h and 
the minimum a t  0200 h (M ikun i 1978). In  asthm atic  pa tien ts ,
plasma cAMP a lso showed a c ircad ia n  v a r ia t io n  s im ila r  to  th a t in  
norm a ls  w ith  tro u g h  va lu e s  a t  0400 h, w h ich  are s ig n i f i c a n t ly  
(p<0.01) lo w e r than th e  peak va lu e s  reco rded  a t  1600 h ( B a r n e s ^
1980c, 1982).
Generally, other workers appear to  have accepted (Galant ^  a l ,  
1980; M eurs jsX j l I ,  1982) t h a t  th e re  i s  no d i f f e r e n c e  i n  
adrenoceptor a f f in i t y  (K^) between normals and asthm atic  pa tien ts . 
In  t h is  study i t  i s  re p o rte d  th a t  in  f a c t  a s th m a tic  p a t ie n ts  do 
seem to  have a s ig n if ic a n t ly  lower (p<0.01) than normals a t  0800 
h, when they are  n o t ta k in g  sa lb u ta m o l. In  s u p p o rt o f these 
re s u lts , the K^*s measured here are com patib le w ith  those o f o ther 
w o rke rs  us ing  [ ^^^I]H Y P  as a b in d in g  l ig a n d  (S a n o jL t-â l,  198lb ;  
P a ie tta  ^  1982). A lso , in  norm al s u b je c ts  on sa lb u ta m o l a
c irc a d ia n  v a r ia t io n  appears in  K j, w i t h  lo w e r  va lu e s  (i#e . 
in c re a s e d  s e n s i t i v i t y )  a t  0800 h ap pe a ring  w ith  the  lo w e r 
adrenoceptor numbers. This would almost seem to  be some form  o f
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compensatory mechanism w ith  the increased s e n s it iv i ty  compensating 
fo r  the reduced adrenoceptor number. I t  would be expected th a t lew 
cAMP le v e ls  would c o rre la te  w ith  reduced receptor a c t iv i t y .  Since 
®max decreased, i t  m ight be reasonable to  expect th a t le s s  cAMP 
would be produced. I f  the  s h i f t  in  was com pensatory then 
possib ly c irc u la t in g  concentrations o f cAMP should not be a ffec ted . 
However, i t  must be remembered th a t c ir c u la t in g  catecholam ines are  
a l so lo w e s t in  the m orn ing  and so s t im u la t io n  o f the  re c e p to r  i s  
probably submaximal. However, other workers (M ikuni ^  j l ,  1978) 
have shown tha t plasma cAMP le v e ls  are lo w e s t in  the morning, and 
so t h is  o b s e rv a tio n  cannot s a t i s f a c t o r i l y  be e x p la in e d , but may 
serve to  m inim ise the f a l l  in  cAMP in  asthm atic pa tien ts .
To in v e s tig a te  the cause o f the m odulation o f beta-adrenoceptor 
numbers, plasma c o r t is o l concentra tions were assayed in  the frozen  
plasma samples. Several workers have found th a t acta in i  s t r a t i  on o f 
exogenous c o r t is o l  le a d s  to  an in c re a s e  in  b e ta -a d re n o c e p to r 
numbers both in  humans (Sano ^  1980) and rodents (Mano ^
1979; H a n d s l ip ^  JÜL, 1981). O the r w o rk  w ith  po lym o rphonuc lea r 
le u c o c y te s  (PMN) has shown th a t  a s th m a tic  p a t ie n ts  on lo n g - te rm  
s te ro id  therapy have a normal number o f beta-adrenooeptors (G alant 
j s l -â l, 1980). In  t h is  s tudy , the  number o f a d ren ocep to rs  va ry  
inve rse ly  w ith  plasma c o r t is o l;  the receptor number i s  lo w e r in  the 
morning when plasma c o r t is o l is  h igher. Also, Davies and Le fkow itz  
( 1980) have shown th a t  a d m in is t r a t io n  o f c o r t is o n e  a c e ta te  
modulates both receptor number (B^g^) and a f f in i t y  (K^) in  both PMN 
and mononuclear leucocytes. This i s  in  agreement w ith  the re s u lts  
in  t h i s  th e s is ,  where B^^gy appears to  va ry  in v e rs e ly  w ith  
endogenous plasma c o r t is d  concentra tions in  both groups. The r d e  
o f c o r t is o l in  the re g u la tio n  o f beta-adrenoceptor fu n c tio n  needs
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fu r th e r  in v e s t ig a tio n .
F rase r ^  j l I  (1981 a) concluded th a t  th e re  i s  a re c ip ro c a l 
c o rre la tio n  between c irc u la t in g  plasma a d re n a lin e  c o n c e n tra t io n s  
and lym phocyte  b e ta -ad re n o cep to r d e n s ity . T h is  study d id  n o t 
e s tim a te  plasma a d re n a lin e  c o n c e n tra tio n s  bu t the  r e s u lt s  w ou ld  
appear to  co n tra d ic t those o f Fraser ^  ^  (1981a), as the  receptor 
density observed was low er in  the morning when plasma adrena line  i s  
lew . However, the conclusions reached by Fraser ^  ( 1981a) a re
tru e  on ly  i f  a d re n a lin e  i s  the so le  c o n t r o l l in g  f a c to r ;  the  
observation th a t two b io lo g ic a l rhythms c o rre la te  w ith  each other 
ch rono log ica lly  is  not s u f f ic ie n t  proof th a t one causes the other 
(C la rk  and H e tz e l, 1980). The in te r - re la t io n s h ip s  o f  c ir c u la t in g  
ca techo lam ine  and lym phocyte  b e ta -a d re n o c e p to r  d e n s ity  a re  
p resen tly  not w e ll resolved and re q u ire  fu r th e r  in v e s tig a tio n .
^nB£LU
In  th e  la s t  few yea rs , th e re  has been some evidence fo r  a lp h a - 
a dreno ce p to r d y s fu n c tio n  in  asthma. Henderson ^  (1979)
demonstrated abnormal ^pha -ad rene rg ic  s e n s it iv i ty  o f the p u p illa ry  
d i la t o r  and v a s o c o n s tr ic to r  m uscles in  s u b je c ts  w ith  asthma. 
O thers have shown th a t there  may be an increased number o f alpha- 
a dreno ce p to r s in  the Im g s  (S z e n tiv a ry i, 1979) and the lymphocytes 
(Szentivary i,  1979; Sano 1981 a,b) o f asthm atic p a tien ts ,
Alpha2~a dreno ce p to r s appear to  be in t r in s ic a l ly  lin k e d  to  the 
adenylate cyclase ^s te m , whereas alpha^-adrenoceptors appear to  be 
coupled to  processes th a t  re g u la te  c e l lu la r  c a lc iu m - io n  f lu x e s  
(L e fk o w itz  ^  j lI»  1984). A lpha2-a d re n o c e p to rs  w ere  s tu d ie d  as 
these seemed to  be the next lo g ic a l candidates to  antagonise beta- 
adrenoceptor fu n c tio n  and to  be invo lved  in  any alphs^adrenoceptor
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dysfunction  in  asthma. Also a high s p e c if ic  ra d io a c t iv ity  alpha2 
lig a n d  ( [ ^H]yohimbine, 70-90 C i/mmol) was re a d ily  a v a ila b le  whereas 
the lig a n ds  which are e ith e r no rnse lec tive  or alpha-j s e le c tiv e  were 
o f low  s p e c if ic  r a d io a c t iv i t y  ( [ ^ H ]d ih y d ro e rg o c ry p t in e , 20-50 
Ci/mmol; [^HJprazosin, 10-30 C i/mmol re sp e c tive ly ). Consequently, 
f o r  the  i n i t i a l  s tu d ie s , in v e s t ig a t io n  o f  a lpha2«adrenocep to r 
fu n c tio n  was chosen.
Having successfu lly  developed a method fo r  alpha2-adrenoceptor 
e s t im a t io n  in  lym phocytes ( T i t in c h i  and C la rk , 1984), the n e x t 
phase o f the study could now be proceeded w ith .
T h is  study was c a r r ie d  o u t f o r  2 reasons
1) To see i f  the  c irc a d ia n  v a r ia t io n  in  be ta2«ad renocep to r 
observed in  "Study 1 " cou ld  a c tu a lly  be re -o b se rve d  in  a 
repeat study.
2 ) To in v e s t ig a te  the  number and s e n s i t i v i t y  (K^) o f  the
lymphocyte alpha2-adrenooeptor to see i f  there i s  a c irca d ia n  
v a r ia t io n  in  a lpha2-a d re n o ce p to r s im i la r  to  th a t  found  in  
beta2~a dreno ce p to r and moreover to  see whether, in  accordance 
w ith  the f in d in g  o f  o th e r w o rke rs  (S z e n tiv a n y i 1979;
Szentivanyi» 1980) there i s  a s h i f t  in  the re la t iv e  numbers o f 
adrenoceptors from beta to  alpha in  lymphocytes o f  asthm atic 
p a t ie n ts . I t  w ou ld  a lso  be v i t a l  to  compare the  r a t io  o f 
alpha2 :beta2 adrenoceptors in  normals and asthm atic  p a tie n ts  
to  v e rifV  re s u lts  produced by o ther w orkers who looked a t  the 
general alpha-adrenoceptor population.
Again each p a tie n t or vo lun teer sample was characterised  using 
7-9  c o n c e n tra t io n s  o f  the  ra d io l ig a n d  f o r  both a lpha2 and be ta2 
aclrenceptor es tim a tion s  and the re sp e c tive  and the were
d e te rm in e d  fro m  S c a tc h a rd  a n a ly s is  (S ca tcha rd , 1949). One
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l im i ta t io n  of th is  study was th a t the samples were only determined 
a t  0800 h and 1800 h as sam p ling  tim e s  w ere a ga in  a f fe c te d  by 
several ex te rna l co n s tra in ts  in c lu d in g  the  amount o f b lood  w h ich  
cou ld  be w ith d ra w n  from  each s u b je c t and th e  t im e  re q u ire d  to  
analyse the samples.
The re s u lts  observed fo r  the beta2-adrenoceptors in  t h is  second 
s tu d y  w ere  e x tre m e ly  i n t e r e s t in g ,  because f o r  co m p a ra b le  
co m b in a tio n s  o f  t im e  and drug the rapy  th e re  was no s ig n i f i c a n t  
d iffe re nce  between the and K j re s u lts  observed fo r  'Study 1"
and 'Study 11" e ith e r  fo r  the normal or the asthm atic groups. Thus 
the d iscussion o f the beta-a dreno ce p to r re s u lts  under 'Study I ” is  
e q u a lly  a p p lic a b le  to  "Study I I "  and no f u r th e r  in s ig h t  w ou ld  be 
gained by repea ting  th is  d iscussion her eu
The fa c t  th a t  these tw o independent s tu d ie s  g iv e  s im i la r  
re s u lts  i s  a va luable observa tion  and strengthens the argument th a t 
a genuine phenomenon (i.eu the  c irc a d ia n  v a r ia t io n  in  re c e p to r  
fu n c tio n ) is  being observed which is  not based on a r te fa c ts  a r is in g  
from the methodology.
Since the com pletion o f the p ra c tic a l aspects o f  th is  study an 
extrem ely im portan t observa tion  has been published by 2 groups o f 
w o rk e rs  (B ertouch  ^  1983; R itc h ie  ^  1983). They have
observed d iu rn a l v a r ia t io n  in  the t o ta l  number o f  lym phocytes. 
T h is  i s  r e f le c te d  in  a d iu rn a l v a r ia t io n  in  lym ph o cy te  subse ts  
(b o th  B and T c e l ls ) .  A t f i r s t  s ig h t  these  r e s u lt s  appear to  have 
im portan t im p lic a tio n s  fo r  the in te rp re ta t io n  o f the adrenoceptor 
fu n c tio n  re s u lts  discussed fo r  "S tudies I  and I I " .
However, i t  should  be remembered t h a t  q u i te  f o r t u i t o u s ly  
ad ren ocep to r k in e t ic s  have been expressed w ith  re fe re n c e  to  10^ 
lym phocytes . T h is  means th a t  th e  r e s u lt s  a re  independen t o f  th e
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number o f c i r c u la t in g  ly m p h o c y te s . S e c o n d ly , i t  has been 
repeatedly shown th a t the be ta - adrenoceptor f in c t io n  i s  e s s e n tia lly  
id e n t ic a l  on lym phocyte  subsets  ( i .e ,  B and T c e l ls )  so th a t  even 
i f  the  r a t i o  o f B to  T c e l ls  changes d u r in g  th e  day (w h ich  has n o t 
been suggested e ith e r  by B e r t o u c h ^ ^ ,  1983 o r R itc h ie  ^  jLL, 
1983) then th is  would no t s ig n if ic a n t ly  a ffe c t the re s u lts  reported  
here. A sa  c o ro l la r y  to  th is ,  a s ig n i f ic a n t  c o r r e la t io n  (p<0.05) 
was found  between lym pho cy te  numbers and lym ph o cy te  p ro te in  
e s tim a tion s  in  th is  study, but as can be seen from Fig 32, there i s  
a la rg e  degree o f s c a tte r .  From the  above, w o rke rs  in  t h i s  f i e l d  
w ou ld  th e re fo re  be w e l l  a dv ise d  to  exp ress t h e i r  ad ren o ce p to r 
k in e t ic  r e s u l t s  in  te rm s  o f  fm o l/IO ^  lym phocytes  r a th e r  than 
fmol/mg pro te iru  Such re s u lts  then have much more relevance to  the 
p a tie n t stud ies as several va ria b le s  are e s s e n tia lly  e lim ina ted .
No s ig n if ic a n t d iffe re n ce  was observed in  the number o f alpha2“  
adr enoce p tor s (Bjjjqj^) between 1800 h and 0000 h in  both normals and 
a s th m a tic  p a t ie n ts  w h ile  o f f  sa lb u ta m o l. A d m in is t ra t io n  o f 
salbutamol d id  no t s ig n if ic a n t ly  a ffe c t alpha2«adr enoce p tor number 
a t  1800 h or 0800 h in  e ith e r group. Other s tud ies  have a lso  found 
th a t  the  number o f a lpha2«ad re n o cep to rs  ( [  ^ H ]y o h im b in e -b in d in g  
s i te s )  on human p la te le ts  i s  n o t s u b je c t to  "d o w n -re g u la t io n " . 
K a r l in e r  ^  3 I  ( 1982) found th a t  in c u b a tio n  o f  p la t e le t s  w ith  
ad rena line  _lD v i t r o  d id  not decrease the number o f  [^H lyohim bine 
b ind ing  s ite s . Furthermore^ Snavely ^  j3l  (1982) and P fe ife r
( 1982) found normal number o f alpha2-a dreno ce p to r s on the p la te le ts  
o f  p a t ie n ts  w ith  ca te ch o l a m in e -s e c re t in g  pheochromocy toma, the  
c l in ic a l  s e tt in g  in  which "dow n-regu la tion" would be most evident.
No s ig n i f ic a n t  d if fe re n c e  in  a lp h a 2-a d re n o c e p to r number was 
observed a t  O8OO h o r 1800 h between the normal and a s th m a tic
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groups w hether o f f  or on sa lb u ta m o l. T h is  c o n tra s ts  w ith  o th e r 
reported  re s u lts  ( S z e n t i v a r y i ^ ^ ,  1979; Sa no ^  1981b) th a t
a s th m a tic  p a t ie n ts  g e n e ra lly  have s ig n i f i c a n t ly  more a lp h a - 
a dreno ce p to r s than normals, However, scene o f these w orkers on ly  
used one concentra tion o f the ra d io lig a n d  to  o b ta in  the and, 
as d iscussed  e a r l ie r ,  the  B ^^^  c a lc u la te d  from  f u l l  s a tu ra t io n  
a n a lys is  would g ive more re l ia b le  re s u lts  than a s in g le  estim ation . 
Concerning the alpha2~a dreno ce p to r a f f in i t y  (K^), there  was no 
s ig n i f i c a n t  d if fe re n c e  between 1800 h and 0800 h in  both no rm a ls  
and a s th m a tic  p a t ie n ts  whether o f f  or on salbutamol. A t the same 
tim e, no s ig n if ic a n t d iffe re nce  was observed between the two groups 
a t  e ith e r  tim e s  w hether o f f  or on sa lb u ta m o l. T h is  i s  in  acco rd  
w i t h  Sano 3 l  ( 1981 b) who a ls o  fo u n d  t h a t  th e re  was no 
s ig n if ic a n t change in  between normals and asthm atic  pa tien ts , 
D a v is  and L ie b e rm a n  (1982) fo u n d  th a t  p la t e le t  a lp h a 2« 
a d re n e rg ic  cAMP responses were normal in  s u b je c ts  w ith  asthm a. 
They stud ied alpha2-ad renerg ic  responses in  p la te le ts  from normal 
sub jec ts  and p a tie n ts  w ith  asthma who had taken no m edication p r io r  
to  the  s tudy, a lpha2-a d re n e rg ic  in h ib i t io n  o f  p ro s ta g la n d in  -  
s tim u la ted  cAMP accum ulation was normal in  p la te le ts  from sub jec ts  
w ith  asthma. The tim e  course o f in h ib i t io n ,  th e  e x te n t o f  
i n h ib i t io n ,  and the do s e -response r e la t io n s h ip  d id  n o t d i f f e r  
between th e  groups. A lso , Barnes ^ ^  (1980a) found th a t  th e re  
was no d if fe re n c e  in  the va lu e s  o f  [^ H lp ra z o s in  (a lpha^ 
se le c tive ) in  lung  membrane homogenates o f an animal model (guinea- 
p ig) o f ckironic asthma and those from co n tro ls .
R egard ing  th e  a lpha2 :b e ta 2 r a t io ,  th e re  was a s ig n i f ic a n t  
d iffe re n ce  in  the ra t io  between 1800 h and 0800 h o f f  sal butanol in  
both normals and asthm atic  p a tie n ts  w ith  the h i ^ e r  r a t io  a t  0800h.
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This s ig n if ic a n t d iffe re n ce  is  not due to  a s h i f t  in  tlie number 
o f be ta2«adr enoce p to r s to  a lpha2« ad renocep to rs , but i s  i n  f a c t  
r e la te d  to  the c irc a d ia n  v a r ia t io n  in  the number o f be ta2"  
adr enoce p to r s between 1800 h and 0800 h in  both groups w h i le  o f f  
salbutamol w ith  the lesse r number o f be ta2~a dreno ce p to r s a t  0800 h. 
T h is  s ig n if ic a n t d iffe rence  in  the alpha2 :beta2 r a t io  between 1800 
h and 0800 h pers is ted  even when both groups were given salbutam ol 
and again th is  was due to  persistence o f the c ircad ia n  v a r ia t io n  in  
be ta2-a  dreno ce p to r number in  both normals and asthm atic  p a tie n ts  on 
salbutam ol therapy.
In  both groups, the alpha2 %beta2 r a t io  a t  0800 h on salbutamol 
was s ig n if ic a n t ly  h igher than a t  0800 h not on salbutamol and th is  
is  due to  the "dow i> regu la tion" o f  beta2-adrenoceptors induced by 
s a lb u ta m o l. The r a t io  a t  1800 h was n o t s ig n i f i c a n t ly  d i f f e r e n t  
o f f  or on salbutamol in  e ith e r  normals or asthm atic  pa tien ts*
No s ig n if ic a n t d iffe re nce s  in  the r a t io  were observed between 
no rm a ls  and a s th m a tic  p a t ie n ts ,  and t h i s  c o n tra s t w ith  o th e r 
reported  re s u lts  (Sano 1981b) th a t asthm atic  p a tie n ts  have
s ig n if ic a n t ly  h igher a lphaibeta r a t io  than normals.
At present, the mechanism o f the observed c irca d ia n  v a r ia t io n  
in  b e ta -a d re n o ce p to r numbers in  e i th e r  groups has n o t been 
in v e s t ig a te d . In  b o th  s tu d ie s ,  the  o b s e r v a t io n  th a t  b e ta -  
adr enoce p tor s are re c ip ro c a lly  co rre la te d  to  plasma c o r t is o l le v e ls  
a re  in  agreem ent w ith  Davies and L e fk o w itz  (1980), b u t appa ren t 
c o n tra d ic t io n s  e x is t  in  th e  l i t e r a t u r e  w here o th e r w o rk e rs  have 
found th a t s te ro ids  increase lym phocyte be ta -a  dreno ce p to r  number 
(Sano ^  _al, 1980). The ro le  o f c o r t is o l remains to  be in ve s tig a te d  
in  much more d e ta i l .  The lo w e s t number o f  b e ta -a  dreno ce p to r  s 
corresponds to  the  o b s e rv a tio n  o f  ‘ m orn ing  d ip * in  a s th m a tic
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p a t ie n ts ,  and th is  d im in is h in g  o f re c e p to r number may w e l l  be a 
p re d is p o s in g  fa c to r  to  the  f a l l  in  FEV^/FVC r a t io .  The 'd e fe c t ' 
may in  f a c t  be e x te rn a l to  the be ta -a  dreno ce p to r  as one re p o r t  
(F ra se r ^  j i l ,  1981b) has suggested th a t  c i r c u la t in g  a u to ­
a n t ib o d ie s  may i n t e r f e r e  w i t h  th e  f u n c t io n a l  b in d in g  o f  
ca te ch o l amines to  the  b e ta -ad re n o cep to r in  some p a t ie n ts  w ith  
asthma. I t  i s  possib le  there fore , th a t there is  no in t r in s ic  beta- 
a dr enoce ptor defect. C erta in ly  the re s u lts  reported  in  th is  th e s is  
c o n ta in  no evidence th a t  the be ta -a  dreno ce p to r  s o f  a s th m a tic  
p a tie n ts  are fu n c tio n a lly  d if fe re n t  from those o f normal sub jec ts ; 
both d is p la y  a c irc a d ia n  v a r ia t io n  in  re c e p to r  number, bo th  are  
d o w n -re g u la te d  by sa lb u ta m o l a d m in is t ra t io n  and th e  number o f 
receptors does not d i f fe r  s ig n if ic a n t ly  between the two groups.
N e ith e r  do th e  r e s u lt s  c o n ta in  any evidence f o r  a lp h a 2-  
a dreno ce p to r  d y s fu n c tio n  in  a s th m a tic  p a t ie n ts .  The c ir c a d ia n  
v a r ia t io n  in  a lpha2 :b e ta 2 r a t io  i s  r e la te d  o n ly  to  th e  c irc a d ia n  
v a r ia t io n  in  beta2-adreno ce p to r  s. Th is does no t p re c lu d e  a lp h a - 
adr enoce p tor s having a fu n c tio n a l ro le  in  asthma. The increase in  
alpha2 :beta2 r a t io  in  the morning may w e ll be a predisposing fa c to r  
to  the f a l l  in  FEV^/FVC r a t io  (morning d ip ) in  asthm atic  p a tie n ts .
In  co n c lu s io n , the  r e s u lt s  re p o rte d  he re  w ou ld  seem to  be in  
agreem ent w ith  o th e r w ork  p u b lis h e d  d u r in g  th e  course o f t h is  
th e s is :  th a t  S z e n tiv a n y i's  h y p o th s is  shou ld  once and f o r  a l l  be 
re je c te d  (C o n o lly , 1980). That is ,  th e re  i s  no i n t r i n s i c  d e fe c t 
e i th e r  in  the be t a - a d ren o ce p to rs  or the  a lpha -a  dreno ce p to r  s o f 
p a tie n ts  w ith  e x tr in s ic  asthma, and no apparent s h i f t  from beta- to  
a lp h a -a  dreno ce p to r  s occu r. The cause o f dyspnoea in  e x t r in s ic  




The components o f m a te ria ls  marked *»* w i l l  be found a t  the end o f 
the Appendix.
1. CHEMICALS AND ASSAY KITS
Aseptic  c a lf  serum
Catechol (0-dilydroxybenzene)
Gibco B io -C u lt L td . 
P ais ley, Scotland
BEH Chemicals L td . 
Pool e, Engl and
Dulbecco's Phosphate Buffered 
S a line  (IX ) (PBS) *
Gibco B io -C u lt L td . 
P a is ley , Scotland
E a rle 's  Balanced S a lt S o lu tion  
(10X) w ithout Sodium Bicarbonate 
(EBSS) *
Gibco B io -C u lt L td  
Pa is ley, Scotland
E a r le 's  Balanced S a lt  S o lu tio n  
(IX ) (EBSS) *
E m u ls ifie r s c in t i l la to r  299 
Cat. No. 6013079 *
TM
Gibco B io -C u lt L td . 
Pa is ley, Scotland
Packard Instrum ents L td . 
Berks, England
Hank's Balanced S a lt  S o lu tio n  
(10X) w ith o u t Sodium Bicarbonate 
(HBSS) *
Gibco B io -C u lt L td . 
Pa is ley, Scotland
Hank's Balanced S a lt  S o lu tion  
(IX ) (HBSS) *
Gibco B io -C u lt L td . 
Pa is ley, Scotland
Hepes bu ffe r powder
(4 -(2 - ly d ro x y e th y l) -1 -
piperaz i neethanesulphonic ac id )
( - )  Isop rena line  b i ta r t ra te  
(F ig . 4)
Iso ton  I I
Flow Labora to ries L td  
A yrsh ire , Scotland
Signa Chemical Co. Ltd. 
Poole, England
C oulter E le c tro n ics  L td . 
Luton, Beds., England
Lymphocyte separation medium * Flow Labo ra to ries  L td . 
A yrsh ire , Scotland
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Magne s i uîi ch lo rid e
( - )  Noradrenaline bi ta r tra te  
(F ig . 5)
û n n iflu o r *
Cat. No. NEF-906
Sodium ch lo rid e  'AnalaR*
Sucrose 'AnalaR'
Toluene 'AnalaR'
Signa Chemical Co. L td . 
Pool e, Engl and
Signa Chemical Co. L td . 
Poole, Engl and
New England Nuclear 
Massachusetts, USA
BDH Chemicals L td .
Pool e, Engl and
BEH Chemicals L td .
Pool e, Engl and
BEH Chemicals L td .
Pool e, Engl and
T rito n  X-100
Trizma base
( 2-  an i  no-2-hy dr oxy methy 1- 
propane-1,3- d io l )
Trypan blue s ta in , 0.4%
Yohimbine hydroch loride 
(F ig . 5)
Zaponin
Bio-Rad p ro te in  assay k i t  
Cat. No. 500-0001
II#D PHASE™ C o rtiso l
Radioimmunoassay k i t
BEH Chemicals L td . 
Poole, England
Signa Chemical Co. L td . 
Poole, England
Gibco B io-C uLt L td . 
Pais ley, Scotland
Signa Chemical Co. L td . 
Pool e, E n^ and
C oulter E le c tro n ics  L td . 
Luton, Beds., England
Bio-Rad Labora to ries  
Watford, England
Corning Medical and 
S c ie n t if ic ,  Essex, 
England
2. miKllt4ARIJS Aim niSPOSABlJS
Evans heparln ised b o tt le s Evans Medical L td . 
L ive rp o o l, England
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Glass ird c ro fib re  f i l t e r s  
grade (GFC), s ize  (2,5 on)
Glass ih ic ro fib re  f i l t e r s  
grade (GFB), s ize  (2.5 on)
Polypropylene tubes 
(12 X 75 r.Ta) Cat. No. 526
Polystyrene tubes 
(12 X 75 r.ni)
Soda glass tubes 
( 12 X 75 nin)
U niversa l conta iners (30 ml)
Whatman LabSales 
Mai dstone, Engl and
Whatman LabSales 
Mai dstone, Engl and
S ars ted t L td . 
Le ices te r, England
MacFarlane Robson L td . 
Glasgow, Scotland
MacFarlane Robson L td . 
Glasgow, Scotland
S te r i l in  L td . 
Middlesex, England
3. RADIOCHEMICALS
1- [  p ro p y l-2 ,3-^H] 
dihy d roa lp reno lo l 
S p e c if ic  R a d io a c tiv ity  
30 -  60 Ci/mmol (F ig . 6)
iodohydroxy- 
benzy lp indo lo l, S p e c if ic  
R a d io a c tiv ity  2200 C i/nmol 
(F ig . 6)
[ methy 1-^H] -yohimbi ne 
S p e c if ic  R ad io a c tiv ity  
70-90Ci/mmol (F ig . 9)
The Radiochemical 
Centre, Amer sham, 
Engl and
New England Nuclear 
D re ie ich , W. Germany
New England Nuclear 
D re ie ich , W. Germany
4. J2BUCS
C lonid ine hydroch lo ride
(Ca ta pres ampoules, 0.15mg/rril)
(F ig . 5)
Ip ra trop ium  bromide (A trovent 
in h a le r)
Boehrlnger Ingelhe im  
Berks., En^and
Boehringer Ingelheim  
B erks., England
Phentolanine mesylate 
(R og itin e  an poules, 10mg/ml) 
(F ig . 5)




(V e n to lin  ta b le ts , 2mg) 
(F ig . 4)
A llen  & Hanburys L td . 
Middlesex, England
The fo l lo w in g  drugs w ere k in d ly  donated by th e  sources
ind ica te d  :
(+) Adrenaline b i ta r t ra te  
(F ig . 4)
( - )  Adrenaline B. P.
H 35/25
P ra c to lo l (F ig . 4)
Kodak L td .
In d u s tr ia l and Research 
Chemical Sales, L iverpoo l 
England




Im peria l Chemical 
In d u s tr ie s  ( IC I)  L td. 
Pharmaceuticals D iv is io n  
Cheshire
Prazosin hydro ch lo ride  
(F ig . 5)
(±) Propranolol 
hydroch lo ride  B.P. (F ig . 4)
( - )  Propranolol hydrochloride
(+) Propranolol lyd ro ch lo rid e





Automatic T r i - Carb L iq u id  
S c in t i l la t io n  Spectrometer 
Model 3330
C oulter counter 
Mo del ZF
M ill ip o re  f i l t r a t i o n
apparatus
Packard Instrum ent L td . 
Berks, England
C oulter E le c tro n ics  L td . 
H e rts ., England
M ill ip o re  (U .K .) L td . 
M ill ip o re  House 
Mi ddl ese x, Engl and
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Mini-bomb c e ll  d is ru p tio n  
chan ber, cat. No. K-881455
MSE M is tra l 4L 
re fr ig e ra te d  cen trifuge
Kontes Glass Co. 
Vineland, N .J ., USA
MSE S c ie n t if ic  
Ins trunen ts , England
U ltra  ce n tr ifu g e  
ftodel L5-65
Beckman Instrum ents INC. 
C a lifo rn ia , USA





V ita log raph  dry wedge 
spirometer
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Lvii.ul'io.çy te . sepa ra tion  medium
Lym phocyte s e p a ra t io n  medium i s  an aqueous s o lu t io n  o f  a h ig h  
d e n s ity  s u c ro s e -e p i c h i o r ohy d r in  po lym e r (F i c o l l  400) and sodiuin 
u ia t r iz o a te .
Ohini f lu o r
O m n if lu o r  i s  a p re c is e ly -b le n d e d  s c in t i l l a t o r  powder composed o f 
Oü';- PPG (2 ,5 -d ip h e n y lü x â z o le )  and 2% b is-M SB ( 1 ,4 -D i- (2 -m e th y  1- 
sty ryD -benzC i je ) .
E m u ls if ie r .s c in t i lla to r_ 2 9 9
E m u ls i f ie r  s c i n t i l l a t o r  2 99 is  a xy le ne  based, c o m p le te  l i q u i d  
s c in t i l l a t i o n  c o c k ta il f o r  aqueous and non-aqueous samples.
■CQMPONENTS__.QF_B_UFF£J(S
B u i'fe r A -  pH 7.6
E a rles  Balanced S a lt  S o lu tio n  (w ith o u t sodium b ica rbona te )
20 i i in o l/ l  Hepes 
O .ld  c a l f  seruii
50 mniol/1 T r is
0 ,9 ‘j so d im  c r iio r id e
0.1 mmol / 1 (± ) p ro p ra n o lo l
B u ffe r  C -  pH 7.6  
50 mmol/1 T r is  
0.9% so d im  c ln lo ride
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Circadian variation in number and affinity of 
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Summary
1. To determine whether circadian variation in 
adrenoceptor function might underlie the ‘morn­
ing dip’ in peak expiratory flow  (PEP) rate and its 
abolition by salbutamol we measured indices o f 
^-adrenoceptor function (Bmax. ^nd K^), the ratio 
F E V i/F V C , and plasma cortisol at 08.00 and
18.00 hours on and o ff salbutamol (4  mg given 
orally every 4 h) in five extrinsic asthmatic 
patients and five normal volunteers.
2. There was a significant circadian variation in 
receptor numbers (B ^ax.) both the control and 
asthmatic groups which was not abolished on 
treatment w ith  salbutamol.
3. Both groups appeared to compensate for 
loss o f receptor number induced by salbutamol 
administration by increasing receptor affin ity.
4 . For comparable combinations o f drug/time, 
there was no significant difference between the 
control and asthmatic groups.
5. We conclude that the ‘morning dip’ observed 
in asthmatic patients cannot simply be explained 
by changes in cell receptor number or affin ity , as 
our results suggest that both groups have intact 
jl-adrenoceptor function. Nevertheless, our 
observations o f the normal circadian rhythm has 
important implications for future studies o f j3- 
adrenoceptors in asthmatic patients.
Key words; /3-adrenoceptors, circadian variation, 
extrinsic asthma, lymphocytes.
Abbreviations: F E V i, forced expiratory volume in 
I s ;FVC , forced vital capacity; HYP, iodohydroxy- 
benzylpindolol; PEF, peak expiratory flow.
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Introduction
Bronchial hyper-reactivity is now recognized as a 
major factor in the development o f bronchial 
asthma and in atopic disease. Szentivanyi [ I ]  has 
postulated a defect in the /3-adrenoceptors. Several 
reports [2 -5 ] seem to support this hypothesis; 
however, others [6 -8 ]  were unable to find a 
significant difference between normal and 
asthmatic subjects. It  has also been suggested by 
others [9] that the receptor abnormaUty is drug 
induced. Patients w ith  asthma have marked 
variations in bronchomotor tone over 24 h which 
contrasts w ith  the lack o f variability in normals. 
This c ircajian variation in the bronchomotor tone, 
often demonstrated as the ‘morning dip’ [10] in 
F E V i, could be due to changes in the numbers 
and/or the affin ity  o f /3-adrenoceptors or related 
to humoral circadian rhythms.
The aim of this study was to investigate /3- 
adrenoceptor function in normal and asthmatic 
subjects at different times, to assess the effect o f  
orally administered /32-agonist (salbutamol) and to 
see whether, in accordance w ith  the hypothesis 
o f Szentivanyi, there was some apparent receptor 
dysfunction in extrinsic asthmatic patients and 
finally i f  exposure to a /32-agonist produced tachy­
phylaxis.
In  this study, lymphocyte /3-adrenoceptors 
(P2 ) were used as a model o f events taking place in 




Five patients w ith  extrinsic asthma and five 
normal volunteers were studied. The asthmatic 
patients were in remission and were all known to 
have reversible airflow obstruction. A ll sympatho­
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mimetic drugs, including salbutamol and theo­
phylline compounds, were stopped and the 
patients maintained on ipratropium bromide as 
necessary for 7 days before commencing the 
study, so that the /3-adrenoceptors will have 
recovered from any /3-agonist induced desensitiza­
tion. None o f the patients was on inhaled or oral 
steroid therapy. The subjects gave informed 
consent and the study was approved by the 
Medical Ethics Committee o f the hospital.
Protocol
Studies were performed in the respiratory unit 
and the asthmatic patients were admitted at least 
2 days before the study was commenced so as to 
become accustomed to the surroundings. Both 
groups were familiar w ith  having blood samples 
taken.
The following sequence o f tests was performed 
on each patient or volunteer. On day 1, 50 ml of 
blood was withdrawn at 18.00 hours for estima­
tion o f plasma cortisol and isolation o f lympho­
cytes for /3-adrenoceptor estimation. On day 2, 
50 ml o f blood was withdrawn as above at 08.00  
hours and then 4 mg o f salbutamol was orally 
administered to the patient or volunteer at 4 
hourly intervals. A t 18.00 hours, a further blood 
sample was taken and the dosage o f salbutamol 
continued. On day 3 (08 .00  hours), 50 m l of 
blood was withdrawn as above, the salbutamol 
stopped and previous therapy resumed. F E V i/F V C  
ratio was determined after taking each blood 
sample.
Isolation o f  lymphocytes
Lymphocytes were prepared from heparinized 
blood by our modification o f the technique o f 
Harris &  Ukaejiofo [12 ], which produced cell 
populations o f approximately 90-95%  lympho­
cytes w ith  the remainder as monocytes and re­
coveries o f 90-94% . Blood (50  m l) was collected 
into Evans heparinized bottles and centrifuged 
(250^max.> 20 min, 15°C). The platelet-rich
plasma was aspirated and stored frozen at — 20°C  
for subsequent plasma cortisol estimations. The 
pellet was diluted 1 :3  (v/v ) w ith  Earle’s Balanced 
Salt Solution (Gibco Bio-Cult Ltd, Paisley, Scot­
land) minus sodium bicarbonate and supplemented 
w ith 0.1%  calf serum and 20 mmol/1 Hepes (F low  
Laboratories Ltd, Ayrshire, Scotland), adjusted 
to pH 7.6 (buffer A). Portions (8  m l) o f the 
dilution were layered on 12 ml o f Lymphocyte 
Separation Medium (F low  Laboratories Ltd) 
and centrifuged (250gm ax., 250 min, 15°C). The 
m ilky layer o f lymphocytes was harvested from
the interface, washed by diluting 1 :3  w ith  buffer 
A, centrifuged (250 fm ax ., 15 min, 15°C) and the 
supernatant discarded. The pellet was resuspen­
ded in 20 m l o f buffer A  and gently disaggregated. 
The addition o f calf serum reduced lymphocyte 
clumping and ensured an adequate yield o f cells. 
Cells were counted in a Coulter Cell Counter; 
final cell concentrations were usually 2 .5 -3 .0  x 
10^ lymphocytes/1. Cell viability remained greater 
than 95% during all the described procedures as 
determined by trypan blue exclusion.
Receptor saturation analysis
The saturation assays were done in poly­
propylene tubes (Sarsted, 12 mm x 75 m m ) in a 
final volume o f 5 0 0 /ul, comprising, for the total 
binding, lymphocyte suspension (2 5 0 -3 5 0 /ug of 
protein) and [ ’^®l]iodohydroxybenzylpindolol 
(1251-h y p , New England Nuclear, West Germany) 
at appropriate concentrations (5 0 -8 0 0  pmol/1) in 
buffer A. In tubes used to determine non-specific 
binding, ( —)propranolol (3 x 10"^mol/1) was also 
added. Total and non-specific binding was esti­
mated in duplicate at each ’^^1-HYP concentra­
tion. The tubes were incubated at 30°C in the dark 
(to  minimize photolysis o f the ’^®1-HYP) for 
45 m in. The reaction was stopped by the addition 
o f a ‘stopping solution’ o f 2.5 m l o f 50 mmol/1- 
Tris (pH  7 .6 ), 0.9%  sodium chloride and 0.1 
mmol/1 (±)propranolol at 37°C. The samples were 
allowed to stand for 45 s before being filtered 
through Whatman GFC fibre-glass filters (pre­
soaked for 60 min in ‘stopping solution’), by 
applying a vacuum o f 3 -4  psi, and the filters were 
rinsed w ith  3 x 10 ml o f 50 mmol/1 Tris (pH  7.6) 
and 0.9% sodium chloride at 37°C. Filtering and 
rinsing were complete w ithin 12 s. The filters 
were air dried, shaken w ith  10 ml o f Scintillator 
299 (Packard) and the radioactivity was de­
termined. Reproducibility o f the assay was as 
follows for five determinations: ^^ax., 6.05 ± 
0 .64  fm ol/10^ lymphocytes; 0 .36  ±0 .05
nmol/1.
Other estimations
Plasma cortisol was estimated by using Cortisol 
( ’^^1) Radioimmunoassay K it (Corning). The 
F E V ,/F V C  ratio was measured w ith  a standard 
Vitalograph.
Statistical methods
Statistical analysis was done w ith  paired 
Student’s Mests (comparisons on the same subject 
group) and two-sample f-tests (comparison
between patient and volunteer groups) as appropri­
ate on an IC  1^2976 computer using the package 
M IN IT A B  (Ryan, Joiner &  Ryan, Pennsylvania 
State University).
Results
FE V i/FV C  ratio
In  the normal group no circadian variation in 
F E V i/F V C  ratio was observed (Table 1), either on 
or o ff salbutamol therapy. Asthmatic patients not 
receiving sulbutamol showed the expected 
circadian variation in F E V J F V C  ratio, giving rise 
to the ‘morning dip’ ( f < 0 .0 5 ) ,  which was 
abolished on giving salbutamol therapy.
For comparable regimens (i.e. salbutamol/time 
combinations), there was no significance between 
the two groups except at 08 .00  hours o ff  salbuta­
mol, when the F E V j/F V C  ratio for asthmatic 
patients was significantly lower than that for the 
normals ( P < 0 .0 01 ), this corresponding to the 
‘morning dip’ in the asthmatic group.
Plasma cortisol concentrations
Plasma cortisol concentrations showed the 
expected circadian variation in both normal and 
asthmatic subjects ( f  < 0 .0 5 ,  Table 1), on and o ff  
salbutamol and administration o f salbutamol did 
not significantly affect plasma cortisol concentra­
tions in either group. For comparable regimens 
there was no significant difference in plasma 
cortisol concentrations between the normal and 
asthmatic groups.
Circadian variation in ^^-ttdrenoceptors
^-Adrenoceptor kinetics
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Receptor number (^ m a x .A  Both normal and 
asthmatic groups not on salbutamol show a 
marked circadian variation in the number (^^ax .)  
o f /32-adrenoceptors found on the lymphocyte 
( f  <  0 .05 , Table 1) w ith  the greater number o f 
receptors at 18.00 hours. This circadian variation 
is not abolished on exposure to salbutamol. Rep­
resentative saturation curves for a normal subject 
on salbutamol are shown in Fig. 1 w ith  the corre­
sponding Scatchard analyses in Fig. 2.
In  both groups, the number o f receptors at
08 .00  hours on salbutamol is also significantly less
5-,
c. 4 -
0 0.2 0.3 0.4 0.5 0.6 0.70.1
'^n-HYP (nmol/1)
F i g . 1. ^^®I-HYP binding to  ly m p h o cy tes o f  a 
typ ica l co n tro l subject while on th e  sa lbutam ol 
regim en at 18.00 h ours (day 2, • )  and 0 8 .0 0  hours 
(day  3, ■^ ).
T a b le  1. Mean values ('^SD) o f  B^^ax., c o rtiso l concentra tions and F E V ^IF V C  (% j in  five  c o n tro l and
fiv e  asthm atic subjects
* P <  0 .0 5 ; <  0 .01 . n.s., n o t significant. In ad d ition , th e  com parison o f co n tro ls w ith  asthm atic
patien ts w ith  and w ith o u t o ra l sa lbu tam ol did n o t reveal any significant d ifference. Sim ilarly sa lbu tam ol 









Control 18.00 9.02 ±2.21 0.49 + 0.23 8.3 ±1.7 83.2±7.2
(5) * n.s. * n.s.
Not on salbutamol 08.00 5.40± 1.16 0.35+0.11 15.1 ±3.3 82.9 ±7.9
On salbutamol 18.00 7.18±2.01 0.46 ±0.14 9.8±3.3 86.2 ±6.8
* * n.s.
08.00 2.01 ±1.74 0.21 ±0.19 18.1 ±2.7 83.9 ±5.8
Asthmatic 18.00 6.86 ±2.72 0.31 ±0.04 11.8±5.7 69.8 ±14.1
(5) *
Not on salburamol 08.00 3.40 ±1.50 0.14±0.06 21.0±8.2 51.9±10.3
On salbutamol 18.00 5.12 + 1.48 0.42±0.15 9.4 ±5.9 71.8 ±14.4
* * n.s.
08.00 1.28 + 0.41 0.23±0.11 22.1 ±9.0 67.5 ± 19.4
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F i g . 2. Scatchard  analysis o f  th e  sa tu ration  d a ta  
from  Fig. 1: 18.00 hours (day 2, • )  and 08 .00  
h ours (d ay  3, ^ ).
than at 08 .00  hours not on salbutamol ( f  < 0 .0 5 ) ,  
showing that ‘down regulation’ o f the receptors 
is induced by salbutamol. This ‘down regulation’ 
is not observed for the 18.00 hour samples.
For comparable regimens no significant d if­
ference in receptor number was observed between 
asthmatic and normal groups.
Receptor affinity (K^). In normals there is no 
significant difference in the receptor affin ity  
(ATd) between 18.00 hours and 08 .00  hours while 
o ff salbutamol, but on salbutamol a circadian 
variation appears, w ith  the significantly lower 
( f  < 0 .0 5 ,  Fig. 2 ) (i.e. the receptor is more 
sensitive) at 08 .00  hours. This compares w ith  
receptor affin ity at 18.00 hours, whdch is not 
significantly different on or o ff salbutamol.
In asthmatic patients, a circadian variation in 
is present both on and o ff salbutamol {P <  
0 .05 ) but the administration o f salbutamol does 
not significantly alter receptor affin ity  at either
0 8 .00  or 18.00 hours.
No significant differences in receptor affin ity  
between normal and asthmatic subjects were 
observed except at 08 .00  hours o ff  salbutamol 
( f <  0 .0 1 , Table 1).
Discussion
The problems o f  using the lymphocyte jl^-adreno- 
ceptor as a model for the lung /3-adrenoceptor has 
not been extensively discussed. However, Davis 
et al. [13] have stated that the /3-adrenoceptors o f 
the lym phocyte, bronchial smooth muscle and 
lung parenchyma have /3; selectivity, although 
they differ quantitatively from each other. 
Bishopric et al. [14] have shown that /3-adreno- 
ceptor function on B- and T-lymphocytes does
not differ significantly. Consequently we, along 
w ith many others, feel justified in using the 
lymphocyte (3-adrenoceptor as a model for the 
lung.
This study was undertaken to investigate the 
number (^max.) ^nd sensitivity (Æ j)  o f the 
lymphocyte /32-adrenoceptors w ith  a view to 
explaining the ‘morning dip’ observed in patients 
w ith  extrinsic asthma. Each patient sample was 
characterized w ith  seven to nine standards, so that 
the 5max. and the could be determined from 
Scatchard analysis [15 ], rather than from just one 
or two standards [5 , 16]. To our knowledge, this 
is the first time that such an extensive study o f the 
effects o f carcadian variation on adrenoceptor 
kinetics has been undertaken in the human 
lymphocyte. Since the lymphocyte is used by 
many workers as a model for the lung /32-adreno­
ceptor [1 7 -2 0 ], this study is o f particular value, 
since many workers neglect to mention the time of 
sampling. One lim itation o f this present work is 
the fact that samples were only determined at
08 .00  and 18.00 hours. However, the need for 
sequential studies restricted the amount o f blood 
which could be withdrawn. Measurement o f cell 
adrenoceptor numbers at only one or two ligand 
concentrations [5, 16] is not adequate to allow 
adrenoceptor characterization, particularly since 
adrenoceptor sensitivity might also be a factor in 
explaining the ‘morning dip’ observed in asthmatic 
subjects.
A  significant circadian variation was demon­
strated in the number o f /32-adrenoceptors (Bmax.) 
in both normal and asthmatic subjects, w ith  the 
lesser number o f adrenoceptors in the early 
(08 .00  hours) sample. This variation persisted 
when both groups were given salbutamol, though 
‘down-regulation’ o f adrenoceptor numbers 
occurred in both groups in the 08 .00  hours 
sample. This accords w ith  the findings o f others 
[21, 22], assuming that their samples were taken 
in the morning. Interestingly, no evidence for 
‘down-regulation’ was found in the late (18.00  
hours) sample and as yet we can offer no explana­
tion for this.
No significant difference in adrenoceptor 
numbers was observed either at 08 .00  or 18.00 
hours between the normal and asthmatic groups 
whether on or o ff  salbutamol, and this contrasts 
w ith  other reported results [5, 17, 23] that 
asthmatic patients generally have significantly less 
/3-adrenoceptors than normal subjects. However, 
most o f  these workers either do not mention the 
time o f sampling or else used only one or two 
concentrations o f radioligand to obtain the Bmax.- 
It  may well be that our results differ because the 
Bmax. data reported here were derived from full
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saturation analysis and not a single estimation. It 
would be expected that the former would give the 
more reliable results.
With regard to the observed circadian variations, 
it has also been found that plasma cAMP concen­
trations in normal subjects demonstrated a cir­
cadian variation w ith  the maximum concentration 
at 14.00 and the minimum at 02 .00  hours [24]. 
In asthmatic patients, plasma cAMP also showed a 
circadian variation similar to that in normals w ith  
trough values at 04 .00  hours, significantly ( P <  
0.01) lower than the peak values recorded at
16.00 hours [25 , 26].
Generally, other workers appear to have 
accepted [20, 27] that there was no difference in 
adrenoceptor affin ity  {K f)  between normal and 
asthmatic subjects. In  this study it is reported that 
in fact asthmatic patients do seem to have a signifi­
cantly lower ( P <  0 .0 1 ) than normals at 08 .00  
hours, not on salbutamol. In  support o f these 
results, the values measured in our assay are 
compatible w ith  those o f other workers w ith  
^^^1-HYP used as binding ligand [19, 28]. Also, in 
normal subjects on salbutamol a circadian varia­
tion appears in w ith  lower values at 08 .00  
hours appearing w ith  the lower adrenoceptor 
numbers. This would almost seem to be some form  
of compensatory mechanism w ith  the increased 
sensitivity compensating for the reduced adreno­
ceptor number. However, other workers [24] have 
shown that plasma cAM P levels are lowest in the 
morning, and so this observation cannot satis­
factorily be explained. Asthmatic patients have a 
circadian variation in both on and o ff  salbuta­
mol, w ith  the lower in the morning, but again, 
as pointed out by others [25, 26] the plasma 
cAMP is also lower in the morning.
To investigate the cause o f the modulation o f  
/3-adrenoceptor numbers, plasma cortisol concen­
trations were assayed. Several workers have found 
that administration o f exogenous cortisol leads to 
an increase in /3-adrenoceptor numbers, both in 
humans [29 ] and rodents [30 , 31]. Other work 
with polymorphonuclear leucocytes has shown 
that asthmatic patients on long-term steroid 
therapy have a normal number o f /3-adrenoceptors 
[27]. In  our study, the number o f adrenoceptors 
appears to vary inversely w ith  plasma cortisol; the 
receptor number is lower in the morning when 
plasma cortisol is higher. Our results fall short o f 
significance and so cortisol is unlikely to be the 
mediator o f this effect. However, Davies &  Lef­
kowitz [32 ] have also shown that administration 
of cortisone acetate modulates both receptor 
^max. 2nd A'd in both polymorphonuclear and 
mononuclear leucocytes. This is in agreement 
with our results, and so the role o f cortisol in the
regulation o f /3-adrenoceptor function needs 
further investigation.
It  has been shown [33] that there is a reciprocal 
correlation between circulating plasma adrenaline 
concentrations and lymphocyte /3-adrenoceptor 
density. Our study did not estimate plasma 
adrenaline concentrations but our results would 
appear to contradict those results [33] as the 
receptor density was lower in the morning when 
plasma adrenaline is low. However, the conclusions 
reached [33 ] are true only if  adrenaline is the sole 
controlling factor; the observation that two  
biological rhythms correlate w ith  each other in 
time is not sufficient proof that one causes the 
other [34 ]. Adrenaline infusion has no effect on 
lymphocyte /3-adrenoceptors [35] and so the inter­
relationships are presently unclear.
A t present, we have no explanation for the 
observed circadian variation in /3-adrenoceptor 
numbers in either group. The lowest number o f 
/3-adrenoceptors corresponds to the observation o f 
‘morning d ip ’ in asthmatic patients, and this 
diminishing of receptor number may well be a 
predisposing factor to the fall in F E V i/F V C  ratio. 
One report [36] has suggested that circulating 
auto-antibodies may interfere w ith  the functional 
binding o f catecholamines to the /3-adrenoceptor in 
some patients w ith  asthma. This is a more likely  
explanation o f the /3-adrenoceptor defect in 
asthmatic patients as our data contain no evidence 
that their /3-adrenoceptors are functionally  
different from those o f normal subjects; both  
display a circadian variation in receptor number, 
both are down-regulated by salbutamol admini­
stration and the number o f receptors does not 
differ significantly between the two groups.
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RECFIT: A M icrocom puter-Based Nonlinear Regression 
Curve-F itting Package fo r the Quantitative Resolution 
of /3-Adrenoceptor Subtypes and Estimation 
of N onspecific B inding
B a r r y  C l a r k , *  A n d r e w  W . K E L M A N ,t G r a h a m  E . T r o p e , t  
AND S a 'a D  J. T iT IN C H I*
* D epa rtm e n t o f  P a th o lo g ica l B iochem istry , Western In firm ary ', G lasgow, G l I  6N T ; '^West o f  
S cotland  H e a lth  B oards, D epa rtm en t o f  C lin ica l Physics and B ioeng ineering, I I  West G raham  
Street, and D epa rtm en t o f  N u c le a r M edic ine, S to b h ill Genera l H osp ita l, G lasgow ; XTennent 
In s titu te  o f  O ptha lm o logy, Western In firm a ry , G lasgow, S cotland
Received August 10, 1983
A dedicated nonlinear regression based curve-fitting packages has been developed for 
quantitative analysis of )3-adrenoceptor subtypes. A feature of this package is the provision 
to obtain initial param eter estimates using a conversational graphical technique where the 
user is prom pted for param eter estim ates, and the resulting curve is displayed over the data. 
Data are then fitted to a one- or two-binding site model with user-selected weighting and 
constraints on the param eters. A novel feature is the provision to estimate the nonspecific 
binding component in the assays as a param eter in the model. The printout for each model 
consists of the param eters and their standard deviations, estimates of the goodness of fit, an 
analysis of residuals, and a graph of the data points overlayed with the fitted curve. The 
nonlinear regression algorithm is based on that of G auss-N ew ton. When unweighted, the 
values determined by RECFIT are essentially the same as those found using the BMDPAR 
programs on an ICL 2976 mainframe computer. The implementation is reasonably efficient; 
a typical run for a two-site fit, using nine data points and estimating nonspecific binding, took 
a total time of about 8 min, excluding data entry and derivation of initial estim ates, 4 min for 
the fitting, 30 sec for graph generation, and 2-3 min for printing of the graph and data.
I n t r o d u c t io n
W hen deve lop ing  recep to r assays in  new  tissues, i t  is essential to  have ana­
ly tic a l too ls  w h ich  w il l  a llo w  de tection  o f  recep to r subtypes i f  such are present. 
R ecen tly , T rope  and C la rk  (1, 2) have developed a system  fo r  the de tection  o f 
/3-adrenergic receptors in  p igm ented c ilia ry  processes; the la tte r are though t to  
be im p lica ted  in  the deve lopm ent o f  g laucom a, a serious eye co n d ition  a ffec ting  
m any people ( i ) .  Some em p irica l evidence {4) suggested tha t the m ain recep­
to rs  present w ere ^ 2 -adrenerg ic recep to rs ; d ifficu ltie s  in  the d issection  p roce­
dures fo r  ob ta in ing  c ilia ry  processes m igh t lead to  some con tam ina tion  w ith  
b lood  vessels, whose receptors are type  /3 i. A  sensitive technique fo r  q u a n tify ­
ing recep to r subtypes was thus essentia l. A d d it io n a lly , T it in c h i and C la rk  (5)
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have recen tly  characte rized  lym p h o cy te  alpha receptors using s im ila r tech­
niques w ith  tr it ia te d  ligands w ith  iden tica l requ irem ents fo r  analysis. E a rly  
w o rk  by B a rne tt et al. ( 6 ) had used a graphica l m ethod derived fro m  the 
classical Scatchard (7 ) data analysis ( “ pseudo S catchard” ) to  assess the re la ­
tive  p ro p o rtion s  o f  recep to r subtypes. H ancock et al. {8) have shown tha t th is 
m ethod p rov ides  less accurate p red ic tions  than a non linear com pute r m odel, 
and have g iven  an analysis o f  the e rrors invo lved .
E x is tin g  packages (S C A T E IT  (5) and S A A M 2 6  (9)) p rov ide  the necessary 
a lgo rithm s fo r  the least squares analysis o f  recep to r subtypes bu t the fo rm e r is 
w rit te n  in  P L /1  and bo th  are o n ly  ava ilab le  on certa in  m in i- o r m ainfram e 
com puters. The in it ia l approach adopted was to  p rov ide  suitable m odel equa­
tions as subroutines to  one o f  the general non linear regression cu rve -fittin g  
packages ava ilab le  on the G lasgow  U n iv e rs ity  IC L  2976 m ainfram e com pute r 
(B M D P A R  {10)) in te rfaced  to  a cus to m -w ritte n  graphics program  based on the 
G H O S T  (7 / )  g raph ica l o u tp u t rou tines bu t th is  approach had several lim ita ­
tio n s ; users were requ ired  to  be fa m ilia r w ith  the com plex IC L  opera ting  sys­
tem  and te x t e d ito r, and access to  the system  was on ly  by means o f  a (s low ) 
rem ote 300-baud line . The p r in te r and p lo tte r w ere also a considerable d istance 
fro m  the D epartm ent, m aking the w ho le  procedure excep tiona lly  tedious.
One o f  the prob lem s associated w ith  ce ll-recep to r studies is the assessment 
o f  ligand w h ich  is bound nonspec ifica lly  (nonspecific  b ind ing , N S B ) to  the 
tissue under analysis. The classic w ay o f  estim ating  th is is to  add su ffic ien t 
un labeled d rug to  saturate a ll the specific receptors and then determ ine how  
m uch labeled ligand is s till bound to  the tissue m em brane. Since the equations 
used to  describe the lig a n d -re c e p to r in te ractions are dependent on how  m uch 
ligand is spec ifica lly  bound the data obta ined fro m  the assays m ust be trans­
fo rm ed  (specific  =  to ta l -  N S B ) as o n ly  to ta l b ind ing  and nonspecific  b ind ing  
can be d ire c tly  de te rm ined  in  the assays. E s tim a tion  o f  N S B  is there fore  v ita lly  
im p o rta n t and it  was decided to  f it  th is  com ponent as an add itiona l param eter in 
the m odel equations. C onsequen tly , a non linear least squares a lgo rithm  w h ich  
a llow s m u ltip le  param eters to  be fitted  s im u ltaneously was essential. N S B  can 
now  be estim ated as a param eter in  the f it, p ro v id in g  ve rifica tio n  o f the data 
obta ined e xp e rim e n ta lly  and g iv ing  greater confidence in  the results.
The advent on an A pp le  I I  m ic rocom pu te r in to  the departm ent lead to  the 
deve lopm ent o f  a package spec ifica lly  ta ilo red  to  recep to r analysis u tiliz in g  the 
in b u ilt  g raphics ca p a b ility  to  d isp lay the results o f  the fit.
T h is  paper describes a com prehensive m enu-driven program  package fo r  
c e ll- re c e p to r  ana lys is ; it is ca lled R E C F IT , and runs on an A pp le  I I  E urop lus 
m ic rocom pu te r.
M ethods
Computer Software
M ost o f  the package is w ritte n  in com piled  M ic ro so ft F O R T R A N  6 6 . Th is 
language was chosen because, un like  A pp le  F O R T R A N  77, it supports doub le ­
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prec is ion  variab les, thus increasing the accuracy o f  the m a trix  opera tions. I t  
also has the advantage o f  com p iling  d ire c tly  to  fast Z-80 m achine code whereas 
F O R T R A N  77 is run  by a re la tive ly  slow  p-code in te rp re te r under the A pp le  
P A S C A L  opera ting  system . D oub le -p rec is ion  variables are used sparing ly , be­
cause they  subs tan tia lly  s low  the cu rve -fittin g  procedures. The lack o f  te x t 
hand ling  in F O R T R A N  6 6  was compensated fo r  by use o f  “ the S T R IN G  80 
b it ”  (K e yb its  In c ., P.O . B ox 592293, M ia m i, F la .) rou tines. These rou tines also 
give d ire c t program  access to  the C P /M  opera ting  system . T h is  a llow s, fo r  
exam ple, the d isk  d ire c to ry  to  be re trieved  and lis ted o r the presence o f  a file  o r 
d isk  to  be ve rified  before attem pts are made to  access it. The graphics program s 
are w ritte n  in M ic ro s o ft B A S IC  80, as F O R T R A N  6 6  does not support h igh- 
reso lu tion  graphics. These in te rp re ta tive  program s are com p iled  using M ic ro ­
s o ft’ s B A S C O M  co m p ile r so that both  languages run  in a com m on env ironm en t 
(C P /M  “ C O M ”  files).
The Package
{a) The model. The equations fitted  by the program  are those described by 
W enke {12) fo r  the co m pe titive  reaction  betw een the free concen tra tions o f  a 
recep to r R , the rad io labe led  ligand [ '- ^ I ]H Y P  ( [ ‘- ‘'IJh yd ro xyb e n zy lp in d o lo l) 
and a )3-adrenoceptor b lock ing  agent B.




Ka and Kg represent the d issoc ia tion  constants o f  [ ' “T ]H Y P  and B.
U nde r steady state cond itions , assuming a constant num ber o f  /3-adrenocep­
to rs R j
R j = R + RB + R - [ ' “ ' I jH Y P , 
the concen tra tion  o f  bound rad io ligand is
R ■ [ '-^ I ]H Y P  =  Ry Ka I B 
^  P Ï Ï H Ÿ P  V ^  j [ 1]
This equation  [1] deals w ith  spec ifica lly  bound drug (R • [ '-^ I]H Y P ). T o  avo id  
trans fo rm a tion  o f  the observed data (to ta l drug bound) by sub traction  o f  an 
estim ated am ount o f  nonspec ifica lly  bound drug (N S B ) we can m o d ify  the le ft- 
hand side o f  F q . [1]:
R • I'-n iH Y P .o ta i -  N S B  =  R t.
Ka /  B 
^  [ ' : ' I ]H Y P  V ^  Â 5 /J 12]
N S B  thus becomes a param eter to  the equation. I f  tw o  types o f  /3-adrenocep­
to rs are present in the tissue under analysis and i f  each com ponent obeys
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sim ple mass ac tion  law  w ith o u t any in te rfe rence , then Eq. [2] can be fu rth e r 
generalized to
R • ['25l]HYP,otai -  N S B  =  Z  1 +  (A :^ /[ ': 'I ]H Y P )(1  +  B/Kb,)
In  E q. [3] i t  is fu r th e r assumed tha t the rad io ligand [ '-T ]H Y P  binds w ith  equal 
a ff in ity  to  )8 i- and /Sz-adrenoceptors, whereas B possesses a d iffe ren t a ff in ity  fo r  
each recep to r subclass. The v a lid ity  o f  these assum ptions has been discussed 
by Engel (14) fo r  ['^^ I]C Y P  ( [ ' “ ‘’IJcyanop indo lo l) and applies equa lly  to  
[ ‘2^I]H YP . W e have used bo th  ligands in ou r studies.
T w o  constants, the concen tra tion  o f  [ ' ‘ T ]H Y P  ([ '-T jC Y P ) in  the assay and 
Ka (the a ff in ity  o f  the rad io ligand  fo r  the recep to r popu la tion  under study) are 
requ ired  by E q. [3]. The fo rm e r is obta ined by coun ting  the standard used in the 
assay, the la tte r is ob ta ined in  a separate experim ent, using sa turation analysis 
and the da ta -reduction  m ethod o f  Scatchard (7). To  s im p lify  the la tte r p roce­
dure a set o f  program s w ritte n  in A pp leso ft B A S IC  is used. The com pute r is 
equipped w ith  a lig h t pen fo r  in te rac tive  ed iting  o f  the regression line and 
deta ils have been published elsewhere by C la rk  et al. (75) in a s im p lified  fo rm  
fo r  s im ila r analyses on ste ro id  receptors.
The data fro m  each m easurem ent o f  the d isp lacem ent curve  are repeatedly 
fitte d  accord ing  to  E q. [3 ], using the m odel o f  / =  one o r tw o  classes o f b ind ing  
sites using an a lgo rithm  based on the G a u ss -N e w to n  m ethod (76) w h ich  sup­
po rts  s im ultaneous es tim ation  o f  up to  10 param eters. I f  N S B  has been esti­
m ated separate ly in  the assay as a m easurem ent it can e ithe r be subtracted fro m  
the to ta l counts at each p o in t and the data fitte d  w ith  and w ith o u t a ttem pting  to 
solve fo r  N S B  as a param eter, o r the observed value fo r  N S B  can be supplied 
s im p ly  as an in it ia l s ta rting  value w ith o u t trans fo rm ing  the data. U sing e ithe r 
m ethod, the observed N S B  can be com pared w ith  the theore tica l N S B  fo r  the 
assay.
F o r the u n kn o w n  param eters the program  prov ides the best estim ates to ­
ge ther w ith  th e ir standard dev ia tions and the sum o f  squares o f  the residuals. 
The goodness o f  f it  is estim ated using the general linear test (27) since the 
m odels fo r  one- and tw o -s ite  f it  can be considered to  fo rm  an h ie ra rch ica l 
series. B y F -tes t analysis the goodness o f  f it  betw een the m odels can be com ­
pared and the m ost app ropria te  m odel selected.
(b) Program structure. The package is also designed to  p rov ide  a ll the neces­
sary fa c ilit ie s  fo r  file  and data hand ling , so tha t it is not ju s t another iso lated 
non linea r least squares regression program . The options ava ilab le  fro m  the 
m ain m enu are deta iled  be low .
(1) Input raw counts. The results o f  the recep to r assays are in the fo rm  o f 
cpm  (counts per m inu te ) fro m  a gamma coun te r, along w ith  the concen tra tion  
o f  m em brane p ro te in  in  the assay. T h is  program  takes the data and converts  
them  in to  m oles o f  drug b o und /m illig ram s p ro te in . I f  using '-^I-labeled drugs, 
co rre c tio n  is made fo r  the age o f  the isotope. A t th is stage, N S B  may be
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subtracted fro m  the data i f  requ ired . The results are o u tpu t to  a w o rk file —  
W O R K .D A T — w h ich  is used by all the o the r program s in  the package.
(2) Manual input. D ata available fro m  ea rlie r experim ents in the fo rm  o f  drug 
concen tra tion  and correspond ing  am ount o f  ligand bound m ay be entered 
in to  the w o rk file  using th is  program .
(3) Editlreview. D ata in the w o rk file  m ay be lis ted  out on the screen fo r  
ve rifica tio n  o r sets o r data (drug concen tra tion  and bound) may be added o r 
deleted. B e fo re  m o d ify in g  the data set, the user should use op tio n  7 to  take a 
copy o f  the in it ia l w o rk file .
(4) Initial estimates. The a lgo rithm  used fo r  the non linea r least squares re ­
quires tha t reasonable in it ia l estim ates are g iven fo r  the fitt in g  param eters. Th is 
can be done by various means such as se rend ip ity  o r based on experience. The 
m ethod chosen here is to  use a graphica l technique w here the user is show n a 
graph o f  the data po in ts  and then asked i f  a one- o r tw o -s ite  f it  is requ ired . The 
program  then prom pts fo r  estimates o f  the various param eters and then 
sketches in the cu rve  correspond ing  to  the supplied param eters. A  typ ica l 
session is show n in F ig . 1 where the user is ob ta in ing  in it ia l estim ates fo r  a tw o - 
site f it  o f  the IPS-339 data shown in  Table  I. B efore  leaving the program  a 
sum m ary o f  the fina l estim ates is g iven on the screen in  con firm a tion .
(5) Fit to 1 or 2 Sites. Once in it ia l estim ates have been obta ined the user may 
proceed to  the non linea r cu rve  fitt in g . A ga in , data en try  is conversa tiona l and 
the assay constants and in it ia l estim ates requ ired  by the program  are entered. 
The user is then p rom pted  fo r  the constra in ts to  be im posed on the param eters 
and the program  then proceeds to  f it the data, p rin tin g  ou t the fina l estim ates, 
th e ir standard dev ia tions , and estimates o f  the goodness o f  f it  and an analysis o f
\
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F ig . 1. Photograph of Apple screen while obtaining initial estimates for a two-site fit on the IPS- 
339 data in Table I. The number in the top right-hand corner of the screen is the maximum 
estimated number of receptors (fmole/mg protein) and remains there at all times to prompt the user. 
The user then enters estim ates for the number of receptors (BMAX. corresponds to Rj, in Eq. [3]) 
and receptor affinity (KD, corresponds to K b, in Eq. [3]) for each site and the program then draws 
the estimated line through the data points. Note that the sum of the two BMAXs approximates to 
the estimated figure of 726. In this example the estimates are reasonable enough to proceed to the 
curve-fitting option.
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TABLE I
S a m p le  D a t a  f o r  IPS-339 w i t h  t h e  A ssay  
C o n s ta n ts  a n d  I n i t i a l  E s t im a te s  a n d  C o n s t r a in t s  
U s e d  f o r  t h e  F i t t i n g  P r o c e d u r e















K a = 410 pmole/liter.
Concentration of [ '’^I]CYP in assay = 710 pmole/liter.
Initial estimates and constraints 
Site 1; RTi =  200 fmole/mg protein (50.0 to 300.0)
K b\ =  2.0E-10 mole/liter (l.OE-11 to l.OE-09)
Site 2: RTi =  500 fmole/mg protein (300.0 to 800.0)
Kb2 = 5.0E-09 mole/liter (l.OE-10 to l.OE-08)
NSB: 2.0 (-2 0 .0  to 20.0)
Weighting factor: 0 (unweighted fit)
Note. The final param eters obtained after fitting this 
data to a two-site fit are given in the results, with the 
corresponding graphical display in Fig. 2.
residuals. I f  requ ired  the f it may then be repeated. The constra in ts  may be 
a ltered m anua lly , o r le ft unchanged. On com p le tion , the fina l param eter esti­
mates are w rit te n  ou t to  d isk . The progress o f  the f it is con tinuous ly  updated on 
the screen and the fitt in g  process may be te rm inated at any tim e by s im p ly  
pressing any key on the keyboard ; the cu rren t values o f  the param eters are then 
p rin ted  o u t as above.
(6 ) Graphical display of fit. T h is  program  takes the fina l param eter estim ates 
fro m  d isk  and the data in  the w o rk file  and produces a fu lly  annotated p lo t as in 
F ig . 2. T h is  p lo t can also be o u tp u t to  the p rin te r fo r  hard copy. Should inspec­
tio n  o f  the p lo t reveal any ob v io us ly  erroneous po in ts , the correspond ing  data 
set can be rem oved fro m  the file  using the E D IT  op tion  and the fitt in g  process 
repeated.
(7) Disc utilities. These p rov ide  the package w ith  fu ll file  handling fa c ilit ie s  
and is m enu d riven . The w o rk file  m ay be copied to  a named file  o r p revious 
data recovered. Saved files m ay be lis ted  o r deleted. Use o f  the pow erfu l 
S T R IN G  80 B IT  rou tines means tha t an a lphabe tica lly  sorted d isk  d ire c to ry
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F ig . 2. Photograph o f Apple screen showing the graphical result of the two-site curve fitting. The 
plot is fully annotated and can be output to the printer for hard copy. Note that goodness of fit ( i.e ., 
one- or two-site) is assessed only by use of the general linear test and not by visual inspection of 
this plot.
can be held inside the program , so that attem pts to  recover a nonex is tan t file , o r 
to  o ve rw rite  an a lready ex is ting  file , can be detected and the user a lerted.
(8 ) General linear test. Th is op tion  holds an F  table at the 5% leve l (22) and 
advises on w he the r a one- o r tw o -s ite  f it is m ore appropria te . S ince the models 
fo rm  a h ie ra rchy  o f  m odels, using the one-site m odel as a reduced (/?) m odel, 
and a tw o-s ite  m odel as a fu ll (F ) m odel then:
SSQr -  SSQf\  . /S S Q f
d ff
is F  d is tribu ted  w ith  dfR -  dff, dfy degrees o f  freedom . Th is program  prom pts 
the user fo r  the residua l sum o f squares (SSQ) and the appropria te  degrees o f 
freedom , evaluates the above equation, looks up the theo re tica l F  value in  its 
table and in fo rm s the user w h ich  m odel gives the best fit.
(9) Return to CPIM.  T h is  op tion  re turns the user to  the C P /M  opera ting  
system  so tha t o th e r program s may be run.
Cell receptor displacement curves. C e ll receptors estim ations w ere done as 
p re v io u s ly  described {1,2, 5).
R e s u l t s  a n d  D is c u s s i o n
B oth  real and co n tr ive d  data were f it  to  one- and tw o -b ind ing -s ite  m odels. 
T yp ica l real data was obta ined using the jg? drug IPS-339 (23) (a g ift fro m  D r. G. 
Le C le rc ) to  disp lace ['^'’I jH Y P  fro m  a prepara tion  o f  c ilia ry  process m em ­
branes. C o n trive d  data was generated using a short B A S IC  program  fed w ith  
theo re tica l param eters equipped w ith  a random  num ber generator to  add erro rs  
in a specified percentage range. W hen fitt in g  the data w ith o u t w e igh ting , 
R E C F IT  gave c lose ly  s im ila r values to  the m ainfram e package B M D P A R  (10). 
The real data, fro m  w h ich  the observed N S B  had a lready been subtracted , f it 
best to  a tw o -s ite  f i t ;  site 1 : /? ti =  175.55 ±  66.25 fm o les /m g  p ro te in , Kb\ = 0.34 
±  0.18 n M ; site 2: R j 2 = 541.31 ±  65.33 fm o les /m g  p ro te in , Kb2 =  3.68 ±  0.67
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n M . The N S B  eva luated to  be -3 .4 4  ±  4.28 (i.e ., essentia lly  zero) show ing that 
the c lassica l w ay o f  de te rm in ing  N S B  (77) was acceptable fo r  IPS-339 in th is  
assay system ; the expected value fo r  N S B  was 0. The graphical ou tpu t o f  the 
fina l f it  is show n in  F ig . 2; an exact facs im ile  o f  the com pu te r screen may be 
sent to  the p r in te r fo r  fu tu re  reference o r to  s im p lify  the w o rk  o f  m edical 
illu s tra t io n  in  p roduc ing  diagram s fo r  papers, theses, etc. The tw o -s ite  f it w ith  
es tim a tion  o f  N S B  to o k  4 m in  fo r  the fitt in g , 30 sec fo r  the graph generation and 
2 -3  m in  to  p r in t the data and graph.
The resu lts  fro m  th is  p a rticu la r data set were o f  in te rest in  tha t they d is­
p layed  a b iphasic d isp lacem ent cu rve  w hen o n ly  one phase w o u ld  have been 
expected. The cause o f  th is  was investigated as it  m ay have meant tha t, fo r  
exam ple, th is  p a rticu la r p repa ra tion  was contam inated w ith  )3, receptors o r tha t 
IPS-339 was d isp lac ing  ['^ ^ I]H Y P  o f f  o the r receptors (e.g., alpha o r h istam ine 
{14)). Repeat experim ents  gave o n ly  one-site fits , so it was suspected tha t th is 
p repa ra tion  o f  c ilia ry  processes was fa u lty . A p a rt fro m  rou tine  data processing 
the re fo re , th is  package has ve ry  real app lica tion  as a research and d iagnostic 
too l.
The non linea r regression a lgo rithm  used in  th is fitt in g  is tha t o f  G auss- 
N e w to n  (76) w ith  the p ro v is io n  fo r  setting constra in ts  on the param eters and 
appears to  be ve ry  robust. The in it ia l developm ent lacked these constra in ts  and 
the program  o ften  fa iled  on fitt in g  d iff ic u lt data sets due to  a rithm e tic  ove rflo w  
as the param eters w ere adjusted in  the in it ia l ite ra tions.
The use o f  non linea r regression a lgo rithm s on m icrocom pute rs  is s till a fa ir ly  
new  area o f  deve lopm ent. General program s are ava ilab le  fo r  the P ET m ic ro ­
com pu te r {18), the Texas T I-59  program m able ca lcu la to r (79) and a m ore re ­
s tric ted  one by D ugg leby (72) bu t these lack fu ll file  handling and graphics 
ca p a b ility . R ecen tly , G reco et al. {20) have produced a dedicated graphics 
package (R O S F IT ) fo r  enzym e k ine tics . S ince R E C F IT  is in tended to  be used 
by c lin ic ians  and c lin ica l b iochem ists a dedicated approach is requ ired  fo r  the 
c e ll- re c e p to r  assays as m any o f  these users are not fa m ilia r w ith  com puters. 
Because o f  th is  it  is im p o rtan t to  help such users deve lop  a “ fe e l”  fo r  th e ir 
data. T o  th is  end, the in it ia l estim ates fo r  the regression are obta ined g raph i­
ca lly . U sers have genera lly  reported  tha t th is  fa c ility  is indeed h e lp fu l, and 
p rov ides ins igh t bo th  in to  the cu rve -fittin g  process and also aids in understand­
ing the fina l p r in to u t. B y  adopting  a dedicated approach, it  is possible to  p ro ­
v ide  com prehensive  e rro r checking  on data inpu t, and to  annotate the graphs 
w ith  m ean ing fu l legends. The p ro v is io n  o f  fu ll file -hand ling  fa c ilit ie s  means that 
data files can be preserved and past results are available fo r  instan t reca ll and 
reprocessing.
In  sum m ary, a com prehensive  package to  enable the quan tifica tion  o f  cell 
recep to r subtypes has been im p lem ented on an A pp le  I I  m ic rocom pu te r. Th is  
has considerab le  advantages ove r the m ainfram e approach; although the actual 
fitt in g  is s low er, the m ic ro co m p u te r is ava ilab le  at bench leve l, 24 h r a day. The 
package is dedicated and easy to  use, w ith  fu lly  annotated graphica l ou tpu t. 
P rin to u t is ava ilab le  im m ed ia te ly  w ith o u t the need to  go outside the depart-
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m ent. Th is  package has been successfu lly used w ith  « i-re c e p to r assays and, 
indeed should be capable o f  use w ith  any recep to r system w h ich  needs q u a n ti­
ta tive  assessment o f  recep to r subpopula tions p ro v id in g  they m eet w ith  the 
lim ita tio n s  and assum ptions ou tlined  fo r  the be ta-receptor system  {13, 14).
R E C F IT  has been designed to  run  on an A pp le  I I  m ic rocom pu te r extended 
by the add ition  o f  a 16K A pp le  Language card, G rapp le r P rin te r Card (Orange- 
M ic ro , 3150 E. L a  Palma, Suite G , A nahe im , C a lif.) to  a llo w  bo th  te x t and 
graphics to  be o u tp u t to  a Paper T ige r 560 p rin te r (2 K  graphics b u ffe r, In tegera l 
D ata System s, M ilfo rd , N .H . 03055), a Z-80 C P /M  card to  g ive access to  the 
C P /M  2.22 56K  opera ting  system (M ic ro so ft C onsum er P roducts, 400 108th 
A ve . N E , Suite 200, B e llevue , W ash. 98004), a 124n. B /W  m o n ito r and 2 A pp le  
d isk  d rives. Users in terested in  the so ftw are  should con tact the p rin c ip a l au tho r 
in the firs t instance.
A c k n o w l e d g m e n t s
The authors thank Dr. R. W. Logan for his encouragement during the development of this 
package and Dr. LeClerc for the gift of IPS-339.
R e f e r e n c e s
1. T ro p e , G . E., C l a r k ,  B., a n d  T i t in c h i ,  S. J. S. Identification of beta-adrenergic receptors in 
the pigmented mammalian iris-ciliary body diaphragm. Exp. Eye Res. 34, 153 (1982).
2. T ro p e , G. E ., a n d  C l a r k ,  B. Beta adrenergic receptors in pigmented ciliary processes. B rit. 
J. O ptham o l. 66, 788 (1982).
3. G h a f o u r ,  I. M., A l l a n  D., a n d  F o u ld s ,  W. S. Common causes of blindness and visual 
handicap in the W est of Scotland. B rit. J . O ptha lm o l. 67, 209 (1983).
4. N a t h a n s o n ,  j . a .  Adrenergic regulation of intra-ocular pressure; Indentification of beta-2 
adrenergic stimulated adenylate cyclase in ciliary processes. P roc. N a t. A cad. Sci. USA  77, 
7420 (1980).
5. T i t in c h i ,  S. J. S., a n d  C l a r k ,  B. Characterisation of lymphocyte alpha-2 receptors, in 
preparation.
6. B a r n e t t ,  D. B ., R u g g , E. L . ,  a n d  N a h o r s k i ,  S. R. Direct evidence of two types of beta- 
adrenoceptor binding site in lung tissue. N atu re  {L o n d o n ) 273, 166 (1978).
7. S c a tc h a r d ,  G . The attractions of proteins for small molecules and ions. A nn. N . Y. A cad . Sci. 
51, 660 (1949).
8. H a n c o c k , A. A., D e L e a n , A. L ., a n d  L e f k o w i t z ,  R. J. Quantitative resolution of beta- 
adrenergic receptor subtypes by selective ligand binding; Application of a computerized model 
fitting technique. M o l. P harm aco l. 16, 1 (1979).
9. B e rm a n , M., a n d  W e iss , M. F . SAAM26— Analysis of data in terms of models (version 6.30- 
75). NIH , Bethesda, Md. 20014.
]0 . R a ls t o n ,  M. In  ' BMDP Biomedical Com puter Program s” (W. J. Dixon and M. B. Brown, 
Eds.), p. 484. Univ. of Calif. Press, Berkeley, 1977.
I ! . C a ld e r b a n k ,  V . J., AND PRIOR, W. A. J. In  “ The GHOST Graphical Output System, Part 1; 
The User Im age.” UKAEA, Culham Laboratory, Abingdon, Oxon, 0X 14 3DB United King­
dom, 1978.
12. D u g g le b y ,  R . G . A nonlinear regression program for small computers. A na l. B iochem . 110, 9 
(1981).
13. W e n k e , M. Drug receptor interactions. In  “ Fundamentals of Biochemical Pharm acology” (Z. 
M. Bacq, Ed.), p. 367. Pergamon, Oxford, 1971.
MICROCOMPUTER ANALYSIS OF RECEPTOR SUBTYPES 257
14. E n g e l ,  G . Identification of different subgroups of beta-receptors by means of binding studies 
in guinea-pig and human lung. Triang le  19, 69 (1980).
15. C l a r k ,  B., K o u s o u ro u , G .,  a n d  L o g a n , R. W. M icroprocessor assisted handling of oestro­
gen receptor assays. C lin . C him . A c ta , 131, 45 (1983).
16. J e n n r ic h ,  R. L , a n d  S am pson, P. F. Application of stepwise regression to nonlinear least 
squares estimation. Technom etrics  10, 63 (1968).
17. M a g u i r e ,  M . E., Ross, E. M .,  a n d  G i lm a n ,  A. G. In  “ Advances in Cyclic Nucleotide 
Research” (P. Greengard and G. A. Robinson, Eds.), Vol. 8, p. 19. Raven Press, New York, 
1977.
18. P e c k , C . C ., a n d  B a r r e t t ,  B . B . Nonlinear least squares regression program for microcom­
puters. J. P harm acok in . B iopha rm aco l. 7, 537 (1979).
19. M u i r ,  K . T. Nonlinear least-squares regression analysis in pharmacokinetics. Application of a 
programmable calculator in model param eter estimation. Comp. B iom ed. Res. 13, 307 (1980).
20. G r e c o , W. R., P r io r e ,  R. L ., S h a r m a w a n d , M., a n d  K o r y t n y k ,  W. ROSFIT: An enzyme 
kinetics non-linear regression curve fitting package for a microcomputer. Comp. B iom ed. Res. 
15, 38 (1982).
21. S n e d e c o r , G. W., a n d  C o c h r a n , W. G. Curvilinear Regression. In  “ Statistical M ethods,” 
6th ed. (G. W. Snedecor and W. G. Cochran, Eds.), p. 447. Iowa State Univ. Press, Iowa, 
1973.
22. B a i le y ,  N. T. J. In  “ Statistical Methods in Biology” (N. T. J. Bailey, Ed.), p. 196. The 
English Universities Press, London, 1959.
23. Im bs, j .  L . ,  M ie s c h , F., S c h w a r t z ,  S., V e l l e y ,  S., L e C le r c ,  G., M a n n , A., a n d  
W e r n u t h ,  G. a  potent new B? adrenoreceptor blocking agent. B r. J. P harm aco l. 60, 347
(1977).
Vol. 121, No. 1, 1984 BIOCHEMICAL AND BIOPHYSICAL RESEARCH COM MUNICATIONS
May 31, 1984 ' 1 -7
ALPHA2 -ADRENOCEPTORS I N  HUMAN LYMPHOCYTES:
D IR E C T  C HA R AC TER ISA TION  BY [ ^ H ] Y O H IM B IN E  B IN D IN G
S a 'a d  T i t i n c h i  a n d  B a r r y  C l a r k
D e p a r t m e n t  o f  P a t h o l o g i c a l  B i o c h e m i s t r y ,  W e s t e r n  I n f i r m a r y ,  
G l a s g o w ,  G l  1 6 N T ,  S c o t l a n d ,  UK
Received April 4, 1984
S U M M A R Y :  [ H ] y o h i m b i n e ,  a  p o t e n t  a n d  s e l e c t i v e  a l p h a g - a d r e n e r g i c  a n t a g o n i s t  
was  u s e d  t o  l a b e l  a l p h a - a d r e n o c e p t o r s  i n  i n t a c t  h u m a n  l y m p h o c y t e s .  B i n d i n g  
o f  [ H] y o h i m b i n e  w a s  r a p i d  ( t 1 «5 - 2 . 0  m i n )  a n d  r e a d i l y  r e v e r s e d  b y  lO uM  
p h e n t o l a m i n e  ( t ^ / 2  =  5 - 6  m i n i  a n d  o f  h i g h  a f f i n i t y  ( K ^  =  3 . 7  ^  0 . 8 6 n M ) j  
A t  s a t u r a t i o n ,  t h e  t o t a l  n u m b e r  o f  b i n d i n g  s i t e s  w a s  1 9 . 9  + 5 . 3  f m o l / 10 
l y m p h o c y t e s .  A d r e n e r g i c  a g o n i s t s  c o m p e t e d  f o r  [ H] y o h i m b i n e  " B i n d i n g  s i t e s  
w i t h  an  o r d e r  o f  p o t e n c y :  c l o n i d i n e  > ( - )  e p i n e p h r i n e  > ( - )  n o r e p i n e p h r i n e  >
( + )  e p i n e p h r i n e  >> ( - )  i s o p r o t e r e n o l ;  a d r e n e r g i c  a n t a g o n i s t s  w i t h  a  p o t e n c y  
o r d e r  o f  y o h i m b i n e  > p h e n t o l a m i n e  > p r a z o s i n .  T h e s e  r e s u l t s  i n d i c a t e  t h e  
p r e s e n c e  o f  a l p h a 2 - a d r e n o c e p t o r s  i n  h u m a n  l y m p h o c y t e s .
IN T R O D U C T I O N :  R a d i o l i g a n d s  h a v e  b e e n  s u c c e s s f u l l y  u s e d  t o  l a b e l  a l p h a -  
a d r e n o c e p t o r s  i n  d i f f e r e n t  t i s s u e s  ( 1 - 5 ) .  I n  t h e  l a s t  f e w  y e a r s  i t  b e c a m e  
c l e a r  t h a t  t h e r e  a r e  t w o  s u b t y p e s  o f  a l p h a  r e c e p t o r s ,  t e r m e d  a l p h a a n d  
a l p h a 2  r e c e p t o r s  ( 6 ) .  A l p h a ^  r e c e p t o r s  i n c l u d e  t y p i c a l  p o s t s y n a p t i c  a l p h a  
r e c e p t o r s  m e d i a t i n g  s m o o t h  m u s c l e  c o n t r a c t i o n ,  a l p h a g  r e c e p t o r s  i n c l u d e  n o t  
o n l y  a l l  k n o w n  p r e s y n a p t i c  a u t o r e g u l a t o r y  a l p h a  r e c e p t o r s  b u t  a l s o  som e l e s s  
t y p i c a l  p o s t s y n a p t i c  r e c e p t o r s  e x i s t i n g  o n ,  f o r  e x a m p l e ,  h u m a n  p l a t e l e t s .  
U s i n g  r a d i o l i g a n d  b i n d i n g  t e c h n i q u e s ,  t w o  d i f f e r e n t  a p p r o a c h e s  h a v e  b e e n  
a p p l i e d  t o  d e t e r m i n e  t h e  p r e s e n c e  o f  a l p h a a n d  a l p h a g  r e c e p t o r s .  T h e  f i r s t  
i n v o l v e s  t h e  u s e  o f  a  n o n - s e l e c t i v e  r a d i o l i g a n d  s u c h  a s  [ ^ H ] 
d i h y d r o e r g o c r y p t i n e  ( [ ^ H ] D H E )  t o  l a b e l  t h e  e n t i r e  a l p h a  r e c e p t o r  
p o p u l a t i o n .  T h e  a l p h a  r e c e p t o r  s u b t y p e s  a r e  d i s t i n g u i s h e d  b y  c o n s t r u c t i n g  
c o m p e t i t i o n  c u r v e s  u s i n g  a n t a g o n i s t  c o m p o u n d s  w h i c h  h a v e  s e l e c t i v e l y  g r e a t e r  
p o t e n c y  f o r  o n e  o r  t h e  o t h e r  a l p h a  r e c e p t o r  s u b t y p e  ( 7 - 1 1 ) ,  f o r  e x a m p l e ,  t h e  
a n t a g o n i s t s  p r a z o s i n  ( a l p h a s e l e c t i v e )  a n d  y o h i m b i n e  ( a l p h a g  s e l e c t i v e ) .  
T h e  s e c o n d ,  t h e  m o s t  u s e f u l  a n d  w i d e l y  a p p l i e d  c r i t e r i o n  f o r  d i s t i n g u i s h i n g  
b e t w e e n  a l p h a  r e c e p t o r  s u b t y p e s ,  i s  b y  u s i n g  r a d i o l i g a n d s  w h i c h  t h e m s e l v e s  
s e l e c t i v e l y  l a b e l  e i t h e r  a l p h a ^  o r  a l p h a 2  r e c e p t o r s  ( 1 2 - 2  1 ) .  [ ^ H ] p r a z o s i n
i s  s e l e c t i v e  f o r  a l p h a ^  r e c e p t o r s  w h e r e a s  ( ^ H ]  y o h i m b i n e  i s  s e l e c t i v e  f o r  
a l p h a 2  r e c e p t o r s .  P r e v i o u s  s t u d i e s  u s i n g  [ ^ H ]  DHE w e r e  a b l e  t o  i d e n t i f y  
a l p h a - a d r e n o c e p t o r s  i n  h u m a n  l y m p h o c y t e s  ( 2 2 ) ,  b u t  t h e  s u b t y p e  w a s  n o t  
d e f i n e d .
T h e  p u r p o s e  o f  t h i s  s t u d y  w a s  t o  c h a r a c t e r i z e  t h e  a l p h a  a d r e n o c e p t o r  
s u b t y p e s  i n  i n t a c t  h u m a n  l y m p h o c y t e s .
MATERIALS AND METHODS: [^ H] y o h i m b i n e  (84.5 C i / m m o l )  w a s  o b t a i n e d  f r o m  N ew  
E n g l a n d  N u c l e a r ,  W e s t  G e r m a n y .  T h e  f o l l o w i n g  d r u g s  w e r e  k i n d l y  d o n a t e d  b y  
t h e  s o u r c e s  i n d i c a t e d :  p r a z o s i n  h y d r o c h l o r i d e  ( P f i z e r ,  U K ) ;  ( - )  e p i n e p h r i n e
* T o  whom c o r r e s p o n d e n c e  s h o u l d  b e  a d d r e s s e d .
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BP ( S m i t h  a n d  N e p h e w ,  U K ) ;  a n d  ( + )  e p i n e p h r i n e  b i t a r t r a t e  ( K o d a k ,  U K ) .  
O t h e r  d r u g s  a n d  c h e m i c a l s  w e r e  o b t a i n e d  f r o m  c o m m e r c i a l  s o u r c e s .
L y m p h o c y t e s  w e r e  i s o l a t e d  a s  d e s c r i b e d  e l s e w h e r e  ( 2 3 ) .
A l p h a 2 “ A d r e n o c e p t o r  A s s a y  -  T h e  s a t u r a t i o n  a s s a y s  w e r e  d o n e  i n  p o l y p r o p y l e n e  
t u b e s  ( S a r s t e d ,  12 x  7 5 m m )  i n  a f i n a l  v o l u m e  o f  5 0 0  u l ,  c o m p r i s i n g  f o r  t h e  
t o t a l  b i n d i n g :  l y m p h o c y t e  s u s p e n s i o n  ( 2 5 0 - 3 5 0  u g  p r o t e i n )  a n d  [ H ] y o h i m b i n e
a t  a p p r o p r i a t e  c o n c e n t r a t i o n s  ( 1 - 2 0  nM ) i n  B u f f e r  A ( E a r l e ' s  B a l a n c e d  S a l t  
S o l u t i o n  m i n u s  s o d i u m  b i c a r b o n a t e  a n d  s u p p l e m e n t e d  w i t h  0.1% c a l f  s e r u m  a n d  
20  mM H e p e s  a t  pH 7 . 6 ) .  I n  t u b e s  u s e d  t o  d e t e r m i n e  n o n - s p e c i f i c  b i n d i n g ,  10 
uM p h e n t o l a m i n e  w a s  a l s o  a d d ^ d .  T o t a l  a n d  n o n - s p e c i f i c  b i n d i n g  w e r e  
e s t i m a t e d  i n  d u p l i c a t e  a t  e a c h  [ H ] y o h i m b i n e  c o n c e n t r a t i o n .  T h e  t u b e s  w e r e  
i n c u b a t e d  a t  2 5C  f o r  2 5  m i n u t e s .  T h e  r e a c t i o n  w a s  s t o p p e d  b y  t h e  a d d i t i o n  
o f  2 . 5  m l  B u f f e r  B ( 5 0  mM T r i s  a n d  0 .9 %  s o d i u m  c h l o r i d e ,  p H  7 . 6 )  a t  2 5 C .  
T h e  s a m p l e s  w e r e  t h e n  f i l t e r e d  t h r o u g h  W h a tm a n  GFC f i b r e - g l a s s  f i l t e r s  ( p r e ­
w e t t e d  i n  B u f f e r  B ) b y  a p p l y i n g  a v a c u u m  o f  3 - 4  p s i ,  a n d  t h e  f i l t e r s  w e r e  
r i n s e d  w i t h  2 x 1 0  m l  o f  B u f f e r  B a t  2 5 C .  F i l t e r i n g  a n d  r i n s i n g  w e r e  
c o m p l e t e  w i t h i n  12  s .  T h e  f i l t e r s  w e r e  a i r  d r i e d ,  s h a k e n  w i t h  10  m l  
s c i n t i l l a t o r  2 9 9  ( P a c k a r d )  a n d  t h e  r a d i o a c t i v i t y  d e t e r m i n e d  ( 5 0 %  
e f f i c i e n c y ) .
D a t a  A n a l y s i s  -  A l l  e x p e r i m e n t s  w e r e  p e r f o r m e d  i n  d u p l i c a t e  a n d  r e p l i c a t e d  
a t  l e a s t  t w i c e .  T h e  n u m b e r  (B ^ ^ )  a n d  s e n s i t i v i t y  (K  . )  o f  t h e  l y m p h o c y t e  
a l p h a 2 ~ a d r e n o c e p t o r s  w e r e  d e t e r m i n e d  f r o m  S c a t c h a r d  a n a l y s i s  ( 2 4 ) .  T h e  
d i s s o c i a t i o n  c o n s t a n t  ( K . )  o f  v a r i o u s  c o m p e t i n g  d r u g s  f o r  b i n d i n g  s i t e s  w as  
c a l c u l a t e d  f r o m  t h e  e q u A i o n  o f  C h e n g  a n d  P r u s o f f  ( 2 5 ) .
A l l  d a t a  s h o w n  a r e  t h e  m ea n  _+ s t a n d a r d  d e v i a t i o n  w h e r e  i n d i c a t e d .
RESULTS:
K i n e t i c  A n a l y s i s  o f  B i n d i n g  -  B i n d i n g  o f  [^ H ]  y o h i m b i n e  t o  h u m a n  l y m p h o c y t e s  
a t  2 5 0  w a s  r a p i d ,  w i t h  h a l f  -  m a x i m a l  s p e c i f i c  b i n d i n g  ( t ^ y 2  ^ 1 . 5 - 2 . 0  m i n
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F i g .  1. T i m e  c o u r s e  o f  ( ^ H ] y o h i m b i n e  b i n d i n g  t o  I n t a c t  h u m a n  l y m p h o c y t e s .  
L y m p h o c y t e s  i n  b u f f e r  A w e r e  i n c u b a t e d  w i t h  [ H ] y o h i m b i n e  ( 5 n M )  i n  t h e  
a b s e n c e  a n d  p r e s e n c e  o f  lO u M  p h e n t o l a m i n e .  A t  t h e  i n d i c a t e d  t i m e s ,  t h e  
s a m p l e s  w e r e  d i l u t e d  w i t h  b u f f e r  B a n d  f i l t e r e d .  S p e c i f i c  b i n d i n g  w a s  
d e t e r m i n e d  i n  d u p l i c a t e  a t  e a c h  t i m e  i n t e r v a l .  ( I n s e t )  t h e  r e g r e s s i o n  l i n e  
( r = 0 . 9 9 )  w a s  d e t e r m i n e d  b y  t h e  p l o t  o f  I n  [B  / ( B  - B .  ) ]  v s .  t i m e ,  w h e r e
B = b i n d i n g  a t  e q u i l i b r i u m  a n d  B ^ =  b i n d i n g  a ^ t i m ^ t .  i s  e q u a l  t o  t h e
siS p e  o f  t h e  l i n e .












F l q . 2 .  T im e  c o u r s e  f o r  d i s s o c i a t i o n  o f  [ ^ H ] y o h i m b i n e  b i n d i n g  t o  i n t a c t  human  
l y m p h o c y t e s .  L y m p h o c y te s  i n  b u f f e r  A w e r e  i n c u b a t e d  w i t h  [ H ] y o h i m b i n e  (5nM )  
f o r  25 m in  t o  a l l o w  e q u i l i b r i u m .  A t  z e r o  t i m e ,  lOuM p h e n t o l a m i n e  was a d d e d  
t o  t h e  s a m p l e s  a n d  s p e c i f i c  b i n d i n g  w a s  d e t e r m i n e d  a t  v a r i o u s  t i m e  
i n t e r v a l s .  100% b i n d i n g  r e f e r s  t o  t h e  s p e c i f i c  b i n d i n g  j u s t  p r i o r  t o  t h e  
a d d i t i o n  o f  p h e n t o l a m i n e  a t  z e r o  t i m e .  ( I n s e t )  f i r s t - o r d e r  r a t e  p l o t  o f  
d i s s o c i a t i o n  o f  [ Hi y o h i m b i n e  b i n d i n g .  Kg i s  e q u a l  t o  t h e  s l o p e  o f  t h e  l i n e .
3 0  m i n  a t  2 5 C .  An i n c u b a t i o n  t i m e  o f  2 5  m i n  w a s  c h o s e n  t o  r e p r e s e n t  
e q u i l i b r i u m  b i n d i n g  i n  s u b s e q u e n t  e x p e r i m e n t s .
T h e  i n i t i a l  r a t e  c o n s t a n t  (K qj^) f o r  t h e  a s s o c i a t i o n  r e a c t i o n  o b t a i n e d  f r o m  
t h e  s l o p e  ( F i g .  1 ,  i n s e t )  w a s  0 . 3 2  m i n "   ^ f o r  5 n M  [ ^ H ]  y o h i m b i n e .  T h e  
d i s s o c i a t i o n  o f  b o u n d  [ ] y o h i m b i n e  a t  2 5 C  w a s  d e t e r m i n e d  b y  i n c u b a t i n g  
l y m p h o c y t e s  t o  e q u i l i b r i u m  a n d  t h e n  a d d i n g  lO uM  p h e n t o l a m i n e  a t  t i m e  z e r o  
a n d  m e a s u r i n g  r e s i d u a l  s p e c i f i c  b i n d i n g  a t  s u b s e q u e n t  t i m e  i n t e r v a l s  
( F i g . 2 ) .  D i s s o c i a t i o n  w a s  r a p i d  w i t h  a  t - | / 2  5 . 0 - 6 . 0  m i n  ( F i g . 2 )  a n d  t h e
f i r s t  -  o r d e r  d i s s o c i a t i o n  r a t e  c o n s t a n t  ( K g )  w a s  0 . 1 3 8  m i n   ^ ( F i g . 2 ,
i n s e t ) .
T h e  s e c o n d  -  o r d e r  a s s o c i a t i o n  r a t e  c o n s t a n t  (K . j )  w a s  t h e n  c a l c u l a t e d  f r o m  
t h e  e q u a t i o n  ( 2 6 ) :  K., = (K  -  K g ) / [ y o h i m b i n e ] , w h e r e  [ y o h i m b i n e ]  i s  e q u a l
t o  t h e  c o n c e n t r a t i o n  o f  [ H] y o h i m b i n e  i n  t h e  a s s a y  ( 5 n M ) ,  K.  ^ w a s  0 . 3 6 4  x
1 0 ' M~^ m i n  ^. T h e  e q u i l i b r i u m  d i s s o c i a t i o n  c o n s t a n t  ( K ^ ) ,  d e t e r m i n e d  f r o m
t h e  r a t i o  o f  K g / K . | ,  w a s  3 .7 9 n M .
S a t u r a b i l i t y  o f  B i n d i n g  -  T h e  b i n d i n g  c h a r a c t e r i s t i c s  o f  [ H] y o h i m b i n e  t o  
i n t a c t  h u m a n  l y m p h o c y t e s  i s  d e s c r i b e d  i n  F i g . 3 .  S p e c i f i c  b i n d i n g  o f  
[ ^ H ] y o i m b i n e  ( t h e  b i n d i n g  t h a t  c o u l d  b e  d i s p l a c e d  b y  lO u M  p h e n t o l a m i n e )  w a s  
c l e a r l y  s a t u r a b l e  a n d  o f  h i g h  a f f i n i t y .  A p p a r e n t  s a t u r a t i o n  o f  b i n d i n g  
s i t e s  s e e m e d  t o  o c c u r  a t  [^ H ]  y o h i m b i n e  c o n c e n t r a t i o n  o f  1 4 - 1 6 n M ,  w i t h  h a l f  
m a x i m a l  b i n d i n g  o c c u r i n g  a t  a b o u t  2 - 3 n M .  S c a t c h a r d  a n a l y s i s  ( F i g . 3 ,  i n s e t )  
o f  t h e  s a t u r a t i o n  d a t a  y i e l d e d  a  s t r a i g h t  l i n e ,  i n d i c a t i n g  t h a t
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F i g  3 .  S p e c i f i c  b i n d i n g  o f  ( v o h i m b i n e  t o  i n t a c t  h u m a n  l y m p h o c y t e s  a s  a 
f u n c t i o n  o f  c o n c e n t r a t i o n  o f  ( H ] y o h i m b i n e .  L y m p h o c y t e s  i n  b u f f e r  A w e r e  
i n c u b a t e d  w i t h  v a r i o u s  c o n c e n t r a t i o n s  o f  [ H ] y o h i m b i n e  i n  t h e  p r e s e n c e  an d  
a b s e n c e  o f  lO u M  p h e n t o l a m i n e .  S p e c i f i c  b i n d i n g  w a s  d e t e r m i n e d  a t  e a c h  
c o n c e n t r a t i o n  o f  [ H] y o h i m b i n e .  ( I n s e t )  S c a t c h a r d  a n a l y s i s  o f  t h e  b i n d i n g  
d a t a  y i e l d i n g  a o f  4 . 2 4 n N  a n d  t h e  t o t a l  n u m b e r  o f  r e c e p t o r s  w a s  2 4 . 8  
f m o l / 1 0 ly m p h o c y t e s .
[ H ] y o h i m b i n e  b o u n d  t o  a  s i n g l e  c l a s s  o f  r e c e p t o r s .  T h e  d i s s o c i a t i o n  
c o n s t a n t  ( K ^ )  o f  b i n d i n g  w a s  3 . 7  ^  0 . 8 6 n M  ( 8  e x p e r i m e n t s )  a n d  t h e  t o t a l  
n u m b e r  o f  b i n d i n g  s i t e s  w a s  1 9 . 9  ^  5 .3  f m o l / 1 0 ^  l y m p h o c y t e s .
I n h i b i t i o n  o f  ( ^ H J Y o h i m b i n e  B i n d i n g  b y  C o m p e t i n g  L i g a n d s  -  B i n d i n g  o f  
y o h i m b i n e  w a s  s t e r e o s p e c i f i c a l l y  i n h i b i t e d  b y  e p i n e p h r i n e  ( T a b l e  1 ) ;  t h e  
( - )  i s o m e r  w a s  m o r e  p o t e n t  t h a n  t h e  ( + )  s t e r e o i s o m e r .  A d r e n e r g i c  a g o n i s t s  
c o m p e t e d  f o r  [ ^ H ] y o h i m b i n e  b i n d i n g  s i t e s  w i t h  a  p o t e n c y  o r d e r  o f  c l o n i d i n e  >
T a b l e  1
Th e  d i s s o c i a t i o n  c o n s t a n t s  (K^)  o f  d r u g s  d e t e r m i n e d  by  c o m p e t i t i o n  f o r
y o h i m b i n e  b i n d i n g
D ru g D i s s o c i a t i o n  C o n s t a n t  ( K ^ ,u M )
C l o n i d i n e 0 . 2 8 + 0 . 0 2 7
( - ) E p i n e p h r i n e 1 .5 1 + 0 . 1 5
{ + ) E p i n e p h r i n e 1 6 . 2 0 + 1 .3
{ - ) N o r e p i n e p h r i n e 6 . 7 4 + 0 . 6 5
( - ) I s o p r o t e r e n o l 1 2 6 . 0 0 + 1 2 . 0
Y o h im b in e 0 . 0 1 + 0 . 0 0 1 1
P h e n t o la m i n e 0 . 0 3 + 0 . 0 0 2 8
P r a z o s i n 2 . 1 0 + 0 . 2
T h e  d i s s o c i a t i o n  c o n s t a n t  ( K ^ ) w a s  c a l c u l a t e d  a c c o r d i n g  t o  t h e  
e q u a t i o n  o f  C heng and  P r u s o f f  ( f t ) .  R e s u l t s  a r e  e x p r e s s e d  a s  t h e  Mean ^  SD 
( 4  e x p t s ) .





-Log^O [A g o n is t ]  (M)
F i q . 4 .  C o m p e t i t i o n  f o r  [ ^ H ] y o h i m b i n e  b i n d i n g  s i t e s  by  a d r e n e r g i c  a g o n i s t s  i n  
i n t a c t  h u m a n  l y m p h o c y t e s .  V a r i o u s  c o n c e n t r a t i o n s  o f  c l o n i d i n e  (A), ( - )
e p i n e p h r i n e  (O)» ( - ) n o r e p i n e p h r i n e  (A)  a n d  ( - ) i s o p r o t e r e n o l  w e r e
i n c u b a t e d  w i t h  l y m p h o c y t e s  a n d  [ H i  y o h i m b i n e  ( 5 n M )  f o r  2 5  m i n .  T h e n ,  t h e  
s a m p l e s  w e r e  d i l u t e d  a n d  f i l t e r e d .  S p e c i f i c  b i n d i n g  w a s  d e t e r m i n e d  i n  
d u p l i c a t e  a t  e a c h  d r u g  c o n c e n t r a t i o n .
( - )  e p i n e p h r i n e  > ( - )  n o r e p i n e p h r i n e  > ( + )  e p i n e p h r i n e  >> ( - )  i s o p r o t e r e n o l ,  
w i t h  K j  v a l u e s  o f  0 . 2 8 ,  1 . 5 0 ,  6 . 7 4 ,  a n d  1 6 . 0 0  uM f o r  c l o n i d i n e ,  ( - )
e p i n e p h r i n e ,  ( - )  n o r e p i n e p h r i n e  a n d  ( + )  e p i n e p h r i n e  r e s p e c t i v e l y  ( F i g . 4  a n d  
T a b l e  1 ) .  T h e  b e t a - a d r e n e r g i c  a g o n i s t ,  ( - )  i s o p r o t e r e n o l ,  w a s  a  v e r y  w e a k  
i n h i b i t o r  o f  [^H ]  y o h i m b i n e  b i n d i n g  (K ^  =  1 2 6 . 0 0  uM , F i g . 4  a n d  T a b l e  1 ) .
T h e  a l p h a - a d r e n e r g i c  a n t a g o n i s t s  p h e n t o l a m i n e ,  y o h i m b i n e  a n d  p r a z o s i n  
c o m p e t e d  f o r  [ ^ H ] y o h i m b i n e  b i n d i n g  s i t e s  w i t h  a p o t e n c y  o r d e r  o f  y o h i m b i n e  
> p h e n t o l a m i n e  > p r a z o s i n  ( F i g . 5 a n d  T a b l e  1 ) .  Y o h i m b i n e ,  a n  a l p h a g  
a d r e n e r g i c  a n t a g o n i s t  c o m p e t e d  f o r  t h e  b i n d i n g  s i t e s  w i t h  a  o f  0 .0 1  uM.  
P h e n t o l a m i n e ,  a n o n - s e l e c t i v e  a l p h a - a d r e n e r g i c  a n t a g o n i s t  c o m p e t e d  w i t h  a  
o f  0 . 0 3  u M .  P r a z o s i n ,  a  s p e c i f i c  a l p h a . j - a d r e n e r g i c  a n t a g o n i s t ,  c o m p e t e d  
w i t h  a K j  o f  2 . 0 0  u M .
D I S C U S S I O N :  E a r l i e r  s t u d i e s  b y  u s  ( 2 3 )  h a v e  i n d i c a t e d  t h e  p r e s e n c e  o f  a  
c i r c a d i a n  v a r i a t i o n  i n  b e t a ^ - a d r e n o c e p t o r  n u m b e r  a n d  a f f i n i t y  i n  l y m p h o c y t e s  
o f  b o t h  n o r m a l s  a n d  a s t h m a t i c  p a t i e n t s .  T o  c o n t i n u e  t h e s e  s t u d i e s  i t  w a s  
e s s e n t i a l  t o  i n v e s t i g a t e  i f  t h e r e  w a s  a  s i m i l a r  v a r i a t i o n  i n  a l p h a 2 / b e t a 2  
r e c e p t o r  r a t i o s  i n  o n e  o r  o t h e r  ( o r  b o t h )  o f  t h e  g r o u p s  a s  o t h e r  w o r k e r s  
h a v e  d e s c r i b e d  d i f f e r e n c e s  b e t w e e n  t h e  a l p h a /  b e t a  r a t i o s  i n  n o r m a l s  a n d  
a s t h m a t i c  p a t i e n t s  ( 2 2 )  b u t  h a v e  n o t  d e f i n e d  t h e  r e c e p t o r  s u b t y p e s .  T h e s e  
w o r k e r s  u s e d  [ ^ H ]  DHE t o  l o o k  a t  t h e  g e n e r a l  a l p h a  r e c e p t o r  p o p u l a t i o n .  
P e r h a p s  a s  a  r e s u l t  o f  t h e  l o w  s p e c i f i c  a c t i v i t y  o f  c o m m e r c i a l l y  a v a i l a b l e  
p r e p a r a t i o n s  o f  [ ^ H ] D H E  w e  w e r e  u n a b l e  t o  r e p r o d u c e  t h e  m e t h o d  
s a t i s f a c t o r i l y ,  a n d  s o  d e v e l o p e d  t h e  m e t h o d  d e s c r i b e d  h e r e  u s i n g  t h e  m uch  
h i g h e r  a c t i v i t y  l i g a n d  [^ H ]  y o h i m b i n e .





F i q . 5 .  C o m p e t i t i o n  f o r  [ ^ H ] y o h i m b i n e  b i n d i n g  s i t e s  by a d r e n e r g i c  a n t a g o n i s t s  
i n  i n t a c t  h u m a n  l y m p h o c y t e s .  V a r i o u s  c o n c e n t r a t i o n s  o f  y o h i m b i n e  (A), 
p h e n t o l a m i n e  (O) a n d  p r a z o s i n  ( # )  w e r e  i n c u b a t e d  w i t h  l y m p h o c y t e s  a n d  
[ H ] y o h i m b i n e  (5n M ) f o r  25  m in .  T h e n ,  t h e  s a m p l e s  w e r e  d i l u t e d  and  f i l t e r e d .  
S p e c i f i c  b i n d i n g  was d e t e r m i n e d  i n  d u p l i c a t e  a t  e a c h  d r u g  c o n c e n t r a t i o n .
[ H] y o h i m b i n e  h a s  b e e n  u s e d  t o  l a b e l  a l p h a 2 - a d r e n o c e p t o r s  i n  a  v a r i e t y  o f  
t i s s u e s  ( 1 7 - 2 1 ) .  O t h e r  w o r k e r s  ( 1 5 , 1 6 )  u s i n g  [ ^ H ] y o h i m b i n e  t o  l a b e l  a l p h a g  
a d r e n o c e p t o r s  i n  h u m a n  p l a t e l e t s  h a v e  s h o w n  t h a t  t h i s  r a d i o l i g a n d  a p p e a r s  t o  
h a v e  a n u m b e r  o f  a d v a n t a g e s  a s  c o m p a r e d  t o  o t h e r  r a d i o l i g a n d s ,  i n c l u d i n g  
l o w e r  n o n - s p e c i f i c  b i n d i n g ,  h i g h e r  s p e c i f i c  a c t i v i t y  a n d  f e w e r  c e l l s  
r e q u i r e d .  A c c o r d i n g l y ,  w e  h a v e  u s e d  [ ^ H ] y o h i m b i n e  i n  o u r  p r e s e n t  s t u d y  t o  
d e m o n s t r a t e  t h e  e x i s t e n c e  o f  b i n d i n g  s i t e s  f o r  t h i s  l i g a n d  on  i n t a c t  h u m a n  
l y m p h o c y t e s .  O u r  r e s u l t s  i n d i c a t e  t h a t  [ ^ H ] y o h i m b i n e  b i n d i n g  w a s  r a p i d  a n d  
r e v e r s i b l e .  S p e c i f i c  b i n d i n g  w a s  h i g h  ( 6 0 - 8 0 % )  a n d  s a t u r a b l e  w i t h  h i g h  
a f f i n i t y .
T h e  d i s s o c i a t i o n  c o n s t a n t  o f  [^ H ]  y o h i m b i n e  o f  3 . 7  _+ 0 .8 6  nM e s t a b l i s h e d  a t  
e q u i l i b r i u m  w a s  v e r y  s i m i l a r  t o  t h a t  o f  3 .3 1  0 . 4 9  nM d e t e r m i n e d  b y  k i n e t i c
d a t a  ( i . e . ,  r a t i o  o f  a s s o c i a t i o n  a n d  d i s s o c i a t i o n  r a t e  c o n s t a n t s ) .  S i m i l a r  
d i s s o c i a t i o n  c o n s t a n t s  h a v e  b e e n  o b s e r v e d  f o r  h u m a n  p l a t e l e t s  ( 1 5 )  a n d  f o r  
h u m a n  a d i p o c y t e  m e m b r a n e s  ( 1 8 ) .
T h e  s t e r e o s p e c i f  i c i t y  o f  t h e  r e c e p t o r  w a s  s h o w n  b y  ( - )  e p i n e p h r i n e  
d i s p l a c i n g  [ ^ H ] y o h i m b i n e  m o r e  p o t e n t l y  t h a n  ( + )  e p i n e p h r i n e .  B i n d i n g  o f  
[ ^ H ] y o h i m b i n e  w a s  i n h i b i t e d  b y  a d r e n e r g i c  a g o n i s t s  w i t h  t h e  p o t e n c y  o r d e r  o f  
c l o n i d i n e  > ( - )  e p i n e p h r i n e  > ( - )  n o r e p i n e p h r i n e  >> ( - )  i s o p r o t e r e n o l  a n d  b y  
a d r e n e r g i c  a n t a g o n i s t s  w i t h  a  p o t e n c y  s e r i e s  o f  y o h i m b i n e  > p h e n t o l a m i n e  > 
p r a z o s i n .  T h e  d i s s o c i a t i o n  c o n s t a n t s  f o r  t h e s e  a d r e n e r g i c  d r u g s  ( T a b l e  1 )  
a r e  i n  a c c o r d  w i t h  d a t a  r e p o r t e d  b y  M o t u l s k y  e t  a l  ( 1 5 )  f o r  h u m a n  p l a t e l e t s .
T h e r e f o r e  t h e s e  o b s e r v a t i o n s  i n d i c a t e  t h e  p r e s e n c e  o f  p u t a t i v e  a l p h a 2 -
a d r e n o c e p t o r s  o n  h u m a n  l y m p h o c y t e s .
Vol. 121, N o . 1, 1984 BIOCHEMICAL A N D  BIOPHYSICAL RESEARCH C O M M U N IC A T IO N S
F i n a l l y  t o  o u r  k n o w l e d g e ,  t h i s  i s  t h e  f i r s t  r e p o r t  t o  c h a r a c t e r i z e  a l p h a 2 ~ 
a d r e n o c e p t o r s  i n  i n t a c t  h u m a n  l y m p h o c y t e s  u s i n g  t h e  r a d i o l i g a n d  
[ ^ H ] y o h i m b i n e .
A c k n o w l e d g m e n t  -  We a r e  g r a t e f u l  t o  D r  R . W . L o g a n  f o r  h i s  s u p p o r t  a n d  
e n c o u r a g e m e n t  d u r i n g  t h e  c o u r s e  o f  t h i s  s t u d y .
REFERENCES:
1. N e w m a n ,  K . D . ,  W i l l i a m s ,  L . T . ,  B i s h o p r i c ,  N .H .  a n d  L e f k o w i t z ,  R . J .
( 1 9 7 8 )  J .  C l i n .  I n v e s t .  6 1 ,  3 9 5 - 4 0 2 .
2 .  W i l l i a m s ,  R . S .  a n d  L e k o w i t z ,  R . J .  ( 1 9 7 8 )  C i r c .  R e s .  4 3 , 7 2 1 - 7 2 7 .
3 .  B e g i n - H e i c k ,  N . , H o u l i h a n ,  P .A .  a n d  S i g o u i n ,  J .  ( 1 9 7 9 )  C a n .  J .  
B io c h e m .  5 7 ,  1 0 4 7 - 1 0 4 9 .
4. H o i c k ,  M . I . ,  M a r k s ,  B .H .  a n d  W i l b e r d i n g ,  C .A .  ( 1 9 7 9 )  M o l .  P h a r m a c o l .
1 6 ,  7 7 - 9 0 .
5 .  C a r m a n - K r z a n ,  M. ( 1 9 8 0 )  A r c h .  i n t .  P h a r m a c o d y n .  2 4 6 ,  2 3 7 - 2 5 0 .
6 .  B e r t h e l s e n ,  S .  a n d  P e t t i n g e r ,  W .A .  ( 1 9 7 7 )  L i f e  S c i .  2 1 ,  5 9 5 - 6 0 6 .
7 .  M i a c h ,  P . J . ,  D a u s s e ,  J - P .  a n d  M e y e r ,  P .  ( 1 9 7 8 )  N a t u r e  2 7 4 ,  4 9 2 - 4 9 4 .
8. H o f f m a n ,  B . B . ,  D e L e a n ,  A . ,  W o o d ,  C . L . ,  S c h o c k e n ,  D .D .  a n d  L e f k o w i t z ,
R . J .  ( 1 9 7 9 )  L i f e  S c i .  2 4 ,  1 7 3 9 - 1 7 4 6 .
9 .  H o f f m a n ,  B.B. a n d  L e f k o w i t z ,  R .J .  ( 1 9 8 0 )  B i o c h e m .  P h a r m a c o l .  2 9 ,  4 5 2  
- 4 5 4 .
1 0 .  H o f f m a n ,  B .B . ,  M u l l i k i n - K i l p a t r i c k ,  D. a n d  L e f k o w i t z ,  R .J .  ( 1 9 8 0 ) .
J .  B i o l .  C h e m .  2 5 5 ,  4 6 4 5 - 4 6 5 2 .
1 1 .  H o f f m a n ,  B . B . , M i c h e l ,  T . ,  M u l l i k i n - K i l p a t r i c k ,  D . , L e f k o w i t z ,
R . J . ,  T o l b e r t ,  M . E . M . ,  G i l m a n ,  H. a n d  F a i n ,  J . N .  ( 1 9 8 0 )  P r o c .  N a t l .  
A c a d .  S c i .  USA 7 7 ,  4 5 6 9 - 4 5 7 3 .
1 2 .  B a r n e s ,  P . ,  K a r l i n e r ,  J . ,  H a m i l t o n ,  C .A .  a n d  D o l l e r y ,  C . ( 1 9 7 9 )
L i f e  S c i .  2 5 ,  1 2 0 7 - 1 2  1 4 .
13.  G r e e n g r a s s ,  P .  a n d  B r e m n e r ,  R. ( 1 9 7 9 )  E u r .  J .  P h a r m a c o l .  5 5 ,  3 2 3 - 3 2 6 .
14. K a r l i n e r ,  J . S . ,  B a r n e s ,  P . ,  H a m i l t o n ,  C . A .  a n d  D o l l e r y ,  C . T .  ( 1 9 7 9 )  
B io c h e m .  B i o p h y s .  R es .  Commun. 9 0 ,  1 4 2 - 1 4 9 .
1 5 .  M o t u l s k y ,  H . J . ,  S h a t t i l ,  S . J .  a n d  I n s e l ,  P . A .  ( 1 9 8 0 )  B i o c h e m .  
B i o p h y s .  R es .  Commun. 9 7 ,  1 5 6 2 - 1 5 7 0 .
16 .  D a i g u j i ,  M . ,  M e l t z e r ,  H .Y .  a n d  U ' P r i c h a r d ,  D .C .  ( 1 9 8 1 )  L i f e  S c i .
2 8 ,  2 7 0 5 - 2 7 1 7 .
17. H o f f m a n ,  B . B . , D u k e s ,  D . F .  a n d  L e f k o w i t z ,  R . J .  ( 1 9 8 1 )  L i f e  S c i .  2 8 ,  
2 6 5 - 2 7 2 .
1 8 .  T h a r p ,  M . D . ,  H o f f m a n ,  B .B .  a n d  L e f k o w i t z ,  R . J .  ( 1 9 8 1 )  J .  C l i n .
E n d o c r i n o l .  M e t a b .  5 2 ,  7 0 9 - 7 1 4 .
1 9 .  M u k h e r j e e ,  A. ( 1 9 8 1 )  B i o c h i m .  B i o p h y s .  A c t a  6 7 6 ,  1 4 8 - 1 5 4 .
20 .  M o t u l s k y ,  H . J .  a n d  I n s e l ,  P . A .  ( 1 9 8 2 )  B i o c h e m .  P h a r m a c o l .  3 1 , 2 5 9 1  
- 2 5 9 7 .
2 1. E n g f e l d t ,  P . ,  A r n e r ,  P . ,  K i m u r a ,  H . , W a h r e n b e r g ,  H. a n d  O s t m a n ,  J .
( 1 9 8 3 )  S c a n d .  J .  C l i n .  L a b .  I n v e s t .  4 3 ,  2 0 7 - 2 1 3 .
2 2 .  S a n o ,  Y . , K r o k o s ,  K . a n d  T o w n l e y ,  R. ( 1 9 8 1 )  J .  A l l e r g y  C l i n .
I m m u n o l .  6 7 ,  5 9  ( A b s t r a c t ) .
2 3 .  T i t i n c h i ,  S . ,  A l  S h a m m a ,  M . , P a t e l ,  K . R . ,  K e r r ,  J . W .  a n d  C l a r k ,
B .  ( 1 9 8 4 )  C l i n .  S c i .  6 6 ,  3 2 3 - 3 2 8 .
2 4 .  S c a t c h a r d ,  G. ( 1 9 4 9 )  A n n .  N .  Y .  A c a d .  S c i .  5 1 ,  6 6 0 - 6 7 2 .
2 5 .  C h e n g ,  Y .  a n d  P r u s o f f ,  W .H .  ( 1 9 7 3 )  B i o c h e m .  P h a r m a c o l .  2 2 ,  3 0 9 9 -
3 1 0 8 .
2 6 .  B e n n e t t ,  J . P . ,  J r .  ( 1 9 7 8 )  i n  N e u r o t r a n s m i t t e r  R e c e p t o r  B i n d i n g
( Y a m a m u r a ,  H . I . ,  E n n a ,  S . J .  a n d  K u h a r ,  M . J . ,  e d s . ) ,  p p .  5 7 - 9 0 ,
R a v e n  P r e s s ,  New Y o r k .
K.vfi. Ki/t /i’» '- ( l i ts j)  34. I ÛX 157
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Identification of Beta-Adrenergic Receptors in the 
Pigm ented M am m alian  Iris-Ciliary Body Diaphragm
B eta-adrenerg ic receptors have been recently  identified in the anim al iris-ciliary  body 
d iaphragm  (Neufield and Page, 1977) and  ciliary processes (Brom berg. G regory and 
Sears, 1980). T he presence of m elanin in non-albino anim al ciliary bodies has 
prevented  us from apply ing  these ligand binding technicpies to  th e  s tu d y  of beta 
re(?eptors and  th e ir  p o ten tia l role in in tra  ocular pressure control, desp ite  a recent 
publication  to  th e  co n tra ry  (B hargava, M akm an and K atzm an , 1980). As a result we 
have developed a sim ple technique to  identify  these receptors in the  pigm ented 
iris-ciliary  body d iaphragm . Iris  ciliary bodies are isolated using an opera ting  
microscope and  beta-recep to rs in the  m elanin-free m em branes are es tim ated  using 
1251-iodohydroxybenzylpindolol (1251-HYP) in a ligand binding assay (modified from 
Insel and  S toolm an, 1978).
Eyes from freshly slaugh tered  ram s were im m ediately  enucleated  and  placed on ice. 
The corneas were rem oved w ith a 6 -8  mm rim of sclera under the  opera ting  
microscope. The iris-ciliary  body d iaphragm  was then  dissected off the  underly ing 
vitreous under d irect vision. W ithin  1 hr o f d ea th  th e  iris-ciliary  body d iaphragm  was 
freed and  placed in to  cold H a r tm a n ’s solu tion  a t  4°C. T issue from  each eye was 
hom ogenized separate ly  in 3 ml o f a buffer solution consisting of 50 mM Tris (pH 7 5) 
and 1 niM-ascorbic acid (Buffer A). T issue was hom ogenized in itially  w ith an 
U ltra tu rrax  (75 % full speed, 5 x 10 sec, 4®C) and  then  20 strokes in a ground glass hand 
hom ogenizer. One am poule o f H yalase (1500 i.u.) was added to  th e  pooled hom ogenate. 
m ixed and  allowed to  s ta n d  for 1 min. The m ix tu re  was th en  centrifuged (3000^, 
20 min. 4°C). The pellet was resuspended in 3 ml o f buffer A and fu rth e r hom ogenized 
with the  I I tra tu rra x  (25%  full speed, 2 x 10 sec, 4°C). The hom ogenate was loaded 
on to  a d iscontinuous sucrose g rad ien t o f 5 ”o : 7 5 and centrifuged (131(K)0^. 18 hr. 
4°C) in a B eckm an SW27 ro tor. This process successfully rem oved all m elanin to  the  
bo ttom  of the  tu b e  and  the  left m em brane particles a t the  interface. E lectron 
m icroscopy has confirm ed the  presence of m elanin free m em brane a t the  5 "o : 75 
interface (Fig. 1 ). The in terface was collected, d ilu ted  in buffer A and  then  re-centrifuged 
(131000 K, 3 hr, 4°C). The pellet was then  resuspended by gentle hand  hom ogenization 
in a buffer contain ing 20 m M  H epes (pH  7 6 ) ,  Earles B alanced S alt Solution  (Flow 
Laboratories) and 0 3 mM-catechol (BD H ) (Assay Buffer). All procedures were p er­
form ed a t 4®C.
To detec t the  presence of beta-adrenerg ic receptors on the m elanin free m em branes 
the ligand 1251-HYP, which has a high affinity for these recep tors (Brown, A urbach, 
H auser and Trexler. 1976) was used. In  these prelim inary  stud ies tw o fundam en tal 
properties of such receptors, nam ely sa tu ra b ility  and stereospecificity. were used to  
s tu d y  how the  ligand binds to  our m em brane p repara tions.
W hen study ing  the  sa tu ra b ility  o f receptors it is essential to  consider only the 
specifically bound 1251-HYP since th is  ligand also b inds non specifically to  the  cell 
m em branes. To do th is, to ta l binding is es tim ated  for a  range o f 1251-HYP 
concentra tions (see Fig. 2) and  then  repeated  in the presence o f 3 x 10 '  M-propranolol. 
This concen tra tion  will displace 1251-HY P only from  th e  beta-recep to rs (see
(K)14 4H3r)/82/0l01.53-l-0i5 .Ç()l.(K)/0 ©  1982 Academic Press Inc. (I.ondon) I.irnited
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Fio. 1. Electron micrograph showing melanin free membrane particles isolated from the 5 % ;7 5 %  
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F ig . 2. Saturation binding curve and Scatchard analysis (inset).
Fig;. 3). Any 1251-HY P which rem ains bound is non-specific b inding (NSB). Specific 
iiinding =  to ta l binding —NSB.
The sa tu ra tio n  assays were done in polypropylene tubes (S arsted t, p a r t  no. 526, 
12 X 75 mm) in a final volum e of 250 fi\ com prising (final concen tra tions in paren thesis) 
for the  to ta l b inding; m em brane suspension (5 -1 0 /tg protein) and  1251-HYP (New 
E ngland N uclear) a t ap p ro p ria te  concen tra tions (0-500 p M ). In  tubes used to
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determ ine NSB ( —) propranolol (3 x 10“® m ) was also added. T o ta ls  and  NSB were 
estim ated  in dup licate  a t each 1251-HYP concentra tion .
To dem o n stra te  stereospecificity  o f the receptors, m em brane suspensions are 
incubated  w ith a fixed concen tra tion  o f 1251-HYP in th e  presence of increasing 
am ounts of th e  ( -t- ) and  ( —) stereoisom ers of propranolo l (1 x 10“ ‘® M  to  1 x 10““* M ,  
see Fig. 3). I f  a functional recep to r is p resen t the  re la tive  potencies a t  d isplacing 
1251-HYP from  the  recep to r should be ( —) >  (-I-).
D isplacem ent assays were done in dup licate  in polypropylene tubes in a final volum e 
of 250 n \ com prising m em brane suspension (5-10 fig  p ro tein), 1251-HY P (150 p M )  and  
( +  ) or ( — ) propranolol ( 1 x 10“ *® m  to  1 x 10““* m ) as ap p ro p ria te  (Fig. 3). To determ ine 
the  to ta l binding, propranolol was om itted  from  th e  assay.
F o r both  experim ents th e  assay  m ix tu res were prepared  on ice and  incubation  was 
com m enced by transfe r of th e  tu b es to  a 36®C w ate r b a th , a t  1 m in in te rvals. W hen 
tran sfe r was com pleted, the  b a th  was covered and  th e  sam ples incubated  in th e  d ark  
(to minim ize photolysis o f the  1251-HYP) for 45 min.
The reaction  was stopped  by adding  2 5 ml o f a stopp ing  so lu tio n ’ o f 50 mM-Tris 
(pH 7 6), 0 9 %  sodium  chloride and  0*1 mM ( ±  ) p ropranolol a t  37®C. The sam ples were 
then  allowed to  s tan d  for 45 sec before filtering th rough  W h atm an  GFC fibreglass 
filters by apply ing  a vacuum  o f 3 -4  psi. M em branes were re ta ined  on th e  filters and  
were rinsed w ith 3 x 10 ml o f 50 mM-Tris (pH 7 6), 0-9%  sodium  chloride a t  37®C. 
F iltering  and  rinsing was com plete w ith in  12 sec.
This stopping  procedure ’ has several effects. F irs tly  the  d ilu tion  m inim izes sam ple 
loss on transfe r of the  tu b e  con ten ts  to  the  filter. Secondly, the  1251 -H Y P  concen tra tions 
fall by a fac tor o f 11 and  since th e  k inetics o f binding of th e  non specifically bound 
ligand, are much m ore rap id  th a n  those o f specifically bound ligand (M aguire, 
W iklund, A nderson and  G ilm an, 1976), there is a tendency  for the  non specifically 
bound ligand to  leave the  m em brane. T hird ly , th is  process is assisted  by the  use of 
propranolol a t  0 1 m M  which, for sim ilar reasons, encourages th e  non specifically 
bound 1251-HY P to  leave the  m em brane while no t significantly  affecting specifically 
bound ligand. Since 1251-HY P also b inds av id ly  to  GFC filters, these are pre-soaked
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(90 min) in stopping  solution ' ; the propranolol sa tu ra te s  the  non-specitie sites on the 
filters.
All these m easures and the  3 x 1 0  ml rinse, significantly reduce non-specificallv 
bound counts trapped  on the  filters (either d irectly  or on the cell m em branes) and 
im prove the reproducib ility  and  sensitiv ity  o f the  assay. XSB is usually  2 0 - 4 0 of 
the to ta l binding.
The filters were air-dried  overn igh t a t room tem p era tu re  and the associated  
rad ioac tiv ity  was determ ined  in a P ackard  A uto  G am m a S cin tilla tion  S pectrom eter. 
M em brane pro tein  concen tra tion  was estim ated  using th e  com m ercially available 
Bio-B ad kit(B io B ad p a r t no. 1401).
F igure 2 shows th a t  1251-HY P binding specifically to  th e  m em brane p repara tions 
does sa tu ra te  and as such is am enable to  sa tu ra tio n  analysis a fte r the  m ethod  of 
S catchard  (1949). The inset to  Fig. 2 shows such an  analysis of the  d a ta . The 
correla tion  coefficient o f th is  line is 95 °o w ith P  <  0 05 ind icating  a single class of 
recep tor b inding sites w ith no in terference from  non-specific binding. The K a 
of b inding in th is  rep resen ta tive  experim en t is 50 pM w ith a B^^^x of 1500 fm ol/rng 
protein .
F igure 3 dem onstra tes the stereospecificity o f the  beta-recep to r sites, ( — ) propranolol 
being m uch m ore p o te n t th a n  ( -t- ) p ropranolo l— K d, the  d isp lacem ent constan t, is 
4 36 X 10“ *® M ( —) and  3 28 x 10“® m  (+  propranolol)— by a factor o f 75. This figure 
is typ ical o f a functional stereospecific be ta  receptor. T he K d values are calcu lated  
from the  equation  K d =  IC 50/(1-f-N /K a) where 1C50 is th e  concen tra tion  of drug  
which displaces 5 0 %  of th e  to ta l specific b inding (specific =  T-N SB, see Fig. 3) and  S 
is the  concen tra tion  of 1251-HY P used in the  d isp lacem ent assays.
W e conclude th a t  the  m em brane fractions isolated by the  above procedures 
d em o n stra te  the presence o f p u ta tiv e  beta  adrenergic receptors as classified by the  
criterion  of sa tu ra b ility  o f specific binding, a  sensitive K a (50 pM) and  stereospecificity 
tow ards ( +  ) and  ( — ) propranolol. This m ethod o f identify ing b e ta  receptors in 
p igm ented eye tissue is o f g rea t value. In  co n tra s t to  o th e r w orkers (B hargava e t al. 
1980) w orking w ith d ifferent species, we find th a t  if beta-recep to rs are es tim ated  in 
crude p repara tions o f sheep eyes, significant and  variab le am oun ts  o f th e  added 
1251-HYP (30 -60% ) will be bound  to  m elanin, in co n tra s t to  th e  cell m em brane 
whicb binds app rox im ate ly  1-2 % , th u s  significantly  affecting the  results o f the  assay, 
no t only by a ltering  the  final concen tra tion  o f 1251-HYP in the  assay, b u t also by 
giving very high non specifically bound  coun ts on filtration , to  th e  d e trim en t of the  
reproducib ility  and  sensitiv ity  o f the  assay,
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Letter to the editor
Graefe’s Archive
for CInfcaf and EjuwItiwiUé
Ophthalmology
S p rin g e r-V e ria g  1985
Beta-adrenergic receptor subtypes iris-ciliary body of rabbits
C.J. Schmitt et al., Graefe’s Arch Clin Exp Ophthalmol (1984) 221:167-170 
B. C la rk / * G.E. Trope/ and S.J.S. Titinchi ^
‘ D epartm ent o f  Pathological Biochemistry, W estern Intlrm ary, G lasgow G l 1 6NT, UK 
'  D epartm ent o f  O pthalm ology, T oron to  G eneral H ospital, 101 College St. O ntario , C anada, M 5G 1L7
Dear Sir. -  We read the above article w ith  interest. As 
workers who have developed a technique fo r investigating 
the presence o f beta-adrenoceptor subtypes in pigmented 
m am malian eyes [1] and published articles on the predom i­
nance o f the beta-2 adrenoceptor subtypes in iris-c ilia ry  
body diaphragms and c ilia ry processes [2-5], we are con­
cerned about several aspects o f this study.
1 ) The use o f [^H ]-D H A  is unusual in this k ind o f study 
where the norm al aims are fo r maximum sensitivity and 
m in im um  tissue requirements as discussed elsewhere [6], 
The use o f  500- 800 pg membrane prote in per assay tube 
appears excessive; w ith  intact lymphocytes we used on ly 
200-300 pg protein per assay tube [7] and only 5-10 pg 
membrane protein fo r eye w ork [ I j.  O ur concern is that 
other workers could have d ifficu lty  in extending this w ork 
ow ing to the large number o f animals (o r amount o f tissue) 
required. It is currently preferable to use [ ‘ *^1]-HYP or 
[*^^I]-C Y P  as the ligand. We estimate that the am ount o f 
protein used here gave 7,000-8,000 cpm specifically bound 
fo r the highest standard (100 nM ) used; these counts could 
have been achieved w ith  only 10-20 pg protein i f  using 
[ '-M ]-H Y P  or [ ‘ ^n i-C Y P .
2) A  more serious concern relates to  the Scatchard anal­
ysis o f  [^ H ]-D H A  binding. N o saturation curves are pre­
sented and no statistics as to assay repeatability are quoted. 
I t  is usual to  publish and AT^  +  SD {n experiments)’ .
We are co nee meed too that ‘ percentage specific b ind­
in g ’ is on ly  quoted at 1 n M  [^H ]-D H A . W hat is i t  at 
100 nM ? O ur experience w ith  tissues from  rat lung and 
rat and guinea pig hearts is that at concentrations o f  [^H ]- 
D H A  above 20 nM , this ligand appears either to solubilise 
in the cell membrane o r to pa rtition  in to  membrane micelles 
(i.e. cannot be displaced by the degree o f washing used 
here). This mechanism appears to be blocked by the p ro ­
prano lo l o r a lprenolo l used in  the non-specific b inding 
tubes and so the trapped ligand does not appear as non­
specific binding. Obviously this w ill seriously d is to rt the 
Scatchard analysis and, in the absence o f  any graphical 
analysis, we are concerned that the observed b ind ing may 
not tru ly  reflect adrenoceptor sites. In  view o f this, it  would 
have been valuable to see evidence tha t the stereospecificity 
o f  the receptor had been preserved.
3) In  the section on “ Determ ination in a tria  and tra ­
chea” , the equation incorporating EC50 and Bmax is nei­
ther described nor referred to. Further, fitt in g  two parame­
ters by non-linear least squares em pirically requires a m in i­
mum o f  8 data points fo r any valid statistical inferences
• Corresponding author
to be drawn. In our own w ork, we would be concerned 
about conclusions drawn on only 5 points, preferring to 
use 7-9.
4) The method o f characterising receptor subtypes by 
p lo tting  PA2 vs pKi seems rather archaic, considering that 
modern methods are available fo r quan tify ing  receptor sub- 
types using mathematical models. This approach has been 
extensively discussed and validated [8] and also adapted 
by us fo r use on a personal m icrocom puter [9]. The method 
described here could not easily be used rou tine ly  on samples 
prepared from  d ifferent sections o f the eye and, in  add ition  
to requiring large amounts o f  tissue, does not give a real 
ind ication o f  the actual proportions o f receptor subtypes 
present. We have shown [2] that greater than 75% o f the 
beta-adrenoceptor subtypes in pigmented c ilia ry  processes 
are o f type beta-2.
W ould the authors care to comment?
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APPENDIX B
Healthy, non-atopic subjects (five men) with no history of asthma or 
respiratory disease (medical and laboratory personnel) participated 
in Study 1 as controls. Their ages were 29,31,35,31 and 35 years.
All subjects were drug free and non-smokers. The subjects gave informed 
consent.
Brief clinical details of asthmatic patients involved in Study 1 
FEVI and FVC are expressed as percentage of predicted given in brackets.
Subject 1 S.M. (F), age 26 years. This patient developed asthma when 
she was 8 years old. Patient was on steroid but it was stopped 3 months 
before the study.
F E V i ,  2 . 5 3  ( 8 3 % ) .  F V C ,  3 . 2 5  ( 9 3 % ) .
Skin prick test: strong reaction to house dust mite, cat fur, feathers,
grass pollen.
RAST IgE test: very high antibody titre to house dust mite.
Therapy: inhaled salbutamol (200ug t.i.d.), sodium cromoglycate (20mg
q.i.d.) and occasional aminophylline suppositories.
Subject 2 K.L. (F), age 19 years. This patient developed asthma in 
childhood.
FEV^, 1.74 (55%). FVC, 2.59 (67%)
Skin prick test : strong reaction to house dust mite, feathers, grass
pollen.
RAST IgE test: high antibody titre to house dust mite.
Therapy: inhaled salbutamol (200ug t.i.d.) and beclomethasone
dipropionate (lOOug q.i.d.).
Subject 3 M.S. (F), age 58 years. This patient developed asthma when 
she was 12 years old.
IB
F E V i ,  0 . 7 7  ( 3 8 % ) .  F V C ,  1 . 7 1  ( 5 7 % ) .
Skin prick test: strong reaction to dust, house dust mite, feathers.
RAST IgE test: moderate antibody titre to house dust mite, cat
epithelium, dog dander.
Therapy: inhaled salbutamol (200ug q.i.d.), inhaled betamethasone
valerate (lOOug q.i.d.).
Subject 4 J.M. (M), age 34 years. This patient developed asthma when
he was 11 years old.
F E V i ,  1 . 5 1  ( 3 7 % ) .  F V C ,  3 . 3 8  ( 6 8 % ) .
Skin prick test: strong reaction to dust, house dust mite, cat fur,
dog hair, feathers, grass pollen.
RAST IgE test: high antibody titre to house dust mite.
Therapy: inhaled salbutamol (200ug t.i.d.) and beclomethasone
dipropionate (lOOug q.i.d.).
Subject 5 J.S. (M), age 23 years. This patient developed asthma in
childhood.
F E V i ,  1 . 5 7  ( 4 9 % ) .  F V C ,  2 . 2 3  ( 5 4 % ) .
Skin prick test: strong reaction to dust, house dust mite, feathers,
grass pollen.
RAST IgE test: moderate antibody titre to house dust mite.




Healthy, non-atopic subjects (four men, one woman) with no history of 
asthma or respiratory disease (medical and laboratory personnel) 
participated in Study II as controls. Their ages were 30,32,35,30 and 
32 years.
All subjects were drug free and non-smokers. The subjects gave informed 
consent.
Brief clinical details of asthmatic patients involved in Study II. 
VEVi and FVC are expressed as percentage of predicted given in brackets.
Subject 1 K.S. (F), age 18 years. This patient developed asthma when 
she was 11 years old.
F E V i ,  2 . 5 8  ( 9 4 % ) .  F V C ,  3 . 3 1  ( 9 3 % ) .
Skin prick test: strong reaction to dust, house dust mite, dog hair,
horses, grass pollen.
RAST IgE test: high antibody titre to house dust mite.
Therapy: inhaled salbutamol (200ug t.i.d.) and inhaled ipratropium
bromide (80ug q.i.d.).
Subject 2 M.M. (F), age 44 years. This patient developed asthma when 
she was 6 years old.
F E V i ,  2 - 3 1  ( 8 4 % ) .  F V C ,  3 . 6 5  ( 9 2 % ) .
Skin prick test: strong reaction to dust, house dust mite, feathers.
RAST IgE test: high antibody titre to house dust mite.
Therapy: inhaled salbutamol (200ug q.i.d.) and sodium cromoglycate
(20mg q.i.d.).
Subject 3 J.M. (M), age 35 years. This patient developed asthma in 
childhood.
F E V i ,  1 . 5  ( 3 9 % ) .  F V C ,  3 . 4  ( 7 3 % ) .
3B
Skin prick test: strong reaction to dust, house dust mite, feathers,
grass pollen.
RAST IgE test: high antibody titre to house dust mite.
Therapy: inhaled salbutamol (200ug q.i.d.) and beclomethasone
dipropionate (lOOug q.i.d.).
Subject 4 R.M. (F), age 35 years. This patient developed asthma when 
she was 5 years old.
F E V i ,  2 . 1  ( 7 6 % ) .  F V C ,  3 . 1 5  ( 9 5 % ) .
Skin prick test: strong reaction to dust, house dust mite, dog hair,
cat fur, feathers, grass pollen.
RAST IgE test: very high antibody titre to house dust mite.
Therapy: inhaled salbutamol (200ug q.i.d.).
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ADDENDUM
Since the completion of writing this thesis, there has been progress, in 
asthma and adrenoceptor research which is now reviewed.
BRONCHIAL ASTHMA 
Autonomic regulation of the airways
Airways obstruction in asthma is due not only to an increase in tone and 
bulk of airway smooth muscle, but may also be due to bronchial mucosal 
edema (resulting from increased microvascular leakage) and from plugging 
of airways by mucus secretions. These events may be brought about by 
the release of inflammatory mediators such as histamine, leukotrienes 
and prostaglandins derived from mast ceils and other inflammatory cells 
in the asthmatic airway (Nadel and Barnes, 1984).
The airways are innervated by a sympathetic, a parasympathetic and 
a third (perhaps vasoactive intestinal peptide (VIP) releasing) nervous 
system (Nadel and Barnes, 1984). These modulate smooth muscle tone and 
submucosal gland secretion and possibly other cell systems in the airways. 
It is therefore possible that autonomic nervous mechanisms may be 
responsible for diurnal changes in bronchomotor tone (Barnes, 1984a).
Human airways are densely innervated by cholinergic nerves, which 
upon activation produce bronchoconstriction. By contrast, the sympathetic 
nerve supply to human airways is very sparse, with no direct innervation 
of airway smooth muscle (Richardson, 1979). Few, if any, adrenergic 
nerve fibres directly supply bronchial muscle (Sheppard e^ 1983) and 
there is no evidence for functional adrenergic innervation (Zaagsma e^ al,
1983). •
Circulating adrenaline
However, beta-adrenoceptor agonists potently relax human airway smooth 
muscle jni vivo and vitro (Barnes e^ 1984) and autoradiographic
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studies in human lung (Carstairs e^ 1985) revealed that beta- 
adrenoceptors were widely distributed, with dense labelling over airway 
epithelium, alveolar walls and submucosal glands, and a lower density 
over airway and vascular smooth muscle.
The beta-adrenoceptors of airway smooth muscle, airway epithelium and 
vascular smooth muscle were of the beta2 subtype. In bronchial 
submucosal glands and alveolar walls, both beta^ and beta2 receptor 
subtypes appeared to coexist.
Thus, in the absence of a functional sympathetic nervous system, 
circulating catecholamines (particularly adrenaline) may be important 
in the physiological regulation of airway tone (Barnes, 1983).
The normal fall in plasma adrenaline at night is closely related 
to the timing of increased bronchoconstriction and is inversely related 
to a rise in plasma histamine concentration (Barnes e_t 1980). Moreover, 
an infusion of adrenaline in low concentration at the time of maximal 
bronchoconstriction reduces the plasma histamine, suggesting that 
circulating adrenaline might act indirectly on the airways by having a 
stabilizing effect on airway mast cells. At night, the normal fall in 
circulating adrenaline might then result in mediator release from 
abnormal asthmatic mast cells.
Further evidence in support of this is that in some asthmatics 
plasma histamine concentrations rose during an infusion of propranolol 
(Ind e^ £l, 1982). In vitro adrenaline has been shown to potently inhibit 
the release of histamine by antigen in passively sensitised human lung 
fragments (Butchers e^ 1980). In asthmatics who develop exercise- 
induced -bronchoconstriction, plasma adrenaline fails to rise on exercise 
(but there was a blunted rise in plasma noradrenaline which is sufficient 
to cause bronchoconstriction) compared with a marked rise in matched normal 
subjects (Warren et al, 1982). The responses to histamine infusion (Ind 
ejt 1983) and to more severe exercise (Larsson ^  1982) were normal.
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Recently Ind ^  £l (1985) found that in acute severe asthma plasma 
noradrenaline concentrations were increased while plasma adrenaline 
concentrations failed to increase. These findings suggest that there 
may be a defect in the release of catecholamine present in asthma, 
although the mechanism remains uncertain, and this might contribute to 
bronchial hyperreactivity.
Thus, endogenous catecholamines may play a protective role in asthma, 
although they are unlikely to play a major role in pathogenesis, since 
normal subjects do not develop bronchial hyperreactivity after beta- 
adrenergic blockade or adrenalectomy (Barnes, 1984b).
Cholinergic mechanisms
Human airway smooth muscle is densely innervated by the vagus nerve, and
stimulation of the vagus causes bronchoconstriction that is mediated by
cholinergic receptors and can be blocked by atropine (Nadel and Barnes,
1984). Autoradiography confirmed a high density of muscarinic receptors
in smooth muscle of large airways (Barnes e^ 1983; Basbaum et al,
1983), but the density of these receptors decreases as the airways become
smaller. It is possible that vagal tone might increase at night, resulting
in bronchoconstriction. Inflammatory mediators such as histamine,
secreted at night might stimulate airway irritant receptors leading to
reflex bronchoconstriction (Barnes, 1985). In addition, gastroesophageal
reflux may initiate vagal reflex bronchoconstriction, and the fall in
plasma adrenaline level may lead to increased cholinergic neurotransmission.
It has not yet been possible to measure vagal tone in the airways at night,
but recordings of heart rate, which may reflect general vagal tone, have
demonstrated a fall in heart rate overnight (Clarke ^  1976), the time
course of which is similar to that of peak flow (Barnes ^  1982). There
is preliminary evidence that anticholinergic drugs may significantly reduce
nocturnal wheezing in some patients, implicating the involvement of
cholinergic mechanisms (Coe and Barnes, 1985).
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Coincidence of rhythms
It seems likely that nocturnal asthma is best understood in terms of 
endogenous circadian rhythms, with an exaggeration of the normal 24-hour 
change in airway tone.
Thus, the fall in circulating adrenaline level may occur at the same 
time as an increase in vagal tone, and both may be regulated by a central 
hypothalamic "clock” (Moore-Ede e^ 1983). In addition, the delayed 
effects of the fall in plasma cortisol level (which precedes that of 
adrenaline by some four hours) may all lead to bronchoconstriction at 
night and in the early morning (Barnes, 1984a, 1985).
In normal subjects, these rhythms have only a small, clinically 
insignificant, effect on airway function. In asthmatic patients, 
however, these same changes produce pronounced bronchoconstriction, 
because of bronchial hyperreactivity. The effect of these rhythms may 
also be further amplified in asthmatics by mediator release from "leaky" 
mast cells (Barnes, 1985).
Nonadrenergic noncholinergic regulation
A third autonomic nervous system, which is nonadrenergic and noncholinergic, 
is well described in the gastrointestinal tract, and more recently was 
described in lung (Richardson, 1981). This nervous system is inhibitory 
for airway smooth muscle and, therefore, defective function of this system 
could contribute to bronchial hyperreactivity in asthma. In the absence 
of functional sympathetic innervation of airway smooth muscle, this 
nonadrenergic inhibitory system is the only nerve-mediated means of 
relaxation in human airway smooth muscle (Davis ^  1982).
Nonadrenergic noncholinergic bronchodilatation has been demonstrated 
in vivo in guinea pigs and in cats by stimulation of the vagus nerve in 
the presence of muscarinic and beta-adrenergic blockade (Irvin e^ 1980; 
Yip e^ 1981). Nonadrenergic noncholinergic nerves may also supply
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submucosal glands, since electrical stimulation in the presence of 
muscarinic and adrenergic blockade produces secretion of mucus in 
isolated ferret tracheal segments (Borson ^  al, 1982).
Studies of this system are hampered by the uncertainty about the 
neurotransmitter and the lack of specific blockers. Although there is 
some evidence in the gastrointestinal tract that one of the neurotransmitters 
may be ATP or a related purine (Burnstock, 1981). A more likely candidate 
for neurotransmitter is vasoactive intestinal peptide (VIP). In human 
lung, VIP nerves are closely associated with airway smooth muscle, 
submucosal glands, and pulmonary vessels, and are present in airway ganglia 
(Dey eh 1981). In animal and human airways, VIP relaxes airway smooth 
muscle in vitro (Davis eiL 1982; Kitamura ^  1980), and in animals
it protects against histamine-and prostaglandin-induced bronchoconstriction 
in vivo (Said, 1982).
VIP acts through specific receptors that, like beta-adrenoceptors, 
activate adenylate cyclase to increase intracellular cyclic AMP content 
(Kitamura e_t 1980). Immunocytochemical studies show that VIP stimulates 
cyclic AMP formation in tracheal epithelium and in submucosal glands 
(Lazarus e^ £l, 1983). Thus, VIP appears to be a promising candidate for 
the neurotransmitter, although the case is not proven. Until a specific 
antagonist becomes available, the role of the nonadrenergic noncholinergic 
nervous system and VIP nerves in the regulation of airway function will 
remain uncertain (Nadel and Barnes, 1984).
Axon reflexes
More recently, it was proposed that axon reflexes with release of potent 
sensory neuropeptides may be involved in the pathophysiological features 
of asthma (Barnes , 1986). In asthma, damage to airway epithelium, 
possibly caused by eosinophil products such as major basic protein and
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eosinophil cationic protein, which are very toxic to airway epithelial 
cells (Frigas ^  1 9 8 0 )  and are detectable in the sputum of
asthmatics (Gleich ^  1 9 8 5 ) ,  exposes C-fibre afferent nerve endings.
Stimulation of these endings by inflammatory mediators such as bradykinin 
may result in an axon (local) reflex with antidromic conduction down 
afferent nerve collaterals and release of sensory neuropeptides such as 
substance P (SP), SP has been found in human airways (Polak and Bloom,
1 9 8 2 ) ,  neurokinin A ,  which is also present in sensory nerves and even 
more potent than SP (Karlsson e^ 1 9 8 4 ) ,  and calcitonin gene-related 
peptide which has also been localised to nerves in airways of several 
species including man (Palmer e_t al^ , 1 9 8 5 )  and is probably co-localised 
with SP in sensory nerves (Lundberg ^  1 9 8 5 ) .
These peptides are potent inducers of airway smooth muscle contraction,
bronchial oedema, extravasation of plasma, mucus hypersecretion, and 
possibly inflammatory cell infiltration and secretion. Thus, axon 
reflexes could account for at least some of the pathophysiology of asthma 
and this concept might lead to new strategies for treatment.
ADRENOCEPTORS
Recently developed methods permit the study of the structure of the 
adrenergic and other plasma-membrane receptors. The two most useful 
approaches are affinity chromatography (Cribnau ^  1 9 8 2 )  and
photoaffinity labelling (Guillory and Jeng, 1 9 8 3 ) .
In affinity chromatography a drug or hormone analogue that combines
with a receptor is covalently linked to a solid support such as Sepharose
beads, usually by a hydrocarbon side chain. When a detergent-solubilized 
extract of the cell membrane is passed over such a column, the receptors 
are adsorbed to the column by means of their binding interaction with the 
immobilized drug. Other proteins pass through. After appropriate washing
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steps, the receptors can be biospecifically eluted in highly purified 
form with specific drugs (agonist or antagonist ligands) with which they
jl;
bind. It is not uncommon for several thousand fold purification to be è
I
achieved in a single such step (Lefkowitz and Caron, 1985).
Columns of the beta-antagonist alprenolol bound to Sepharose beads, 
for example, have been useful in purifying the beta-adrenoceptors. When 
coupled to other conventional methods of protein purification, such as 
high-preformance liquid chromatography, these techniques can yield receptor 
preparations purified essentially to homogeneity (Lefkowitz e^ 1983).
The other approach used to study aspects of membrane-receptor 
structure is photoaffinity labelling. This is accomplished by synthesising 
a drug or hormone analogue that contains a photoactivatable group in its 
structure. The photoactivatable compound must retain high affinity for 
binding specifically to the receptor. An example would be an azide moiety 
(-N3 ), which upon ultraviolet irradiation breaks down to the very reactive 
free radical nitrene (Lefkowitz and Caron, 1985). Such methods have been 
successfully applied to both subtypes of beta-adrenoceptors (betaj and beta2 ) 
(Lefkowitz et 1983) and alpha^-adrenoceptors (Leeb-Lundberg e^ 1984).
In each case a ^^^1 -ta g ge d high-affinity receptor antagonist was synthesised 
that contained an arylazide group. After the drug is allowed to bind to the 
receptors in membrane-bound or purified form, non-specific binding 
interactions can be disrupted by washing, the preparation is subjected to 
ultraviolet irradiation. The resulting formation of the chemically reactive 
species (nitrene) leads to covalent incorporation of the drug into the 
receptor macromolecule.
As in other types of approaches to ligand binding, validation of the
method is based on the specificity of the receptor. Thus, it is necessary
to document that a series of drugs block covalent incorporation of the
photoaffinity label into the receptor with potencies comparable to those
with which they occupy the receptors. In the case of the adrenoceptors,
it would be expected (for example) that (-) isomers of agonists and
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antagonists would be more effective than (+) isomers in blocking such 
covalent incorporation into the receptors.
After incorporation, the covalently labelled receptor can be 
visualised by sodium dodecyl sulfate-polyacrylaraide-gel electrophoresis 
(SDS-PAGE) followed by autoradiography. It appears that beta-i and beta2  
adrenoceptor subtypes consist of peptides of similar molecular mass 
(Stiles e^ 1983). Alpha2 ~sdrenoceptors also appear to have a mol 
mass similar to that of the beta-adrenoceptors, i.e. 60-64 000 daltons 
(Regan ^  £ l , 1984). In contrast, the alpha^-adrenoceptors have mol masses 
of 80 000 (Leeb-Lundberg e_t al, 1984).
It is of interest that a variety of adenylate cyclase coupled receptors 
have now been visualised by photoaffinity or photoaffinity crosslinking 
experiments (Herberg j&t zLl, 1984; Coltrera e^ al^ , 1981; Landmann et al,
1983). All appear to have mol mass of 60 000-70 000 daltons. This 
suggests that their structures may be similar indeed (Lefkowitz and Caron, 
1985). These receptors all appear to be intrinsic membrane glycoproteins. 
Beyond that, however, very little is known about the details of their 
molecular architecture. Another point worthy of emphasis is that the 
receptors appear to consist of only a single peptide (Lefkowitz and Caron, 
1985). This contrasts with the more complicated pattern observed for 
example with the nicotinic cholinergic receptor (Noda _e^  1983) which
has multiple subunits, or for the insulin receptor which has two distinct 
subunits (Ullrich e;t 1985).
Molecular mechanisms of adrenoceptors desensitisation
Desensitisation, the tendency of biological responses to wane over time 
despite the continuous presence of a stimulus of constant intensity, is 
observed in organisms as diverse as bacteria and mammals (Sibley and 
Lefkowitz, 1985). Recently, new insights into the molecular mechanisms 
underlying these phenomena have emerged from the study of the receptors
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coupled to the second messenger-generating system adenylate cyclase.
These mechanisms involve sequestration or down-regulation of the receptors 
from the cell surface as well as functionally significant covalent 
modifications of the receptors and/or guanine nucleotide regulatory 
proteins.
Among the receptor-effector systems that mediate the effects of many 
hormones and drugs in man and other animals is the adenylate cyclase 
system, which synthesises the second messenger cyclic AMP. Persistent 
stimulation of the system by catecholamines or by synthetic analogues 
leades to rapid desensitisation of the cAMP response with consequent 
blunting of physiological responses, for example, the bronchodilator 
effect of adrenaline in the treatment of asthma or the inotropic effect 
of adrenergic agents in the treatment of congestive heart failure.
Hormone-induced desensitisation has usually been divided into two 
general categories referred to as agonist-specific or homologous 
desensitisation and agonist-nonspecific or heterologous desensitisation. 
The term "homologous" is used to designate that form of desensitisation 
in which only the subsequent response to the desensitising hormone is 
attenuated while the efficacy of other hormone activators is unimpaired. 
Conversely, heterologous desensitisation indicates that incubation with 
one agonist attenuates the response to multiple, different agonists 
operating through distinct receptors (Sibley and Lefkowtiz, 1985).
Homologous desensitisation
Homologous desensitisation in cultured mammalian cells exhibits a 
complex phenomenon consisting of multiple sequential events (Perkins,
1983; Harden, 1983; Hertel and Perkins, 1984). An initial step involves 
a rapid 'uncoupling' of the receptors from the other components of the 
adenylate cyclase system, which may involve sequestration of receptors
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from the cell surface. They may reside in endocytotic vesicles or they 
may be in a compartment of membrane that remains contiguous with the 
plasma membrane (Strader ^  £l, 1984).
Stadel eit ^  (1983) showed that the beta-adrenoceptors that were 
located in the cytosolic fraction after desensitisation in frog erythrocytes 
were sedimentable at 158 OOOg, indicating that these receptors were 
located in light membrane particles or vesicles. These were devoid of 
adenylate cyclase activity and the guanine nucleotide regulatory protein. 
Comparable findings have been obtained using the rat lung as an vivo 
model of homologous desensitisation (Strasser ^  1984).
Others (Waldo e;t 1983; Toews ^  1984) have also provided
results consistent with sequestration of receptors during homologous 
desensitisation in astrocytoma cells. Sucrose-density gradient 
centrifugation of control astrocytoma cell lysates resulted in a single 
peak of beta-adrenoceptor binding activity located with enzyme markers 
for plasma membranes including adenylate cyclase activity. In contrast, 
after desensitisation to isoprenaline, the beta-adrenoceptors were present 
not only in the plasma membrane peak, but also in a peak sedimenting at 
light sucrose densities devoid of adenylate cyclase activity or other 
plasma membrane or cell surface markers. Similar findings have been 
reported using C6 glioma cells (Hertel ^  al, 1983a,b).
Strulovici ^  ^  (1983) have tested the functional activity of the
sequestered receptors that can be recovered in light membrane particles
in frog erythrocytes and were shown to be functionally active. Similar
conclusions have been reached by Clark eif ^  (1985) in characterising
the sequestered receptors found in S49 cell light membrane fractions.
Nonetheless they are desensitised. Thus, the desensitisation appears to
be due to their sequestration away from their normal effector guanine
nucleotide regulatory protein and catalytic components rather than to
any inherent functional alteration in the receptors (Lefkowitz and
Caron, 1985). Recently it has been found that preincubation of intact
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human mononuclear leucocytes with isoprenaline reduced the number of 
surface beta-adrenoceptors, measured by radioligand binding at 4C, by 
about 70% without affecting receptor affinity (De Blasi ^  1986).
This was caused not by receptor degradation but more likely by their 
internalisation to a cellular compartment not accessible to the 
radioligand. In fact, the same receptor number was found in control and 
desensitised cells when binding was measured at 37C.
A subsequent event involves a down-regulation of receptor number 
exhibited by a decrease in the ability to detect beta-adrenoceptors with 
radiolabelled antagonists (Hertel et_ £l, 1983a,b).
Down-regulation occurs more slowly than the initial sequestration process 
in most cell types, and the exact fate of these beta-adrenoceptors is not 
known with certainty. In some cases it seems clear that the receptors 
are proteolytically degraded and new receptor synthesis is required to 
regenerate them (Frederich e^ 1983). In others, the number of beta- 
adrenoceptors can return to control levels even in the absence of new 
protein synthesis (Doss ^  1981). This suggests that these down-
regulated receptors can regain their binding activity with time. Although 
beta-adrenoceptor-guanine nucleotide regulatory protein coupling seems to 
be necessary for maximal down-regulation to occur, activation of adenylate 
cyclase and the generation of cAMP is not required (Mahan e_t al^ , 1985).
Other workers (Snavely ^  1985) found that infusion of adrenaline
or noradrenaline elevated plasma levels of each catecholamine 1 0 - to 2 0 - 
fold and decreased rat renal cortical alpha^-adrenoceptor number about 
50% without changing alpha2~receptor number. Isoprenaline infusion 
raised plasma levels of this catecholamine, but had no effect on the 
number of either alpha^- or alpha2 ~adrenoceptors. Renal cortical beta- 
adrenoceptor number was decreased by infusion of all three catecholamines. 
However, the beta^- and beta^-adrenoceptors were altered selectively by
15B
the different agonists. Infusion of noradrenaline decreased both beta^ -^ 
and beta2 -receptor number, but was more effective for the beta^-receptors.
The decrease in beta-receptor number due to adrenaline infusion was largely 1; 
due to loss of the renal cortical beta^-receptors. Infusion of isoprenaline 
decreased the number of both betaj- and beta^-receptors (69% and 75% 
respectively).
These results indicate that adrenoceptor subtypes are differentially down- 
regulated by elevated levels of circulating catecholamines and that this 
differential loss of receptors depends on the nature of the receptor 
subtype, the agonist, and perhaps also whether catecholamines are infused 
rather than increased by pheochromocytoma.
It has concluded by others (Brodde e^ 1985) that glucocorticoids 
as well as ketotifen, an antianaphylactic drug, can accelerate recovery 
of density and responsiveness of lymphocyte beta2 ~adrenoceptors desensitised 
by long-term treatment with beta2 -agonists. Such an effect may have 
clinical implications for preventing tachyphylaxis of asthmatic patients 
against therapy with beta-agonists.
These processes seem to occur in all normal cells that exhibit 
homologous desensitisation, although their kinetics can vary considerably. 
Homologous desensitisation is thus associated with alterations occurring 
at the receptor level of the adenylate cyclase system (Sibley and Lefkowitz,
1985). It has also been demonstrated that acute desensitisation of alpha^- 
adrenoceptors on human platelets occur after short term and long term 
exposure to catecholamines, which is not mediated through mechanisms of 
receptor internalisation and reductions in receptor number (Jones e^ al,
1985, 1986). The present findings suggest that the coupling of the 
platelet alpha2 ~adrenoceptor to adenylate cyclase may be altered after 
exposure to agonists.
The biochemical mechanisms involved in homologous desensitisation are 
not yet known with certainty. Studies of homologous desensitisation in
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cell-free systems have indicated a requirement for phosphorylating 
conditions (Salomon e_t £l, 1981). Recently, Sibley (1985) have
shown directly that homologous desensitisation of adenylate cyclase in 
frog erythrocytes is associated with phosphorylation of the beta- 
adrenoceptor. This phosphorylation is induced in a stereospecific 
fashion by isoprenaline and is blocked by propranolol. The phosphorylation 
state of the receptor stoichiometrically increases about three fold on 
desensitisation. Interestingly, prostaglandin (PGE^) does not promote 
beta-adrenoceptor phosphorylation despite the fact that PGE^ activates 
adenylate cyclase in these cells (Sibley et_ 1985). This observation 
agrees well with the notion that homologous desensitisation is not cAMP- 
mediated. The nature of the protein kinase that phosphorylates the 
beta-adrenoceptor during homologous desensitisation is unknown.
There are at least two potential mechanisms by which receptor 
phosphorylation could contribute to the homologous desensitisation.
One possibility is that the phosphorylation induces or triggers the 
sequestration of the receptor from the cell surface. Another possibility 
is that the phosphorylation results in a functional modification in the 
receptor protein such that it is less efficacious in activating adenylate 
cyclase (Sibley and Lefkowitz, 1985).
Heterologous desensitisation
Heterologous forms of desensitisation of adenylate cyclase occur in many 
tissues and cell types. This form of desensitisation represents a broad 
pattern of refractoriness in which the response to multiple hormones and 
sometimes nonhormonal effectors is impaired. In contrast to homologous 
desensitisation (which may be unimechanistic), heterologous desensitisation 
certainly occurs by more than one mechanism. In many cell types, heterologous 
desensitisation occurs in addition to the homologous form of desensitisation, 
thus making its analysis difficult. In general, however, the heterologous
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response occurs with a slower onset than the homologous one, suggesting 
that heterologous desensitisation represents an adaptive response to 
relatively prolonged stimulation (Sibley and Lefkowitz, 1985).
Heterologous desensitisation has been extensively studied in simple 
avian erythrocyte systems that possess beta-adrenoceptors and adenylate 
cyclase (Stiles ^  al, 1984). Heterologous desensitisation in avian 
erythrocytes is associated with modifications in the adenylate cyclase 
system at both the level of the receptor and the guanine nucleotide 
regulatory proteins. It should be pointed out that structural and/or 
functional alterations of the enzyme catalytic unit cannot be excluded 
although there is no evidence for this at present.
It seems reasonable to propose that the mechanisms of heterologous 
desensitisation elucidated in erythrocytes are not unique to this cell 
type. Thus, one major means of achieving heterologous desensitisation 
would be modification(s) in the guanine nucleotide regulatory proteins.
The nature of these modifications is not yet known, although one hypothesis 
suggests that a phosphorylation event is involved. Although, in some 
systems, cAMP seems to induce the guanine nucleotide regulatory proteins 
modification (Stadel ^  £l, 1981), in others it seems not to be involved 
(Rich e_t 1984; Noda e_t 1984).
Another major pathway of heterologous desensitisation is modification of 
the receptor proteins. In this case the effect is not receptor 
sequestration or down-regulation as in homologous desensitisation but a 
functional uncoupling of the receptor from adenylate cyclase. Evidence 
from avian erythrocytes indicates that phosphorylation is the probable 
mechanism for producing the functional modification.
Moreover, because of the heterologous nature of the desensitisation 
it is reasonable to suppose that all the receptors coupled to adenylate 
cyclase would probably be modified in this way, that is, phosphorylated 
(Sibley and Lefkowitz, 1985).
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Radioligand binding techniques
Beta-adrenoceptors have been defined and characterised in membranes of 
many tissues as well as on intact cells by using radiolabelled agonists 
and antagonists.
In contrast with studies on membrane preparations, studies on living 
cells often suffer from a very high proportion of non-specific low affinity 
binding when hydrophobic radiolabelled ligands such as and ^25j_Qyp
are used (Porzig e^ 1981; Andre ^  1981; Meurs e_t 1982).
These binding sites not coupled with the biological response may mimic 
receptor binding with e.g. rapid (reversible) association time course and 
displacement by antagonists (Kerry and Scrutton, 1983).
Therefore the main problem in studies of beta-adrenoceptor properties of 
intact cells using radiolabelled ligands is to discriminate between 
stereospecific low capacity binding of these ligands to receptors and 
non-stereospecific high capacity binding to cellular membranes and 
possibly to intracellular structures. Dax and Partilla (1982) have shown 
that non-specific low affinity binding was at least in part directly related 
to the hydrophobicity of the ligand.
Others (Maloteaux £t 1983) suggested that such a displaceable 
binding could represent a possibility of the diffusion of labelled ligand 
through the cell membrane and its accumulation in the lysosomal compartment.
Recently, Rademaker et ^  (1985) found that there were two types of
saturable binding, besides the well-known non-specific binding, when
hydrophobic ligands were used for investigating the vesiculisation of
beta-adrenoceptors on cultured HeLa and Chang liver cells. The first
(compartment I) representing beta-adrenoceptors with high affinity
(^H-DHA 0.8nmol/l, ^25j_Qyp 27pmol/l) and low capacity (10-20fmol/mg
protein), the second (compartment II) had a rather high affinity (^H-DHA
400nmol/l, ^25y_Qyp 30nmol/l) and a very high capacity (20 000-25 OOOfmol/mg
protein). The affinity of adrenergic agents for compartment II correlates
very well with the calculated hydrophobicity. It is concluded that these
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types of binding sites might interfere with the determination of 
adrenoceptor binding sites when hydrophobic ligands are used. When 
using hydrophobic ligands like these special care should be taken to 
avoid such interference.
Future studies
In conclusion, the results reported in this thesis showed that lymphocyte 
adrenoceptor function in the asthmatic group was similar to that of the 
control group.
At present, one of the concerns is that it is not clear how well the 
lymphocyte adrenoceptors resemble those on the cells of target organs.
The extent to which the regulatory properties of the adrenoceptors in 
these cells will directly correlate with those in the less accessible, 
but more physiologically relevant receptor sites such as the lung remains 
to be determined.
Therefore, future studies should answer the following:
1. What are the effects of administered beta-agonists on lung adrenoceptors 
function iji vitro?
2. How does the status and activity of the lung adrenoceptors compare 
with the lymphocyte adrenoceptors from the same subjects?
3. Is there a circadian variation in adrenoceptor function on the lung 
membranes of animal models (rats)?
Recently developed techniques for purification of adrenoceptors 
(affinity chromatography and photoaffinity labelling) should permit the 
following studies:
a. Cao antibodies be raised to the purified receptor protein?
b. Could antibodies be used for future adrenoceptor studies?
Finally, it is important to continue the investigation of the molecular 
mechanisms involved in the effects of drugs on receptors, because receptors 
represent the molecular entity through which many pharmacologically active
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agents interact, and also because a variety of disease processes may 
involve changes in the density of catecholamine receptors. It is also 
worth noting that changes in catecholamine receptors occur as a consequence 
of the administration of agents widely used in the treatment of diseases 
ranging from hypertension to depression. An understanding of the molecular 
properties of catecholamine receptors may thus lead to significant 
improvement in our ability to treat various diseases.
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